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Cells communicate with each other and respond to environmental cues by sending and
receiving signals. Many external signals (ligands) are detected through G protein-coupled
receptors (GPCRs), a major class of transmembrane proteins. GPCRs transduce these
external signals into appropriate intracellular responses, enabling the cell to adapt to its
environment. Malfunctions in these signalling pathways can lead to a range of human
diseases and hence GPCRs have become attractive candidates for pharmacological design.
The activation of a single receptor has the ability to induce numerous intracellular re-
sponses. Coupling this with the great number of dierent GPCR-types expressed in human
cells means that understanding the basic principles of signal transduction and termina-
tion in humans is complicated. This study utilises the more simplistic eukaryotic yeast
Schizosaccharomyces pombe (S. pombe) to overcome this complexity, as it contains only
two GPCR types and hence the cross-talk between pathways is greatly reduced, whilst the
structure and signalling functions of GPCRs are often evolutionarily conserved between
yeast and humans.
Mathematical modelling was used to aid the understanding of GPCR signalling in S.
pombe and to inform experimental design. Specically, an ordinary dierential equation
model rst developed by Croft et al. (2013) was extended to include all known downstream
signal transduction, regulation and termination events. This model is the rst of its kind to
describe a whole GPCR signalling pathway within S. pombe. Although it accurately predicts
the cellular response to GPCR signalling it could only reproduce the biological plateau in
temporal response with the addition of a `yet unknown mechanism' GPCR degradation
term. This motivated the investigation of how GPCRs in S. pombe are internalised from
the plasma membrane in response to ligand stimulation.
The primary mechanism for signal termination is via internalisation of the GPCR. This
study identied three potential casein kinases (Cki1, Cki2 and Cki3) that promote internali-
sation of the S. pombe GPCRMam2. Microscopy analyses in combination with quantitative
transcriptional, cell growth and cell cycle position assays uncovered a novel role for these
kinases: that Cki2 regulates cell size during vegetative growth, Cki1 and Cki3 regulate the
GPCR-response pathway and that Cki3 is essential for completing cytokinesis in S. pombe
that have already undergone formation of a conjugation tube in response to ligand. Confo-
cal microscopy of uorescent labelled Mam2 indicated a role for Cki2 in the internalisation
and hence termination of the GPCR-response pathway. These ndings add to the growing
body of evidence that casein kinases are implicated in GPCR desensitisation.
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Introduction
1.1 Cellular signalling
Cells communicate with each other and respond to environmental cues by sending and
receiving signals. These signals are translated into appropriate intracellular responses to
enable the cells to adapt to their environment. Lipophilic signalling molecules such as
testosterone, progesterone and derivatives of vitamins A and D are able to cross the cell
membrane and activate cytosolic or nuclear receptors. However, the majority of signalling
molecules are lipophobic, and often require a mechanism of signal transduction to transfer
the message across the cell membrane. Transmembrane (TM) receptors transduce external
signals into complex but co-ordinated intracellular pathways, leading to changes in gene
expression, ion balance and enzyme activity.
The largest family of TM receptors are the G protein-coupled receptors (GPCRs). In
2001, the completion of the human genome project identied approximately 23,000 genes
[1], and subsequent analysis uncovered over 800 potential GPCR coding regions [2]. These
receptors are activated by a myriad of ligands, which include ions, proteins, lipids, sugars,
nucleotides and photons (reviewed in [3]). Receptors can couple to an equally wide array
of intracellular signalling molecules to induce a diverse range of signalling outcomes.
The sheer volume of signalling responses that are governed by GPCRs means that mal-
functions in the receptors or their associated signalling pathways are responsible for a
wide array of human disorders, including allergic rhinitis, pain, hypertension, addiction,
schizophrenia and cancer to name a few [4]. Unsurprisingly, GPCRs are estimated to con-
stitute 35% of pharmaceutical drug targets world wide (reviewed in [5]). Central to the
detection and treatment of such GPCR-related disorders is an understanding of the core
principles and underlying mechanisms of GPCR signal transduction and termination.
1
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1.1.1 Yeast as a model organism for understanding cell signalling
In higher eukaryotes such as humans, the diverse range of GPCRs that are expressed on
the cell-surface at any one time and their ability to couple to and activate a number of
dierent pathways in response to ligand-binding can result in multiple cellular responses.
This makes it dicult to fully dissect the role of individual components and processes of
GPCR signal transduction and termination. For this reason, lower eukaryotes such as yeast
are an attractive system for studying signalling responses in isolation, mainly due to the
reduced number of signalling components present in each cell and hence, the integration
of responses to dierent stimuli and cross-talk between separate pathways can be greatly
reduced.
In addition to the reduction in complexity, yeast has been used as a model organism
because many of the signalling components and mechanisms are conserved in higher eu-
karyotes [6]. For example, the observation that cell viability could be restored by expressing
the oncogenic mammalian H-ras sequence in the budding yeast Saccharomyces cerevisiae
(S. cerevisiae) strains lacking the equivalent homologs (RAS1 and RAS2 ) illustrated that
both sequence and biological function was evolutionarily conserved [7].
Another important example using the ssion yeast Schizosaccharomyces pombe (S. pombe)
was not only the discovery of genes that controlled cell cycle progression, but the observa-
tion that the mechanism of cell division including the concept of `checkpoints' (which are
specic points during the cell cycle at which a cell evaluates whether it should progress to
the next stage) were conserved between yeast and humans [8, 9]. These studies provided an
insight into the cell division process, which lead to a greater understanding of the human
cell cycle and as a result, the development of treatments for diseases such as cancer [10].
Yeast are regarded as genetically tractable simple eukaryotes because it is relatively
straightforward to create mutant strains, overexpress gene products in excess and generate
auxotrophic and enzymatic reporter strains with which to monitor signal transduction.
One such example is the S. pombe pheromone-responsive b-galactosidase reporter strains
[11]. These strains have been modied to include the bacterial lacZ gene in place of the
pheromone-responsive sxa2 gene enabling quantication of pheromone-induced signalling.
This study utilises the ssion yeast S. pombe reporter strains to help understand the basic
principles of GPCR signal transduction, regulation and termination.
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1.2 An introduction to GPCRs
1.2.1 GPCR structure
GPCRs have been identied in every eukaryotic organism [12] and share a common structure
comprising seven TM a-helical regions connected by alternating intracellular and extracel-
lular loops (IC/EC). These structures are combined with an extracellular N-terminal and
intracellular C-terminal domain, which dier in length and function (Figure 1.1). The EC
loops and N-terminus have functional roles in ligand recognition, whilst the intracellular
regions are implicated in signalling and scaolding roles by interacting with downstream
signalling machinery.
The intracellular C-terminal domains of GPCRs are thought to form an eighth helical
coiled-coil region oriented in parallel to the cell membrane [13, 14], which can undergo
palmitoylation (the covalent attachment of a 16-carbon fatty acid group) and consequently
associate with the plasma membrane forming an `IC4' region [15] (Figure 1.1). In response
to ligand-binding, the receptor can activate heterotrimeric guanine-nucleotide-binding pro-
teins (G proteins) (reviewed in [3]).
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Figure 1.1: GPCR structure. GPCRs are composed of seven transmembrane-spanning
a-helical domains (labelled 1-7). Each TM is connected by alternating intracellular and
extracellular loop regions (denoted IC1-IC3 and EC1-EC3). GPCRs contain an extracel-
lular N-terminus (NH2) and an intracellular C-terminal tail (COOH), which is thought to
form an eighth helical region oriented along the plasma membrane, creating a potential
intracellular loop region (IC4). The receptor is coupled to a G protein via the IC2 and IC3
loops. Activation occurs when an appropriate ligand binds the receptor.
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1.2.2 GPCR families
Although all GPCRs share a common structure they can be can be grouped into six families
(A-F or I-VI) based upon structural similarities, function and ligand-binding [12] (Table
1.1). Class D, the fungal mating-pheromone receptors will be the focus of this study.
Family Name
A Rhodopsin-like receptors
B Secretin-like receptors
C Metabotrophic glutamate receptors
D Fungal mating-pheromone receptors
E cAMP receptors
F Frizzled/smoothened receptors
Table 1.1: Types of GPCR families. The classication of six GPCR families.
1.3 Signal transduction via GPCRs
Despite the large range of ligands that bind to activate GPCRs, most receptors share a
common signalling mechanism of coupling to heterotrimeric G proteins (reviewed in [3]).
G proteins belong to a highly conserved superfamily that are structurally identied by the
presence of a phosphate-binding loop (P-loop) [16].
1.3.1 Signalling via G proteins
G proteins are binary switches that are `o' when bound to guanosine diphosphate (GDP)
and `on' when bound to guanosine triphosphate (GTP). The P-loop is responsible for the
correct positioning of the triphosphate moiety of the bound nucleotide [16]. Activation of
the G protein stabilises the eector binding site via an interaction with a conserved threo-
nine residue in switch I and a glycine residue in the switch II region, which form hydrogen
bonds with the g-phosphate of GTP in combination with a Mg2+ cofactor (reviewed in [17])
(Figure 1.2a). This functionality is conferred by an 20 kDa G domain that is conserved
across all G proteins [18].
G protein activation occurs spontaneously, but can be accelerated by interactions with
guanine nucleotide-exchange factors (GEFs). GEFs function to reduce the anity of the
G protein for guanine nucleotides by altering the phosphate binding site, favouring the
release of GDP for the more cellularly abundant GTP molecule [19]. Similarly, all G
proteins contain a weak intrinsic GTP-hydrolysis activity, which can be accelerated by
GTPase accelerating proteins (GAPs), switching the G protein from a GTP `on' state to
a GDP `o' state (Figure 1.2b). G proteins exist in two forms, as either monomeric or
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Figure 1.2: Nucleotide binding and hydrolysis on G proteins. (a) Ribbon diagram
of RAS, the archetypical GTPase, with bound GTP shown in a ball-and-stick model, the
Mg2+ ion as a black sphere and the P-loop in yellow (constructed in Swiss-PDB viewer,
PDB code 121P). The Switch I and II regions are coloured red. (b) G proteins become
activated when GDP is released and a molecule of GTP binds. This process is catalysed
by guanine nucleotide-exchange factors (GEFs). The cycle is reset through the intrinsic
GTPase activity of the G protein, however, this can be accelerated through interaction
with a GTPase-activating protein (GAP). GTP bound G proteins transduce the signalling
via an interaction with an eector protein.
heterotrimeric, and control a myriad of signalling pathways such as cell growth, vesicle and
protein transport and cytoskeleton assembly [20].
1.3.2 Monomeric G proteins
One of the earliest identied monomeric G proteins was the p21 Ras oncogenes: a 21
kDa family of proteins that were found to be activated in many human cancers ([21] and
reviewed in [22]). A vast number of Ras-like proteins are now known and the family is often
referred to as the Ras family of small G proteins [23, 24]. Within this family it is possible
to recognise ve subfamilies: Ras, Rho, Rab, Ran and ADP-ribosylation factor (Arf) [25];
the Ran family plays a role in nuclear transport, whereas the Arf and large Rab family of
proteins function in membrane tracking [26].
Ras and Rho families are involved in cell signalling [26]. Ras proteins are typically
activated through receptor tyrosine kinases (RTKs) and have been shown to play a key
role in transducing extracellular growth factor signals via mitogen activated protein kinase
(MAPK) cascades to promote cell growth [27]. In addition to activation of MAPK cascades,
Ras proteins can mediate signal transduction via other G proteins. In particular, members
of the Rho family of GTPases, which can be subdivided into six classes, with the most
well characterised being the Rho, Rac and Cdc42 groups [28]. One important discovery
involving G protein activation by other G proteins, was Ras activation of Rac with the aid
of the Rho GEF T-cell lymphoma invasion and metastasis-inducing protein 1 (Tiam1) [29].
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Tiam1/Rac signalling aects cell migration, invasion and tumour metastasis and as such
these proteins have been implicated in many humans cancers [30].
1.3.3 Heterotrimeric G proteins
G proteins can also exist as dissociable heterotrimeric complexes consisting of a Ga, Gb and
Gg subunit [31], which couple to the intracellular regions of the GPCR. A ligand binding to
the extracellular site of the receptor causes an 30% rotation in TM6 [32], which separates
it from TM3 exposing the IC2 and IC3 regions of the receptor [33]. This conformational
change promotes the release of GDP on the Ga subunit and subsequent binding of GTP,
thereby activating the G protein. In this manner, the activated GPCR acts as a GEF
for the heterotrimeric G protein by promoting the release of GDP. As a consequence of G
protein activation, a hydrophobic binding pocket necessary for the association of the Gbg
dimer is lost [18] and as a result the Ga and Gbg subunits can dissociate. Both subunits
are able to interact with a range of eector molecules (reviewed in [3], described in greater
detail below and summarised in Figure 1.3).
1.3.3.1 Signalling through the Ga subunit
The type of Ga subunit generally classies the G protein heterotrimer and is more commonly
the signal transducer [35]. Four G protein families exist: Gas, Gai, Gaq and Ga12 and are
classied by their target proteins ([36, 37] and reviewed in [38]).
Active receptors that couple via Gas stimulate adenylyl cyclase, a membrane-bound
enzyme that catalyses the conversion of adenosine triphosphate (ATP) to cyclic adeno-
sine monophosphate (cAMP). The rise in cAMP levels activates protein kinase A (PKA)
and initiates a cascade of phosphorylation reactions within the cell thereby transducing
signalling [39] (Figure 1.3). Classical physiological eects of PKA activation in skeletal
muscle and liver cells promotes glycolysis to produce glucose, whilst activation in kidney
cells promotes exocytosis of aquaporin 2, thereby regulating water secretion in the urine.
Receptors that couple via Gaq, once activated, stimulate the activity of the plasma
membrane-bound enzyme phospholipase C (PLC) [40]. PLC cleaves the membrane lipid
phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and
diacylglycerol (DAG). IP3 diuses from the plasma membrane to the endoplasmic reticulum
(ER) where it binds IP3-gated calcium (Ca
2+)-release channels. As a consequence, the
cytosolic concentration of Ca2+ increases, inuencing the activity of proteins, such as PKC
by promoting its translocation from the cytosol to the plasma membrane [35]. PKC can
then be activated by a combination of Ca2+, DAG and a negatively charged membrane
phospholipid phosphatidylserine [41]. Once activated, the second messenger PKC initiates
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Figure 1.3: Heterotrimeric G proteins activate many signalling pathways. The
binding of a ligand favours the release of GDP for GTP on the Ga subunit and as such the
GPCR acts as a GEF for the G protein. Following activation, the Ga and Gbg subunit
dissociate activating many signalling responses. Subtypes of Ga such as Gas, Gai, Ga12
and Gaq, subsequently bind to and regulate the activity of eectors such as adenylyl cy-
clase, RhoGEF and phospholipase C (PLC). These modulate downstream eectors directly
or by generating second messengers (such as cyclic AMP (cAMP), diacylglycerol (DAG)
and inositol-1,4,5-trisphosphate (IP3) that modulate further downstream eectors, such as
protein kinase A (PKA) and protein kinase C (PKC). Following release the Gbg dimer
subunit can also bind to and regulate certain downstream eectors, such as ion channels,
PLC, the Rho G protein Cdc42 and phosphoinositide 3-kinase (PI3K). Figure is adapted
from [34] and incorporates some resulting physiological responses following activation.
a cascade of phosphorylation reactions to transduce signalling inside the cell with one typical
physiological role being contraction in smooth muscle cells (Figure 1.3).
GPCRs that couple via Gai inhibit adenylyl cyclase and have additional roles in the PLC
pathway. Their associated Gbg subunits can bind and activate ion channels, for example
potassium (K+)-channels [37]. Finally, Ga12 proteins activate the family of monomeric Rho
GTPases (via activation of Rho GEFs) to regulate the actin cytoskeleton (reviewed in [38])
(Figure 1.3).
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1.3.3.2 The Gbg subunit as the signal transducer
The Gbg dimer can also activate a host of downstream eectors including Ca2+-channels,
MAPKs, phospholipases, phosphoinositide 3-kinase (PI3K), G protein-coupled receptor ki-
nases (GRKs) and the essential Rho G protein Cdc42 (reviewed by [42]). Gbg dimers also
have important roles in mediating the opening of inwardly rectifying K+-channels, primarily
in neurons of the central nervous system (CNS) [43, 44] (Figure 1.3).
1.3.4 Signal transduction via MAPKs
As stated earlier, mitogenic cascades transduce signalling inside the cell. The signal is
transferred via sequential phosphorylation, typically beginning with activation of a MAP
kinase kinase kinase (MAP3K), which activates a MAP kinase kinase (MAP2K) and nally,
a MAP kinase (MAPK) (Figure 1.4). Phosphorylation occurs within the activation loop on
serine, threonine and on occasions tyrosine residues. Mitogenic pathways are often used for
transmitting cytoplasmic signalling to the nucleus to activate transcription factors altering
gene expression. In mammalian cells there are three canonical MAPK signalling cascades:
the extracellular signal-regulated kinases (ERK), c-Jun N-terminal kinase/stress-activated
protein kinases (JNK/SAPK) and p38 kinases, the activation of these results in a variety
of cellular responses including: proliferation, apoptosis, cell cycle arrest, cytokine release
and embryonic development [45, 46] (Figure 1.4).
GPCRs can activate MAPKs via several distinct mechanisms: via their Gbg subunits,
b-arrestin/endocytotic pathways (discussed later), transactivating RTKs [47], which classi-
cally signal via Ras to activate the ERK pathway, or via second messengers following acti-
vation of there associated Ga subunits. Some receptors, such as the gonadotropin-releasing
hormone (GnRH) receptor can activate the three canonical MAPK cascades, depending
on which Ga subunit it is associated with. Specically, activation of GnRH receptor (by
GnRH) when coupled to Gaq (depending on the cell type) can activate the ERK, JNK
and p38 MAPK pathways to regulate biosynthesis and secretion of gonadotropins such as
follicle-stimulating hormone (FSH) and luteinizing hormone (LH) [48, 49].
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Figure 1.4: Three canonical mammalian MAPK cascades. Extracellular stim-
uli such as growth factors and environmental stress can induce the activation of MAPK
cascades. There are three canonical members of the MAPK family: extracellular signal-
regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase 1-3 (JNK 1-3) and p38, which
regulate a host of cellular processes. In addition, GPCRs can also activate these MAPK
cascades via activation of the heterotrimeric G protein subunits.
1.3.5 GPCR signalling in S. pombe
Contrary to humans where over 800 GPCRs have been identied [1], the S. cerevisiae
and S. pombe yeasts both contain only two GPCR-mediated signal transduction pathways:
one to sense the availability of nutrients and the second to detect and respond to the
presence of mating-pheromones [50]. S. cerevisiae propagates pheromone signalling via the
Gbg subunit, whereas in S. pombe signalling is transduced via the Ga subunit. As the
Ga subunit is more commonly the signal transducer in mammalian systems, this study
investigates GPCR signalling in S. pombe as this is more relevant to higher eukaryotes.
Haploid S. pombe cells proliferate via mitosis when carbon and nitrogen sources are
plentiful. The detection of extracellular glucose via the GPCR Git3 results in the activation
of Gpa2 (a Ga-subunit) [51]. GTP-bound Gpa2 activates Cyr1, an adenylyl cyclase, which
increases the cellular concentration of cAMP [52], resulting in activation of PKA. There
are at least two pathways downstream of PKA, one leading to sexual development and the
other to gluconeogenesis (reviewed in [50]). Both pathways are regulated by PKA but can
be activated to dierent extents: for example, nitrogen depletion enhances transcription
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of ste11, a gene that encodes a transcription factor (TF) required for mating and meiosis
[53, 54] whereas, glucose depletion promotes gluconeogenesis through induction of fbp1
(fructose-1,6-bisphosphatase) [55] (Figure 1.5).
Adenylyl Cyclase
(Cyr1)
cAMP
PKA
Ste11
NO Ste11 expression
NO mating
Git3
Glucose/nitrogen 
binding
GTP 
Gpa2
Figure 1.5: When nutrients are plentiful Ste11 is not expressed. When glucose
and nitrogen are available they bind to activate the GPCR Git3, which activates the Ga
protein Gpa2 via GDP for GTP exchange. GTP-bound Gpa2 activates adenylyl cyclase
(Cyr1) resulting in an increase in cAMP levels, which activates PKA, resulting in the
inhibition of Ste11 a gene that encodes the transcription factor Ste11, which is required
to up-regulate genes required for mating and meiosis [53, 54].
Under conditions of starvation, signal transduction along the PKA pathway is reduced.
As a result, intracellular cAMP levels fall facilitated by the action of the phosphodiesterase
Cgs2, which converts cAMP to AMP [56]. Only under conditions of starvation do S. pombe
cells prepare to mate with an opposite mating-type partner. The reduction in nutrients
increases expression of the TF Ste11, which prepares the cells for mating by up regulating
and expressing cell-specic GPCRs on the plasma membrane and promoting the release of
pheromones to attract a partner [57].
1.3.5.1 S. pombe cells arrest in G1 phase when nutrients are low
When nutrients are scarce S. pombe cells arrest in the G1 phase of the cell cycle to ensure
that in the event of meeting a mating partner, the cells contain only one complement of
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DNA. During mitotic growth the cyclins Cdc13 and Cig2 form complexes with a cyclin-
dependent kinase Cdc2, to regulate the G2/M and G1/S phase transition of the cell cycle,
respectively [58]. To exit mitosis and progress to G1 phase, Cdc13 is degraded by the
Anaphase-promoting complex/cyclosome [59]. In response to starvation the cAMP/PKA
pathway is inhibited. This enhances the formation and activation of the cyclosome [60]
and thus increases degradation of Cdc13, eectively down regulating Cdc2 and preventing
an adequate signal to progress from G1 into S phase. A G1 arrest is maintained during
the mating process through additional destruction of the cyclin Cdc13 by Rum1, a protein
upregulated by Ste11 in response to pheromone stimulation.
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Figure 1.6: The processes involved in mating in S. pombe . S. pombe cells exist as
either M or P-type cells, which proliferate via mitosis when nutrients are plentiful. Under
conditions of starvation mating-pheromones are secreted (M-cells release M-factor and P-
cells release P-factor), which bind the opposite mating type receptor to elicit a number of
responses, including elongation from a single tip (forming conjugation tubes) towards cells
of the opposite mating type (dotted arrow indicates direction of growth). Upon meeting,
cells conjugate to form a diploid zygote, which sporulates to form ascospores.
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1.3.5.2 The mating-response in S. pombe
M-cells (h ) express the GPCR Mam2 and release M-factor [61], whereas P-cells (h+)
express the GPCR Map3 and release P-factor [62]. When the appropriate pheromone
binds an opposite mating type receptor, an intracellular signalling cascade is initiated [63].
The activation of this pathway leads to potentiation through the morphological pathway
(where cells form conjugation tubes in the direction of the pheromone) and up regulation
of mating-responsive genes, including genes that are required to maintain the cells in G1
arrest, rum1 [64], and sxa2, a serine carboxypeptidase that is secreted exogenously to
cleave pheromone [65, 66]. Once two heterothallic cells meet, this promotes conjugation
and karyogamy, leading to sporulation [67] (Figure 1.6).
1.3.5.3 GPCR signal transduction in the S. pombe pheromone-response
Initiation of the mating-response signalling pathway is via the binding of either P-factor
or M-factor pheromone to Mam2 and Map3, respectively. As with mammalian GPCRs the
ligand-binding event triggers activation of Gpa1 (a Ga subunit) through nucleotide (GDP
to GTP) exchange [63]. GTP-bound Gpa1 activates the downstream monomeric G protein
Ras1, most likely via the GEF Ste6 [68]. Ras1 provides a branching point in the pathway,
with GTP-bound Ras1 being able to activate two distinct eectors. One pathway involves
activation of a MAP kinase cascade via sequential phosphorylation of Byr2, Byr1 and Spk1
[69]. The activation of the MAPK Spk1 is thought to promote phosphorylation of Ste11
inducing genes required for mating [70] (Figure 1.7).
The second pathway controls the morphology response (the growth towards the mating
partner); this occurs via the activation of Scd1, one of two GEFs for the Rho-like monomeric
G protein Cdc42 [71, 72], the second is Scd2, which facilitates Scd1's interaction with Cdc42
[73]. GTP-bound Cdc42 can then activate a number of downstream eectors. One of
these eectors is the protein kinase Shk1 [74], which targets Tea1 (a protein that regulates
microtubule dynamics and recruits actin) to the cell tips, thereby promoting cell elongation
[75]. Shk1 also interacts with the MAP3K Byr2 by promoting its active conformation [76].
Another eector of Cdc42 is the Boi-like protein Pob1 (Boi-like meaning that is resem-
bles the function of the BOI proteins in S. cerevisiae, which are involved in polar growth
[77]), which is targeted to the cell tips to promote an interaction between the formin For3
and Cdc42. This interaction removes the autoinhibition of For3 and the resulting Cdc42
activation of For3 assembles actin cables for myosin V-directed transport, which guides
a multi-protein exocyst complex, which directs vesicles to the plasma membrane [78{81].
Pheromone-induced activation of this pathway therefore results in both a transcriptional
and morphological response in the form of elongation of the cell towards its mating partner
(Figure 1.7).
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Figure 1.7: M-type S. pombe pheromone-response pathway. Activation of Mam2,
the GPCR in response to P-factor promotes GDP for GTP exchange on the G protein Gpa1.
GTP-bound Gpa1 activates another G protein Ras1 via an interaction with Ste6. Ras1 can
then activate two pathways: The transcriptional pathway, which transduces signalling via
a MAPK cascade consisting of Byr2, Byr1 and Spk1, which then phosphorylates the TF
Ste11 promoting transcription of a number of mating-responsive genes such as sxa2 and
rum1. The morphological pathway, resulting in activation of the essential G protein Cdc42
via two GEFs Scd1 and Scd2. Active Cdc42 regulates the organisation of microtubules
(via Shk1) and actin nucleation (through Pob1-mediated For3 activation, For3 not shown).
Shk1 also phosphorylates Byr2 (a MAP3K), which modulates pheromone responsive gene
transcription. The G proteins Gpa1 and Ras1 are negatively regulated by Gap1 and Rgs1
and Spk1 is dephosphorylated by the phosphatase Pmp1.
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1.4 Regulation of GPCR signal transduction
All cells have developed mechanisms for detecting the change in stimulus through a re-
versible process of adaptation or signal termination, where a prolonged exposure to the
signal decreases the cells response to that level of stimulus. Switching o activated recep-
tors and G proteins and by returning the levels of second messengers, protein phosphoryla-
tion and other changed metabolites to their original values, returns the cells to a `normal'
state, which primes the cell ready to respond to other stimuli. There are various modes of
signal regulation within GPCR signal transduction pathways, such as removing the source
of stimulus, removing or inactivating the GPCR, deactivating the G protein or regulating
signal transduction of downstream signalling components.
Simple eukaryotic organisms such as the ssion yeast S. pombe use highly conserved
signal transduction mechanisms to regulate cell behaviour and as such, have been utilised to
understand fundamental cell signalling processes in mammalian cells [72, 82{85]. However,
few studies have focused on the regulation of signal transduction [86, 87] and to date no
studies have investigated receptor inactivation within the pheromone-response pathway of
S. pombe.
The pharmaceutical industry invest billions of dollars each year to discover therapeutic
compounds for GPCRs that give desired physiological eects (reviewed in [5]). Many long-
term treatments that target these receptors result in the patient becoming tolerant to
the drug. This tolerance often results in having to increase the dosage to deliver the same
physiological outcome, which can be debilitating for the patient and lead to undesirable side
eects. Understanding how these receptors are regulated at the plasma membrane is key to
developing appropriate treatments for diseases. This thesis therefore aims to elucidate the
mechanisms of GPCR signal regulation and termination of S. pombe in greater depth with
a particular emphasis on how the GPCR is regulated in response to P-factor stimulation.
1.4.1 Regulation of GPCR signal transduction via ligand depletion
Some cells have developed mechanisms for attenuating GPCR signalling responses by de-
pleting the extracellular ligand. The process of degrading extracellular ligand to attenuate
and desensitise the signalling response is conserved from humans to yeast. In human pancre-
atic b-cells, two intestine secretion insulin (incretin) peptide hormones: glucose-dependent
insulin-releasing polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), are both secreted
in response to food ingestion and bind to activate the GIP and GLP-1 GPCRs, respectively
[88]. Activation of these receptors stimulates the secretion of insulin from pancreatic b-cells
to stimulate glucose uptake. Following GIP and GLP-1 peptide secretion these hormones
are rapidly (<4 mins) degraded by the enzyme dipeptidyl peptidase-4 (DPP-4) [89], which
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is expressed on the cells' surface [90]. As a result, the majority of GIP and GLP-1 is in-
activated before reaching the systemic circulation. By degrading the ligand this prevents
continuous stimulation of the pathway and therefore, regulates insulin secretion [91].
In S. cerevisiae BAR1, an aspartyl protease, is released by a-type cells of the S. cere-
visiae following stimulation by a-factor mating-pheromone [92]. a-factor is a tridecapeptide
(13-residue oligopeptide) [93] that is inactivated by BAR1 through cleavage of the protein
between a leucine residue at position six and lysine residue at position seven [94]. Inacti-
vation of the extracellular pheromone plays an important role in the cells' recovery from
pheromone stimulation [95].
Following this discovery, a similar mechanism in S. pombe was also discovered. In re-
sponse to the pheromone (P-factor) S. pombe M-cells produce and secrete Sxa2, a car-
boxypeptidase which cleaves P-factor at the C-terminal leucine residue. The secretion of
Sxa2 reduces the extracellular concentration of P-factor allowing the cells that have not yet
mated to return to mitotic growth [96{98].
S. pombe P-cells on the other hand that secrete M-factor do not possess the ability
to degrade extracellular M-factor [99]. M-factor is a hydrophobic nonapeptide with a C-
terminal cysteine residue that is both carboxyl-methylated and S-farnesylated on the thiol
group to become active [100, 101]. Following its synthesis and modication M-factor is
transported across the cell membrane by Mam1, an ATP-dependent peptide transporter
belonging to the ATP-binding cassette (ABC) superfamily of proteins [102]. To date, no
protein has been identied that degrades exogenous M-factor.
1.4.2 Regulating signalling response via GPCR desensitisation
Many GPCR signalling pathways do not degrade extracellular ligand but instead use a
variety of other mechanisms for attenuating signalling response. One of these is regulating
the localisation and activity of key signalling molecules such as the GPCR, G protein and
regulatory proteins ([103] and reviewed in [104]). In particular, many cells control the level
of signal transduction by regulating the GPCR. In some elds this is dened as receptor
desensitisation, in which there exist three modes (reviewed in [105]):
1. Receptor inactivation by preventing an interaction with the G protein and thus, signal
transduction.
2. Receptor sequestration, typically by internalising the receptor from the cell membrane
preventing further activation by a ligand.
3. Receptor down-regulation, where the GPCRs are degraded following internalisation.
In each case, receptor desensitisation requires phosphorylation by specic protein kinases
to initiate these processes. The time frames over which these processes occur range from
seconds (phosphorylation) to minutes (internalisation) and hours (down-regulation).
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1.4.3 Receptor phosphorylation promotes GPCR desensitisation
The most rapid mechanism by which GPCRs are uncoupled from heterotrimeric G pro-
teins is via covalent modication on the intracellular receptor domains as a consequence
of phosphorylation by specic kinases, typically on serine and threonine residues. Human
GPCRs are the targets of many kinases including second messenger kinases such as PKA
and PKC, casein kinases, receptor tyrosine kinases (RTKs) including the second messengers
Akt/protein kinase B (PKB) and most notably G protein-coupled receptor kinases (GRKs)
(summarised in Figure 1.8 and discussed in detail below).
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Insulin
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Figure 1.8: Protein kinases that phosphorylate GPCRs. The schematic shows
protein kinases (purple box) that have been shown to phosphorylate GPCRs and the main
functional consequences.
1.4.3.1 GPCR phosphorylation by second messengers
GPCR phosphorylation can result from a feedback mechanism where the receptor is phos-
phorylated to prevent G protein activation by the second messenger kinase it activates,
which consequently reduces the activity of the kinase. GPCRs that signal via Gas increase
cAMP levels within the cell which activates PKA. One of PKAs targets is the upstream
receptor, where phosphorylation of the IC3 loop or C-terminal domain sterically inhibits an
interaction with the G protein [106, 107]. One classic example of GPCR phosphorylation
by PKA is the b2-adrenergic receptor [108].
In a similar fashion, signalling via Gaq activates PKC, and sometimes one of PKC's
targets is the upstream receptor, where phosphorylation of the intracellular regions prevents
G protein-coupling. A well studied example of this is the angiotensin II type 1 (AT1)
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receptor, which couples to a Gaq that when activated results in the activation of PKC,
which subsequently phosphorylates the C-terminal AT1 receptor domains [109].
Although S. pombe contains both PKA and PKC, when nutrients are scarce and the cells
initiate a mating response, as a direct result these kinases' activity is signicantly reduced
(Figure 1.5). It is therefore unlikely that PKA or PKC are active and able to phosphorylate
the GPCR Mam2 in response to pheromone stimulation. This suggests that Mam2 may be
phosphorylated by other kinases.
1.4.3.2 GPCR phosphorylation by casein kinases
Multiple studies within yeast and mammalians cells have highlighted a role for casein ki-
nases in phosphorylating GPCRs in response to ligand-binding. Casein kinases are highly
conserved ubiquitous serine/threonine protein kinases that can be grouped into two major
families based upon structural similarities: casein kinase 1 (CK1), a family of monomeric
proteins that can be further classied into seven isoforms (a, b, g1, g2, g3, d, e), and casein
kinase 2 (CK2), a group of tetrameric proteins that consist of two a catalytic and two b
regulatory subunits [110].
Studies on the mating-pheromone receptors of S. cerevisiae have demonstrated an essen-
tial role for two CK1 homologs, YCK1 and YCK2 in the phosphorylation of specic serine
residues in the C-terminal domain of STE2 (a GPCR), promoting its internalisation from
the plasma membrane [111{114]. Although the pheromone-induced mating response path-
way in S. pombe has been studied for over 25 years and casein kinases have been identied,
however, no studies have suggested a possible role for these kinases in phosphorylation of
GPCRs.
In mammalian cells, CK1a was rst shown to phosphorylate human photoactivated
rhodopsin [115] and later was demonstrated to phosphorylate the muscarinic 1 (M1) [116,
117] and muscarinic 3 (M3) receptors [118, 119]. In addition to phosphorylation of the
C-terminal tail region, CK1a appeared to regulate the ability of the M3 receptor to favour
coupling to the ERK mitogenic pathway [119, 120], suggesting that GPCR phosphorylation
by casein kinases may direct signalling to other pathways than G proteins.
The CK2 family has also been shown to phosphorylate GPCRs. The rst example of
this came from studies of the thyrotropin-releasing hormone (TRH) receptor where muta-
tion of potential CK2 phosphorylation sites in the C-terminal tail resulted in a reduction
in receptor phosphorylation and loss of internalisation [121]. Later, CK2 was identied in
phosphorylating residues in the IC3 loop of the M3 receptor [122]. Interestingly, phospho-
rylation of the M3 receptor by CK2 did not result in receptor internalisation but enhanced
coupling of the receptor to the JNK pathway [122]. Further evidence for the involvement
of CK2 in GPCR phosphorylation was illustrated with the dopamine 1 (D1) and adenosine
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A2A receptors. This study suggested a potential mechanism of the phosphorylation event
uncoupling the G proteins from their cognate receptors following ligand-binding [123].
It should be noted that both CK1 and CK2 have been shown to have roles within GPCR
signal transduction pathways that do not involve phosphorylating the ligand-bound GPCR
but regulate other signal transduction machinery. A good example of this is the involvement
of CK1a and CK1g in Wnt signalling, a crucial pathway for activating gene transcription
to control processes during embryonic development and in regeneration of tissues in adult
organisms [110, 124{128].
1.4.3.3 GPCR phosphorylation by the insulin receptor and second messenger
Akt/PKB
Ligand-induced GPCR phosphorylation has been shown to occur via other plasma mem-
brane receptors and their downstream eectors. Specically, the insulin-like growth factor
1 (IGF1) receptor (a RTK) was shown to stimulate the phosphorylation and internalisation
of the b2-adrenergic receptor in response to insulin [129, 130]. Further studies suggested a
mechanism whereby insulin receptor activation of PIP3K drives the activity of Akt/PKB,
which directly phosphorylates the b2-adrenergic receptor in its C-terminal domain [131].
To date there have been no RTKs identied in yeast and therefore unlikely to promote
phosphorylation of the GPCR Mam2.
1.4.3.4 GPCR phosphorylation by G protein-coupled receptor kinases
The most characterised of the kinases that phosphorylate ligand-bound GPCRs are GRKs.
There are seven GRKs in humans that share a similar residue assembly: including an 25
residue N-terminal tail (implicated in GPCR binding), followed by a regulators of G protein
signalling (RGS) homology domain (RGS proteins act as GAPs for G subunits, this region
therefore provides specicity for a GRK interaction with a particular Ga subunit [132]),
which is disrupted by the protein kinase domain and nally, a C-terminal region containing
structural elements responsible for membrane or Gbg targeting [133].
Unlike other kinases, GRKs do not require phosphorylation in their activation loop to
achieve an activated state, instead they are directly activated by docking with ligand-bound
GPCRs [134, 135]. Once activate, the GRK is able to multi-phosphorylate the ligand-bound
receptor enabling high-anity binding of b-arrestin, which uncouples the G protein from
the receptor, preventing further G protein-mediated signal transduction [136]. It should be
noted that to date, no GRK or b-arrestin homologs have been identied in yeast.
b-arrestins are ubiquitously expressed in all cell types, and function not only to in-
hibit GPCR/G protein-coupling but also promote receptor internalisation and b-arrestin-
mediated signalling, serving as scaolds for numerous signalling pathways. These pathways
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include the Src family of tyrosine kinases (that are recruited to b-arrestin bound GPCRs)
and in particular MAPK cascades such as ERK, JNK and p38 pathways ([137] and reviewed
in [138, 139]).
1.4.4 Receptor internalisation
Many dierent types of kinases have been shown to phosphorylate GPCRs (summarised in
Figure 1.8). In addition to phosphorylation of the intracellular receptor domains preventing
G protein activation, phosphorylation can also promote endocytosis (internalisation) of the
receptor from the plasma membrane. Although b-arrestins were initially discovered as pro-
teins that prevent receptor/G protein-coupling, later they were associated with facilitating
receptor endocytosis via clathrin-coated pits (CCPs).
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Figure 1.9: b-arrestin dependent GPCR internalisation. GPCRs are phospho-
rylated by GRKs on their C-terminal tail and IC3 residues following ligand-binding and
activating the extracellular binding pocket. This phosphorylation event promotes the bind-
ing of b-arrestin and prevents further G protein activation (thereby terminating G protein
signalling). The arrestin protein is recognised by clathrin-coated machinery (AP-2 and
clathrin), which binds and envelopes the GPCR. nally the GTPase dynamin helps pinch
o the clathrin-coated vesicle resulting in endoyctosis of the GPCR into the cytosol.
Mammalian b-arrestins exist in a constitutively phosphorylated state in the cytosol and
are dephosphorylated upon binding activated GPCRs at the plasma membrane (reviewed in
[139]). Dephosphorylation of the arrestin molecule upon binding the active receptor results
in a conformational change in the C-terminal domain of the arrestin protein revealing
residues that bind the endocytotic machinery; specically clathrin and the clathrin adaptor
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complex AP-2 [140{142]. Once bound, invagination of the plasma membrane with the
GPCR and b-arrestin protein occurs, enveloped with clathrin and AP-2 complexes, which
guide the formation of intracellular vesicles. The release of the vesicle from the plasma
membrane is aided by the activity of the GTPase dynamin, which helps pinch o the
clathrin-coated vesicles (CCVs) resulting in the internalisation of the cell-surface receptor
into the cytosol (Figure 1.9). The two best characterised receptors that are endocytosed
following GRK phosphorylation are the b2-adrenergic receptor and rhodopsin [133].
Several GPCRs are internalised in an b-arrestin-independent manner. The b1-adrenergic
receptor for example is guided by GRK2 to clathrin-coated pits (CCPs) via an interaction
between clathrin and a clathrin box present on the C-terminus of GRK2 and is subsequently
endocytosed [143]. Active GPCRs can also be internalised in a clathrin-independent manner
via interactions with planar lipid rafts and caveolae that internalise cell-surface receptors
into vesicles (reviewed in [144]).
1.4.5 Down-regulation of GPCRs by degradation
Another important observation that lead to our present view of GPCR regulatory mech-
anisms came form classical studies of the b2-adrenergic receptor [106, 145, 146]. It was
shown that phosphorylation of the intracellular receptor domains by GRKs occurs when
the GPCR forms an active conformation (ligand-bound) and that these receptors are sub-
sequently internalised and tracked to the degradation pathway (down-regulated) [145].
This type of GPCR regulation is termed homologous, as the ligand-binding event on that
type of receptor promotes down-regulation of those receptors only. This selective property
of GRKs to phosphorylate only active receptor conformations infers that GRK-mediated
phosphorylation is generally considered a paradigm for homologous desensitisation.
It was also observed that phosphorylation of the b2-adrenergic receptor by activated
PKA is not preferential to whether the GPCR is bound to ligand [147]. Activation of any
receptor that stimulates adenylyl cyclase within the cell can activate PKA and thus, PKA
can potentially activate other receptors that are active or inactive. Down-regulation of an
non ligand-bound GPCR as the result of activation of a dierent type of GPCR is generally
known as heterologous desensitisation [148]. Phosphorylation of the b2-adrenergic receptor
by PKA is considered a classical example of heterologous down-regulation [149].
Following endocytosis, the receptor can be tracked to recycling endosomes and (fol-
lowing dephosphorylation, removal of the ligand and removal of other associated proteins
such as arrestins) subsequently recycled back to the plasma membrane (reviewed in [104]).
However, most often the receptor is tracked to the lysosome for degradation thereby
reducing its expression levels on the cell-surface and hence, is down-regulated (reviewed
in [104]). What controls the fate of the receptor following its internalisation is still not
entirely known. Some studies have shown that cytoplasmic sequences present in certain
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GPCRs promote sorting of internalised receptors to lysosomes [150], as well as sequences
that promote [151] or prevent [152] rapid recycling of endosomes (vesicles) to the plasma
membrane.
1.4.6 GPCR sorting following ubiquitination
In addition to phosphorylation of the GPCR initiating the process of receptor internalisa-
tion, another post-translational modication process for sorting GPCRs has been observed.
Ubiquitination is the process of covalently attaching a protein of ubiquitin (a highly con-
served polypeptide of 76 amino acids) to a substrate lysine residue (ubiquitination) [153],
which acts as a sorting signal for the protein. The process of ubiquitination is mediated by
the concerted action of three enzymes. First ubiquitin is activated in an ATP-dependent
process by an activating enzyme E1, second a conjugating enzyme E2 accepts ubiquitin
from E1 and nally, a ubiquitin protein ligase E3 transfers the activated ubiquitin from E2
to the substrate lysine residue (Figure 1.10). Other amino acids such as cysteine, serine
and threonine can be ubiquitinated, however this has only been shown to occur on proteins
lacking available lysines [154].
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Figure 1.10: Ubiquitination of target protein. Ubiquitin (Ub) is activated by cova-
lent attachment to E1 enzyme in an ATP-dependent reaction and is subsequently trans-
ferred to an E2 (ubiquitin-conjugating) enzyme. Ubiquitin is transferred from E2 to the
lysine residue of the target protein with the assistance of an E3 (ubiquitin ligase) enzyme.
After several cycles of ubiquitination, the target protein can become multiubiquitinated
(forming a chain of ubiquitin molecules on the substrate).
Chapter 1: Introduction 22
Ubiquitin molecules can either be ligated onto substrate lysine residues or other ubiquitin
proteins forming polyubiquitin chains. Depending on whether the substrate is monoubiq-
uitinated (one ubiquitin polypeptide on a single lysine), multimonoubiquitinated (several
single ubiquitin molecules to dierent lysine residues in a protein) or polyubiquitinated
(forming a polymeric chain of ubiquitin molecules from a single lysine residue) can de-
termine the fate of the target protein [155]. For example, ubiquitination of proteins can
either signal for their degradation via the proteasome or lysosome, alter their cellular lo-
cation, aect their functional activity or promote/prevent protein interactions ([156, 157]
and reviewed in [158]).
Ligand-promoted ubiquitination of GPCRs typically initiates its internalisation and traf-
cking to the lysosome for degradation [159]. Following endocytosis into endosomes the re-
ceptors are sorted into the multivesicular body (MVB); a distinct endosomal compartment
containing intracellular vesicles associated with endosomal degradation. The ubiquitin tags
on the receptors are recognised by proteins of the endosomal sorting complex required for
transport (ESCRT) machinery, many components of which contain ubiquitin-binding do-
mains (UBDs), which provide a framework for a network of ubiquitin interactions that lead
to the sorting and degradation of the cargo by the lysosome [160] (Figure 1.11).
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Figure 1.11: Degradation by ubiquitination of GPCRs. Following ubiquitination
of the GPCR it is internalised into vesicles in a clathrin-dependent manner. The early
vesicles fuse with early endosomes and develop into the multivesicular body (MVB). The
ubiquitinated receptors (with yellow tags) are recognised by ubiquitin-binding domains of
ESCRT proteins (green), which help invaginate the GPCRs into intracellular lumens. The
MVB then fuses with the lysosome where the GPCRs are degraded.
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Some GPCRs such as the vasopressin type-2 receptor (V2R) [161] and protease-activated
receptor 2 (PAR2) [162] are only ubiquitinated following GRK phosphorylation and the
subsequent binding of b-arrestin. One supposition for this requirement is that the b-arrestins
may serve as adaptors to bring as yet unidentied E3 ligases to the receptors in a ligand-
dependent manner [163].
1.4.7 Constitutive internalisation of GPCRs
GPCRs also internalise independently of ligand stimulation (constitutive internalisation),
however a conserved mechanism for how this occurs is still unknown (reviewed in [164]).
Some GPCRs, for example the b2-adrenergic and M3 receptor have been shown to con-
stitutively internalise via clathrin-independent mechanisms and following internalisation
are recycled back to the plasma membrane [165]. In response to ligand activation the b2-
adrenergic and M3 receptors were shown to switch from a clathrin-independent to clathrin-
dependent endocytosis mechanisms, resulting in these receptors being tracked to the
lysosome for degradation [165]. What initiates the internalisation of these receptors via
the clathrin-independent mechanism is unknown. Some studies suggest that constitutive
internalisation occurs when the receptor momentarily forms an active complex, resulting
in a conformation that mimics the ligand-bound state, which is then phosphorylated and
endocytosed in a clathrin-dependent manner [166].
Ubiquitination of the S. cerevisiae receptor STE2 is essential for its constitutive and
ligand-induced internalisation [112]. For some GPCRs such as the protease-activated
receptor-1 (PAR1) [167] and the chemokine CXCR7 [168], ubiquitination of these receptors
in fact enhances rather then reduces the concentration of the GPCR at the membrane.
These studies showed that mutating lysine residues in the C-terminal domain of the GPCR
resulted in an increase in constitutive internalisation. These studies illustrate that con-
served mechanisms of how ubiquitination controls GPCR internalisation are still unknown.
1.4.8 The role of GPCR C-terminal domains
The C-terminus of GPCRs are not only important targets of post-translational modication
such as phosphorylation and ubiquitination, but also act as scaolds around which other
signalling components can organise. Receptor function and tracking is regulated by a
variety of GPCR interacting proteins (GIPs) that interact with the C-terminal domain of
GPCRs [169]. One example is the intracellular protein dishevelled (Dsh) described earlier.
The Dsh protein is required to interact with the PDZ-domain (a conserved binding motif
that plays a role in the organisation of protein complexes on the membrane through binding
to consensus C-terminal motifs in target proteins [170]) of the frizzled receptors C-terminal
domain in order to initiate a signalling cascade [171].
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RGS proteins are another classic group of proteins that have been shown to interact
with the C-terminal tail of GPCRs to enhance their localisation at the plasma membrane
[172, 173] and to promote selectivity of RGS function [172, 174{176]. Examples of these are
the µ-opioid and d-opioid receptors, in which there C-terminal domains provide a scaold
that RGS4 can bind and as a result can regulate signalling [177].
Key features within the C-terminal domain of GPCRs regulate their localisation and
sorting. For example, the presynaptic terminal localisation of metabotropic glutamate
receptors has been shown to be dependent on the presence of a PDZ motif in its C-terminus,
which interacts with an intracellular kinase to regulate function and localisation [178]. The
C-terminal tail of the calcitonin receptor was show to interact with lamin an actin-binding
protein to enhance its recycling to the membrane following ligand-induced endocytosis [179].
The S. cerevisiae pheromone-receptor STE2 was shown to be present in greater quantities
at the cell surface when mutated to lack the C-terminal tail, illustrating that the C-terminal
tail is required for receptor sorting [180].
Another important example, is the essential interaction between the two neurotransmit-
ters gamma-aminobutyric acid (GABA) B1 and GABA B2 receptors via their C-terminal
domains to confer signal transduction. GABA B1 contains the GABA-binding site, but ex-
pressed alone is not tracked to the cell-surface [181]. In contrast, the GABA B2 subunit is
sequestered to the cell-surface but does not contain a GABA-binding site [181]. Only when
co-expressed together do these subunits interact via their C-terminus creating a coiled-coil
region and hence, transduce signalling inside the cell [182, 183].
1.4.9 Internalisation of the M-type receptor Mam2
The mechanisms or proteins that promote receptor internalisation/desensitisation in S.
pombe have not yet been described, but GPCRs in general are known to internalise following
phosphorylation (by specic kinases on serine and threonine residues) of the C-terminal tail
and intracellular loops of the receptor. A number of possible sites for phosphorylation have
been identied on the C-terminus of Mam2, which appear to be required for pheromone-
dependent internalisation. Specically, the removal of an 8-residue sequence (YSISDESE)
from the C-terminal tail (Figure 1.12), increased both the potency of pheromone and plasma
membrane localisation of the receptor ([173]; E. McCann, PhD thesis, 2010). These three
serine residues were therefore considered potential targets of ligand promoted phosphory-
lation and internalisation of Mam2.
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Figure 1.12: Sequence of the predicted C-terminal tail of Mam2. Possible sites
of phosphorylation (by serine and threonine kinases) are highlighted in blue and possible
sites of ubiquitination (on lysine residues) are highlighted in red. The YSISDESE sequence
is highlighted in bold with a dashed border and includes the three serine residues, which
are suggested to have a role in Mam2 internalisation (E. McCann, PhD thesis, 2010).
In other yeast, GPCR phosphorylation on serine residues is involved in receptor in-
ternalisation [112]. Specically, the three serines within the SINNDAKSS sequence (a
region of the C-terminal tail) of the S. cerevisiae a-factor receptor STE2 have been shown
to be hyperphosphorylated following treatment with a-factor, which is a prerequisite for
monoubiquitination of the neighbouring lysine (K) residue to mediate ligand-stimulated
endocytosis [111{114]. Phosphorylation of the SINNDAKSS sequence is also a requirement
of constitutive internalisation [112].
Like STE2, Mam2 displays both constitutive and ligand-induced internalisation. Fluo-
rescent labelled Mam2 was shown to reside in the yeast vacuole (equivalent to the mam-
malian lysosome) and the plasma membrane of untreated cells [184], which then internalised
from the plasma membrane following treatment with P-factor [173]. There is no evidence for
the recycling of Mam2 or STE2 following their internalisation from the plasma membrane
in response to ligand-binding [185, 186]. Given serine phosphorylation is essential for recep-
tor internalisation and ubiquitination of the neighbouring lysine residue in S. cerevisiae, a
potentially similar mechanism may occur in S. pombe, however no lysine residues neighbour
any serines within the C-terminal tail of Mam2, which suggests that the mechanisms for
internalisation may be dierent between the two yeast species (Figure 1.12).
Neither S. pombe or S. cerevisiae carry homologues of GRKs or b-arrestin proteins,
which traditionally phosphorylate and promote endocytosis via clathrin-coated vesicles of
mammalian GPCRs. However, two S. cerevisiae casein kinases YCK1 and YCK2 have
been shown to promote phosphorylation and internalisation of STE2 [112]. To date, there
have been no proteins identied in S. pombe that phosphorylate the C-terminal tail or
intracellular loops of Mam2 to promote its internalisation.
1.4.10 Regulators of G protein signalling
The heterotrimeric Ga subunit contains two catalytic residues required for GTP hydrolysis;
a glutamate in switch II which correctly orientates the water molecule, to enable transfer
of the g-phosphate and an arginine in switch I, which stabilises the transition state for the
Ga-subunit to have an intrinsic GTPase activity [17]. Ga subunits contain all the required
catalytic residues to perform the GTPase function required for the termination of signalling.
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However, the intrinsic GTPase rate can be enhanced by a class of GAP proteins known
RGS proteins. RGS proteins act allosterically to stabilise the transition state, increasing
the rate of GTP hydrolysis [187]. A study using RGS4 from rats showed it stabilises the
exible regions of the Gai subunit into a conformation resembling the transition state and
as a result, was assumed to lower the activation energy required for GTP hydrolysis [188].
Therefore, RGS proteins typically promote signal desensitisation by increasing the rate of
GTP hydrolysis on the G protein.
S. pombe, contains only one RGS species, Rgs1, which targets the Ga subunit Gpa1 by
catalysing its hydrolysis from a GTP to GDP [87]. Cells decient in Rgs1 are hypersensitive
to pheromone and are unable to mate despite undergoing a G1 arrest and conjugation
tube formation [87, 189]. Counter-intuitively, Rgs1 was shown to confer both negative and
positive regulation of pheromone signalling depending on the cellular concentration of Rgs1
and pheromone stimulation [190]. In addition, the localisation of Rgs1 and its ability to
regulate Gpa1 has been shown to be dependent on a physical interaction between the C-
terminal domain of Mam2. Fluorescent labelled Rgs1 was observed in the nucleus rather
than the plasma membrane following the removal of the C-terminal tail of Mam2 and was
localised to the plasma membrane when co-expressed with full length Mam2 [173].
1.4.11 G protein regulation by GAPs
Like Ga subunits, monomeric G proteins contain a conserved glutamate on the switch II
region which is required for the coordination of the water molecule during GTP hydrolysis
[17]. However, monomeric G proteins do not contain the catalytic arginine which is required
for GTPase activity. In the case of monomeric G proteins, GAPs donate the catalytic
arginine residue and therefore, aid the termination of the G protein response [19, 191].
In the S. pombe mating response pathway the monomeric G protein Ras1 is regulated
via the GAP, Gap1. Loss of Gap1, results in hypersensitivity to pheromone and a reduced
ability for the S. pombe to mate with an opposite mating type partner [86]. Unlike Rgs1,
which has been shown to have both a positive and negative regulatory role on signalling in
S. pombe, Gap1 has only been shown to negatively regulate Ras1 [96] (Figure 1.7).
1.4.12 MAPK regulation by phosphatases
Signal transduction via MAPK cascades typically requires the addition of phosphate groups
on tyrosine, serine and threonine residues of the target protein. Protein phosphatases
act to remove these regulatory phosphate groups and typically aim to terminate signal
transduction [192]. Protein phosphatases can be divided into three groups: the protein
tyrosine phosphatases, serine/threonine phosphatases and dual specicity phosphatases,
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which as the name suggest can remove the phosphate group from phosphotyrosine and
phosphoserine/phosphothreonine residues (reviewed in [193]).
In addition to GPCR signal activation via directly or indirectly activating MAPK cas-
cades, GPCRs have been shown to regulate MAPK phosphatases that deactivate MAPKs.
For example, Ga12 has been shown to directly stimulate PP5 [194] as well as PP2A [195]
phosphatases, which have been suggested to play a role in attenuating p38 (a MAPK)
(reviewed in [196]).
Recovery from pheromone stimulation in S. pombe can be enhanced by phosphatases
which regulate the MAPK cascades. The key site for regulation of the pheromone-induced
MAPK cascade is Spk1, which when phosphorylated activates the transcription factor,
Ste11. A dual-specicity phosphatase Pmp1 is thought to dephosphorylate Spk1 in order
to reduce pheromone-dependent gene transcription [11].
Like kinases, phosphatases act on several substrates within the cell [197]. Other phos-
phatases that target MAPKs in S. pombe are the Pyp1 and Pyp2 phosphatases. These have
been shown to dephosphorylate the stress-activated Sty1 MAPK [198, 199]. Pmp1 has also
been shown to dephosphorylate Pmk1, the MAPK of the cell integrity MAPK cascade [200].
The cell integrity MAPK pathway is thought to be involved in cell wall construction, mor-
phogenesis, cytokinesis and ion homeostasis as deletion of either member of the cascades
causes hyperosmotic stress or elevated temperatures and morphological defects with cells
displaying septa [201{204].
1.5 Mathematical modelling of GPCRs
Many studies have employed computational modelling approaches to understand the com-
plex behaviour of signalling networks, such as those initiated from GPCRs (reviewed ex-
tensively in [205]). Mathematical models can be used as tools to hypothesise mechanisms
and infer parameters such as reaction rates and species concentrations, often with the aim
of guiding experimental design and thus reducing the time in the laboratory.
1.5.1 Equilibrium models
Existing GPCR signalling models focus on the pharmacology of dierent equilibrium states
of the receptor. These types of models describe how the addition of ligand and/or G protein
changes the equilibrium between two distinct receptor conformations, inactive receptor (R)
and active receptor (R) (reviewed in [206, 207]). These models include terms for describing
anity, the eectiveness of how a ligand binds the receptor and ecacy, the ability of a
ligand to induce an intracellular response; two important quantities which are key in drug
design.
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Two of the most inuential equilibrium models to date are the cubic ternary complex
model of GPCR signalling [208] (Figure 1.13) and the operational model of pharmacological
agonism [209] (reviewed in [210]). The cubic ternary model accounts for constitutive activity
of the receptor and was the rst to model and explain inverse agonism (a ligand that binds
to the receptor to reduce its activity below the basal level). Whereas, the operational
model of pharmacological agonism was the rst to describe how GPCR activity can be
modulated in either a positive or negative fashion, by the binding of ligands to sites that
were topographically distinct from the ligand-binding site [211].
RG LRG
LRR
G binding
R activation
L binding
R*G LR*G
LR*R*
Figure 1.13: Cubic ternary complex model of GPCR signalling. The receptor
can exist in two states: inactive (R) and active (R). The equilibrium between these two
states can depend on Ligand (L) and or G protein (G) binding (gure adapted from [212]).
1.5.2 Kinetic models
Another type of GPCR signalling network approach is a kinetic model, which aims to link
time-course data of GPCR binding with the kinetics of early (such as G protein activation)
and later (for example, eector activation, MAPK activation and GPCR desensitisation)
downstream signalling events (which are not captured in equilibrium models). Kinetic mod-
els of this type are generally formulated as ordinary dierential equations (ODEs), which
describe how the concentration of each species evolves with time. Other types of kinetic
models also exist: ones that use partial dierential equations (PDEs) to describe spatial
information and also stochastic models, which unlike the previously discussed deterministic
models assume that events are probabilistic and therefore, multiple simulations must be
run to obtain statistical power (which can be computationally heavy depending on the of
signalling components).
Kinetic models are based on interactions through collisions (the basis of mass action
kinetics) whereby proteins are assumed to move by diusion. The law of mass action states
that the rate of a chemical reaction is proportional to the product of the concentrations
of the reactants, where a rate parameter is used to dene the probability of a reaction to
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occur if two molecules approach each other. A simple example of mass action kinetics can
be described by considering that two species A and B collide forming a complex AB.
A + B
k1  *) 
k2
AB
where k1 is the forward reaction rate of unit [time]
 1[conc] 1, while k2 is the backward
reaction rate of unit [time] 1. Note that reaction rate units are not uniquely dened but
rather depend on the reaction. Three ODEs can be formulated for each species:
d[A]
dt
=  k1[A][B] + k2[AB] (1.1)
d[B]
dt
=  k1[A][B] + k2[AB] (1.2)
d[AB]
dt
= k1[A][B]  k2[AB] (1.3)
which has an equilibrium point for [C]
[A][B]
=
k1
k2
, at this point the concentrations of each species
reaction do not change with time. By formulating a network of biochemical reactions in
this way, the dynamics of biological system can be investigated, specically with the goal
of analysing the behaviour of the individual variables and also of the complete system at
the same time. Kinetic models of this type can be tested for perturbations where molecules
or interactions are removed from the system, which then can be compared with knock-out
experiments, or provide biological predictions.
The most extensively modelled GPCR system that has been described using kinetic
models of this form, is the pheromone-response pathway of S. cerevisiae. The earlier mod-
els focused on STE2 (the mating-type GPCR), which is activated via a-factor pheromone,
signalling through the Gbg subunit and included reactions for describing signal desensi-
tisation by the RGS species (SST2) [213]. A kinetic model describing these species was
developed and demonstrated that transcriptional induction of the RGS protein SST2, was
caused by free (active) Gbg subunits that produces a negative feedback loop, leading to
desensitisation of the pathway [213]. A similar model based upon data measuring the time
and dose-dependent loss of uorescence resonance energy transfer (FRET) between the
cyan uorescent protein (CFP)-tagged Ga and the yellow uorescent protein (YFP)-tagged
Gbg subunits suggested a relationship between G protein activation and transcriptional
induction of mating-response genes [214].
Most GPCR models aim to understand how drugs bind and activate the receptor and
G protein. Often these mathematical models are based on components of the pathway
that are located at the plasma membrane and do not include the intracellular signalling
cascades. Only one model of an entire GPCR signalling pathway has been developed;
the pheromone-response pathway in S. cerevisiae [215]. This mathematical model was
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developed to include the additional lamentous growth pathway in S. cerevisiae [216] and
by varying the parameters to investigate the model reactions, new hypotheses regarding
the contribution of distinct mechanisms to overall crosstalk between the two pathways were
described.
1.5.3 Modelling the pheromone-response pathway in S. pombe
The mating process of S. pombe involves both extracellular and intracellular mechanisms
that transduce signalling using a combination of fast (seconds) responses, such as protein
modications and slow (minutes to hours) responses such as transcriptional regulation, cell
migration and cell cycle arrest. Mathematical analysis of large-scale signalling networks
such as the S. pombe mating-response requires the integration of several events that happen
at diverse spatial and temporal scales.
Previous modelling eorts of the S. pombe mating-response have focused on pheromone
binding the GPCR and signal transduction via the G protein. Smith et al. (2009) produced
the rst kinetic model of GPCR signalling of the mating-response in S. pombe. They
were able to reproduce experimental data with the existence of an inactive GTP-bound
state of the G protein [190]. This novel idea placed signicant importance on rapid GTP-
hydrolysis, rather than retention of a GTP-bound state to produce a maximal signalling
response and as such was termed the `inert state hypothesis'. They suggested that the RGS
protein could act as both a positive regulator, accelerating the conversion of bound-GTP to
GDP on the G protein (thus allowing the GDP-bound G protein to associate with ligand-
occupied receptors for reactivation) and a negative regulator, by hydrolysing GTP prior to
the interaction of a GTP-bound G protein with its eector [190].
Croft et al. (2013) developed the kinetic model further to include an additional spatial
regulation of the RGS species in transducing signalling in the mating-response pathway of
S. pombe [173]. Using a combination of confocal imaging and quantitative b-galactosidase
assays they showed that a physical interaction between the RGS species and the C-terminal
domain of Mam2 was essential for RGS plasma membrane localisation and consequent
hydrolysis of the G protein [173]. These results highlighted the importance of the receptor
tail in transducing and regulating the signalling response.
The previous mathematical models of the S. pombe pheromone-response pathway can
not reproduce some transcriptional end-point data such as deleting the proteins Gpa1 and
Pmp1 because these species are not contained within in the model. Activation of Gpa1
promotes GDP for GTP exchange on the monomeric G protein Ras1 and this in turn
signals via a MAPK cascade to phosphorylate the transcription factor Ste11 to up-regulate
genes required for mating.
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1.6 Aims of the project
This study aims to investigate, identify and describe the underlying mechanisms involved
in GPCR internalisation in response to ligand stimulation in the ssion yeast S. pombe.
By critiquing the literature of the regulatory mechanisms of GPCR signalling in S.
pombe, gaps in the current state of knowledge in this eld seemed evident. First, the
currently accepted mathematical model of GPCR signalling in S. pombe lacked known
signalling species and regulatory mechanisms. To gain a more in depth understanding
of how regulatory components in S. pombe maintain and control signalling response the
mathematical model will be extended to include all known mechanisms. And nally, there
is no literature describing how GPCRs are internalised in response to ligand stimulation
in S. pombe and specically, what proteins initiate this process. Interestingly S. pombe
does not contain homologs of GRKs or b-arrestins (the canonical apparatus which initiate
GPCR desensitisation mechanisms in mammalian cells). Therefore, an investigation to
identify the kinases that initiate GPCR internalisation and their roles within S. pombe
should be performed. Below are the objectives for each chapter:
 Chapter 3 extends the current mathematical model of GPCR signalling to include all
known points of signal regulation. Although the mechanisms for receptor internal-
isation in response to ligand stimulation are unknown in S. pombe, the simulations
from Chapter 3 emphasise that internalisation is a key mechanism for modelling the
experimental data which motivates Chapter 4.
 Chapter 4 identies protein kinases that may promote internalisation and investigates
their role within the pheromone-signalling response in S. pombe.
 Finally, Chapter 5 seeks to understand the dierent mechanisms of receptor inter-
nalisation and investigates how the kinases identied in Chapter 4 inuence GPCR
internalisation.
The following chapter, Materials, methods and constructs, contains details of experimen-
tal and theoretical approaches used throughout this study. References to sections within
Materials, methods and constructs are quoted throughout this document; hence the reader
may continue reading from Chapter 3.
Chapter 2
Materials, methods and constructs
2.1 Materials
2.1.1 General laboratory reagents
Laboratory reagents were supplied by Sigma-Aldrich Co. Ltd. (Poole, Dorset, UK) and
were of analytical grade, unless otherwise stated.
2.1.2 Molecular biology reagents
Restriction enzymes, T4 deoxyribonucleic acid (DNA) ligase and Taq DNA polymerase
(from Thermus aquaticus) were supplied by Invitrogen Ltd (Paisley, Scotland, UK). Ther-
mosensitive alkaline phosphatase was supplied by Promega (Southampton, UK). FastStart
high delity DNA polymerase blend was purchased from Roche Diagnostics Ltd (Lewes,
East Sussex, UK). All oligonucleotides were synthesised by Invitrogen Ltd.
2.1.3 Photographic supplies
DNA gels were visualised using a G:Box iChemi gel documentation system with GeneTool
analysis software (Syngene, Cambridge, UK).
2.1.4 P-factor (pheromone)
High-performance liquid chromatography (HPLC) puried P-factor (pheromone) was syn-
thesised by AltaBioscience (University of Birmingham, Birmingham, UK) using Biotech
Instruments BT7300 Peptide Synthesiser.
2.1.5 Growth medium
Yeast extract, luria broth and select agar were supplied by Invitrogen Ltd. Plates and liquid
medium for the selective growth of S. pombe were made using Amino Acid selective medium
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(AA) and for S. cerevisiae were made using Single Drop-out minimal medium (SD). Rich
(Yeast Extract) medium was used with appropriate amino acid supplements (250 µg/ml) as
required. For example, YEALU was YE medium supplemented with adenine, leucine and
uracil. Plates were made with 1.5% (w/v) select agar. The following medium are made by
dissolving the reagents in reverse osmotically ltered (RO) water.
Table 2.1: Dened Minimal Medium (DMM) (Per litre)
NH4CL 5 g
Na2HPO4 2.2 g
Phthalic acid 3 g
Glucose 20 g
L-adenine (add as required for selective medium) 0.5 g
L-leucine (add as required for selective medium) 0.5 g
L-uracil (add as required for selective medium) 0.5 g
Salts (50x Stock) 10 ml
Vitamins (1,000x Stock) 1 ml
Minerals (10,000x Stock) 100 µl
Table 2.2: Stock solution of salts (50x) (Per litre)
MgCl2.6H2O 52.5 g
CaCl2.2H2O 735 mg
KCl 50 g
Na2SO4 2 g
Table 2.3: Stock solution of vitamins (1,000x) (Per 100 ml)
Nicotinic acid 1 g
Inositol 1 g
Pantothenic acid 500mg
Biotin 400 mg
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Table 2.4: Stock solution of minerals (10,000x) (Per litre)
Citric acid 1 g
Boric acid 500 mg
MnSO4.H2O 500 mg
ZnSO4.7H2O 400 mg
Molybdic acid 305 mg
FeCl3.6H2O 200 mg
KI 100 mg
CuSO4.5H2O 40 mg
Table 2.5: Yeast extract medium (YE) (Per litre)
Yeast extract 5 g
Glucose 30 g
Table 2.6: Selective medium (AA) (Per litre)
Yeast nitrogen base (without amino acids) 6.7 g
Glucose 20 g
Amino acid mix 1.5 g
Select amino acid mix 0.5 g
Chapter 2: Materials, methods and constructs 35
Table 2.7: Amino acid mix
L-alanine 2 g
L-arginine 2 g
L-asparagine 2 g
L-cysteine 2 g
L-glutamine 2 g
L-glutamate 2 g
L-glycine 2 g
L-isoleucine 2 g
L-lysine 2 g
L-phenylalanine 2 g
L-proline 2 g
L-serine 2 g
L-threonine 2 g
L-tryptophan 2 g
L-tyrosine 2 g
L-valine 2 g
myo-inositol 2 g
para-amino benzoic acid 0.4 g
Table 2.8: Select amino acid mix (components as required)
Adenine 2 g
L-histidine 2 g
L-leucine 4 g
Uracil 2 g
L-methionine 2 g
Table 2.9: YPDA medium (Per litre)
Peptone 20 g
Yeast extract 10 g
20% glucose (w/v) 100 ml
L-adenine 0.1 g
Chapter 2: Materials, methods and constructs 36
Table 2.10: SD (Single Drop-out minimal medium) (Per litre)
Yeast Nitrogen base w/o a.a containing (NH4)2SO4 6.7 g
Drop-out solution 100 ml
20% glucose (w/v) 100 ml
Table 2.11: Drop-out solution
L-adenine 0.2 g
L-arginine 0.2 g
L-histidine 0.2 g
L-isoleucine 0.2 g
L-leucine 1 g
L-lysine 0.3 g
L-methionine 0.2 g
L-phenylalanine 0.5 g
L-threonine 2 g
L-tryptophan 0.2 g
L-tyrosine 0.3 g
L-uracil 0.2 g
L-valine 1.5 g
2.1.6 Bacterial strain
Plasmid amplication was performed using Escherichia coli (E. coli) strain DH5a supplied
by Stratagene (Cambridge, UK). E. coli strain DH5a genotype: supE44 hsdR17 endA96
thi-1 relA1 recA1 gyrA96.
2.1.7 Yeast strains
To dierentiate between genes and protein from two species of yeast: S. pombe genes are
denoted yfg1 and proteins Yfg1, whereas S. cerevisiae genes are denoted YFG1 and proteins
YFG1.
2.1.7.1 S. cerevisiae strain
The yeast strain AH109 was used in the yeast 2-hybrid system (supplied by BD Biosciences
Clontech (Oxford, UK)) and has the following genotype: MATa, TRP-901, LEU2-3, 112,
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URA3-52, HIS3-200, GAL4, GAL80, LYS2::GAL1UAS-GAL1TATA-HIS3, MEL1,
GAL2UAS- GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZ
2.1.7.2 S. pombe strains
Standard nomenclature was used to describe the S. pombe strains used in this study (Ta-
ble 2.12). Deletions of genes are referred to as yfg1-D10 in which 1,000 base pairs (bp) of
the yfg1 locus had been deleted. Gene disruption using the selectable ura4 or kanamycin-
resistance (kanR) are denoted as yfg1 ::ura4+ and yfg1 ::kanR, respectively and gene re-
placement as yfg1::yfg2. Creation of reporter strains in which expression of a reporter gene
is linked to the promoter of an endogenous gene at the original locus are referred to as
pro1>rep1.
All strains are mating type stable with deletion of the mat2 and mat3 [217]. Therefore
mat1-M, mat2/3 strains encodeM-cells that are incapable of switching mating type. The
majority of strains used in this study contain mutations of the ade6 gene and deletions of
the leu1 and ura4 genes, which encode enzymes involved in the biosynthesis of adenine,
leucine and uracil, respectively. The product of the cyr1 gene is adenylate cyclase and
disruption of this ORF allows S. pombe to undergo sexual dierentiation during mitotic
growth [53].
The sxa2 gene encodes an extracellular serine carboxypeptidase, which degrades exoge-
nous P-factor [218]. Disruption of this ORF prolongs the response to P-factor stimulation
and increases the functionality of reporter strains [11]. To create the reporter strain JY544
(sxa2>lacZ ) the sxa2 ORF was replaced with bacterial lacZ genes thereby enabling P-
factor induction of b-galactosidase under the control of the transcription factor Ste11. lacZ
encodes b-galactosidase an enzyme that converts ONPG into galactose and o-nitrophenol,
which absorbs visible light at 420 nm and therefore, provides an indirect measure of signal
amplication through the pathway.
The Cdc42/Rac interactive-binding (CRIB) domain binds specically to GTP-bound
Cdc42 [219]. A plasmid containing the CRIB domain fused to three tandem repeats of GFP
under the control of the shk1 promoter was integrated into S. pombe strains containing a
ura4 point mutation [83]. These strains enabled the localisation of Cdc42-GTP to be
visualised using confocal microscopy.
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Strain Genotype Source
JY444 mat1-M, mat2/3::LEU2 , leu1-32, ura4-D18 [220]
JY448 mat1-M, mat2/3::LEU2 , leu1-32, ura4-D18, sxa2>lacZ [221]
JY544 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2>lacZ [11]
JY630 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, rgs1::ura4+,
sxa2>lacZ
[190]
JY949 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, pmp1::ura4+,
sxa2>lacZ
[11]
JY1025 mat1-P, mat2/3::LEU2 , leu1-32, ura4-D18 [11]
JY1169 mat1-M, mat2/3::LEU2 , leu1-32,ade6-M216, ura4-D18, cyr1-D51, mam2-D10,
sxa2>lacZ
[222]
JY1285 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, gpa1-D12 [82]
JY1291 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, mam2-D10,
rgs1-D14, sxa2>lacZ
[11]
JY1353 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, mam2::ura4+ [173]
JY1538 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, gap1::ura4 ,
sxa2>lacZ
[223]
JY1600 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, cki3::ura4+,
sxa2>lacZ
TS
JY1601 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, ste6::ura4 ,
sxa2>lacZ
[223]
JY1618 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, gap1::ura4 ,
rgs1::ura4 , sxa2>lacZ
CW
JY1622 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, efc25::ura4 ,
ste6::ura4 , sxa2>lacZ
TS
JY1673 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, scd1::KanR,
sxa2>lacZ
[223]
JY1674 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, gap1::ura4 ,
scd1::KanR, sxa2>lacZ
[223]
JY1689 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, ura4 ::[shk1
promoter: ScGIC2 CRIB domain:3xGFP:Ura4+], sxa2>lacZ
WC
JY1718 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, gap1::ura4 ,
rgs1::ura4 , sxa2>lacZ
TS
JY1720 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, mam2-D10,
cki3::ura+, sxa2>lacZ
TS
JY1722 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, cki2::ura4+,
sxa2>lacZ
TS
JY1727 mat1-M, mat2/3::LEU2 , leu1-32,ade6-M216, ura4-D18, cyr1-D51, mam2-D10,
cki1::ura+, sxa2>lacZ
TS
JY1730 mat1-M, mat2/3::LEU2 , leu1-32, ura4-D18, cki3::ura+ sxa2>lacz TS
JY1731 mat1-M, mat2/3::LEU2 , leu1-32, ade6-M216, ura4-D18, cyr1-D51, cki1::ura4+,
sxa2>lacZ
TS
JY1734 mat1-M, mat2/3::LEU2 , leu1-32,ade6-M216, ura4-D18, cyr1-D51, mam2-D10,
cki2::ura+, sxa2>lacZ
TS
Table 2.12: S. pombe strains used in this study. The strain name, genotype and
source is displayed. TS refers to strains produced in this study, WC refers to strains created
by Wayne Croft (University of Warwick, UK) and CW refers to strains created by Cathryn
Weston (University of Warwick, UK).
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2.2 Methods
2.2.1 Cloning techniques
DNA preparation and manipulations were performed using standard methods [224] or QI-
AGEN DNA Mini / QIAGEN Plasmid Maxi Kits (Qiagen, West Sussex, UK). Restriction
endonucleases were used according to manufacturers' recommendations. DNA fragments
were analysed by electrophoresis on 1-2% (w/v) agarose gels containing 0.5 µg/ml ethidium
bromide. Purication of DNA from agarose gels were performed using the QIAquick Gel
Extraction Kit (Qiagen, West Sussex, UK).
2.2.2 Transformation of E. coli
Chemically competent E. coli DH5a cells were prepared and transformed with plasmid
DNA using a heat shock approach described by Sambrook et al. (1989) [224].
2.2.3 Transformation of S. pombe
S. pombe was transformed with circularised plasmid DNA or linear DNA fragments using
a lithium acetate method as described by Okazaki et al. (1990) [225], with a heat shock
approach.
2.2.4 Polymerase chain reaction
Taq DNA polymerase (Invitrogen Ltd) was used to screen bacterial colonies and yeast
strains for insertion or deletion of DNA fragments. FastStart high delity polymerase blend
(Roche Diagnostics Ltd) was used for amplifying DNA fragments for cloning. Reactions
were performed according to manufacturers' recommendations.
2.2.4.1 Screening plasmid DNA from bacterial cells
A single bacterial colony was suspended in 100 µl water and stored at 4C. 1 µl of this
suspension was used as the template in a 10 µl PCR reaction.
2.2.4.2 Screening yeast genomic DNA
1 µl of yeast genomic DNA (200 - 400 ng) was used as the template in a 10 µl PCR reaction.
2.2.5 Double stranded DNA sequencing
All plasmid DNA was sequenced with oligonucleotides that bind specic regions within the
plasmid to conrm no mutations were added during amplication in bacteria or the PCR
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reaction. Sequencing was performed by the Molecular Biology Service at the University of
Warwick or Source BioScience LifeSciences (Nottingham, UK).
2.2.6 Preparation of yeast genomic DNA
Genomic DNA was isolated from yeast using the protocol from Homan and Winston
(1987) [226]. Briey, 10 ml of yeast culture was grown to a density of 1x107 cells/ml and
harvested at 2000 rpm for 5 min. Cells were washed in distilled water and 200 µl Blue
Buer (2% (w/v) Triton X-100, 1% (w/v) sodium dodecyle sulphate (SDS), 100 mM NaCl,
10 mM Tris-HCl, pH 8.0 and 1 mM ethylene-diaminetetraacetic acid (EDTA)) was used
to resuspend the yeast. 200 µl of a 1:1 phenol:chloroform and 400 µl acid-washed glass
beads (425-600 µm diameter) were added and the tube was vortexed for 3 min to promote
cell lysis. 200 µl Tris-HCl-EDTA (TE) (pH 7.5) was added immediately and the solid and
aqueous phase separated at 13500 rpm for 5 min at 4C. The aqueous phase was transferred
to 1 ml ice-cold ethanol, mixed by inversion and genomic DNA was harvested at 13500 rpm
for 5 min at 4C. The pellet was washed with 70% (v/v) ethanol, dried and resuspended
in 50 µl TE (pH 7.5). Preparation of genomic DNA by this method typically yields 10-20
µg DNA.
2.2.7 Cell number and size analysis
Cell densities and median cell volumes were determined using a Z2 Coulter® Particle
counter with Isoton II azide-free electrolyte, both supplied by Beckman Coulter (Luton,
Bedfordshire, UK).
2.2.8 b-galactosidase assays
2.2.8.1 S. pombe
b-galactosidase assays of S. pombe cultures were performed using a method modied from
Dohlman et al. (1995) [227]. Cells were cultured to a density of 5x106 cells/ml in DMM
(lacking thiamine unless stated) and 500 µl aliquots transferred to 2 ml Safe-Lock Eppen-
dorf tubes containing varying concentrations of P-factor diluted in HPLC-grade methanol
(and dried to remove the methanol). Tubes were incubated at 29C for the length of the
assay on a rotating wheel and 50 µl transferred to 750 µl Z-buer (Table 2.13) containing
2.25 mM o-nitrophenyl-D-galactoside and incubated on a rotating wheel at 29C for a fur-
ther 90 min. Reactions were halted by addition of 200 µl 2M Na2CO3 and b-galactosidase
production calculated as the ratio of ONPG product formed (detected by optical density
(OD) measurement at 420 nm using an Ultrospec 3000; Pharmacia Biotech, Uppsala, Swe-
den) to assayed cells (determined using a Coulter Channelyser; Beckman Coulter, Luton,
Bedfordshire, UK) using the formula OD420/10
6 assayed cells.
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Table 2.13: Z-buer
NaPO4 (pH 7.0) 0.1 M
KCl 10 mM
MgSO4 1 mM
b-mercaptoethanol 50 mM
(v/v) chloroform 0.5%
(w/v) SDS 0.005%
2.2.8.2 S. cerevisiae
S. cerevisiae cells were cultured to a density of 5 x 105 cells/ml in SD with 2 ml transferred
to 8 ml YPDA medium and incubated at 29C for 3 h. 1.5 ml aliquots were transferred to
1.7 ml Eppendorf tubes and centrifuged with pellets resuspended in 300 µl Z-buer lacking
b-mercaptoethanol. Tubes underwent 3 rounds of freeze-thawing in liquid nitrogen and
100 µl was transferred to 700 µl Z-buer and 160 µl Z-buer containing 13.28 mM ONPG,
followed by incubation on a rotating wheel at 29C until development of yellow colouration.
Reactions were halted by addition of 400 µl 1M Na2CO3 and b-galactosidase production
calculated as the ratio of ONPG product formed (OD at 420 nm) per min to assayed cells
(determined with OD600) using the formula OD420/(t x OD600).
2.2.8.3 Analysis of data from b-galactosidase assays
Non-linear regression of dose-response data and statistical analysis was completed us-
ing GraphPad Prism software version 6.0 for Mac OS X (GraphPad Software Inc., San
Diego, CA, USA). Where possible, sigmoidal dose response curves using the log(agonist)vs
response-variable slope (four parameter) were t to dose-response data and a bell-shaped
curve was tted to non-monotonic responses.
2.2.9 Calculating doubling time
S. pombe cells were cultured in liquid DMM to a density of 2x106 cells/ml and their
cell density measured three times (as described in section 2.2.7). The average of the three
densities were taken (N0). The cultures were then grown for a further 8 h and the cell
densities were measured again three times and the average was calculated (N8). During
exponential growth phase cell cultures grow according to cell density with Nt:
Nt = N0 exp(kt) (2.1)
after dening the initial density, N0, where t is the time between cell density measurements
(t = 8 h in our case) and k is a growth constant or frequency (number of times it has grown
Chapter 2: Materials, methods and constructs 42
per unit time) where in the case of doubling k = ln(2)DT , where DT is the doubling time in
hours. Therefore DT can be calculated by:
DT =
8ln(2)
ln

N8
N0
 (2.2)
2.2.10 Yeast 2-hybrid assay
AH109 was co-transformed with the vectors pGBKT7 and pGADT7 (BD Biosciences) ex-
pressing proteins of interest. The two plasmids were selected by growth on SD medium
lacking leucine and tryptophan. Upon protein interaction, the GAL4 transcription factor
is reconstituted and the appropriate reporter genes are activated, resulting in growth on
medium also lacking histidine and adenine.
2.2.11 Yeast mating assays
Cells were cultured in liquid DMM to a density of 5x106 cells/ml. 400 µl of each mating
type strain were mixed and harvested at 2000 rpm for 3 min. Cells were resuspended
in 20 µl of sterile water and 10 µl spotted onto 2xDMM plates containing 100-fold lower
NH4Cl than detailed in section 2.1.5. Non-mixed controls were also spotted onto the plates.
Following 72 h incubation at 29C the rst plate was used to perform an Iodine staining
assay as described in section 2.2.11.1 and the second plate was used to determine CFU
recovery (section 2.2.11.2).
2.2.11.1 Iodine staining
The plate was exposed to iodine crystals for 10 min or until staining was observed.
Brown/Black colony colouration occurred from iodine staining of the starch contained
within spore cell walls and indicated a successful mating [220].
2.2.11.2 CFU recovery assay
Each colony from the plate was collected and suspended in 1 ml of sterile water. Two
separate 1 in 100 dilutions were then made from each 1 ml culture. One of these was plated
onto separate YE plates at nal dilution factors of 1 in 1,000 and 1 in 10,000 respectively.
The other was placed in a 55C heat block for 10 min to lyse the yeast cells but retain the
spores formed from mating. This heat-treated sample was then plated onto separate YE
plates at nal dilution factors of 1 in 1,000 and 1 in 10,000. Following 72 h incubation, the
number of colonies on each plate were counted using a G:Box iChemi gel documentation
system with GeneTool analysis software (Syngene, Cambridge, UK). The number of colony
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forming units (CFU) as a percentage of the total (colony survival) was calculated using the
following equation:
CFU recovery (%) =
Number of colonies formed after heat treatment
Number of colonies formed before heat treatment
x 100
The CFU recovery assay was developed by Michael Bond, University of Warwick, 2010
[228].
2.2.12 Visualisation of cell wall and septa
1 ml of cultured cells were harvested and resuspended in 20 µl sterile water containing 0.1
mg/ml calcouor white (Sigma-Aldrich Co. Ltd.). 4 µl of cell suspension was transferred
to a solid DMM (2% (w/v) agarose) pad on a glass slide and imaged using the microscopes
described in section 2.2.14.
2.2.13 Visualisation of nuclei
90 µl of S. pombe cells were xed by adding 10 µl of 36.5% (v/v) formaldehyde solution
and incubating at 21C for 10 mins. After this time harvest the cells and wash twice with
phosphate buered saline (PBS) to remove the formaldehyde and resuspended in 10 µl of
PBS. 2.5 µl of this culture to a microscope slide and dry in a fume hood for 5 mins. 2 µl of
cells was mixed with 2 µl 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI) (Vecta
shield mounting medium with DAPI; Vector Lab, Inc.) on a slide immediately before
imaging as described in section 2.2.14.
2.2.14 Fluorescence microscopy
Strains were cultured in the appropriate medium to a density of 5x106 cells/ml. 2 µl of
cell culture was transferred directly to a solid DMM (2% (w/v) agarose) pad made on a
glass microscope slide (by pipetting 50 µl of liquid agarose onto one slide and compressing
the agarose with second slide allowing the agarose pad to solidify, thereby creating a at
surface) and the residual medium was allowed to dry. A coverslip was placed over the cells
on the agar pad and sealed with a Vaseline, Lanolin and Paran (VALAP) mixture (made
by equal parts by weight) to prevent drying of the sample. Images were then obtained
using either a True Confocal Scanner Leica TCS SP5 microscope (Leica Microsystems
Ltd., Milton Keynes, UK) (section 2.2.14.2) or DeltaVision system wide-eld deconvolution
microscope (section 2.2.14.3). Image acquisition and subsequent deconvolution of images
from the DeltaVision system was performed with softWoRx (applied precision) software.
Deconvolution was performed with the following settings; Ratio = conservative, Number of
cycles = 8 and Noise ltering = high.
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2.2.14.1 Time-series live-cell imaging
Microscope slides for time-series imaging of live cells were prepared as in section 2.2.14.
P-factor was added at the desired concentration to the DMM (2% (w/v) agarose) pad and
imaged with either of the microscopes described in section 2.2.14.
2.2.14.2 Leica SP5 microscope
Cells were imaged by taking a Z-stack at time = 0 h and subsequently every 15 min for
a period of 16 h, unless otherwise stated in the experiment. The imaging procedure was
set up such that cells were focused at 0 h and the Z position noted (Zfocus). The Z-stack
was then dened such that 20 Z-slice images would be obtained from Zfocus - 10 µm to
Zfocus + 10 µm to allow for drift in the focal plane over the course of the experiment. The
time-series experiment was setup such that both light-eld and uorescence images were
generated.
Table 2.14: List of gures taken using Leica SP5
Figure 4.2a
Figure 4.5
Figure 4.7
Figure 4.7
Figure 4.8
Figure 4.12b
Figure 4.14
Figure 4.15
Figure 4.17
Figure 4.22
Figure 4.24
Figure 4.26
Figure 4.28
Figure D.1
2.2.14.3 DeltaVision wide-eld microscope
Cells were imaged by taking Z-stacks from time = 0 h and subsequently every 15 min for a
period of 16 h, unless stated otherwise in the experiment. The imaging procedure was set
up such the bottom of the cell was focused at 0 h and the distance between that Z position
and the coverslip was measured (Zdistance). At each time point in the series the Zdistance
was kept constant before taking 20 Z-stacks of 0.3 µm.
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Table 2.15: List of gures taken using DeltaVision
Figure 5.3
Figure 5.6
Figure 5.7b
Figure 5.8a
Figure 5.10
Figure 5.11
Figure 5.15
Figure 5.20
Figure 5.21
Figure 5.22a
Figure E.1
Figure E.2
2.2.15 Flow cytometry
Flow cytometry was performed using a Becton, Dickinson and Company (BD) LSR II ow
cytometer (BD Biosciences, Oxford, UK).
2.2.15.1 Flow cytometry analysis of cell DNA content
Cells were grown in minimal medium to a density of 1x107 cells/ml (unless otherwise
stated). 1 ml of culture was sonicated, harvested at 2000 rpm for 5 min and xed in 1 ml
of ice cold 70% (v/v) ethanol overnight. 300 µl of xed cells were then washed in 3 ml
of 50 mM sodium citrate and resuspended in 500 µl of 50 mM sodium citrate containing
0.1 mg/ml RNase A. Cells were incubated at 37C for 2 h before the addition of 500 µl
of 50 mM sodium citrate containing 8 g/ml propidium iodide. Up to 30,000 particles per
sample were then analysed using the ow cytometer, measuring the intensities of staining
with propidium iodide. Excitation was achieved using a 488 nm laser and emission detected
using a 575/26 nm band pass lter with a 550 nm long pass lter. Protocol described by
Sazer and Sherwood (1990) [229].
2.2.16 Cell viability assay
Analysis of cell viability was performed using the LIVE/DEAD® Funga Light™ yeast vi-
ability kit (Invitrogen Ltd.), which utilises two nucleic acid stains, propidium iodide and
SYTO®9, which dier in ability to translocate across the cell membrane. Viable cells will
only contain SYTO®9 whereas non-available cells that have a comprised cell membrane,
will contain both dies. The reduction in SYTO®9 signal in non-viable cells caused by the
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forster resonance energy transfer (FRET) between the two uorophores is detected using
ow cytometry and provides a quantitative measure of the percentage of non-viable cells
within a population [230].
Cells were cultured to a density of 5x105 cells/ml in DMM and 500 µl aliquots trans-
ferred to 2 ml Safe-lock tubes (Eppendorf Ltd.) containing P-factor pheromone (diluted in
HPLC-grade methanol and dried to remove methanol). Following 16 h incubation at 29oC
on a rotating wheel, cells were washed twice in 1 ml PBS and stained in 1 ml PBS con-
taining 1 µl SYTO®9 (3.34 mM in dimethyl sulfoxide) and 1 µl propidium iodide (20 mM
in dimethyl sulfoxide). The percentage of cells containing both dyes was evaluated using
a BD LSR II ow cytometer. Both dyes were excited using a 488 nm laser and emission
detected using a 550 nm long pass lter with a 575/26 nm band pass lter for propidium
iodide and a 505 nm long pass lter with a 530/30 nm band pass lter for SYTO®9.
2.2.17 Statistical signicance
All statistical signicance was calculated using pairwise comparisons with either one-way
or two-way ANOVA with a Dunnet's multiple comparison test.
2.2.18 Image analysis
All image processing was performed using the open source software ImageJ
(http://rsb.info.nih.gov/ij/). Cell segmentation and tracking was performed using the
Quantitative Imaging of Membrane Proteins (QuimP) plugin for ImageJ, rst described
by Dormann et al. (2002) [231] and further developed to quantify spatio-temporal patterns
of uorescently labelled proteins in the cortex of moving cells [232{234]. All images to
be analysed with QuimP were processed by creating maximal projections from Z-stacks
and subtracting background pixel intensity prior to analysis unless otherwise stated in the
experiment.
2.2.18.1 Cell segmentation and tracking
QuimP software was used to segment individual cells within an image. Cell selection was
where possible, randomised by using a random number generator to obtain a coordinate on
the image and subsequently selecting the closest cell to this co-ordinate (based on distance
to the closest cell edge).
2.2.18.2 Single cell quantication
The image analysis software QuimP calculates uorescence measurements from pixel inten-
sities and cell size measurements based on the cell outline for each single time point image
or for each frame of a given time-series set of images. Statistical signicance of the data
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generated from QuimP was analysed using GraphPad Prism software version 6.0 for Mac
OS X (GraphPad Software Inc., San Diego, CA, USA).
2.2.19 Computational methods
Modelling and simulation were performed using code written and implemented within Math-
ematica 9.0.1.0 (Wolfram Research Inc., USA). The xCellerator (California Institute of
Technology, USA, 2005) package for Mathematica was used to facilitate in silico experi-
mentation and hypothesis modication. The package takes a reaction scheme as input and
produces an equivalent system of ordinary dierential equations (ODEs).
2.2.19.1 Numerical dierential equation Solver
Systems of ODEs were solved using the in-built Mathematica function NDSolve with the
default options. This function has a range of available algorithms at its disposal and selects
the most appropriate depending on the type of system being solved. It automatically
adjusts step-size to achieve the specied accuracy and precision, which in all cases were set
to Automatic and found to function without introducing any signicant numerical errors.
2.2.19.2 Simulation of dose-response Curves
To simulate the addition of pheromone after a certain time, the ligand concentration was
increased from zero up to a range of concentrations (1 nM - 100 µM) corresponding ap-
proximately to the concentrations seen by cells in an assay. The system was allowed to
reach steady state in the absence of ligand before it was added. The increase in ligand
concentration was not quite instantaneous, instead a tanh function was used to avoid nu-
merical errors that can occur at discontinuities during the solving process. It is assumed
that binding of ligand to receptor depletes the local availability of ligand. The output is
taken to be the number of active eector complexes and is integrated over the duration of
the simulated assay to mimic the accumulation of the reporter gene b-galactosidase, which
in S. pombe is very stable. The accumulated quantity is plotted against the stimulating
quantity of ligand to produce a simulated dose-response curve.
2.2.19.3 Simulated modied strains
Modications to the simulated wild type (WT) strain were achieved by altering the values
used for reaction rate constants, usually setting some of them to zero to prevent the required
reactions from occurring, or by altering the initial concentrations of some species to simulate
additional plasmid-borne expression or gene deletions.
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2.3 Constructs
2.3.1 Creation of constructs for gene disruption
This section describes the generation of constructs to allow insertion of exogenous DNA
(such as the ura4 cassette) in place of the endogenous gene through homologous recombina-
tion. All constructs were created in the pBluscriptKS (pKS, Stratagene) vector (JD1776).
Table 2.16 details all integration constructs used in this study.
Name Description source
JD3535 pKS-gap1::ura4 C. Weston, PhD thesis, 2013
JD3903 pKS-cki1::ura4 This study
JD3905 pKS-cki3::ura4 This study
JD3908 pKS-cki2::ura4 This study
Table 2.16: Plasmids used for gene integration
2.3.1.1 Disruption of cki1
The cki1 open reading frame (ORF) was disrupted by insertion of the ura4 cassette into a
9 base pair (bp) region from position 1 from the ATG start codon. To drive the integration
of the ura4 cassette, a 452 bp 5' untranslated region (UTR), together with the rst 419
bp of the cki1 ORF was amplied from S. pombe genomic DNA using sense (JO3125) and
antisense (JO3126) oligonucleotide, which introduced an XbaI and EcoRI site at each end
of the PCR product, respectively. The 971 bp PCR product and the pKS vector (JD1776)
was digested with XbaI and EcoRI before ligating.
Inverse PCR amplication was performed with a sense oligonucleotide (JO3078) starting
from position 10 relative to position 1 from the ATG codon and an antisense oligonucleotide
(JO3075) starting from position -1 relative to the ATG codon. These oligonucleotides
contained half a BamHI site, such that when the PCR product was ligated to re-circularise
the vector this introduced a full BamHI site and removed the rst 9 bp of the cki1 ORF.
Finally, the ura4 cassette was inserted as a BamHI fragment into the BamHI digested
integration construct described above to produce JD3903 (Figure A.1). This construct was
used to produce cki1 strains (containing the ura4+ cassette running antisense relative to
the direction of the cki1 ORF) through homologous recombination, using a lithium acetate
transformation [225] of S. pombe with XbaI and EcoRI digested JD3903.
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2.3.1.2 Disruption of cki2
The cki2 ORF was disrupted through insertion of the ura4 cassette into a 8 bp region
relative to position 1 from the ATG codon. To drive the integration of the ura4 cassette
a 469 bp 5' UTR together with the rst 435 bp of the cki2 ORF was amplied from
S. pombe genomic DNA using a sense (JO3127) and antisense (JO3128) oligonucleotide,
which introduced an XbaI and HindIII site, respectively. The 904 bp PCR product and
pKS vector (JD1776) was digested with XbaI and HindIII before ligating.
Inverse PCR amplication was performed vector described above with a sense oligonu-
cleotide (JO3088) starting from position 9 relative to position 1 from the ATG codon and
an antisense oligonucleotide (JO3082) starting from position -1 relative to the ATG codon.
These oligonucleotides contained half a BamHI site, such that when the PCR product was
ligated to re-circularise the vector. This introduced a full BamHI site in place of the rst
8 bp of the cki2 ORF.
Finally, the ura4 cassette was inserted as a BamHI fragment into BamHI digested
integration construct to produce JD3908 (Figure A.2). This construct can be used to
produce cki2 strains (containing the ura4+ cassette running antisense relative to the
direction of the cki2 open reading frame) through homologous recombination, using a
lithium acetate transformation [225] of S. pombe with XbaI and HindIII digested JD3908.
2.3.1.3 Disruption of cki3
The cki3 ORF was disrupted through insertion of the ura4 cassette into a 9 bp region
relative to position 1 from the ATG codon. To drive the integration of the ura4 cassette
a 480 bp 5' UTR together with the rst 422 bp of the cki3 ORF was amplied from
S. pombe genomic DNA using a sense (JO3129) and antisense (JO3130) oligonucleotide,
which introduced an XbaI and HindIII site respectively. The PCR product and pKS vector
(JD1776) was digested with XbaI and HindIII before ligating.
Inverse PCR amplication was performed on the resulting vector with a sense oligonu-
cleotide (JO3132) starting from position 10 relative to position 1 from the ATG codon and
an antisense oligonucleotide (JO3131) starting from position -1 relative to the ATG codon.
These oligonucleotides contained half a BamHI site, such that when the PCR product was
ligated to re-circularise the vector. This introduced a full BamHI site in place of the rst
9 bp of the cki3 ORF.
Finally, the ura4 cassette was inserted as a BamHI fragment into BamHI digested
integration construct to produce JD3905 (Figure A.3). This construct can be used to
produce cki3 strains (containing the ura4+ cassette running antisense relative to the
direction of the cki3 open reading frame) through homologous recombination, using a
lithium acetate transformation [225] of S. pombe with XbaI and HindIII digested JD3905.
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2.3.2 Constructs for constitutive gene expression
This section describes the generation of constructs to allow expression of genes from the
pREP3x or pREP4x vectors. The pREP vectors, which contain the inducible nmt1 (no
message in thiamine) promoter allow the control of gene expression through the addition
or removal of thiamine from the growth medium and are used to control the expression of
the exogenous genes in S. pombe [235].
Yeast strains used in this study are auxotrophic in the S. pombe gene leu1, which encodes
b-isopropylmalate dehydrogenase, a protein required for leucine biogenesis [236]. pREP3x
constructs exploit this auxotropic phenotype by using the leu1 for selection. pREP3x
plasmids contain the S. cerevisiae LEU2 gene, which complements for the loss of leu1
[235]. Similarly, pREP4x constructs use the S. pombe gene ura4 for selection, as these
plasmids contain the ura4 gene [237]. ura4 encodes orotidine-5'-phosphate decarboxylase,
which is essential for biogenesis of uracil. ura4 can be used for both positive and negative
selection. Growth in the presence of 5' uoroorotic acid (FOA) causes cytotoxicity, whilst
the absence of uracil leads to auxotrophy for ura4 disruptants [238].
It should be noted that throughout this study a modied version of pREP3x was used,
which contains an EcoRV site directly before the BamHI site in the pREP multiple cloning
site (MCS). Table 2.17 lists all vectors used in this study to generate constructs for con-
trolled gene expression and Table 2.18 lists all the vectors used to express exogenous genes
throughout this study.
The following nomenclature has been used to describe the expression of genes and binding
domains etc. in this study. S. pombe cells transformed with pREP3x-Yfg1 and abbreviated
to pYfg1 for example, implies that cells express Yfg1.
Name Description source
JD1776 pKS Stratagene
JD2320 pGADT7 BD clontech
JD2935 pREP3x-Mam25 [173]
JD3374 pKS-Mam2tail E. McCann, PhD thesis, 2010
JD3386 pREP3x [235]
JD3453 pKS-mCherry M. Bond, PhD thesis, 2012
JD3590 pREP3x-Mam2-mCherry [173]
Table 2.17: Plasmids used to generate constructs for increased gene expression
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2.3.2.1 Creation of pREP3x-Cki constructs
These constructs were used in section 4.5.9 to elucidate the eect of constitutive expression
of either Cki1, Cki2 and Cki3 in S. pombe cells. The ORFs of Cki1, Cki2 and Cki3 were
amplied by PCR from an S. pombe cDNA library (created by Dr. Stephen J. Elledge
[239] and kindly provided by Professor Jonathan Millar, University of Warwick) using a
sense and antisense oligonucleotide, which introduced a full BamHI site at either end of the
PCR fragment (for oligonucleotides see Figure A.4). The PCR product was then digested
with BamHI and cloned into BamHI digested pREP3x (JD3386) to create pREP3x-Cki1
(JD3893), pREP3x-Cki2 (JD3766) and pREP3x-Cki3 (JD3782) (Figure A.4), which enables
expression of Cki1, Cki2 and Cki3 respectively in S. pombe under the control of the inducible
nmt1 promoter.
2.3.2.2 Creation of pGADT7-Cki1/Cki2/Cki3 constructs
These constructs were used in section 5.2 to elucidate a possible protein-protein interaction
between Cki1/ Cki2/ Cki3 with either the C-terminal tail of Mam2 or Rgs1. The pGADT7
vector (JD2320) was designed, such that when a protein of interest is fused to the GAL4
transcriptional activation domain (AD) and when co-transformed with a protein of interest
expressed from pGBKT7 vector fused to the GAL4 DNA-binding domain (BD), induces
transcription of the reporter gene lacZ. Expression of -galactosidase will only occur if these
two proteins of interest interact and bind to the GAL4-responsive promoter, indicating a
possible protein-protein interaction.
The ORFs of Cki1, Cki2 and Cki3 were amplied by PCR from an S. pombe cDNA library
(created by Dr. Stephen J. Elledge [239] and kindly provided by Professor Jonathan Millar,
University of Warwick) using a sense and antisense oligonucleotide, which introduced a full
BamHI site at either end of the PCR fragment (for oligonucleotides see Figure A.5). The
PCR product was then digested with BamHI and cloned into the BamHI digested MCS
of pGADT7 (JD2320) to create pGADT7-Cki1 (JD3770), pGADT7-Cki2 (JD3771) and
pGADT7-Cki3 (JD3763) (Figure A.5), which enables expression of Cki1, Cki2 and Cki3
respectively in S. cerevisiae under the control of the T7 promoter.
2.3.2.3 Creation of pREP3x-Mam22K-mCherry
Ubiquitination typically occurs on lysine residues. There are four lysine residues in the
C-terminal tail of Mam2: at position 307, 329, 345 and 346 from codon 1 from the ATG.
This construct was used in Chapter 5 to elucidate the eect of removing the two lysine
codons 307 and 329 on the signalling behaviour and localisation of Mam2.
Mam2 tagged mCherry was amplied on pREP3x-Mam2-mCherry (JD3590) (a plasmid
where the glutamine at position 304 (Q304) relative to position 1 (ATG) has been altered
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from CAA to CAg so that this residue forms the front half of a PvuII restriction site),
using a mutagenic sense oligonucleotide (JO2955), initiated directly downstream of Q304
and an antisense oligonucleotide (REP2). Amplication with JO2955 introduced a muta-
tion at the 307th and 329th codons of Mam2, changing the lysine codon (AAA) to arginine
(AgA) by a single base mutation. The PCR product (Figure A.6, highlighted in grey) was
ligated into PvuII digested pKS-Mam2tail. The small fragment produced from a digest
with XhoI andBamHI digested pKS-Mam22K-mCherry was ligated into XhoI/BamHI di-
gested pREP3x (JD3386) to produce pREP3x-Mam22K-mCherry (JD3802), which enables
expression of the mutated receptor in S. pombe cells under the control of the inducible nmt1
promoter (Figure A.6).
2.3.2.4 Creation of pREP3x-Mam24K-mCherry
To abolish ubiquitination of the C-terminal tail of Mam2, all four lysine residues (at codon
positions 307, 329, 345 and 346 from codon 1 from the ATG) were either mutated or
removed to elucidate their inuence on the localisation and signalling behaviour of Mam2
(Chapter 5).
pREP3x-Mam25 (JD2935) (where the last 5 amino acid residues of Mam2 have been
removed, which include lysine residues 345 and 346 and this plasmid has also been altered
at Q304 from CAA to CAg so that this residue forms the front half of a PvuII restriction
site) was amplied with sense (JO2955) and antisense (REP2) oligonucleotide to create a
PCR product that changed the 307th and 329th lysine (AAA) codons to arginines (AgA).
The PCR product (Figure A.7, highlighted in grey) was ligated into PvuII digested pKS-
Mam2tail to create pKS-Mam24K. A second PCR amplication was performed on pKS-
Mam24K with sense (REP1) and antisense (JO3038) oligonucleotides. This produces a DNA
fragment (Figure A.7, boxed by a red dotted line) that includes an XbaI site upstream of the
Mam2 ATG codon and excludes the Stop codon, such that when the fragment is digested
with XbaI and ligated into XbaI/ PvuII digested pKS-mCherry it creates a vector that
lacks any of the lysine residues in the C-terminal tail of Mam2 and is tagged with mCherry
(pKS-Mam24K-mCherry).
Finally, the small fragment produced when digesting pKS-Mam24K-mCherry with XhoI
and BamHI was ligated into XhoI/BamHI digested pREP3x (JD3386) to produce pREP3x-
Mam24K-mCherry (JD3804), which enables expression of the mutated receptor in S. pombe
under the control of the inducible nmt1 promoter (Figure A.7).
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Name Description Source
JD557 pREP41x [98]
JD636 pREP41x-Sxa2 [98]
JD1170 pGBKT7 BD Clontech
JD1627 pREP3x-Mam2 [184]
JD2261 pREP3x-GFP [222]
JD2320 pGADT7 BD Clontech
JD2332 pREP3x-Gpa1 [82]
JD2388 pREP4x-Rgs1 [82]
JD2555 pREP3x-Rgs1 [87]
JD2673 pREP3x-Gpa1G223S [82]
JD2880 pREP3x-Mam2tail [173]
JD2885 pREP3x-Mam2-GFP [184]
JD2999 pREP3x-Mam25-GFP [173]
JD3001 pREP3x-Mam213-GFP [173]
JD3003 pREP3x-Mam221-GFP [173]
JD3007 pREP3x-Mam237-GFP [173]
JD3180 pGADT7-Rgs1 [173]
JD3182 pGBKT7-Rgs1 [173]
JD3221 pGBKT7-Mam2tail [173]
JD3280 pGBKT7-Map3tail E. McCann, PhD thesis, 2010
JD3284 pGBKT7-STE2tail E. McCann, PhD thesis, 2010
JD3317 pREP3x-Mam2tail-GFP [173]
JD3386 pREP3x [235]
JD3514 pREP3x-mCherry [228]
JD3590 pREP3x-Mam2-mCherry [173]
JD2621 pREP3x-Mam2tail-mCherry [173]
JD3681 pREP-RBD M. Bond, University of Warwick
JD3763 pGADT7-Cki3 This study
JD3766 pREP3x-Cki2 This study
JD3770 pGADT7-Cki1 This study
JD3771 pGADT7-Cki2 This study
JD3782 pREP3x-Cki3 This study
JD3893 pREP3x-Cki1 This study
JD3802 pREP3x-Mam22K-mCherry This study
JD3804 pREP3x-Mam24K-mCherry This study
Table 2.18: Inducible plasmids The name, description and source of the plasmids used
in this study.
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Figure 3.1: The current S. pombe model. P-factor binds the GPCRMam2 promoting
GDP/GTP exchange on the G protein Gpa1. GTP-bound Gpa1 activates Ras1 via the
GEF Ste6, transducing signalling via sequential phosphorylation of a MAPK cascade (Byr2,
Byr1 and Spk1), resulting in activation of Ste11 (not included), which induces transcription
of mating-responsive genes. There are various points of regulation through the pathway
(highlighted with red text) including: Rgs1, which catalyses the hydrolysis of Gpa1. Gap1,
which hydrolyses Ras1 and Pmp1 a phosphatase that regulates the action of Spk1 (Figure
adapted form [50]). The red dashed box highlights components described in the previous
models and the purple box contains components that are incorporated into the model in
this chapter.
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3.1 Chapter aim
This chapter extends the previously discussed mathematical models of the S. pombe mating-
response pathway to include all known components, including known points of adaptation
(signal regulation) (Figure 3.1).
3.2 Background
The rst kinetic model of the S. pombe mating-response pathway by Smith et al. (2009)
was developed on quantitative data via the use of lacZ reporter strains [190]. These types of
assays will henceforth be referred to as end-point data, as the assay is performed following 16
h of pheromone treatment (for details on how these reporter strains are used as an indirect
measure of pheromone activation see section 2.1.7.2). The rst mathematical model could
only reproduce the end-point data with the existence of a novel inactive GTP-bound state
of the G protein [190]. The inactive-GTP bound state placed signicant importance on
rapid GTP-hydrolysis rather than retention of a GTP-bound state to induce a maximal
transcriptional response. They suggested that the RGS protein could act as both a positive
regulator, accelerating the conversion of inactive-GTP to GDP on the G protein (thus
increasing the pool of GDP-bound G protein to associate with ligand-occupied receptors
for reactivation) and a negative regulator, by hydrolysing GTP prior to eector activation
via the G protein (Figure 3.2).
The second model by Croft et al. (2013) was an extension of the rst and imposed spatial
regulation of the RGS species [173]. A combination of confocal imaging and end-point data
demonstrated that a physical interaction between the RGS species and the C-terminal
domain of Mam2 (the GPCR) was essential for RGS plasma membrane localisation and
consequent hydrolysis of the G protein. These ndings highlighted the importance of the
receptor tail in transducing and regulating signalling response in S. pombe.
Previous modelling eorts were incapable of recapitulating all end-point data as only
terms for describing pheromone binding Mam2 (a GPCR), signal transduction via Gpa1 (a
G protein) and signal regulation by Rgs1 (the RGS species) were described (Figure 3.1).
The signal transduction pathway is more complex than this. GTP-bound Gpa1 promotes
GDP/GTP exchange on the monomeric G protein Ras1, signals via a MAPK cascade to
phosphorylate the transcription factor Ste11, which then up-regulates mating responsive
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genes (including sxa2 ) (reviewed in [50]). Therefore, a complete model that incorporates
all known components of the pathway will be described in this chapter.
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Figure 3.2: Rgs1 can both negatively and positively regulate signalling. (a)
A model of the inert state hypothesis. The GTP-bound Ga-subunit enters an inert state
while remaining associated with an eector molecule following activation of downstream
signalling. GTP-hydrolysis is the only exit from the inert state and an RGS protein can
both positively and negatively regulate signalling through acceleration of GTP-hydrolysis.
(b) In vitro end-point data adapted from Smith et al. (2009) [190], which highlights the
negative (-ve) and positive (+ve) role of Rgs1. (c) Smith et al. (2009) in silico output
showing that simulating the deletion of RGS recapitulates the experimental data.
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3.3 Implementation of model
The implementation of the Croft et al. (2013) model [173], which included the inert state
hypothesis and spatial regulation of Rgs1 is summarised below to illustrate how the models
described in this chapter were simulated and to set a benchmark for extending the model.
3.3.1 The addition of ligand
In the in vitro experiments S. pombe strains were grown to mid-exponential growth phase
prior to treatment with pheromone. To simulate this in silico, the initial ligand concen-
tration, L(0), was set to zero for a simulated period of 14 h (t0=14 h). This enabled the
system of ODEs to equilibrate before the addition of ligand. The concentration of ligand
was then rapidly but not discontinuously increased to the specied concentration L(t0)
using Equation 3.1 (Figure 3.3).
L(t) =
L(t0)
2

tanh
 
b(t  t0)

+ tanh
 
bt0

(3.1)
Increasing the constant b alters the sharpness of the transition, i.e. closer to a step-function.
The value of b used in the simulations was 100 as this was found to be suciently sharp
to allow the application of ligand close to instantaneous and yet smooth enough that the
numerical dierential equation solving algorithm remained accurate in this region [173, 190].
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Figure 3.3: Ligand application. Comparison between ligand application using a dis-
continuous step function (black) and the smooth tanh function described in Equation 3.1
(blue), with L(t0)=1000 and b=0.5 for visualisation.
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3.3.2 Measuring the response
The S. pombe pheromone-response was measured by determining the b-galactosidase ac-
tivity following a period of treatment with pheromone (typically 16 h). Measuring b-
galactosidase activity per cell is a proxy for the concentration of b-galactosidase. This
therefore provides an indirect measure of sxa2 transcription and hence, signal transduction
through the pathway. This can be simulated in silico by an integral from t=0 h up to
a short time after the system reaches a new equilibrium tassay (following treatment with
ligand) [11]. A cascade of linear relaxation elements (z1(t), z2(t) and z3(t)) was applied to
the number of active eector molecules (in the case of the Croft et al. (2013) model this is
GaGTPEector however, as the model was extended this species changed) and
R tassay
0 z3(t)
was the quantity measured. The cascade was applied by augmenting the system of dier-
ential equations with Equations 3.2 - 3.4.
z10(t) = GGTPEector  z1(t) (3.2)
z20(t) = z1(t)  z2(t) (3.3)
z30(t) = z2(t)  z3(t) (3.4)
These equations empirically and simplistically model the components downstream of the
G protein and reects the time dierence between the dynamics of the G protein cycle and
expression of b-galactosidase. A value of g=32 was used to stretch the response time to that
observed in time-course data [190]; induction of b-galactosidase in response to pheromone
becomes detectable between 2 h and 4 h [11]. It should be noted that as the model was
extended the cascade of relaxation elements were removed.
3.3.2.1 The model output
When reaction rates (k) were unknown, these were assigned an arbitrary value and heuris-
tically determined to best t the experimental data. This technique was implemented in
the previous mathematical models of the S. pombe mating-response and is a technique em-
ployed to extend the model in this chapter. The Croft et al. (2013) model reaction scheme
with the corresponding reaction rates k (Table 3.2) was transformed into a systems of ODEs
(as detailed in 2.2.19). The resulting systems of ODEs can be simulated with the initial
species concentrations as described in Table 3.1 and solved using the in-built Mathematica
function NDSolve with the default options.
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Species Concentration (nM) Assumptions Source
L 0 - 100,000
R 205 Calculated [184]
GaGDP 205 Assumed 1:1 ratio with R [213, 215, 240{242]
Gbg 205 1:1 ratio with GaGDP [213, 215, 240{242]
RGSc 60 Same as S. cerevisiae RGS species [241]
Eector 205 1:1 ratio with GaGDP [190]
All other species concentraions were set to 0 nM
Table 3.1: Initial species concentrations used to simulate the wild type S.
pombe response. Initial (when t=0 h) concentrations of species before the system is
equilibrated and source/or justication for using these concentrations are described.
Ligand / G protein signalling
L + R ! LR k1 0.0025 nM 1h 1
Gabg+ R ! RGabg k2 0.005 nM 1h 1
Gabg + LR ! LRGabg k3 0.02 nM 1h 1
L + RGabg ! LRGabg k4 0.005 nM 1h 1
L + RRGSm ! LRRGSm k5 0.005 nM 1h 1
Gabg + RRGSm ! RRGSmGabg k6 0.005 nM 1h 1
Gabg + LRRGSm ! LRRGSmGabg k7 0.02 nM 1h 1
L + RRGSmGabg! LRRGSmGabg k8 0.005 nM 1h 1
G protein activation
LRGabg ! GaGTP + Gbg + LR k9 50 h 1
Gabg ! GaGTP + Gbg k10 0.2 h 1
LRRGSmGabg ! GaGTP + Gbg + LRRGSm k11 40 h 1
Eector + GaGTP ! GaGTPEector k12 10 nM 1h 1
RGS tracking
RRGSc ! RRGSm k13 0.0005 h 1
RRGSm ! RRGSc k14 0.005 h 1
R + RRGSc ! RRGSm k15 0.1 nM 1h 1
RRGSm ! R + RRGSm k16 100 h 1
LR + RRGSc ! LRRGSm k17 0.1 nM 1h 1
LRRGSm ! LR + RRGSm k18 100 h 1
RGbg + RRGSc ! RRGSmGabg k19 0.1 nM 1h 1
RRGSmGabg ! RGabg + RRGSm k20 0.1 h 1
LRGabg + RRGSc ! LRRGSmGabg k21 0.1 nM 1h 1
GaGTP + RRGSc ! RRGSmGaGTP k22 60 nM 1h 1
RRGSmGaGTP ! GaGTP + RRGSc k23 0.05 h 1
inertGaGTPEector + RRGSc ! RRGSminertGaGTPEector k24 0.0001 nM 1h 1
Switching o / recycling G protein
GaGTPEector ! Eector + inertGaGTP k25 1 h 1
GaGTP ! GaGDP k26 0.005 h 1
GaGTP + RRGSm ! RRGSmGaGTP k27 500 nM 1h 1
RRGSmGaGTP ! GaGDPP + RRGSc k28 2.5 h 1
GaGTP + LRRGSm ! LRRGSmGaGTP k29 100 nM 1h 1
LRRGSmGaGTP ! GaGDPP + LRRGSm k30 2.5 h 1
GaGTP + RRGSm ! RRGSmGaGTP k31 0.5 nM 1h 1
RRGSmGaGTP ! GaGDPP + RRGSm k32 0.5 h 1
inertGaGTPEector ! GaGDPP + Eector k33 0.005 h 1
inertGaGTPEector + RRGSm ! RRGSminertGaGTPEector k34 50 nM 1h 1
RGSminertGaGTPEector ! GaGDPP + RRGSc + Eector k35 0.3 h 1
inertGaGTPEector + LRRGSm ! LRRGSminertGaGTPEector k36 50 nM 1h 1
LRRGSminertGaGTPEector ! GaGDPP + LRRGSm + Eector k37 0.3 h 1
GaGDPP ! GaGDP + P k38 1000 h 1
GaGDP + Gbg ! Gabg k39 1000 nM 1h 1
P ! ; k40 10 h 1
Table 3.2: The Croft et al. (2013) model reaction scheme. 40 reactions are
described each with an associated rate constant (k). Reactions included terms for the
inert state hypothesis of the Ga species (inertGaGTP) and the spatial regulation of RGS,
with separate cytoplasmic (RGSc) and membrane bound RGS (RGSm) species [173].
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Eector Eector0(t)=- k12Eector(t)GaGTP (t) + k25GaGTPEector(t)
Gabg Gbg0(t)=- k10Gabg(t) - k3Gabg(t)LR(t) - k2Gabg(t)R(t) + k39Gbg(t)GaGDP(t)
- k7Gabg(t)LRRGSm(t) - k6Gabg(t)RRGSm(t)
Gbg Gbg'(t)=k10Gabg(t) + k9LRGabg(t) - k39Gbg(t)GaGDP(t) +
k11LRRGSmGabg(t)
L L0(t)=- 1
2
k1L(t)R(t)(Tanh(t0b) - Tanh(b(t0-t))) -
1
2
k4L(t)RGabg(t)
(Tanh(t0b) - Tanh(b(t0-t))) -
1
2
k5L(t)(Tanh(t0b) - Tanh(b(t0-t)))RRGSm(t) -
1
2
k8L(t)(Tanh(t0b) - Tanh(b(t0-t)))RRGSmGabg(t)
LR LR0(t)=- k3Gabg(t)LR(t) + k9LRGabg(t) + 12 k1L(t) R(t)(Tanh(t0b) -
Tanh(b(t0-t))) + k18LRRGSm(t) - k17LR(t) RRGSc(t)
LRGabg LRGabg'(t)=k3Gabg(t)LR(t) - k9LRGabg(t) + 12 k4L(t)RGabg(t)(Tanh(t0b) -
Tanh(b(t0-t))) - k21LRGabg(t) RRGSc(t)
P P0(t)=- k40P(t) + k38GaGDPP(t)
R R0(t)=- k2Gabg(t)R(t) - 12k1L(t)R(t)(Tanh(t0b) - Tanh(b(t0-t))) -
k15R(t)RRGSc(t) + k16RRGSm(t)
RGabg RGbg0(t)=k2Gabg(t)R(t) - 12k4L(t)RGabg(t)(Tanh(t0b) - Tanh(b(t0-t))) -
k19RGabg(t) RRGSc(t) + k20RRGSmGabg(t)
GaGDP GaGDP0(t)=- k39Gbg(t)GaGDP(t) + k38GaGDPP(t)
GaGDPP GaGDPP0(t)=- k38GaGDPP(t) + k26GaGTP(t) + k33inertGaGTP(t) +
k30LRRGSmGaGTP(t) + k37LRRGSminertGaGTP(t) + k28RRGSmGaGTP(t)
+ k35RRGSminertGaGTP(t) + k32RRGSmGaGTP(t)
GaGTP GaGTP0(t)=k10Gabg(t) + k9LRGabg(t) - k26GaGTP(t) -
k12Eector(t)GaGTP(t) - k29GaGTP(t)LRRGSm + k11LRRGSmGabg(t) -
k22GaGTP(t)RRGSc(t) - k27GaGTP(t)RRGSm(t) + k23RRGSmGaGTP(t) -
k31GaGTP(t)RRGSm(t)
GaGTPEector GaGTPEector0(t)=k12Eector(t)GaGTP(t) - k25GaGTPEector(t)
inertGaGTP inertGaGTP0(t)=k25GaGTPEector(t) - k33inertGaGTP(t) -
k36inertGaGTP(t)LRRGSm(t) - k24inertGaGTP(t)RRGSc(t) -
k34inertGaGTP(t)RRGSm(t)
LRRGSm LRRGSm0(t)=- k18LRRGSm(t) - k7Gabg(t)LRRGSm(t) -
k29GaGTP(t)LRRGSm(t) - k36inertGaGTP(t)LRRGSm(t) +
k11LRRGSmGabg(t) + k30LRRSmGaGTP(t) + k37LRRGSminertGaGTP(t) +
k17LR(t)RRGSc(t) +
1
2
k5L(t)(Tanh(t0b) - Tanh(b(t0-t)))RRGSm(t)
LRRGSmGabg LRRGSmGabg'(t)=k7Gabg(t)LRRGSm(t) - k11LRRGSmGabg(t) +
k21LRGabg(t)RRGSc(t) + 12 k8L(t)(Tanh(t0b) - Tanh(b(t0-t)))RRGSmGabg(t)
LRRGSmGaGTP LRRGSmGaGTP0(t)=k29GaGTP(t)LRRGSm(t) - k30LRRGSminertGaGTP(t)
LRRGSminertGaGTP LRRGSminertGaGTP0(t)=k36inertGaGTP(t)LRRGSm(t) -
k37LRRGSminertGaGTP(t)
RRGSc RRGSc0(t)=- k13RRGSc(t) - k17LR(t)RRGSc(t) - k21LRGabg(t)RRGSc(t)
- k15R(t)RRGSc(t) - k19RGabg(t)RRGSc(t) - k22GaGTP(t)RRGSc(t) -
k24inertGaGTP(t)RRGSc(t) + k14RRGSm(t) + k23RRGSmGaGTP(t) +
k28RRGSmGaGTP(t) + k35RRGSminertGaGTP(t)
RRGSm RRGSm0(t)=k18LRRGSm(t) + k13RRGSc(t) - k14RRGSm(t) -
k27GaGTP(t)RRGSm(t) - k34inertGaGTP(t)RRGSm(t) + k16RRGSm(t) +
k20RRGSmGabg(t)
RRGSmGaGTP RRGSmGaGTP0(t)=k22GaGTP(t)RRGSc(t) + k27GaGTP(t)RRGSm(t) -
k23RRGSmGaGTP(t) - k28RRGSmGaGTP(t)
RRGSminertGaGTP RRGSminertGaGTP0(t)=k24inertGaGTP(t)RRGSc(t) +
k34inertGaGTP(t)RRGSm(t) - k35RRGSminertGaGTP(t)
RRGSm RRGSm0(t)=k15R(t)RRGSc(t) - k16RRGSm(t) - k6Gabg(t)RRGSm(t) -
1
2
k5L(t)(Tanh(t0b) - Tanh(b(t0-t)))RRGSm(t) - k31GaGTP(t)RRGSm(t) +
k32RRGSmGaGTP(t)
RRGSmGabg RRGSmGabg'(t)=k19RGabg(t)RRGSc(t) + k6Gabg(t)RRGSm(t) -
k20RRGSmGabg(t) - 12k8L(t)(Tanh(t0b) - Tanh(b(t0-t)))RRGSmGabg(t)
RRGSmGaGTP RRGSmGaGTP0(t)=k31GaGTP(t)RRGSm(t) - k32RRGSmGaGTP(t)
z1 z10(t)= 3
2
Eector(t)GaGTP - 3
2
z1(t)
z2 z20(t)= 3
2
z1(t) - 3
2
z2(t)
z3 z30(t)= 3
2
z2(t) - 3
2
z3(t)
Table 3.3: Croft et al. (2013) system of ODEs. Each species associated dierential
equation describes the rate of change of that species concentration with respect to time.
The ODEs are generated with the reactions rates k described in the Croft et al. 2013
reaction scheme (Table 3.2). b=100 (constant for ligand addition) and t0=14 (equilibration
time before ligand application).
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3.4 Extending the model
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Figure 3.4: Modelling Ras1 activation. P-factor binds the GPCR Mam2 promoting
GDP/GTP exchange on the G protein Gpa1. GTP-bound Gpa1 activates Ras1 via the
GEF Ste6, transducing signalling via sequential phosphorylation of a MAPK cascade (Byr2,
Byr1 and Spk1), resulting in activation of Ste11 (not included), which induces transcription
of mating-responsive genes. There are various points of regulation through the pathway
(highlighted with red text) including: Rgs1, which catalyses the hydrolysis of Gpa1. Gap1,
which hydrolyses Ras1 and Pmp1 a phosphatase that regulates the action of Spk1 (Figure
adapted form [50]). The red dashed box highlights components described in the previous
models, the purple dashed box contains components that are yet to be described in this
chapter and the yellow box highlights species that will be described in this section.
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3.4.1 The RAS model: Part 1 - activation of Ras1 via Gpa1
During the development of the model, generic terms have been used to describe the com-
ponents of the pheromone-induced pathway of S. pombe and these are listed in Table 3.4.
Protein species Modelling species
P-factor L
Mam2 R
Gpa1 Ga
- Gbg
Rgs1 RGS
Ste6 GEF
Ras1 RAS
Gap1 GAP
Byr2 MAP3K
Byr1 MAP2K
Spk1 MAPK
Pmp1 PhTase
Table 3.4: Species terms used in the models. General species terms used to describe
components of the pheromone-response pathway.
P-factor binds and activates Mam2 promoting nucleotide exchange on Gpa1 [63]. Active
GTP-bound Gpa1 promotes nucleotide exchange on the monomeric G protein Ras1. Like
other monomeric G proteins, Ras1 requires an interaction with a GEF to enhance the
release of GDP and thus, enable G protein activation through the binding of GTP [19].
S. pombe contains two known GEFs for Ras1: Ste6 and Efc25 [68, 243]. In addition to
promoting GDP disassociation on Ras1, these activating proteins direct Ras1 signalling to
dierent downstream eectors by potentiating either the transcriptional or morphological
pathway [244] (Figure 1.7).
Strains lacking ste6 prevents mating in S. pombe but does not aect the cells' morphol-
ogy, i.e. cells retain a typical barrel shape during mitotic growth and form conjugation
tubes following treatment with P-factor [68]. Conversely, strains lacking efc25 mate like
WT cells but display a spherical rather than a barrel shape morphology. Spherical shaped S.
pombe have been observed in other studies, typically when proteins required for cell polarity
are mutated or removed [73, 243]. These studies suggest that Ste6 directs Ras1 signalling
via the transcriptional pathway and Efc25 directs Ras1 signalling via the morphological
pathway (Figure 3.5).
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Figure 3.5: Ras1 has two known downstream targets. P-factor binding the GPCR
Mam2, promotes nucleotide exchange on Gpa1. GTP-bound Gpa1 activates the G protein
Ras1 via an interaction with either Ste6 or Efc25, which directs Ras1 signalling to either
the transcriptional or morphological pathway, respectively. Rgs1 regulates signalling by
catalysing the hydrolysis of GTP on Gpa1 (Figure adapted from [223]).
Overexpression of Efc25 inste6 strains rescues pheromone-induced transcription, whereas
overexpression of Ste6 in mitotically growing untreated efc25 cells does not rescue the
defects in cell morphology (C. Weston, PhD thesis, 2013) (i.e. cells maintain a spheri-
cal shape). These data along with the knowledge that Ste6 is pheromone-inducible [68],
suggests that Ste6 requires an interaction with another protein to activate Ras1. It seems
plausible that this interaction could be the G protein subunit Gpa1, as its self is pheromone-
inducible and G proteins have been shown to enhance GEF activity in other systems [245].
Therefore, it was assumed that Gpa1 binds Ste6 prior to activation of Ras1.
To include the binding of Gpa1 to Ste6 prior to Ras1 activation in the model, the Eector
species from the Croft et al. (2013) model (Table 3.2) was replaced with a generic GEF
term to represent Ste6. Following this, the Croft et al. (2013) model including the Eector
species replaced with GEF is referred to as the `RAS model'.
To simulate Ras1 activation, two reactions were included in the RAS model. One de-
scribing the binding of GDP-bound RAS to GaGTPGEF to form an inert-trimeric complex
consisting of Ga, GEF and RAS and a second equation describing the dissociation of the
trimeric complex, releasing GTP-bound RAS and inertGaGTPGEF (reaction 41 and 42,
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respectively from Figure 3.6a). These reactions satisfy the inert state hypothesis proposed
by Smith et al. (2009), which suggests that following activation of one Eector molecule
(for this model, RAS), the Ga complex enters an inert state that can be recycled back to
GDP-bound Ga via an interaction with RGSm (Figure 3.6b).
GEF + GaGTP ! GaGTPGEF k33=13 nM 1h 1
GaGTPGEF + RASGDP ! inertGaGTPGEFRASGTP k41=50 nM 1h 1
inertGaGTPGEFRASGTP ! inertGaGTPGEF + RASGTP k42=4 h 1
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Figure 3.6: RAS activation. (a) Reactions describing the activation of RAS activation
with associated rate constants and a (b) schematic describing the reactions from part (a);
the inert state is highlighted in grey.
Overexpression of Ste6 or Ras1 in wild type (WT) S. pombe strains does not aect
P-factor induced transcription (C. Weston, PhD thesis, 2013, [228]). Therefore, the con-
centration of Ste6 and Ras1 was assumed to not be a limiting factor during signal transduc-
tion in response to P-factor. Thus the initial concentration of the GEF and RASGDP in the
RAS model was assumed to equal the concentration of the G protein ([GaGDP]=[GEF]=
[RASGDP]=205 nM).
The previous mathematical models of the S. pombe mating-response pathway impose
the inertGaGTP as a separate physical state [173, 190]. In the RAS model, GaGTP is
bound in complex with GEF and the GaGTPGEFRASGTP trimeric-complex becomes inert
following the binding and subsequent activation of a single RAS species. Recycling of the
inertGaGTPGEF complex was assumed to occur with the same mechanisms as proposed
for inertGaGTP in the previous models [173, 190], i.e. inertGaGTPGEF binds RGSm
and LRRGSm with the same anity as inertGaGTP in the Croft et al. (2013) model.
In addition, inertGaGTPGEF binds RGSc with a slower anity and thus maintains the
importance of spatial regulation of the RGS species in transducing signalling response.
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3.4.1.1 Partial activation of RAS by GaGTP
Loss of the G proteins, Gpa1 or Ras1, prevents mating in S. pombe [63, 246]. This was
veried by performing a b-galactosidase assay (as described in section 2.2.8.1) with WT
(JY544), gpa1 (JY1285) and ras1 (JY630) strains, as no b-galactosidase activity was
observed following 16 h of treatment (Figure 3.7a). The equivalent in silico experiment
recapitulated the lack of transcriptional response when removing Gpa1 and Ras1 (Figure
3.7b). Specically, the RAS model with reactions 41 and 42 (Figure 3.6) was simulated
with initial species concentrations described in Table 3.5, following successive changes of
[GaGDP]=0 nM to reect gpa1 cells and [RASGDP]=0 nM to reect ras1 cells and
measuring the accumulation of RASGTP after 16 h simulated induction.
Species Initial concentration (nM)
L 0 - 100,000
R 205
GaGDP 205
Gbg 205
RGSc 60
GEF 205
RASGDP 205
All other species were set to 0 nM
Table 3.5: Initial concentrations for species in the RAS model. For simulation of
wild-type cells.
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Figure 3.7: The simulation was unable to recapitulate the b-galactosidase ac-
tivity observed in ste6 cells. (a) Figure adapted from C. Weston, PhD thesis, 2013.
(b) Deletion of Ste6, Gap1 and Ras1 can be simulated in silico by running the RAS model
with reactions 41 and 42 (Figure 3.6) with species concentrations described in Table 3.5,
following successive changes of [GEF]=[GaGDP]=[RASGDP]=0 nM and measuring the ac-
cumulation of RASGTP after 16 h simulated induction.
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Deletion of ste6 reduces maximal transcriptional expression but does not prevent b-
galactosidase activity (Figure 3.7a). This suggested that Ras1 could be partially activated
by another protein in response to P-factor. The equivalent in silico experiment [GEF]=0
nM did not produce any response (Figure 3.7b) as no Ste6-independent mechanisms for
RAS activation had been included in the model.
The most likely candidate to activate Ras1 was the other Ras1 GEF Efc25. However, a
dose-dependent increase in b-galactosidase activity was also observed in the double ste6 and
efc25 deletion strain (Figure 3.7a). Therefore, Ras1 can be activated in P-factor-dependent
manner by another protein. The only known P-factor-dependent signalling species upstream
of Ras1 is Mam2 (a GPCR) and Gpa1 (a G protein). If the receptor directly activated Ras1
then b-galactosidase activity would have been observed in the gpa1 b-galactosidase assay,
yet no such response was observed (Figure 3.7a). This suggests that Ras1 could be activated
by Gpa1 or another protein that has yet to be identied.
As S. pombe Ras1 has been studied extensively over the last 20 years and no such
protein has been identied in activating Ras1 in a pheromone-dependent manner, Gpa1
was assumed to partially activate Ras1. This activation of Ras1 via Gpa1 was included in
the model by the following equation:
GaGTP + RASGDP ! GaGTP + RASGTP k50=0.00034 nM 1h 1
The rate at which GaGTP promotes nucleotide exchange on RAS (k50) was chosen to be
0.00034 nM 1h 1 as this displayed a 75% reduction in the model output when [GEF]=0
nM, which is qualitatively similar reduction as observed in vitro (Figure 3.8).
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Figure 3.8: Perturbation of rate k50 (GaGTP activating RAS). (a) Figure adapted
from C. Weston, PhD thesis, 2013. (b) The RAS model plus reactions 41, 42 and 50
including species concentrations described in Table 3.5 were simulated with reaction rates
k50 when [GEF]=0 nM. Response units were measured by the accumulation of RASGTP
after 16 h simulated induction. k50=0.00034 nM
 1h 1 showed an 75% reduction (as seen
in vitro) when [GEF]=0 nM in comparison to simulations with [GEF]=205 nM.
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3.4.2 The RAS model: Part 2 - regulation of Ras1 via Gap1
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Figure 3.9: Modelling Ras1 inactivation via Gap1. P-factor binds the GPCR
Mam2 promoting GDP/GTP exchange on the G protein Gpa1. GTP-bound Gpa1 activates
Ras1 via the GEF Ste6, transducing signalling via sequential phosphorylation of a MAPK
cascade (Byr2, Byr1 and Spk1), resulting in activation of Ste11 (not included), which
induces transcription of mating-responsive genes. There are various points of regulation
through the pathway (highlighted with red text) including: Rgs1, which catalyses the
hydrolysis of Gpa1. Gap1, which hydrolyses Ras1 and Pmp1 a phosphatase that regulates
the action of Spk1 (Figure adapted form [50]). The red dashed box highlights components
described in the previous models, the purple dashed box contains components that are yet
to be described in this chapter and the yellow box highlights species that will be described
in this section.
Chapter 3: Model Extension 68
Ras proteins contain a weak intrinsic GTPase activity, which is greatly enhanced through
interaction with GAPs [247]. Ras1 is regulated through interaction with Gap1 (a GAP) [86].
A previous study has shown that Ras1 binds Gap1 via the second glycine residue within
the P-loop of Ras1 [223], analogous to mammalian systems [248]. Therefore, regulation
of Ras1 was included in the model by assuming RASGTP binds a generic species GAP to
promote GTP hydrolysis (Table 3.6).
RASGTP + GAP ! RASGTPGAP k44=0.00075 nM 1h 1
RASGTPGAP ! RASGDPP + GAP k45=10 nM 1h 1
RASGTP ! RASGDPP k48=10 nM 1h 1
RASGDPP ! RASGDP + P k49=1000 nM 1h 1
Table 3.6: Reactions for inactivation of RAS via GAP. RASGTP forms a complex
with GAP to create a RASGTPGAP complex, which disassociates to release GAP and
RASGDP (reactions 45, 48 and 49).
The initial concentration of GAP was not assumed to be a limiting factor for signal trans-
duction and therefore the concentration of [GAP]=205 nM, equivalent to the concentration
of RAS (Table B.1). The RAS model including reactions describing the activation of RAS
(reactions 41, 42 and 48) and reactions describing regulation of RAS via GAP (reactions 44,
45, 48 and 49) were collated and from this point on referred to as the `RAS model' (for the
full RAS model reaction scheme and initial conditions see Appendix B).
Species Initial concentration (nM)
L 0 - 100,000
R 205
GaGDP 205
Gbg 205
RGSc 60
Ste6 205
RASGDP 205
GAP 205
All other species were set to 0 nM
Table 3.7: Initial concentrations for species in the RAS model. For simulation of
wild-type cells.
It seems counterintuitive that a regulator of signalling such as Rgs1 increases maximal
signalling when overexpressed and reduces maximal signalling when removed in vivo (Figure
3.10a, see 2xRgs1 for overexpression and rgs1 for deletion of Rgs1). The Ras model was
able to recapitulate the changes in maximal expression displayed in vitro (Figure 3.10b),
as it included reactions which maintained the inert state hypothesis of the GaGTP species.
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The RAS model was simulated with species concentrations described in Table B.1, but
varying RGSc concentration in succession from 0 nM, 60 nM, 120 nM and 180 nM with the
output measuring the accumulation of RASGTP after 16 h simulated induction.
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Figure 3.10: Ras model reproduces the positive and negative role on signalling.
(a) Experimental data adapted from Smith et al. (2009) [190]. Error bars represents
SEM. (b) Simulations of the Ras model (Appendix B) with initial concentrations de-
scribed in Table B.1 but by varying RGSc concentration from [RGSc]=0 nM (0xRGS),
[RGSc]=60 nM (1xRGS), [RGSc]=120 nM (2xRGS) to [RGSc]=180 nM (3xRGS) were
created by measuring the accumulation of RASGTP after 16 h simulated induction.
Contrary to Rgs1, overexpression of Gap1 in WT S. pombe strains reduces maximal
signalling response (C. Weston, PhD thesis, 2013). This suggests that Gap1 negatively
regulates P-factor signalling. To elucidate whether Gap1 is a sole negative regulator of sig-
nalling and to determine whether the reactions described in the RAS model for inactivation
of RAS via GAP accurately describe the mechanism of Ras1 activation, a b-galactosidase
assay was performed with WT (gap1+) and gap1 (JY1538) strains. Cells were grown
to mid-exponential growth phase before treatment with a range of P-factor concentrations
(from 0 µM to 100 µM).
After 16 h strains were assayed for b-galactosidase activity (as described in section
2.2.8.1). gap1 cells displayed an increase in basal signalling at 41 lacZ units in com-
parison to WT strains at 11 lacZ units (however, this was not considered statistically
signicant, as p=0.1502 when n=5 (where n represents the number of independent experi-
ments) calculated using a Student's t-test) and a non-monotonic response peaking at 100
nM was observed (Figure 3.11a).
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Figure 3.11: The Ras model did not recapitulate the non-monotonic response.
(a) WT (JY544) and gap1 (JY1538) strains were grown to mid-exponential growth phase
before treatment with a range of P-factor concentrations (from 0 µM to 100 µM). After 16
h strains were assayed for b-galactosidase activity (as described in section 2.2.8.1). Data
shown is the average of ve independent experimentsSEM. The results are in agreement
with previously published work [223]. (b) Simulations of the RAS model with initial con-
centrations described in Table B.1 with [GAP]=205 nM and [GAP]=0 nM to simulate WT
and gap1 cells in vitro, were performed by measuring the accumulation of RASGTP
complexes following 16 h simulated induction.
The equivalent in silico experiment for strains lacking gap1 did not capture the non-
monotonic response displayed in vitro (Figure 3.11). Instead an increase in basal signalling
(also observed in vitro) and maximal transcriptional response was observed (Figure 3.11b).
Simulations of the RAS model with initial concentrations described in Table B.1 were per-
formed with [GAP]=205 nM to simulate WT cells and [GAP]=0 nM to simulate gap1 cells,
by measuring the accumulation of RASGTP complexes following 16 h simulated induction.
S. pombe cells lacking gap1 were shown to increase cell lysis following prolonged treat-
ment with P-factor [223]. These observations could explain the non-monotonic response of
gap1 cells observed in vitro (Figure 3.11a). To determine whether cells became increas-
ingly non-viable in response to treatment with P-factor, a cell viability assay (as described
in section 2.2.16) was performed with WT (gap1+) and gap1 strains that were grown
to mid-exponential growth phase before treatment with a range of P-factor concentrations
(from 0 µM to 100 µM) for 16 h.
A P-factor-dependent increase in non-viable cells was observed in both gap1+ cells (WT
strains) and gap1 cells (Figure 3.12). However, a signicant increase in the percentage
of non-viable cells was observed following 10 µM P-factor treatment (as WT displayed
122% whereas gap1 cells displayed 853% of cells were non-viable, p<0.0001 when
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n=3, Student's t-test). The P-factor-dependent increase in cell lysis corresponded with
the loss of b-galactosidase activity observed in gap1 strains (Figure 3.11). These data
therefore suggested that gap1 cells are less likely to survive, following treatment with P-
factor in the absence of Ras1-GTP hydrolysis thus, indicating that Gap1 is essential during
the S. pombe mating-response to induce a maximal signalling response [223].
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Figure 3.12: gap1 became non-viable with increasing P-factor concentration.
WT (JY544) and gap1 (JY1538) strains were grown to mid-exponential growth phase
before treatment with a range of P-factor concentrations (from 0 µM to 100 µM). After
16 h a cell viability assay was performed (as described in section2.2.16), which indicates
the percentage of non-viable cells within a population. Data shown is the average of three
independent experiments SEM. The results are in agreement with previously published
work [223].
GTP-bound Ras1 transduces signalling via Byr2 (a MAP3K) to enhance gene tran-
scription and Scd1 (a GEF for the essential G protein Cdc42) to initiate conjugation tube
formation [249] (Figure 3.13). Rga4 is a GAP for Cdc42 [250]. Increasing Rga4's concen-
tration in gap1 strains does not prevent P-factor-induced cell lysis, whereas increasing
Cdc42 concentration in gap1 strains partially rescues cell viability [223]. Together, with
the knowledge that deletion of Cdc42 or its downstream eectors is lethal to the cell [74, 77],
these data suggest that a reduction rather than an increase in Cdc42 activation promotes
cell lysis in gap1 strains. These data also suggest that Cdc42 becomes activated via form-
ing a complex with Ras1; and therefore, loss of Gap1 renders Cdc42 in complex and thus
is less likely to active its downstream eectors; mimicking a strain lacking Cdc42, which is
lethal (Figure 3.13).
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Figure 3.13: Loss of Gap1 reduces Cdc42 activation promoting cell lysis. Ras1
activation via Ste6 directs signalling to the MAPK cascade (Byr2, Byr1 and Spk1) re-
sulting in transcription of mating-responsive genes. Activation of Ras1 via Efc25, directs
Ras1 to activate Cdc42 (an essential G protein) via an interaction with Scd1 (and Scd2).
GTP-bound Cdc42 activates Shk1 and Pom1, proteins required for polarised cell growth
(conjugation tube formation). The two pathways are linked as Shk1 facilitates Byr2 ac-
tivation. Gap1 promotes GDP for GTP exchange on Ras1 and Rga4 acts as a GAP for
Cdc42. When Gap1 is present, Cdc42 is released from a Ras1/Scd1/Scd2/Cdc42/Gef1
complex (red dashed box), by Ras1 hydrolysis. However, when Gap1 is removed Cdc42
becomes stuck in complex and is therefore less likely to activate its downstream eectors
(illustrated by the grey arrows).
The RAS model did not contain terms for Ras1 activation of the morphological (conju-
gation tube formation) pathway and was therefore unable to replicate the non-monotonic
b-galactosidase response caused by cell lysis (Figure 3.11). Creating an in vivo system,
which prevents P-factor-dependent cell lysis whilst simultaneously increases maximal b-
galactosidase activity when gap1 is deleted, would suggest that Gap1 acts as a sole negative
regulator and that the reactions described in the RAS model were plausible.
S. pombe strains lacking Scd1 have not been shown to signal signicantly dierent
to strains containing endogenous scd1 [223]. This was conrmed by performing a b-
galactosidase assay (as described in section 2.2.8.1) with WT (JY544) and scd1 (JY1673)
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cells following growth to mid-exponential growth phase and treatment with varying P-factor
concentrations (0 µM to 100 µM) for 16 h (Figure 3.14). A reduction in maximal response
and pEC50 was observed in scd1 strains, however, these were not considered signicant
(for p-values see Figure 3.14c).
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Figure 3.14: Scd1 is not required for pheromone-induced gene transcription.
(a) Deletion of Scd1 directs Ras1 signalling via Byr2. (b) b-galactosidase assay (as de-
scribed in section 2.2.8.1) with WT (JY544) and scd1 (JY1673) strains following growth
to mid-exponential growth phase and treatment with varying P-factor concentrations (0
µM to 100 µM) for 16 h. The results are in agreement with previously published work
[223]. (c) The table displays basal, maximal and corresponding p-values determined using
a Student's t-test. Data shown is the average of three independent experiments SEM.
These data, together with the knowledge that deletion of Scd1 causes spherical cells that
do not form conjugation tubes in response to P-factor, indicated that the transcriptional
and morphological pathways could be separated via removal of Scd1 [73, 223]. Therefore,
deletion of both scd1 and gap1 would provide a system to measure the transcriptional
eect due to loss of gap1 in S. pombe by preventing cell lysis (Figure 3.15a). Hence, WT
(JY544), gap1 (JY1538), scd1 (JY1673) and scd1gap1 (JY1674) cells were grown
to mid-exponential growth phase, treated with a range of P-factor concentrations (from 0
µM and 100 µM) for 16 h and assayed for b-galactosidase activity to assess the eect of
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removing gap1 on maximal response and cell viability (as described in section 2.2.8.1 and
2.2.16, respectively).
Maximal b-galactosidase activity was signicantly increased in strains lacking gap1 and
scd1 in comparison toscd1 cells (Figure 3.15b: from 1812 lacZ units to 537 lacZ units,
p=0.0148 when n=3 using a Student's t-test). A signicant reduction in the percentage
of non-viable cells (from 902% to 413%) was exhibited upon deletion of scd1 in gap1
strains (Figure 3.15c: p=0.0001 when n=3, Student's t-test). These data suggest that when
cell lysis is prevented in strains lacking Gap1, maximal response is increased. Therefore,
Gap1 most likely acts as a negative regulator of signalling when cell lysis is prevented.
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Figure 3.15: Scd1 depletion facilitated quantication of removing gap1. (a) Loss
of Scd1 and Gap1 amplies signalling of Ras1 via Byr2. WT (JY544), gap1 (JY1538),
scd1 (JY1673) and scd1gap1 (JY1674) strains were grown to mid-exponential growth
phase before treatment with a range of P-factor concentrations (from 0 µM to 100 µM). Af-
ter 16 h strains were assayed for (b) b-galactosidase activity (as described in section 2.2.8.1)
and (c) cell viability assay (as described in section 2.2.16) to determine the percentage of
non-viable. Data shown is the average of three independent experiments SEM.
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3.4.3 The MAPK cascade
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Figure 3.16: Modelling the MAPK cascade. P-factor binds the GPCR Mam2 pro-
moting GDP/GTP exchange on the G protein Gpa1. GTP-bound Gpa1 activates Ras1
via the GEF Ste6, transducing signalling via sequential phosphorylation of a MAPK cas-
cade (Byr2, Byr1 and Spk1), resulting in activation of Ste11 (not included), which induces
transcription of mating-responsive genes. There are various points of regulation through
the pathway (highlighted with red text) including: Rgs1, which catalyses the hydrolysis of
Gpa1. Gap1, which hydrolyses Ras1 and Pmp1 a phosphatase that regulates the action
of Spk1 (Figure adapted form [50]). The red dashed box highlights components described
in the previous models, the purple dashed box contains components that are yet to be
described in this chapter and the yellow box highlights species that will be described in
this section.
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3.4.3.1 Ras1GTP forms a complex with Byr2
The mitogen-activated protein kinase Byr2 acts downstream of Ras1 and is required for
pheromone-induced sexual dierentiation in S. pombe [76]. Byr2 contains a Ras-binding
domain (RBD) in its N-terminal 230 amino acid region [251] and is recruited to the plasma
membrane in a P-factor-dependent manner via binding Ras1 [252]. Despite this, it is unclear
whether the binding of Ras1 to Byr2 transduces signalling. To answer this question, the
RBD of Byr2 that had previously been cloned (by M. Bond at the University of Warwick,
2012) into the pREP3x vector (JD3681, pRBD) and the vector alone control (JD3386)
were transformed into WT strains (JY544; sxa2>lacZ ) and assayed for b-galactosidase
activity following growth to mid-exponential growth phase and treatment with varying
concentrations of P-factor for 16 h (as described in section 2.2.8.1), to quantify the aect
on transcription.
Expression of RBD signicantly reduced maximal transcriptional response from 231
lacZ units to 20.3 lacZ in comparison to WT strains (p<0.0001, Student's t-test) (Figure
3.17a). This suggests that RBD sequesters endogenous Ras1 thereby inhibiting the binding
of Ras1 with Byr2. These data indicated that signal transduction is only successful when
Ras1 forms a complex with Byr2.
The RAS model was extended to include the binding of Ras1 to Byr2, described by the
following reaction:
RASGTP + MAP3K ! RASGTPMAP3K k43=9 nM 1h 1
This reaction was simulated with the RAS model using initial concentration [MAP3K]=205
nM and measuring the accumulation of RASGTPMAP3K complexes after 16 h simulated
induction (Figure 3.17, WT).
The competitive sequestration of Ras1 between Byr2 and RBD was simulated in silico
using the RAS model with reaction 43 and an additional reaction which described RASGTP
binding RBD with the same rate (k43=kRBD=9 nM
 1h 1). The initial concentrations of
all species are described in Table B.1 but with [MAP3K]=205 nM and [RBD]=1000 nM.
The accumulation of RASGTPMAP3K complexes was then measured in silico following
16 h simulated induction. Simulated expression with the RBD results in a reduction in
maximal response similar to the in vitro data (Figure 3.17), suggesting that reactions and
rates used to describe the S. pombe mating-response could be plausible.
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Figure 3.17: Expression of the RBD in WT cells reduces transcription. (a) The
WT strain JY544 was transformed with pREP3x (JD3386) and pRBD (JD3681) and grown
to mid-exponential growth phase before treatment with a range of P-factor concentrations
(from 0 µM to 100 µM). After 16 h cells were assayed for b-galactosidase (as described
in section 2.2.8.1). Data shown is the average of three independent experiments SEM.
(b) Competitive sequestration of Ras1 between Byr2 and RBD was simulated in silico
using the Ras model including two reactions that described RASGTP binding RBD and
Byr2 with the same rate (k) but with diering initial concentrations ([Byr2]=205nM and
[RBD]=1000 nM) and all other initial species concentrations as described in Table B.1;
the output was the accumulation of RASGTPMAP3K complexes following 16 h simulated
induction.
3.4.3.2 Sequential activation of Byr2, Byr1 and Spk1
MAPK cascades relay information typically from the membrane into the nucleus promot-
ing changes in gene expression. Cascades consists of three kinases: MAP3K, MAP2K and
MAPK, which transmit signalling from one component to another by sequential phospho-
rylation [253].
In S. pombe, the binding of Ras1 to the N-terminus of Byr2 (a MAP3K) prevents autoin-
hibition of the Byr2 kinase catalytic domain (CD) [76], which promotes kinase activation.
The CD of Byr2 then phosphorylates Byr1 (a MAP2K), which in turn phosphorylates Spk1,
a MAPK that has been suggested to promote phosphorylation of the transcription factor
Ste11 [69, 70, 254{258].
Byr2, Byr1 and Spk1 are structurally and functionally related to the S. cerevisiae MAPK
proteins STE11, STE7 and FUS3, respectively [259]. However, the S. cerevisiae mitogenic
cascade requires the scaold protein STE5 to sequester all three components of the cascade,
insulating the mating-response MAPK kinases from other signalling pathways, such as the
starvation response, which also requires STE7 and STE11, but activates KSS1 (a MAPK)
to promote a growth response [260{264]. To date no STE5 homologue has been identied
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in S. pombe. Therefore, Byr2, Byr1 and Spk1 were not assumed to bind in complex to
promote signal transduction (Figure 3.18a).
MAPK signal transduction was incorporated into the RAS model (with reactions 43, 44,
45, 48 and 49) by the addition of reactions 51-54 (Figure 3.18b), which describe the phos-
phorylation of MAP2K by RASGTPMAP3K and subsequent phosphorylation of MAPK.
Dissociation of the complexes are also included. The initial concentrations of the MAPK
cascade were unknown and therefore assumed to be equivalent to other species concentra-
tions, as not to be a limiting factor during the response Table 3.8.
MAP3K
MAP2K
MAPK
RAS
GTP
Transcriptional 
response
P
P
P
RAS
GDPGAP
MAP2K
MAPK
MAP3K
MAP2K + RASGTPMAP3K!MAP2KP + RASGTPMAP3K k51 0.005 nM 1h 1
MAP2KP + MAPK ! MAP2KP + MAPKP k52 1 nM 1h 1
MAP2KP ! MAP2K k53 8 h 1
MAPKP ! MAPK k54 8 h 1
Figure 3.18: MAPK signalling in the S. pombe mating-response pathway. The
complex RASGTPMAP3K promotes phosphorylation of MAP2K, which in turn phospho-
rylates MAPK. The negative regulator GAP promotes nucleotide exchange on RAS.
Species Initial concentration (nM)
L 0 - 100,000
R 205
GaGDP 205
Gbg 205
RGSc 60
GEF 205
RASGDP 205
GAP 205
MAP3K 205
MAP2K 205
MAPK 205
All other species were set to 0 nM
Table 3.8: Initial concentrations for species in the RAS model including nega-
tive regulation by GAP and the MARK. For simulation of wild-type cells.
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Phosphorylation of the transcription factor (Ste11) by MAPKP was not included in
this version of the model because there was insucient evidence to suggest a mechanism
for how and in which cellular compartment (i.e. cytoplasm or nucleus) Spk1 promotes
phosphorylation of Ste11.
3.4.4 Regulation of Spk1 by Pmp1
Mam2 Mam2
Rgs1
Gpa1
GDP
Gpa1
GTP
P-factor
Gap1
Ras1
GDP
Byr2
Byr1
Spk1
Ste6
Transcriptional response
Pmp1
Spk1
Currently
described
P-factor
Ras1
GTP
P
P
P
P
Described in
this section
Figure 3.19: Modelling deactivation of Scd1 via Pmp1. P-factor binds Mam2
promoting GDP/GTP exchange on the G protein Gpa1. GTP-bound Gpa1 activates
Ras1 via the GEF Ste6, transducing signalling via sequential phosphorylation of a MAPK
cascade (Byr2, Byr1 and Spk1), resulting in activation of Ste11 (not included), which
induces transcription of mating-responsive genes. There are various points of regulation
through the pathway (highlighted with red text) including: Rgs1, which catalyses the
hydrolysis of Gpa1. Gap1, which hydrolyses Ras1 and Pmp1 a phosphatase that regulates
the action of Spk1 (Figure adapted form [50]). The red box highlight components that
have been described and the yellow box highlights species that will be described in this
section.
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MAPK cascades are deactivated by negative regulators that modulate the intensity
and duration of the signal. To date, only Pmp1 a dual-specicity phosphatase has been
suggested to negatively regulate the action of the MAPK cascade, specically Spk1 [11][221].
The action of Pmp1 negatively regulating Spk1 was included in the model reaction scheme
by the following reaction, where PhTase represents the PhTase Pmp1:
PhTase + MAPKP ! PhTase + MAPK k55 0.04 nM 1h 1
The RAS model equations including reactions that describe regulation by GAP (reactions
44,45,48,49), signal transduction via the MAPK (reactions 43,51-54) and regulation of the
MAPK by PhTase (reaction 55) were collated and termed the KR model (see section 3.5).
The deletion of pmp1 in vivo resulted in an increase in b-galactosidase activity in compar-
ison to WT cells (Figure 3.20a, the experimental data collected in this study was published
in Mos et al. (2013) [221], please see Appendix G). The equivalent in silico experiment
recapitulated the in vitro assay (Figure 3.20b). Simulations of the KR model with initial
concentrations described in Table 3.8, alternating [PhTase]=205 nM and [PhTase]=0 nM
and measuring the accumulation of MAPKP complexes following 16 h simulated induction.
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Figure 3.20: The KR model recapitulated the increase in maximal response
observed in vitro. (a) WT (JY544) and pmp1 (JY949) strains were grown to mid-
exponential growth phase and treated with a range of P-factor concentrations from 0 µM
to 100 µM for 16 h before being assayed for b-galactosidase activity (as described in sec-
tion 2.2.8.1). Data shown is the average of three independent experiments SEM. This
data has been published in [221]. (b) simulations of the KR model with initial concentra-
tions described in Table 3.8 but alternating [PhTase]=205 nM and [PhTase]=0 nM and
measuring the accumulation of MAPKP complexes following 16 h simulated induction.
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3.5 KR model: includes all known signalling components
Mam2 Mam2
Rgs1
Gpa1
GDP
Gpa1
GTP
P-factor
Gap1
Ras1
GDP
Byr2
Byr1
Spk1
Ste6
Transcriptional response
Pmp1
Spk1
The Final model
includes all
components
P-factor
Ras1
GTP
P
P
P
P
Figure 3.21: The KR model. P-factor binds the GPCR Mam2 promoting GDP/GTP
exchange on the G protein Gpa1. GTP-bound Gpa1 activates Ras1 via the GEF Ste6,
transducing signalling via sequential phosphorylation of a MAPK cascade (Byr2, Byr1
and Spk1), resulting in activation of Ste11 (not included), which induces transcription
of mating-responsive genes. There are various points of regulation through the pathway
(highlighted with red text) including: Rgs1, which catalyses the hydrolysis of Gpa1. Gap1,
which hydrolyses Ras1 and Pmp1 a phosphatase that regulates the action of Spk1 (Figure
adapted form [50]). The red dashed box highlights components that have been described
in the KR model.
The previous model by Croft et al. (2013) [173] was extended to include the downstream
signalling components of the S. pombe mating-response pathway up to and including the
activation of the MAPK Spk1. The KR model reaction scheme displayed by Table 3.9 was
developed on our current understanding of the system based on experimental data collected
in this study and from the literature.
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Ligand / G protein signalling
L + R ! LR k1 0.0025 nM 1h 1
Gabg + R ! RGabg k2 0.005 nM 1h 1
Gabg + LR ! LRGabg k3 0.02 nM 1h 1
L + RGabg ! LRGabg k4 0.005 nM 1h 1
L + RRGSm ! LRRGSm k5 0.005 nM 1h 1
Gabg + RRGSm ! RRGSmGabg k6 0.005 nM 1h 1
Gabg + LRRGSm ! LRRGSmGabg k7 0.02 nM 1h 1
L + RRGSmGabg ! LRRGSmGabg k8 0.005 nM 1h 1
G protein activation
LRGabg ! GaGTP + Gbg + LR k9 50 h 1
Gabg ! GaGTP + Gbg k10 0.2 h 1
LRRGSmGabg ! GaGTP + Gbg + LRRGSm k11 40 h 1
RGS tracking
RRGSc ! RRGSm k12 0.0005 h 1
RRGSm ! RRGSc k13 0.005 h 1
R + RRGSc ! RRGSm k14 0.1 nM 1h 1
RRGSm ! R + RRGSm k15 100 h 1
LR + RRGSc ! LRRGSm k16 0.1 nM 1h 1
LRRGSm ! LR + RRGSm k17 100 h 1
RGabg + RRGSc ! RRGSmGabg k18 0.1 nM 1h 1
RRGSmGabg ! RGabg + RRGSm k19 0.1 h 1
LRGabg + RRGSc ! LRRGSmGabg k20 0.1 nM 1h 1
GaGTP + RRGSc ! RRGSmGaGTP k21 60 nM 1h 1
RRGSmGaGTP ! GaGTP + RRGSc k22 0.05 h 1
Switching o / recycling G protein
GaGTP ! GaGDP k23 0.005 h 1
GaGTP + RRGSm ! RRGSmGaGTP k24 500 nM 1h 1
RRGSmGaGTP ! GaGDPP + RRGSc k25 2.5 h 1
GaGTP + LRRGSm ! LRRGSmGaGTP k26 100 nM 1h 1
LRRGSmGaGTP ! GaGDPP + LRRGSm k27 2.5 h 1
GaGTP + RRGSm ! RRGSmGaGTP k28 0.5 nM 1h 1
RRGSmGaGTP ! GaGDPP + RRGSm k29 0.5 h 1
GaGDPP ! GaGDP + P k30 1000 h 1
GaGDP + Gbg ! Gabg k31 1000 nM 1h 1
P ! ; k32 10 h 1
Ras1 activation
GEF + GaGTP ! GaGTPGEF k33 13 nM 1h 1
GaGTPGEF + RASGDP ! inertGaGTPGEFRASGTP k41 50 nM 1h 1
inertGaGTPGEFRASGTP ! inertGaGTPGEF + RASGTP k42 4 h 1
Activation of Byr2
RASGTP + MAP3K ! RASGTPMAP3K k43 9 nM 1h 1
GaGTP + RASGDP ! GaGTP + RASGTP k50 0.00034 nM 1h 1
Recycling of Gpa1 / Ste6 complex
inertGaGTPGEF + RRGSc ! RRGSminertGaGTPGEF k34 0.0001 nM 1h 1
inertGaGTPGEF ! GaGDPP + GEF k36 0.005 h 1
inertGaGTPGEF + RRGSm ! RRGSminertGaGTPGEF k37 0.3 nM 1h 1
RRGSminertGaGTPGEF ! RGaGDPP + RRGSc + Ste6 k38 0.3 h 1
inertGaGTPGEF + LRRGSm ! LRRGSminertGaGTPGEF k39 50 nM 1h 1
LRRGSm inertGaGTPGEF ! GaGDPP + LRRGSm + GEF k40 0.3 h 1
Regulation of Ras1 by Gap1
RASGTP + GAP ! RASGTPGAP k44 4.2 nM 1h 1
RASGTPGAP ! RASGDPP + GAP k45 8 h 1
RASGTPMAP3K + GAP ! RASGDPPMAP3KGAP k46 0.00075 nM 1h 1
RASGTPMAP3KGAP ! RASGDPP + MAP3K + GAP k47 10 h 1
RASGTP ! RASGDPP k48 10 h 1
RASGDPP ! RASGDP + P k49 1000 h 1
MAPK activation and deactivation
MAP2K + RASGTPMAP3K!MAP2KP + RASGTPMAP3K k51 0.005 nM 1h 1
MAP2KP + MAPK ! MAP2KP + MAPKP k52 1 nM 1h 1
MAP2KP ! MAP2K k53 8 h 1
MAPKP ! MAPK k54 8 h 1
PhTase + MAPKP ! PhTase + MAPK k55 0.04 nM 1h 1
Table 3.9: Reaction scheme for the KR model.
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3.6 Validation of the KR model
The development of the mathematical model to include downstream signalling components
has resulted in signicant changes to the reaction scheme (although not compromising
the key elements of G protein cycling, GPCR-RGS interactions and spatial regulation
of the RGS). As a result, validation of the KR model was performed to ensure the new
model remains able to reproduce the biological data that the original model could simulate.
Validation should provide a greater condence in the core hypotheses built into the model
and subsequently in using the KR model as a predictive tool.
Unless stated otherwise the KR model reaction scheme (Table 3.9) was simulated with
initial species concentrations described in Table 3.10 by measuring the accumulation of
MAPKP complexes following 16 h simulated induction.
Species Initial concentration (nM)
L 0 - 100,000
R 205
GaGDP 205
Gbg 205
RGSc 60
GEF 205
RASGDP 205
GAP 205
MAP3K 205
MAP2K 205
MAPK 205
PhTase 205
All other species were set to 0 nM
Table 3.10: Initial concentrations for species for simulating the KR model. For
simulation of wild-type cells.
3.6.1 Blocking the GPCR-RGS interaction
It has been shown that deletion of rgs1 or removal the C-terminal domain of Mam2 results
in a two-fold decrease in maximal transcriptional response, an increase in basal signalling
and an increase in potency of P-factor, when compared to WT (rgs1+) cells with full length
Mam2 [173] (Figure 3.22a). These ndings highlighted that an interaction between Rgs1
and the C-terminal domain of the Mam2 was essential for a WT signalling response. The
KR model recapitulated the signalling characteristics of the in vitro assay i.e. an increase
in basal and decrease in maximal signalling response was observed. This was achieved
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in silico by removing all RGS species ([RGSc]=0 nM) and blocking interactions between
the receptor (R) and RGS (k14=k16=k18=k20=0) however, the KR model was unable to
reproduce the increase in potency (Figure 3.22b).
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Figure 3.22: Model testing: Removal of the receptor tail. (a) rgs1 (JY630)
and mam2 (JY1169) transformed with pREP3x-Mam2 (pMam2, JD1627) and pREP3x-
Mam2tail (pMam2tail, JD2880) S. pombe cells were grown to mid-exponential growth
phase before treatment with a range of P-factor concentrations (from 0 µM to 100 µM)for 16
h and then assayed for b-galactosidase activity (gure adapted from [173]). (b) Simulations
are of the KR model in an unmodied system (GPCR), when all GPCR-RGS interaction
reactions are blocked (k14=k16=k18=k20=0) in Table 3.9 (GPCR
 RGSinteraction) and when
[RGS]=0 nM (No RGS).
3.6.2 Negative role of RGS in the absence of a GPCR-RGS interaction
It has been shown that in strains lacking Mam2 sequential increases in Rgs1 concentration
reduces basal signalling response, suggesting that in this environment Rgs1 acts as a sole
negative regulator, contrary to its role when Mam2 is present [173] (Figure 3.23a). The
KR model reproduced the reduction in signalling response with increasing RGSc concen-
tration ([RGSc]=0 nM, [RGSc]=60 nM, [RGSc]=120 nM and [RGSc]=180 nM) (Figure
3.23b), suggesting that the reactions used to extend the model still captured the signalling
behaviours.
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Figure 3.23: Model testing: RGS inuence in the absence of a receptor. (a)
mam2 S. pombe (JY1169) transformed with pREP3x (JD3386, 1xRgs1), pREP3x-Rgs1
(JD2555, 2xRgs1) and both pREP3x-Rgs1 and pREP4x-Rgs1 (JD2555 + JD2388, 3xRgs1)
and mam2rgs1 (JY1291), which lacks endogenous Rgs1 (Rgs1) were grown to mid-
exponential growth phase and treated with a range of P-factor concentrations from 0
µM to 100 µM for 16 h before being assayed for b-galactosidase activity (as described
in section 2.2.8.1). Data shown is the average of three independent experiments SEM.
Experimental data adapted from [190]. (b) Simulations were with [R]=0 nM and varying
RGS concentration from [RGSc]=0 nM, [RGSc]=60 nM, [RGSc]=120 nM and [RGSc]=180
nM.
3.6.3 Dependence on RGS concentration
The concentration of GaGTP is likely to be a critical control point in a system where
GaGTP is the signal transducer. In the model, the RGS species accelerates the hydrolysis
of GaGTP and therefore, these RGS species are key regulators of signal transduction. As
a consequence, signal output should be sensitive to the concentration of RGS and this has
been shown in vitro by Smith et al. (2009) [190].
To validate if the KR model is sensitive to RGS concentration WT S. pombe cells (JY544)
were transformed with pREP3x (JD3386, 1xRgs1), pREP3x-Rgs1 (JD2555, 2xRgs1) and
both pREP3x-Rgs1 and pREP4x-Rgs1 (JD2555 and JD2388, 3xRgs1) and these strains
along with rgs1 (JY630) cells were grown to mid-exponential growth phase before treat-
ment with a range of P-factor concentrations (from 0 µM to 100 µM) for 16 h and assayed
for b-galactosidase activity (as described in section 2.2.8.1).
The experiment showed that increasing Rgs1 concentration in vitro increased maximal
signalling response and reduced the potency of P-factor (Figure 3.24a, 2xRgs1), whereas
further increasing the cellular concentration of Rgs1 caused a reduction in maximal sig-
nalling response and even further reduction in potency in comparison to cells containing
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endogenous levels of Rgs1 (Figure 3.24 a, 3xRgs1). These data illustrated the dual pos-
itive and negative role that Rgs1 can have one signalling response [190]. The KR model
was able to replicated the positive and negative signalling characteristics of Rgs1 in silico
by increasing the concentration from [RGSc]=0 nM (0xRGS), [RGSc]=60 nM (1xRGS),
[RGSc]=120 nM (2xRGS) and [RGSc]=180 nM (3xRGS) (Figure 3.24b).
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Figure 3.24: Model testing: dependence of Rgs1 concentration. (a) WT S.
pombe cells (JY544) that were transformed with pREP3x (JD3386, 1xRgs1), pREP3x-
Rgs1 (JD2555, 2xRgs1) and both pREP3x-Rgs1 and pREP4x-Rgs1 (JD2555 + JD2388,
3xRgs1) and rgs1 (JY630) cells (Rgs1) were grown to mid-exponential growth phase
before treatment with a range of P-factor concentrations (from 0 µM to 100 µM). After
16 h cells were assayed for b-galactosidase activity (as described in section 2.2.8.1). Data
shown is the average of three independent experiments SEM. Experimental data adapted
from [190]. (b) Simulations of the KR model with [RGSc]=60 nM (1xRGS), [RGSc]=120
nM (2xRGS) and [RGSc]=180 nM (3xRGS).
Additional validations of the KR model were conducted against previously determined
experimental data. The model was found to qualitatively agree with experimental data from
a range of experiments including conditions of Gpa1 overexpression, Mam2 overexpression
and when expressing an Rgs1 insensitive Gpa1 mutant (Appendix C).
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3.6.4 Gbg as the signal transducer
In some GPCR signalling systems such as the pheromone-response pathway in S. cerevisiae,
Gbg rather than the Ga is the signal transducer [265]. The previous models of the S. pombe
mating-response pathway were able to recapitulate the S. cerevisiae transcriptional mating-
response data (B. Smith, PhD thesis, 2009 and W. Croft, PhD thesis, 2012). However, these
models only included reactions up to and including the G protein binding and activating an
Eector species, which in the case of the S. cerevisiae system would be the MAP3K STE20.
The S. pombe system is more complex than this as Gpa1 activates another G protein Ras1
via the GEF Ste6 prior to signal transduction to a mitogenic cascade.
In S. cerevisiae, loss of SST2 (a RGS protein) increases basal, maximal transcriptional
response and the potency of a-factor, whereas overexpression of SST2 reduces maximal
transcriptional response and potency, characteristics typical of a negative regulator [266].
The model developed in this thesis was able to simulate a system where Gbg was the signal
transducer by some basic modications, mainly that Ste6 was activated by Gbg rather than
GaGTP (Table 3.11, reaction k33) and all reactions involving inertGaGTP (k37 - k42) were
removed (Table 3.11).
The equivalent in silico experiment was simulated using the version of the model that
signals via the Gbg (Table 3.11); specically, simulations were of an unmodied system
(RGS), when no RGS species was present [RGS]=0 nM (No RGS) and when RGS concen-
tration was doubled ([RGS]=120 nM, 2xRGS) (Figure 3.25).
Although the No RGS simulation displayed an elevated basal response, it was unable
to capture the increase in potency and maximal transcriptional response observed in vitro
[266], instead a constant elevated signalling prole, which did not display a dose-dependent
change in response units was observed. In addition, the Gbg model was unable to capture
the reduction in maximal transcriptional response and potency observed when overexpress-
ing the RGS protein SST2 and there was no dierence in dose-response proles between
1xRGS and 2xRGS (Figure 3.25). Only now that the KR model includes downstream
components of the Ga could it discriminate between the two yeast systems.
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Ligand / G protein signalling
L + R ! LR k1 0.0025 nM 1h 1
Gabg + R ! RGabg k2 0.005 nM 1h 1
Gabg + LR ! LRGabg k3 0.02 nM 1h 1
L + RGabg ! LRGabg k4 0.005 nM 1h 1
L + RRGSm ! LRRGSm k5 0.005 nM 1h 1
Gabg + RRGSm ! RRGSmGabg k6 0.005 nM 1h 1
Gabg + LRRGSm ! LRRGSmGabg k7 0.02 nM 1h 1
L + RRGSmGabg ! LRRGSmGabg k8 0.005 nM 1h 1
G protein activation
LRGabg ! GaGTP + Gbg + LR k9 50 h 1
Gabg ! GaGTP + Gbg k10 0.2 h 1
LRRGSmGabg ! GaGTP + Gbg + LRRGSm k11 40 h 1
RGS tracking
RRGSc ! RRGSm k12 0.0005 h 1
RRGSm ! RRGSc k13 0.005 h 1
R + RRGSc ! RRGSm k14 0.1 nM 1h 1
RRGSm ! R + RRGSm k15 100 h 1
LR + RRGSc ! LRRGSm k16 0.1 nM 1h 1
LRRGSm ! LR + RRGSm k17 100 h 1
RGabg + RRGSc ! RRGSmGabg k18 0.1 nM 1h 1
RRGSmGabg ! RGabg + RRGSm k19 0.1 h 1
LRGabg + RRGSc ! LRRGSmGabg k20 0.1 nM 1h 1
GaGTP + RRGSc ! RRGSmGaGTP k21 60 nM 1h 1
RRGSmGaGTP ! GaGTP + RRGSc k22 0.05 h 1
Switching o / recycling G protein
GaGTP ! GaGDP k23 0.005 h 1
GaGTP + RRGSm ! RRGSmGaGTP k24 500 nM 1h 1
RRGSmGaGTP ! GaGDPP + RRGSc k25 2.5 h 1
GaGTP + LRRGSm ! LRRGSmGaGTP k26 100 nM 1h 1
LRRGSmGaGTP ! GaGDPP + LRRGSm k27 2.5 h 1
GaGTP + RRGSm ! RRGSmGaGTP k28 0.5 nM 1h 1
RRGSmGaGTP ! GaGDPP + RRGSm k29 0.5 h 1
GaGDPP ! GaGDP + P k30 1000 h 1
GaGDP + Gbg ! Gabg k31 1000 nM 1h 1
P ! ; k32 10 h 1
Ras1 activation
Ste6 + Gbg ! GbgSte6 k33 13 nM 1h 1
GbgSte6 + RASGDP ! GbgSte6RASGTP k34 50 nM 1h 1
GbgSte6RASGTP ! GbgSte6 + RASGTP k35 4 h 1
Activation of Byr2
RASGTP + Byr2 ! RASGTPMAP3K k36 9 nM 1h 1
Gbg + RASGDP ! Gbg + RASGTP k49 0.00034 nM 1h 1
Regulation of RAS by GAP
RASGTP + GAP ! RASGTPGAP k43 4.2 nM 1h 1
RASGTPGAP ! RASGDPP + GAP k44 8 h 1
RASGTPMAP3K + GAP ! RASGDPPByr2GAP k45 0.00075 nM 1h 1
RASGTPMAP3KGAP ! RASGDPP + Byr2 + GAP k46 10 h 1
RASGTP ! RASGDPP k47 10 h 1
RASGDPP ! RASGDP + P k48 1000 h 1
MAPK activation and deactivation
Byr1 + RASGTPMAP3K!MAP2KP + RASGTPByr2 k50 0.005 nM 1h 1
MAP2KP + MAPK ! MAP2KP + MAPKP k51 1 nM 1h 1
MAP2KP ! MAP2K k52 8 h 1
MAPKP ! MAPK k53 8 h 1
PhTase + MAPKP ! PhTase + MAPK k54 0.04 nM 1h 1
Table 3.11: Reaction scheme for the KR model with Gbg as the signal trans-
ducer. This model was simulated with the initial conditions from the KR model (Table
3.10).
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Figure 3.25: Model testing: Gbg as the signal transducer. The KR model was
modied such that Gbg was the signal transducer (Table 3.11). The model was simulated
with RGS concentration at 0 nM (No RGS), 60 nM (RGS) and 120 nM (2 x RGS). The
concentration of ligand was varied over the range 0 nM - 100 µM following 16 h simulated
induction. Output from the model shows the accumulation of MAPKP over the duration
of the simulated assay.
3.7 Use of the model as a predictive tool
The KR model was developed using experimental data collected both in this study and
from the literature. It could qualitatively reproduce all of the end-point (assayed after 16 h
of P-factor treatment) experimental data currently available. The consistency between the
experimental data and the KR model output increased the condence in the mechanism
proposed in the reactions for signal transduction and regulation. As a consequence, the KR
model was used to predict system level signalling behaviour under perturbed conditions of
interest.
3.7.1 Removal of GAP causes RGS to act as a sole negative regulator
Rapid hydrolysis of Gpa1 (a G protein), is essential for a maximal transcriptional response
in S. pombe [190]. Gpa1 and Ras1 (the two known G proteins that act on the transcriptional
pathway) are regulated by Rgs1 and Gap1, respectively [86, 87]. The KR model (created
in this study) was the rst of its kind to include the downstream components Ras1 and
Gap1.
In the presence of GAP, the KR model predicts the RGS species has a negative and
positive role on signalling response (Figure 3.26a, see maximals), which was conrmed
experimentally [190] (Figure 3.24). However, when GAP is absent ([GAP]=0 nM) the KR
model predicts that the RGS species acts as a sole negative regulator; where increasing
RGS concentration decreases maximal signalling response (Figure 3.26b).
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Figure 3.26: The KR model predicts that by removing GAP the RGS will act
as a sole negative regulator. Simulations of the KR model with 0 nM (0xRGS), 60
nM (1xRGS), 120 nM (2xRGS) and 180 nM (3xRGS) of RGS species. The concentration
of ligand in the simulation was varied over the range 0 µM to 100 µM following 16 h
simulated induction. Simulations are the result of (a) GAP being present with initial
concentration of 205 nM (b) and in the absence of GAP with initial concentration of 0 nM.
The corresponding basal and maximal simulated values are displayed in the table
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To identify whether the KR models' prediction was accurate in terms of signalling be-
haviour, an equivalent in vitro experiment was performed; a rgs1gap1 S. pombe strain
(JY1718) was rst created by transforming pKS-gap1::ura4 (JD3535) digested EcoRI and
XbaI, into the rgs1 strain JY630, which inserts a ura4 cassette into the endogenous
ORF of gap1 (for details see section 2.2.3). gap1 (JY1618) cells were then transformed
with pREP3x (JD3386) creating a strain with one endogenous copy of Rgs1 (1xRsg1),
pREP3x-Rgs1 (JD2555) containing two copies of Rgs1 (2xRgs1) and both pREP3x-Rgs1
(JD2555) and pREP4x-Rgs1 (JD2388) thus creating a strain with three copies of Rgs1
(3xRgs1). These strains, along with JY1718 (0xRgs1), were grown to mid-exponential
growth phase, treated with a range of P-factor concentrations and after 16 h were assayed
for b-galactosidase activity (as described in section 2.2.8.1).
In the presence of endogenous Gap1, Rgs1 displayed a negative and positive inuence on
b-galactosidase activity, consistent with previous observations [190] (Figure 3.27a). How-
ever, when Gap1 was absent, deletion of Rgs1 signicantly increased basal signalling re-
sponse in comparison to strains containing endogenous Rgs1 (1xRgs1) (from 22 lacZ units
to 112 lacZ units, p<0.0001 when n=5, Student's t-test). The observed increase in basal
activity in rgs1gap1 strains was consistent with the in silico experiment
([RGSc]=[GAP]=0 nM) from the KR model (Figure 3.26b). The KR model also predicted
that increasing RGS concentration reduced basal signalling response however, a signicant
eect on basal response was not observed in vitro (p>0.05, when n=3, Student's t-test).
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Figure 3.27: Rgs1 acts as a negative regulator. (a) Experimental data adapted
from Smith et al. (2009) [190]. (b) gap1 S. pombe cells (JY1538) were transformed
with pREP3x (1xRgs1), pREP3x-Rgs1 (2xRsg1) and nally both pREP4x-Rgs1 and
pREP3x-Rgs1 (3xRsg1), these strains and a rgs1gap1 strain JY1718 were grown to
mid-exponential growth phase before treatment with a range of P-factor concentrations
(from 0 µM to 100 µM). Following 16 h stimulation strains were assayed for b-galactosidase
activity (as described in section 2.2.8.1). Data shown is the average of three independent
experiments SEM.
Strains lacking gap1 but containing Rgs1 displayed a non-monotonic response (Figure
3.27b). Interestingly, the size of the peak (distance from the x-axis) decreased and displayed
a horizontal shift (to right) with increasing Rgs1 concentration (Figure 3.27b, see 1xRgs1,
2xRgs1, 3xRgs1). It has been shown that the non-monotonic response observed in gap1
is caused by cell lysis (Figure 3.12). It was also suggested that a plateau in signalling
response was observed at100 nM P-factor prior to the reduction in b-galactosidase activity
caused by an increase in non-viable cells [223] (Figure 3.27b, dotted line indicates potential
maximal response). The reduction in b-galactosidase peak height with increasing Rgs1
concentration may suggest that maximal transcriptional response decreases with increasing
Rgs1 concentration. In addition, the horizontal shift in the peak to the right indicates that
cell lysis is reduced with Rgs1 concentration. It should be noted that the KR model predicts
that maximal transcriptional response decreases with increasing RGSc concentration when
[GAP]=0 nM, which is illustrated by the in vitro assays.
To verify that cell lysis was indeed reduced in strains lacking gap1 and containing higher
concentration of Rgs1 (2xRgs1 and 3xRgs1), the same strains used in the b-galactosidase
described above were assayed for cell viability following treatment with 0 µM to 100 µM P-
factor (as described in section 2.2.16). An increase in the basal percentage of non-viable cells
was observed between 0xRgs1 and 1xRgs1 at 13% to 104% non-viable, however this was
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not considered statistically signicant (p=0.1127 when n=3, Student's t-test) (Figure 3.28).
In addition, strains lacking functional Rgs1 and Gap1 did not display a dose-dependent in-
crease in non-viable cells in response to increasing P-factor treatment. Instead, a linear
response was observed, consistent with the constant elevated b-galactosidase activity ob-
served in the transcriptional assay (Figure 3.27b).
gap1 expressing endogenous Rgs1 (1xRgs1) exhibited the greatest percentage of lysed
cells reaching a maximal of 754% (Figure 3.28). Increasing the cellular concentration by
2xRgs1 and 3xRgs1 signicantly reduced the percentage of non-viable cells to 474% and
492%, respectively (p=0.0088 and p=0.0038 for n=3, respectively, Student's t-test). A
reduction in non-viable cells was not observed between 2xRgs1 and 3xRgs1, even though
a reduction and shift in peak size (to the right) in b-galactosidase activity was observed
(Figure 3.27b).
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Figure 3.28: Cell lysis is reduced with increasing Rgs1 concentration.
rgs1gap1 (JY1718, 0xRgs1) cells and gap1 (JY1618) cells transformed with 1xRgs1,
2xRgs1 and 3xRgs1 were grown to mid-exponential growth phase before treatment with a
range of P-factor concentrations (from 0 µM to 100 µM). After 16 h a cell viability assay
was performed as described in section 2.2.16. Flow cytometry was used to determine the
percentage of non-viable cells within each population. Data presents three independent
experimentsSEM.
The increased cell lysis at high (1 µM) P-factor concentrations (in comparison to 12%
non-viable [223]) prevents a dose-dependent transcriptional response, consistent with the
results observed in another study [223]. Despite the non-monotonic response, increasing
Rgs1 concentration in strains lacking Gap1 reduced maximal signalling response consistent
with the KR model prediction. As observed earlier in this chapter (Figure 3.15), removing
Scd1 (a GEF for the essential G protein Cdc42) directs signalling to the transcriptional
pathway (via Byr2), alleviating the amount of cell lysis. To establish whether increasing
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the cellular concentration of Rgs1 reduces maximal transcriptional response, b-galactosidase
assays were performed in strains lacking Scd1. Specically, scd1gap1 cells (JY1674)
were transformed with 1xRgs1, 2xRgs1 and 3xRgs1, grown to mid-exponential growth
phase, treatment with a range of P-factor concentrations (from 0 µM to 100 µM) and
after 16 h assayed for b-galactosidase activity and cell viability (as described in section
2.2.8.1 and section 2.2.16). Increasing the cellular concentration of Rgs1 in scd1gap1
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Figure 3.29: Maximal b-galactosidase activity decreases with increasing Rgs1
concentration. scd1gap1 (JY1674) cells transformed with 1xRgs1, 2xRgs1 and
3xRgs1 were grown to mid-exponential growth phase before treatment with a range of
P-factor concentrations (from 0 µM to 100 µM). After 16 h cells were assayed for (a)
b-galactosidase activity (as described in section 2.2.8.1)and (b) a cell viability assay was
performed (as described in section 2.2.16). Flow cytometry was used to determine the
percentage of non-viable cells within each population. Data shown is the average of three
independent experiments SEM.
strains decreases maximal b-galactosidase activity (Figure 3.29a). A signicant reduction
in b-galactosidase response was observed between scd1gap1 cells expressing 1xRgs1 and
2xRgs1 (from 363 lacZ units to 61 lacZ units, p=0.0006 when n=3, Student's t-test).
Complementary to the reduction in b-galactosidase observed, a signicant increase in cell
viability was observed with increasing Rgs1 concentration from 1xRgs1 at 466% non-
viable to 2xRgs1 at 62% non-viable (p=0.0028 when n=3, Student's t-test). Further
increasing the Rgs1 concentration (to 3xRgs1) did not signicantly reduce cell viability
(3xRgs1: 91% when compared to 2xRgs1, p=0.6899 when n=3, Student's t-test). It
should be noted that the percentage of cell lysis displayed in the scd1gap1 strains with
1xRgs1 and 2xRgs1 was less than the cell lysis observed in the WT S. pombe strain JY544
(122%). Together these data support the KR model prediction that Rgs1 behaves as a
negative regulator when Gap1 is removed.
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3.8 Modelling time-series data
The KR model was validated and could recapitulate all of the end-point data currently
available. However, the KR model had not been investigated to determine if it could
replicate the signalling behaviour of time-course data. Therefore, a transcriptional time-
course assay was performed using the WT (sxa2>lacZ ) strain JY544. The cells were grown
to mid-exponential growth phase, treated with a range of P-factor concentrations from 0
µM to 100 µM and assayed for b-galactosidase activity every 2 h from 0 h to 16 h (as
described in section 2.2.8.1). At low (1 nM and 10 nM) P-factor concentrations a negligible
increase in transcriptional response in comparison to untreated cells was observed by 16 h
(Untreated: 11 lacZ units compared to 1 nM 20.1 lacZ units) (Figure 3.30a).
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Figure 3.30: The KR model did not recapitulate the plateau in transcriptional
response. (a) The WT strain JY544 was grown to mid-exponential growth phase before
treatment with a range of P-factor concentrations (from 0 µM to 100 µM) for 16 h and
assayed for b-galactosidase activity (as described in section 2.2.8.1) every 2 h from 0 h to 16
h. Data shown is the average of three independent experiments SEM. (b) The equivalent
in silico experiment was performed using the KR model (Table 3.9). Simulations are of an
unmodied system over a simulated 16 h period. The concentration of ligand was varied
over the range 0 µM to 100 µM. Output from the model shows the accumulation of MAPKP
over the duration of the simulated assay.
b-galactosidase response of cells treated with 100 nM P-factor increased following 0 h and
4 h of treatment and then plateaued between 6 h to 8 h displaying 60.3 lacZ units from
8 h to 16 h (Figure 3.30a). Following 1 µM P-factor, transcriptional response continued
to increase with time until 14 h, where a plateau in response was observed (Figure 3.30a).
Cells treated with 10 µM and 100 µM both reached a maximal signalling plateau of 321
lacZ units by 10 h.
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Consistent trends were observed when comparing the in silico experiment with the b-
galactosidase time-course assays, i.e. by increasing the concentration of ligand increased
the number of response units (Figure 3.30). However, the KR S. pombe model was unable
to capture the plateau in b-galactosidase activity when simulated with >1 µM, instead
the response units increased continuously over the 16 h simulated assay. The plateau in
response suggested that lacZ, the gene that encodes b-galactosidase, was no longer being
transcribed.
3.8.1 Internalisation of Mam2
As discussed in the Introduction, numerous mechanisms exist for terminating GPCR sig-
nalling, primarily via the removal of the ligand or inactivation of the receptor. M-type
S. pombe cells secrete Sxa2, a serine carboxypeptidase, in response to P-factor stimula-
tion, which hydrolyses the extracellular pheromone and hence, removes the ligand signal
[218, 267]. However, the S. pombe strains used in this study were sxa2  and thus were
unable to hydrolyse P-factor, yet still exhibited a transcriptional plateau, suggesting that
other mechanisms were responsible for signal termination.
In response to ligand-binding, receptors are often phosphorylated by specic kinases in
their intracellular domains to initiate internalisation from the plasma membrane. Mam2,
theM-type S. pombe pheromone receptor is internalised in response to P-factor [173], how-
ever the specic kinases that promote internalisation are unknown and there identication
is the focus of Chapter 4. To include internalisation of the receptor into the model a generic
kinase term, K, was assumed to interact with the ligand-bound receptor and cause it to
become inactive (Equation 3.5).
RL+K ! ;+K k56 = 0:05 nM 1h 1 (3.5)
The addition of equation 3.5 to the KR model resulted in the model simulating the
plateau in transcriptional response observed with time (compare Figure 3.31a and 3.31b),
however the model lacked qualitative agreement with the end-point (following 16 h treat-
ment) transcriptional data when varying the concentration of RGS (compare Figure 3.31d
with 3.24b). The rate of receptor desensitisation k56=0.05 nM
 1h 1 was chosen as this
exhibited a plateau in simulated response units by 8 h (when simulated with 100 µM)
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as observed in the time-course experiment and appeared to be the best qualitative t for
varying the concentration of RGS for the end-point data.
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Figure 3.31: The addition of receptor desensitisation into the KR model ex-
hibited a qualitative agreement with the temporal data. (a) The WT strain JY544
was grown to mid-exponential growth phase treated with 1 nM and 100 µM P-factor for
16 h and assayed for b-galactosidase activity (as described in section 2.2.8.1) every 2 h
from 0 h to 16 h. Data shown is the average of three independent experiments SEM. (b)
The KR model (Table 3.9) with equation 3.5, which includes receptor desensitisation was
simulated over a 16 h period with 1 µM and 100 µM P-factor concentration. Output from
the model shows the accumulation of MAPKP over the duration of the simulated assay.
(c) Experimental data adapted from Smith et al. (2009) [190]. (d) The KR model (Table
3.9) with equation 3.5, which includes receptor desensitisation was simulated with varying
concentrations of P-factor (from 0 µM to 100 µM P-factor). Output from the model shows
the accumulation of MAPKP over the duration of the simulated assay for 16 h.
Equation 3.5 assumes that the ligand-bound receptor is phosphorylated by a single kinase
to become inactive. This is a simple way of presenting the process of receptor desensiti-
sation. For example, some GPCRs are multi-phosphorylated by either a single kinase or
multiple kinases within their C-terminal domains and hence receptor desensitisation may
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not be a binary switch. One example discussed previously is the phosphorylation of the
Sc. cerevisiae pheromone receptor STE2. This receptor desensitisation event requires both
yeast casein kinases YCK1 and YCK2 to phosphorylate the C-terminal tail to promote the
same amount of internalisation from the membrane [112]. Perhaps a reason why the KR
model simulated with equation 3.5 is unable to show a good qualitative t is that perhaps
receptor desensitisation is a multi-step process which is not incorporated in the model. To
incorprate these terms of receptor desensitisation into the model rst we must understand
which kinases promote internalisation in S. pombe and how these kinases control the level
or response of receptor inactivation or internalisation in response to pheromone.
3.9 Summary
The previous ODE models of the S. pombe mating-response pathway were limited when
understanding the pathway as a whole, as only reactions describing the receptor R, Ga
and RGS species were included. The transcriptional pathway is more complex than this
and therefore, the latest version of the model by Croft et al. (2013) was extended to
include all downstream signalling components upto and including Spk1 (a MAPK). As
a result, a complete model termed the KR model was created, which was developed on
experimental data collected both in this study and from the literature. The KR model
could qualitatively reproduce the signalling characteristics of the end-point (assayed after
16 h of P-factor treatment) experimental data, which motivated its use as a predictive tool.
When Gap1 was available in vitro Rgs1 acts as a negative and positive regulator of
signalling [190]. The KR model predicted that by deletion of Gap1 (the negative regulator
of Ras1), Rgs1 acts as a sole negative regulator. The equivalent in vitro experiment showed
that in cells treated with 100 nM P-factor, Rgs1 did in fact act as a negative regulator
however, the increasing non-viability of cells prevented a typical sigmodal response at higher
concentrations. Cell lysis was prevented by deletion of Scd1 (a GEF for CDC42), which
transduces signalling via the MAP3K Byr2. Inscd1gap1 strains cell lysis did not prevent
sigmodial response to P-factor and indicated that Rgs1 acted as a sole negative regulator
of signalling when treated with >100 nM, consistent with the KR model prediction.
The KR model was also simulated over time and compared with the equivalent in vitro
time-series b-galactosidase activity experiments. The model displayed qualitative trends
with the experimental data; showing that the number of response units increased with ligand
concentration. However, the model was unable to capture the plateau in b-galactosidase
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activity observed in vitro. The plateau in response suggested that lacZ, the gene that
encodes b-galactosidase, was no longer being transcribed. Attenuation of GPCR signalling
occurs if the ligand (P-factor) is removed or the GPCR (Mam2) prevented from activating
the G protein. Commonly, GPCRs are internalised following ligand-binding, to prevent
continual stimulation and control the amount of activation through the pathway. The
KR model was then simulated with a simple receptor desensitisation term that inactivated
ligand-bound receptors, which showed a qualitative agreement with the time course data but
lacked agreement with the end point data. The kinase(s) or processes involved in receptor
desensitisation (including internalisation) are unknown and therefore, the identication of
the protein(s) responsible for this process will be the focus of the next chapters.
Chapter 4
The role of Cki1, Cki2 and Cki3 in
P-factor signalling
4.1 Background
The KR model developed in chapter 3 was unable to replicate the temporal plateau in
b-galactosidase activity produced by WT (sxa2>lacZ ) cells following treatment with P-
factor (Figure 3.30). The plateau in response suggested that lacZ, the gene that encodes
b-galactosidase, was no longer being transcribed. As stated in the Introduction, numerous
mechanisms exist for terminating GPCR signalling, primarily via the removal of the ligand
or inactivation of the receptor. M-type S. pombe cells secrete Sxa2, a serine carboxypep-
tidase, in response to P-factor stimulation, which hydrolyses the extracellular pheromone
[218, 267]. The sxa2  strain used in this time-course assay was unable to hydrolyse P-
factor, yet still exhibited a transcriptional plateau, suggesting that other mechanisms were
responsible for signal termination.
GPCRs are often internalised following phosphorylation of the intracellular receptor
domains in response to ligand-binding to prevent further signal transduction via the G
protein. Mam2, the M-type S. pombe pheromone receptor, is internalised in response to
P-factor [173]. However, the specic kinase(s) that promote this process have not yet been
described. This chapter seeks to identity and characterise potential Mam2 kinase(s) in the
M-type S. pombe pheromone-response pathway.
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YCK1  MSM---PIASTT--LAVNNLTN-ING---NANFNVQ-AN----KQLHHQAVDSPARSSMTA
YCK2  MSQVQSPLTATNSGLAVNN--NTMNSQMPNRS-NVRLVNGTLPPSLH---V-S---SNLNH
CKI1  MS-----------------------G--------------------Q--------------
CKI2  MN-----------------------S--------------------Q--------------
CKI3  MS--------TTS------------S--------------------H--------------
YCK1  TTAANSN---SNS-SRDDSTIVGLHYKIGKKIGEGSFGVLFEGTNMINGVPVAIKFEPRKT
YCK2  NTG-NSSASYSGSQSRDDSTIVGLHYKIGKKIGEGSFGVLFEGTNMINGLPVAIKFEPRKT
CKI1  -----NN-------------VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS
CKI2  -----TS-------------VVGVHYRVGRKIGEGSFGVIFDGMNLLNNQLIAIKFEPKKS
CKI3  -----SN-------------VVGVHYRVGKKIGEGSFGMLFQGVNLINNQPIALKFESRKS
YCK1  EAPQLRDEYKTYKILNGTPNIPYAYYFGQEGLHNILVIDLLGPSLEDLFDWCGRKFSVKTV
YCK2  EAPQLKDEYRTYKILAGTPGIPQEYYFGQEGLHNILVIDLLGPSLEDLFDWCGRRFSVKTV
CKI1  DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNILVIDLLGPSLEDLLDLCGRKFSVK-T
CKI2  EAPQLRDEYRTYKLLVGNAGIPNVYYFGQEGLHNILVIDLLGPSLEDLFEWCGRRFSVK-T
CKI3  EVPQLRDEYLTYKLLMGLPGIPSVYYYGQEGMYNLLVMDLLGPSLEDLFDYCGRRFSPK-T
YCK1  VQVA-VQMITLIEDLHAHDLIYRDIKPDNFLIGRPGQPDANNIHLIDFGMAKQYRDPKTKQ
YCK2  VQVA-VQMITLIEDLHAHDLIYRDIKPDNFLIGRPGQPDANKVHLIDFGMAKQYRDPKTKQ
CKI1  VAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ
CKI2  VAMTAKQMLSRVQTIHEKNLVYRDIKPDNFLIGRPSSRNANMVYMVDFGMAKYYRDPKTKQ
CKI3  VAMIAKQMITRIQSVHERHFIYRDIKPDNFLIGFPGSKTENVIYAVDFGMAKQYRDPKT--
YCK1  HI--PYREKKSLSGTARYMSINTHLGREQSRRDDMEALGHVFFYFLRGHLPWQGLKAPNNK
YCK2  HI--PYREKKSLSGTARYMSINTHLGREQSRRDDMEAMGHVFFYFLRGQLPWQGLKAPNNK
CKI1  HI--PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK
CKI2  HI--PYSERKSLSGTARYMSINTHLGREQSRRDDLESLGHVFMYFLRGSLPWQGLKAANNK
CKI3  HVHRPYNEHKSLSGTARYMSINTHLGREQSRRDDLESMGHVFMYFLRGSLPWQGLKAATNK
YCK1  QKYEKIGEKKRSTNVYDLAQGLPVQFGRYLEIVRSLSFEECPDYEGY-RKLLLSVL-DDLG
YCK2  QKYEKIGEKKRLTNVYDLAQGLPIQFGRYLEIVRNLSFEETPDYEGY-RMLLLSVL-DDLG
CKI1  QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYD-YLQGLFSKVLER-LN
CKI2  HKYEKISEKKQSTSISELCAGFPNEFSKYMTYVRSLEFDEEPDYA-FLQELFDDVL-RANG
CKI3  QKYEKIGEKKQVTPLKELCEGYPKEFLQYMIYARNLGYEEAPDYD-YLRSLFDSLLLR-IN
YCK1  ETADGQYDWMKLNDGRGWDLN------INKKPN---LHG---Y-GHPN---------PPNE
YCK2  ETADGQYDWMKLNGGRGWDLS------INKKPN---LHG---Y-GHPN---------PPNE
CKI1  TTEDENFDWNLLNNGKGWQ-SL-K-----SR-N--A-ET-EN--------QRS-SK-PP-A
CKI2  DTNDGVYDWMLLNDGKGWE-SS-S-----SHFSVVAMKRRKNYLGL-NVVQNDDSR-----
CKI3  ETDDGKYDWTLLNNGKGWQYSAAKQHVVQRRHT----QG-TN-----N--RRQ-STIPPYA
YCK1  -KSR-KH--RNKQLQM----------QQL--QMQ-Q--L--Q-----Q-Q-Q-Q------Q
YCK2  -KSK-RH--RSKNHQYSSPDHHHHYNQQQ--QQQ-Q--A--QA----QAQAQAQAK---VQ
CKI1  PKLESK----SPALQ-----NHA-STQNVVSK-RSDYE---KPFAEPHLN-S--AS-DSAE
CKI2  -K---KN---S-TLQ----------TQNM--RFKSSYGV--R--G-PR-NYS---SFD-AL
CKI3  -RTR-QNLLSSPSKQ--TPVNNV-VDASVATQ-K-D-GIPGKA-ASPQVQQQQQTS--SAQ
YCK1  QQYAQK-T-----E-ADMR-NSQ--YK--P--------------KLDPTS---YEAYQH--
YCK2  QQQLQQ-A-----Q-AQQQAN-R--YQLQPDDSHYDEERE--ASKLDPTS---YEAYQQ--
CKI2  ---PSKNA-PLVRQ--EQSASKKTIYA-HSSR-GYDRVRPMYVSQ--PSNNA-VGV-NHPN
CKI3  QQQPQR-----V----EQPA---------P-Q----------TTQ--PTQ---VD------
YCK1  ---Q---T--Q-Q---K--YL--QEQ-QKRQQQQKLQEQQLQEQQLQQQQQQQQQLRA-TG
YCK2  ---Q---T--Q-Q---K--YA--QQQ-QK-QMQQK--SKQF----------------ANTG
CKI1  DSSEERVTREQVQNATKETEAP-K-K-KK-----S-----F--------------------
CKI2  D------------NS--DSEA------KG-----G-----F--------------------
CKI3  -------T--Q-Q-AAKP--APSKEKSRK-----K-----F--------------------
YCK1  QPPSQPQAQTQSQQFGARYQPQQ-QPSAALRTPEQHP-N--DD-NSSLAASHKGFFQKLGC
YCK2  ---AN--GQTN------KY-PYNAQPTA---NDEQNAKNAAQDRNSN-KSS-KGFFSKLGC
CKI1  ------------------W----------AS----------------I----------LSC
CKI2  ------------------F-----------D----------------M----------ICC
CKI3  ------------------H----------LR----------------L----------LSC
YCK1  -C--------*
YCK2  -C--------*
CKI1  -C-SGSNEDT*
CKI2  RCFS------*
CKI3  RCFS------*
CKI1  ---PNQNSLP--NPPTETKATT-TV----PDRSG------LATNQ--P---APVDV--H--
1  61  
62  122  
123  183  
184  244  
245  305  
306  366  
367  427  
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611  671  
672  683  
Figure 4.1: 67-69% homology between the S. cerevisiae proteins YCK1 and
YCK2, with the S. pombe proteins Cki1, Cki2 and Cki3. Sequences were aligned
using MutiAlin version 5.4.1 [268]. Gaps (-) were included to optimise the alignment,
identical residues are highlighted in red, conservative changes in blue and non-conservative
changes have no colouring.
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4.2 Identifying potential kinases that promote Mam2 inter-
nalisation
In S. cerevisiae, two yeast casein kinases YCK1 and YCK2 phosphorylate serine residues
in the C-terminal tail of the pheromone GPCR STE2 to promote its internalisation [112,
269, 270]. A protein BLAST search with YCK1 and YCK2 was performed against the 96
protein kinases in S. pombe [271] to identify potential candidates that phosphorylate Mam2
in response to P-factor stimulation. Three casein kinase proteins Cki1, Cki2 and Cki3, were
identied in the protein BLAST search and displayed a 67-69% sequence homology with
YCK1 and YCK2 [272] (Figure 4.1). A previous study showed that Cki1, Cki2 and Cki3
were non-essential, with loss of these proteins exhibiting no observable cellular phenotypes
during vegetative growth [272, 273]. However, these kinases' role in the pheromone-induced
signalling pathway of S. pombe has not yet been investigated.
4.3 Cki1, Cki2 and Cki3 are not essential for mitotic growth
Cki1, Cki2 and Cki3 disruption strains were created from M-type S. pombe cells that lack
both cyr1 and sxa2 (for details on how these strains were created see section 2.3.1). cyr1
encodes adenylyl cyclase, with deletion of this gene enabling sexual dierentiation during
mitotic growth [53]. sxa2 produces a serine carboxypeptidase that hydrolyses exogenous
P-factor [218, 267], with loss of this gene product, protracting the pheromone-induced
signalling response [96]. Five standard analyses were performed with the kinase disruption
strains during mitotic growth to verify that any aberrant phenotypes observed during this
chapter was the direct result of pheromone treatment.
Wild type (WT) (JY544; sxa2 cyr1 ), cki1 (JY1731; sxa2 cyr1  cki1::ura4+), cki2
(JY1722; sxa2 cyr1  cki2::ura4+) and cki3 (JY1600; sxa2 cyr1  cki3::ura4+) strains
were grown to mid-exponential growth phase, stained with calcouor white and imaged to
assess cell morphology (as described in section 2.2.12). Calcouor white is a uorescent
stain that specically binds linear (1,3)-b-d-glucan, a polysaccharide present in the cell wall
that when imaged under UV light can be used to assess cell morphology and deposition of
the cell wall material [274]. Microscopy analysis of the kinase disruption strains did not
indicate a dierence in cell size, shape or cell wall biogenesis in comparison to WT strains
(Figure 4.2a).
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Figure 4.2: Loss of cki2 increased cell area and volume during vegetative
growth. WT (JY544), cki1 (JY1731), cki2 (JY1722) and cki3 (JY1600) strains
were grown to mid-exponential growth phase before (a) staining with calcouor white and
imaged in the bright eld and UV channel (section 2.2.12). Scale bar represents 10 µm. The
resulting images were analysed using QuimP to quantify (b) area and (c) circularity (section
2.2.18), the gure includes the QuimP output of a circle and straight-line for comparison,
here m represents the number of individual cells analysed. During exponential growth phase
strains were measured for (d) cell volume (section 2.2.7) and (e) doubling time (section
2.2.9), here n represents the number of independent experiments performed. Statistical
signicance was calculated using one-way ANOVA. p<0.05, p<0.01 and   p<0.001.
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QuimP software, a set of plugins for ImageJ, allows segmentation of cells within a uo-
rescent image and can provide quantitative information regarding morphological variables
such as area (cell size) and circularity (cell shape) (for details see section 2.2.18). Indi-
vidual cells from the calcouor white images (Figure 4.2a) were analysed using QuimP to
detect changes in their area and circularity. cki2 and cki3 strains displayed a signicant
increase in cell area in comparison to WT strains (WT: 282 µm2 (m=18, where m rep-
resents the number of individual cells analysed) compared with cki2 : 351 µm2 (m=23)
and cki3 : 413 µm2 (m=20), p=0.0213 and p<0.001 respectively, one-way ANOVA)
(Figure 4.2b). The QuimP analysis did not detect a signicant dierence in circularity
between the WT and kinase disruption strains (Figure 4.2c) (p>0.05, one-way ANOVA).
Detecting changes in cell volume of cki1, cki2 and cki3 disruption strains provides an
indirect measure of how these kinases regulate cell size. A cell volume assay (as described
in section 2.2.7) was performed with WT, cki1, cki2 and cki3 cells following their
growth to mid-exponential phase. The 64 µm3 cell volume exhibited by WT (JY544) cells
was consistent with those previously observed for the strain JY544 [223]. cki2 strains
displayed a signicant increase in cell volume in comparison to WT cells (WT at 641.5
µm3 compared with cki2 at 752 µm3, p=0.007 when n=4 using one-way ANOVA, n
represents the number of independent experiments performed) (Figure 4.2d). Contrary to
the QuimP measurement of cell area (Figure 4.2b), cki3 cells did not display an increase
in cell volume.
Proteins that regulate cell cycle progression in S. pombe have been identied by measur-
ing the time it takes for the population to grow, measured by the doubling time (DT) [275].
sxa2+cyr1+ M-type S. pombe cells grown in minimal medium have a DT of 2.5 h [53, 276].
The WT strain (JY544) used in this thesis was cyr1  and displayed a DT of 4.50.4 h,
consistent with previously observations for this strain [50]. Disrupting cki1, cki2 and cki3
(for details on the method see section 2.2.9) did not signicantly aect these strains DT
in comparison to WT cells (p>0.05, using one-way ANOVA) (Figure 4.2e), suggesting that
none of the kinases are required for cell cycle progression during mitotic growth.
Together, the results obtained in section 4.3 suggest a potential role for Cki2 and perhaps
Cki3 in regulating cell size during vegetative growth. A critical role of Cki1, Cki2 and Cki3
in regulating cell shape, division or cell wall biogenesis was not observed. Therefore, any
aberrant phenotypes observed during this chapter are most likely the result of treatment
with P-factor.
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4.4 Cki2 and Cki3 regulate mating in S. pombe
The function of Cki1, Cki2 and Cki3 within the S. pombe mating-response pathway has not
yet been investigated. Therefore, four standard mating-response assays were employed to
elucidate these kinases' role within the pathway: including the quantication of transcrip-
tion of mating-responsive genes, the measurement of conjugation tube formation, quan-
tication of the population in G1 and the measurement of successful mating event by
quantifying the production of ascospores (Figure 4.3).
Up-regulation of
mating-responsive
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Mam2
P-factor binding
Under conditions of starvation cells enter a G1 arrest
S. pombe cells
elongate forming
conjugation tubes
Elongation
from a 
single tip
3. Quantified 
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cell volume
2. Quantified 
by sxa2>lacZ
reporter strain
Mating-responsive genes
G1 arrest
Conjugation tube 
formation
Aggultination
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forming a diploid 
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Figure 4.3: Four assays employed in chapter 4 to measure the pheromone-
response pathway in M-type S. pombe cells. Nutrient limitation initiates a G1 arrest.
P-type S. pombe cells release P-factor, which binds theM-type GPCR Mam2. The binding
of P-factor initiates a signalling cascade within the cell, resulting in the transcription of
mating-responsive genes (including genes required to maintain the cells in a G1 arrest,
conjugation, agglutination and conjugation tube formation) and elongation from a single
tip forming a conjugation tube towards a mating partner. When two opposite mating-type
cells meet they fuse to form a diploid zygote that sporulates to form ascospores. Prior
to mating, three assays can be employed to assess the signalling response (red boxes),
these include quantifying signal transduction by utilising a reporter strain sxa2>lacZ [11],
quantifying conjugation tube formation by measuring cell volume [11] and assessing the
percentage of cells that contain one complement of DNA [221, 229]. The mating event
its self can be quantied by utilising the heat resistant properties of ascospores [173, 228].
The assays are labelled 1-4 to represent the order at which these are assessed during this
chapter.
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When two opposite S. pombe mating type cells aggregate, they fuse to form a diploid
zygote that sporulates to form ascospores [277]. The production of ascospores is the combi-
nation of pheromone successfully binding and activating the GPCR, signal transduction to
transcribe mating-responsive genes, a G1 arrest ensuring the cells contain one complement
of DNA ready for mating and initiation of conjugation tube formation towards the mating
partner (reviewed in [50]). The production of ascospores is therefore the ultimate indicator
of a successful mating event (Figure 4.3 assay 1).
Detecting changes in ascospore production in the kinase disruption strains created in
section 2.3.1, may indicate whether Cki1, Cki2 and Cki3 play a role in mating. Sxa2, the
serine carboxypeptidase that is exogenously secreted in response to P-factor to cleave ex-
ternal pheromone is essential for mating [218]. The kinase disruption strains are sxa2  and
therefore constitutive expression of Sxa2 from the pREP41x-Sxa2 vector (JD636, pSxa2)
was used to compensate for the lack of endogenous Sxa2 during the mating assays, as
described previously [98].
WT (JY544; sxa2 cyr1 ), cki1 (JY1731; sxa2 cyr1  cki1::ura4+), cki2 (JY1722;
sxa2 cyr1  cki2::ura4+) and cki3 (JY1600; sxa2 cyr1  cki3::ura4+) strains containing
pSxa2 together with positive (JY444: sxa2+cyr1+) and negative (JY544 transformed with
pREP41x, JD557) controls were mixed with mating-type stable P-cells (JY1025) and grown
to mid-exponential growth phase before an iodine staining assay was performed (for details
see section 2.2.11.1). This assay utilises the property that iodine stains the starch within
the ascospore cell wall, with a brown/black colouration indicating a successful mating event
[220]. A qualitative dierence in colour intensity between the unmated and mated colonies
for each strain was observed (except for the unmated control), suggesting that Cki1, Cki2
and Cki3 were not essential for mating in S. pombe (Figure 4.4a).
In addition, to provide a quantitative readout of mating, the same strains were used to
assay their ascospore production by utilising the heat-resistant property of ascospores (as
detailed in section 2.2.11.2) (Figure 4.3 assay 1). The sporulation assay determines the
percentage of colony forming units (CFU) or spore formation following a heat inactivation
step at 50 C for 10 minutes [228]. cki2+pSxa2 strains displayed a signicant reduc-
tion in CFU recovery in comparison to WT+pSxa2 cells (a reduction from 29.93.7% to
10.22.8% was observed, p=0.0339 when n=3, one-way ANOVA). Conversely, disruption of
cki3 resulted in a signicant increase in CFU recovery (an increase from WT at 29.93.7%
to 54.78.1%, p=0.0089 when n=3, one-way ANOVA).
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The reduction in CFU recovery observed in cki2 strains is consistent with previous
observations [278] and suggests that Cki2 may have a potentiating role during the mating-
response. Whereas, the increase in CFU recovery observed in cki3 strains suggest that
Cki3 may negatively regulate the mating-response in S. pombe.
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Figure 4.4: Disruption of cki2 and cki3 aected ascospore recovery. WT (JY544;
sxa2 , cyr1 ), cki1 (JY1731; sxa2 cyr1  cki1::ura4+), cki2 (JY1722; sxa2 cyr1 
cki2::ura4+) and cki3 (JY1600; sxa2 cyr1  cki3::ura4+) S. pombe M-cells containing
pREP41x-Sxa2 (JD636, pSxa2) together with positive (JY444: sxa2+cyr1+) and nega-
tive (JY544: sxa2cyr1 cells containing pREP41x, JD557) control strains were mixed
with mating-type stable P-cells (JY1025: sxa2 ) and grown to mid-exponential growth
phase and mating was assessed using an (a) iodine staining assay where the formation of
brown/black colonies indicate successful mating (section 2.2.11.1) and a (b) quantitative
sporulation assay, which measures the percentage of colony forming units (CFUs)/spore
formation (section 2.2.11.2). Data shown is the average of three independent experiments
SEM. Statistical signicance was calculated using one-way ANOVA, p<0.05, p<0.01
and   p<0.001.
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4.5 P-factor signalling in S. pombe
The mating assays in section 4.4 showed that disruption of Cki2 and Cki3 aected the
production of ascospores. This suggests that Cki2 and Cki3 could be aecting the earlier
signalling events (prior to ascospore production) such as signal transduction to initiate
transcription of mating-responsive genes, the G1 arrest, the formation of conjugation tubes
towards a mating partner or the process of fusion to form a diploid zygote (Figure 4.3)
(reviewed in [277]). To determine which mating-responsive processes Cki2 and Cki3 may
be inuencing in response to P-factor in S. pombe, a number of assays which focus on the
earlier events of the mating-response were performed (Figure 4.3 assays 2-4)
4.5.1 Cki1 and Cki3 regulate conjugation tube formation
The binding of P-factor to activate Mam2 results in signal transduction via Ras1, an essen-
tial G protein required for mating in S. pombe [246]. Signal transduction via Ras1 activates
the cell polarity pathway, governed by the Rho-like GTPase Cdc42. Enhanced activation
of Cdc42 in response to P-factor activation of Mam2 leads to cell growth from a single tip
forming a conjugation tube towards a mating partner [97].
To elucidate the role of Cki1, Cki2 and Cki3 during conjugation tube formation WT,
cki1, cki2 and cki3 strains were grown to mid-exponential growth phase before treat-
ment with a range of P-factor concentrations (from 0 µM to 100 µM). After 16 h (at times
consistent with other assays [11, 173, 228]) cells were stained with calcouor white and
imaged to assess cell morphology in response to treatment (for details see section 2.2.12).
Visualising cells under bright eld light can highlight defects in the integrity of membranes,
such as the cell, nuclear and vacuola membranes. cki1 and cki2 strains did not show
any observable dierences in the integrity of membranes in comparison to WT cells.
WT (JY544) cells displayed conjugation tubes following treatment with 100 nM, 1 µM
and 10 µM P-factor (Figure 4.5, arrows highlight the tip of the conjugation tube). This
was also displayed for cki1 and cki2 strains (Figure 4.6 and 4.7, respectively), however
an increase in conjugation tube length was visible in cki1 cells following treatment with
100 nM P-factor in comparison to WT cells.
Following treatment with 10 nM P-factor, cki3 cells display a morphology similar to
WT (Figure 4.8). However, following treatment with >10 nM P-factor, cells displayed
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hyper-elongated (extended) conjugation tubes, undulating cell structure, septa and aber-
rant deposition of cell wall material within the cytoplasm. During vegetative growth, cell
morphology ofcki3 cells was indistinguishable fromWT strains (Figure 4.2) and therefore,
the adverse morphologies observed here are the most likely result of P-factor treatment.
The microscopy analyses suggested that Cki1 and Cki3 may function as negative regu-
lators of the morphology pathway (that controls conjugation tube formation) in S. pombe
as disruption of these proteins caused hyper-elongated conjugation tubes and in the case
of cki3 aberrant cellular shapes in comparison to WT cells. In addition, cki3 cells dis-
played septa, suggesting that a loss in function of Cki3 was inuencing progression through
the cell cycle (Figure 4.8).
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Figure 4.5: WT (JY544; sxa2 cyr1 ) cells elongated in response to P-factor
treatment. WT S. pombe cells were grown to mid-exponential growth phase, treated with
a range of P-factor concentrations (from 0 µM to 10 µM) and following 16 h of treatment
cells were stained with calcouor white and imaged under bright eld and UV light (section
2.2.12). Bright eld images are the projection of the three central Z-stacks. White arrows
indicate conjugation tube formation. Scale bars represents 10 µM.
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Figure 4.6: cki1 (JY1731; sxa2 cyr1  cki1::ura4+) cells were hyper-
elongated in response to P-factor treatment. cki1 cells were grown to mid-
exponential growth phase, treated with a range of P-factor concentrations (from 0 µM
to 10 µM) and following 16 h of treatment cells were stained with calcouor white and
imaged under bright eld and UV light (section 2.2.12). Bright eld images are the pro-
jection of the three central Z-stacks. White arrows indicate conjugation tube formation.
Scale bars represents 10 µM.
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Figure 4.7: cki2 (JY1722; sxa2 cyr1  cki2::ura4+) cells elongated in re-
sponse to P-factor treatment in a similar fashion to WT cells. cki2 cells were
grown to mid-exponential growth phase, treated with a range of P-factor concentrations
(from 0 µM to 10 µM) and following 16 h of treatment cells were stained with calcouor
white and imaged under bright eld and UV light (section 2.2.12). Bright eld images
are the projection of the three central Z-stacks. White arrows indicate conjugation tube
formation. Scale bars represents 10 µM.
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Figure 4.8: cki3 (JY1600; sxa2 cyr1  cki3::ura4+) cells displayed adverse
morphological defects in response to P-factor treatment. cki3 cells were grown
to mid-exponential growth phase, treated with a range of P-factor concentrations (from
0 µM to 10 µM) and following 16 h of treatment cells were stained with calcouor white
and imaged under bright eld and UV light (section 2.2.12). Bright eld images are the
projection of the three central Z-stacks. Scale bars represents 10 µM. Images were selected
to show phenotype;  indicate deposition of the cell wall material and arrows highlight the
undulating cell structure and septa.
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4.5.2 Cki1 and Cki3 regulate signal transduction of mating-responsive
genes and conjugation tube formation in S. pombe
A number of mating-responsive genes are upregulated in response to P-factor stimulation
[57]. One of these genes is sxa2. Replacement of sxa2 with lacZ provides a quantitative
measure of signal transduction from activation of the receptor to upregulation of the mating-
responsive genes [11] (Figure 4.3 assay 2). In addition to the upregulation of mating-
responsive genes, S. pombe cells elongate from a single tip towards the source of pheromone
(reviewed in [50]) and this elongation event can be indirectly quantied by measuring the
median cell volume of the population [11] (Figure 4.3 assay 3).
To ascertain the role Cki1, Cki2 and Cki3 in signal transduction to promote upregula-
tion of mating-responsive genes and conjugation tube formation, WT (JY544: sxa2>lacZ ),
cki1 (JY1731: sxa2>lacZ ),cki2 (JY1722: sxa2>lacZ ) andcki3 (JY1600: sxa2>lacZ )
strains were grown to mid-exponential growth phase, treated with a range of P-factor con-
centrations (from 0 µM to 100 µM) and after 16 h were assayed for b-galactosidase activity
(section 2.2.8.1) and cell volume (section 2.2.7). These are two standard assays for mea-
suring signal transduction in S. pombe [173, 190, 223].
cki1 and cki3 strains displayed a signicant increase in maximal transcriptional
response in comparison to WT cells (p=0.0002 and p<0.0001, when n=5, respectively,
determined using one-way ANOVA) (Figure 4.9). There was no signicant dierence in
basal b-galactosidase activity or pEC50 between WT, cki1, cki2 and cki3 strains
(Figure 4.9b).
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Figure 4.9: Disruption of cki1 and cki3 increased maximal transcriptional re-
sponse following P-factor treatment. WT (JY544), cki1 (JY1731), cki2 (JY1722)
and cki3 (JY1600) strains were grown to mid-exponential growth phase before treatment
with a range of P-factor concentrations (from 0 µM to 100 µM). After 16 h cells were assayed
for b-galactosidase activity (see section 2.2.8.1). Statistical signicance was determined us-
ing one-way ANOVA, p<0.05, p<0.01 and   p<0.001. Data shown are mean of ve
independent determinants SEM.
A signicant increase in basal cell volume was observed in cki2 strains in comparison
to WT cells (from 621 µm3 to 733 µm3, p=0.0254 when n=3, one-way ANOVA) (Figure
4.10). The increase in basal cell volume of cki2 was consistent with the assay performed
during vegetative growth (section 4.3). This continuity provides supporting evidence that
Cki2 regulates cell size, but only during vegetative growth, as cki2 cells did not show an
increase in cell volume following treatment with >100 nM P-factor (Figure 4.10b).
In addition to increasing b-galactosidase activity, disruption of cki1 and cki3 in S. pombe
cells signicantly increased maximal cell volume in comparison to WT strains (Figure 4.10).
WT cells displayed a maximal cell volume of 821 µm3, which increased to 983 µm3 in
cki1 strains and more than doubled to 1643 µm3 in cki3 cells (p=0.0262 and p<0.0001
when n=3, respectively, one-way ANOVA). The increase in cell volumes observed in cki1
and cki3 strains were consistent with the hyper-elongated conjugation tubes observed
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in the microscopy analysis (section 4.5.1), providing further evidence that Cki1 and Cki3
negatively regulate signal transduction prior to conjugation tube formation. In addition
to an increase in cell volume following treatment with >100 nM P-factor, cki3 cells also
displayed a signicant increase in potency of P-factor showing a reduction in pEC50 from
7.40.1 (WT cells) to 6.90.1 (p=0.0241 when n=3, one-way ANOVA). This increase in
potency indicates that less P-factor is required to induce the same conjugation tube length.
Together, these data suggest Cki1 and Cki3 negatively regulate signal transduction prior
to upregulation of mating-responsive genes and conjugation tube formation.
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Figure 4.10: Disruption of cki1 and cki3 increases maximal cell volume fol-
lowing P-factor treatment. WT (JY544), cki1 (JY1731), cki2 (JY1722) and cki3
(JY1600) strains were grown to mid-exponential growth phase before treatment with a
range of P-factor concentrations (from 0 µM to 100 µM). After 16 h cells were assayed
for cell volume (see section 2.2.7). Statistical signicance was determined using one-way
ANOVA with a Dunnett's multiple comparison test, p<0.05, p<0.01 and   p<0.001.
Data shown is the average of three independent experiments SEM.
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4.5.3 Cki3 regulates signal transduction directly upstream of transcrip-
tion of mating-responsive genes
The increase in maximal b-galactosidase activity observed in cki1 and cki3 strains
indicates a role for Cki1 and Cki3 in regulating signal transduction prior to upregulation
of the mating-responsive genes (section 4.5.2). To assess whether Cki1 and Cki3 regulate
proteins involved in the signal transduction pathway directly or whether a delay/feedback-
mechanism exists, b-galactosidase expression was analysed over time. WT (sxa2>lacZ ),
cki1 (sxa2>lacZ, cki1::ura4+), cki2 (sxa2>lacZ, cki2::ura4+) and cki3 (sxa2>lacZ,
cki3::ura4+) strains were grown to mid-exponential growth phase before treatment with
a range of P-factor concentrations (from 0 µM to 100 µM). Strains were assayed for b-
galactosidase activity every 2 h from 0 h to 16 h (for details see section 2.2.8.1).
Changes in b-galactosidase activity were detectable following 4 h of treatment with P-
factor (Figure 4.11). A previous study has shown that Sxa2 expression is detectable after
1 h [11]. However, the strains used in this thesis are sxa2>lacZ, where lacZ gene encodes
b-galactosidase, which is detectable by cleaving ONPG and hence, it takes longer to detect
changes in gene expression in these strains. The time at which changes in b-galactosidase
activity is observed (4 h) is consistent with another study that has used sxa2>lacZ S.
pombe strains [190].
A signicant increase in b-galactosidase activity following disruption of cki1 was only ob-
served from 14 h (WT displayed 301 lacZ units compared with 372 lacZ units, p=0.0395
when n=3, Student's t-test), whereas a signicant increase in transcriptional response of
cki3 was observed following 4 h of P-factor treatment (at 4 h WT displayed 101 lacZ
units compared with 212 lacZ units displayed by cki3 cells, p=0.0101 when n=3, Stu-
dent's t-test) (Figure 4.11). WT strains reached a plateau by 10 h, consistent with pre-
vious studies [11, 190], suggesting that by this time b-galactosidase was no longer being
transcribed. cki2 cells displayed a similar temporal prole to WT strains, reaching a
maximal signalling plateau by 10 h, whereas cki1 and cki3 strains did not reach a
temporal plateau in b-galactosidase activity until 12 h (Figure 4.11).
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Figure 4.11: An increased transcriptional response was observed by 14 h and 4
h for cki1 and cki3 strains, respectively. WT (JY544), cki1 (JY1731), cki2
(JY1722) and cki3 (JY1600) strains were grown to mid-exponential growth phase and
treated with a range of P-factor concentrations (from 0 µM to 10 µM). Cells were assayed
for b-galactosidase activity every 2 h from 0 h to 16 h as indicated (section 2.2.8.1). Data
shown are mean of three independent experiments SEM.
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The increase in b-galactosidase activity detected in cki1 cells was not observed until 14
h. This suggested that Cki1 may not regulate the proteins involved in signal transduction
from the receptor to transcription of the mating-responsive genes, otherwise the increase in
b-galactosidase activity would be observed from 4 h. Instead, this suggests that a positive
feedback mechanisms exists whereby production of one of the mating-responsive genes may
regulate Cki1 activity [11]. Contrary to the cki1 disruption strains, cki3 cells displayed
an increase in transcriptional response from 4 h, indicating that Cki3 may act directly
upstream of transcription of mating-responsive genes (i.e. on the proteins involved in
signal transduction from Mam2 to the transcription factor Ste11).
4.5.4 Strains lacking Cki3 did not return to mitotic growth following
P-factor treatment
WT (sxa2>lacZ ) S. pombe M-cells have been shown to increase cell volume following
treatment with P-factor, reaching a maximal size following 8 h to 12 h of treatment and
then a reduction in cell volume, reaching the size of mitotically growing WT strains by 36 h
[11] (Figure 4.12a). This suggests that upon unsuccessfully locating an appropriate mating
partner, cells recovered from the response and continued to proliferate via mitosis. Deletion
of Pmp1, a dual-specicity phosphatase that is thought to negatively regulate the action
of the mating-response MAPK Spk1 [256], showed that cell volume continued to increase
over the entire 36 h assay [11] (Figure 4.12a), suggesting that these cells were unable to
recover and return to mitotic growth.
Strains lacking Pmp1 (pmp1 ) not only displayed hyper-elongated conjugation tubes
in response to P-factor but also showed an increase in maximal b-galactosidase activity
following 16 h of treatment (Figure 4.12b/c) [11, 221]. The increase in cell volume, b-
galactosidase activity and elongated conjugation tubes are all similar phenotypes observed
in the cki1 and cki3 strains shown in this study (Figure 4.9 and 4.10) and therefore
cki1 and cki3 strains may also be unable to recover from pheromone stimulation and
return to mitotic growth. To assess whether the kinase disruption strains were able to
recover from P-factor stimulation and return to mitotic growth, cell volume was measured
every 0 h, 16 h, 24 h and 36 h (as described in section 2.2.7) with WT (JY544; sxa2>lacZ ),
cki1 (sxa2>lacZ, cki1::ura4+), cki2 (sxa2>lacZ, cki2::ura4+) and cki3 (sxa2>lacZ,
cki3::ura4+) strains after growth to mid-exponential growth phase and treatment with 10
µM P-factor.
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Figure 4.12: pmp1 (sxa2>lacZ, pmp1::ura4+) cell volume increased over the
36 h assay following P-factor treatment. WT (JY544), pmp1 (JY949) and cki3
(JY1600) strains were grown to mid-exponential growth phase and treated with a range
of P-factor concentrations from 0 µM to 100 µM for 16 h (a) pmp1 cell volume data
adapted from [11]. (b) Cells were stained calcouor white and imaged under UV light as
described in section 2.2.14. Both cki3 and pmp1 cells displayed hyper-elongated cells.
Scale bar represents 10 µm. (c) cells were assayed for b-galactosidase activity: removing
Pmp1 shows an increase in transcriptional response.
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Figure 4.13: Strains lacking cki3 did not show a non-monotonic cell volume
distribution over time. WT (JY544), cki1 (JY1731), cki2 (JY1722) and cki3
(JY1600) strains were grown to mid-exponential growth phase and treated with 10 µM
P-factor. (a) Following treatment for 0 h, 16 h, 24 h and 36 h cells were assayed for
cell volume (as described in section 2.2.7). (b) Cells were also assayed for b-galactosidase
activity every 4 h from 0 h to 36 h (as described in section 2.2.8.1). Data shown is the
mean of four independent experiments SEM.
The WT strain displayed an increase in cell volume following 0 h to 24 h of treatment
with P-factor and then a reduction between 24 h and 36 h (Figure 4.13a). In addition, the
WT strains did not reach the cell volume of mitotically growing cells by 36 h. Instead, the
population cell volume was still greater than that observed at 16 h (WT at 16 h was 842
µm3 and at 36 h was 963 µm3). This is dierent to what has previously been observed
for the WT strain JY544 by Didmon et al. (2002), where a reduction in cell volume was
observed following 12 h P-factor treatment [11] (Figure 4.12a). These data suggest that
by 36 h WT strains had not recovered from pheromone-stimulation or returned to mitotic
growth as expected.
Strains lacking cki1 and cki2 maintained the same non-monotonic temporal prole as
WT cells, increasing cell volume between 0 h and 24 h and then reducing cell volume
between 24 h and 36 h. In comparison to WT strains, cki1 cell volume was increased
at 16 h, 24 h and 36 h (Figure 4.13a). cki3 cells reached a maximal cell volume size
which was greatly increased in comparison to WT cells at 16 h (rather than at 24 h which
was observed by WT cells) and maintained this maximal response over the 36 h assay
rather than reducing cell size (Figure 4.13a). These data suggest that cells lacking Cki3 are
unable to recover from P-factor stimulation by progressing through the cell cycle to grow
mitotically.
The reduction in cell volume between 24 h and 36 h in WT strains suggest that a
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proportion of cells within the population had recovered from the G1 arrest and completed
cell division. The converse may be true for strains lacking cki3, where the plateau in
maximal cell volume suggested that these cells had maintained the G1 arrest and fail to
return to mitotic growth.
Rum1, a cyclin dependent kinase, is upregulated in response to treatment with P-factor
[57]. Upregulation of Rum1 maintains the cells in a G1 arrest by degrading the cyclin
Cdc13, a protein essential for the G1 to S phase transition of the cell cycle [64, 97, 279].
The WT strain JY544 exhibited a plateau in b-galactosidase activity following 10 h of
treatment (Figure 3.30a). This suggests that lacZ, the gene that encodes b-galactosidase,
was no longer being transcribed. If transcription of lacZ had been halted during the assay,
it is likely that rum1 transcription had also been halted as the transcription factor Ste11
controls the regulation of both lacZ (sxa2>lacZ ) and rum1 in response to P-factor. If
rum1 was no longer being transcribed than S. pombe cells should have recovered from the
G1 arrest and returned to mitotic growth.
WT cells and strains lacking cki1 and cki2 may have began to recover from the G1
arrest, as a reduction in population cell volume was observed (most likely due to the cells
dividing to become smaller in size, Figure 4.13a). However, cki3 cells did not display a
reduction in population cell volume. This may be a result of Rum1 still being transcribed
in these strains. To determine whether b-galactosidase was still being transcribed following
treatment with P-factor and hence, possibly Rum1; b-galactosidase assays were performed
with WT, cki1, cki2 and cki3 strains following growth to mid-exponential growth
phase, treatment with 10 µM P-factor, every 2 h from 0 h to 36 h (as detailed in section
2.2.8.1).
All strains reached a plateau in b-galactosidase activity by 12 h (Figure 4.13b). This
suggested that by 12 h, lacZ and probably rum1 was no longer being transcribed. If Rum1
was no longer being expressed then all the strains should have began to recover from the
G1 arrest. These results therefore suggest that another mechanism other than Rum1 is
maintaining cki3 cells in a G1 arrest was preventing the cells from dividing.
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4.5.5 Strains lacking Cki3 exhibit aberrant morphologies following 36 h
treatment with P-factor
To understand why cells lacking cki3 were unable to divide following prolonged treatment
with P-factor, the morphology of the strains was analysed upto 36 h treatment (as only
cells following treatment for 16 h had previously been observed, Figure 4.8).
WT, cki1, cki2 and cki3 strains were grown to mid-exponential growth phase,
treated with 10 µM P-factor for 36 h, stained with calcouor white and imaged to assess
cell morphology (as described in section 2.2.12). Strains lacking cki2 were indistinguishable
from WT strains (Figure 4.14), i.e. there was no observable dierence in cell shape, size or
integrity of the membranes (bright eld images). Strains lacking cki1 and cki3 exhibited
hyper-elongated conjugation tubes in comparison to WT strains. These elongated cells
observed in the microscopy images are consistent with the increase in cell volume displayed
after 36 h treatment in these cells (Figure 4.13). In the case ofcki3 strains, the microscopy
analysis revealed septa (Figure 4.14, arrows), aberrant deposition of the cell wall material
within the cytoplasm (indicated by the dispersion of calcouor staining around the septa)
and a variation in cytoplasmic texture between septa (Figure 4.14, bright eld).
The variation in membrane integrity observed between septa at 36 h in cki3 strains
was not observed following 16 h of treatment (Figure 4.8), suggesting that this cellular
phenotype becomes exaggerated with time. Therefore, a time-course microscopy analysis
was performed with the cki3 strain JY1600 every 4 h from 20 h to 36 h (as described in
section 2.2.12) to investigate the changes in integrity of the membranes with time. At 20 h
`nodules' were observed and with increasing time, multiple projection tips were common-
place (Figure 4.15). The frequency of cells displaying a disruption in cell wall biogenesis,
indicated by the irregular positioning of calcouor white staining (cell wall material) within
the cytoplasm was pronounced following 24 h treatment (Figure 4.15, 's). The integrity of
the cell's membranes were evident following 24/28 h of treatment with P-factor. Septated
cells were highly conserved in strains lacking cki3, suggesting that cells attempted to divide
yet were unable to complete cytokinesis (Figure 4.15, arrows).
It should be highlighted that during vegetative cell growth cki3 strains (JY1600) did
not display defects in growth as measured by the DT or defects in cell morphology (Figure
4.2). The adverse morphological defects observed in cki3 cells is therefore a result of
treatment with P-factor.
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Figure 4.14: The appearance of septa is a dominant phenotype of cki3 S.
pombe cells following P-factor treatment for 36 h. WT (JY544), cki1 (JY1731),
cki2 (JY1722) and cki3 (JY1600) strains were grown to mid-exponential growth phase
before treatment with 10 µM of P-factor for 36 h. Cells were stained with calcouor white
and imaged under bright eld and UV light as described in section 2.2.14. Calcouor white
images are maximal projections of Z-stacks. Scale bar represents 10 µm. Arrows highlight
septa in the cki3 strain.
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Figure 4.15: cki3 cells displayed adverse morphological defects in response
to P-factor. The cki3 strain JY1600 was grown to mid-exponential growth phase and
treated with 10 µM P-factor. Cells were stained with calcouor white and imaged with
bright eld and UV light every 4 h from 20 h to 36 h (as detailed in section 2.2.12). Scale
bar represents 10 µm. Images were selected to represent the best example of phenotype;
multiple projection tips are visible, arrows and 's highlight septa and aberrant disposition
of the cell wall within the cytoplasm, respectively.
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4.5.6 The number of cells displaying septa increases with time following
P-factor treatment
cki3 strains displayed a constant elevated cell size in response to treatment with P-factor
that did not begin to recover from treatment as observed with WT cells (Figure 4.13a).
Microscopy analysis of cki3 strains in response to P-factor highlighted that septated
cells were prominent, indicating that these cells attempted to divide yet where unable to
complete cell division (Figure 4.15). To assess how dominant the septa phenotype was
in strains lacking cki3 in response to P-factor, the number of cells displaying septa was
quantied following treatment for 16 h and 36 h. WT, cki1, cki2 and cki3 strains
were grown to mid-exponential growth phase before treatment with 10 µM P-factor. Cells
were stained with calcouor white and imaged (as detailed in section 2.2.12) following
treatment for 16 h and 36 h. Each cell in the corresponding image was then categorised by
the number of septa displayed, either containing no septum, one septum or septa (0, 1 or
2, respectively).
No signicant dierence in the number of cells displaying septa was observed between
WT and cki1 or cki2 strains at 16 h or 36 h (Figure 4.16, p>0.05 when the number
of cells (m)>90 in three experiments, two way ANOVA with a Dunnett's multiple com-
parison test, for the values see Figure 4.16). However, the percentage of cells displaying
septa in cki3 strains was signicantly increased following 16 h and 36 h of treatment (16
h: p=0.002 and 36 h: p<0.001, when the number of cells (m)>90 in three independent
experiments, two-way ANOVA with a Dunnett's multiple comparison test, for the values
see Figure 4.16). Importantly, the percentage of cells displaying septa at 36 h (50%) was
much greater than at 16 h (9%) (Figure 4.16), suggesting the number of cki3 cells that
attempt to divide increases with time following treatment with P-factor.
To conrm that the increase in septa observed in cki3 strains was the direct eect
of loss of Cki3 function and not a combinatorial eect of disrupting cyr1 and cki3, the
number of cells displaying septa was investigated with WT cyr1+ (JY448) and cki3 :
cyr1+ (JY1730) strains. These strains were grown to mid-exponential growth phase in SSL
medium (which lacks a nitrogen source), treated with 10 µM P-factor for 36 h and then
stained with calcouor white and imaged (as described in section 2.2.12). Each cell in the
corresponding image was categorised by the number of septa displayed (either 0, 1 or 2).
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(a)
WT cki1 cki2 cki3
Septum 16 h 36 h 16 h 36 h 16 h 36 h 16 h 36 h
0 (%) 882 922 902 922 870.1 895 792 254
1 (%) 111 50.6 81 61 121 84 121 252
2 (%) 11 32 31 21 11 31 93 502
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Figure 4.16: The number of septated cki3 cells increased following treatment
with P-factor. WT (JY544, sxa2 ), cki1 (JY1731, sxa2 ), cki2 (JY1722, sxa2 )
and cki3 (JY1600, sxa2 ) strains were grown to mid-exponential growth phase before
treatment with 10 µM P-factor. After 16 h and 36 h cells were stained with calcouor white
and imaged in the UV channel (as described in section 2.2.12) before all the individuals
cells in the image were categorised by septum index (0 septum, 1 septum or 2 septa).
Statistical signicance was calculated using two-way ANOVA with a Dunnett's multiple
comparison test, where  indicates a p-value<0.05,  indicates a p-value<0.01 and   
indicates a p-value<0.001. Data shown is the average of three independent experiments
SEM.
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A signicant increase in the percentage of cells displaying septa between WT and cki3
cyr1+ strains was observed (from 21% to 452%, p<0.001 when the number of cells
(m)>90 in three independent experiments, two-way ANOVA) (Figure 4.17). Both cyr1+
and cyr1  cki3 strains displayed a signicant increase in the percentage of septated cells,
suggesting the septa phenotype was the result of disrupting cki3.
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Figure 4.17: P-factor induced septa is conserved in cyr1+ cki3 strains. WT:
cyr1+ (JY448) and cki3 : cyr1+ (JY1730) strains were grown to mid-exponential growth
phase in SSL medium to mimic a nutrient free environment priming the cells for mating.
Strains were treated with P-factor for 36 hand then stained with calcouor white and im-
aged under UV light (as described in section 2.2.12). Each cell in the image was categorised
into the septum index (0 septum, 1 septum or 2 septa). The gure includes the data for
cyr1  strains from Figure 4.16 for comparison. Scale bar represents 10 µm. Data shown
is the average of three independent experiments SEM.
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4.5.7 Cki3 is required to maintain S.pombe cells in a G1 arrest following
P-factor treatment
WT cells and strains lacking cki1 and cki2 displayed an increase in cell volume following
24 h of treatment with P-factor and then a reduction thereafter (Figure 4.13a). In addi-
tion, these strains displayed a plateau in b-galactosidase activity by 12 h (Figure 4.13b),
suggesting that lacZ and therefore, rum1 (a gene that encodes Rum1, a protein required
to maintain the cells in a G1 arrest) was no longer being transcribed. Contrary to the
WT strains, cells disrupted in cki3 did not display the reduction in cell volume from 24
h even though a plateau in b-galactosidase activity was observed (Figure 4.13), suggest-
ing that these cells were maintained a G1 arrest by a dierent mechanism. Microscopy
analysis illustrated that the number of cells displaying septa increased with time (Figure
4.17), demonstrating that cki3 cells attempted to divide yet were unable to complete cell
division.
The data collected in this study provide conicting evidence for whethercki3 cells were
maintained in a G1 arrest or not in response to treatment with P-factor. Therefore, DNA
content was measured in these strains to assess what percentage of the cell population was
arrested in G1 phase of the cell cycle following treatment with P-factor (Figure 4.3 assay 4).
The assay utilises propidium iodine, a stain that binds stoichiometrically to DNA, which can
be used to quantify the DNA content of individual cells in a population via ow cytometry
[229]. WT (JY544), cki1 (JY1731), cki2 (JY1722) and cki3 (JY1600) strains were
grown to mid-exponential growth phase, treated with 10 µM P-factor and then cell cycle
position (or DNA complement) was analysed every 4 h from 0 h to 36 h (as described in
section 2.2.15.1).
After 4 h of P-factor treatment all strains displayed a shift from predominantly two
complement (2C, G2 phase) to one complement (1C, G1 phase) DNA content (Figure 4.18).
The shift into G1 phase was consistent with the detectable changes in Sxa2 expression
following treatment with P-factor [190] (Figure 4.11). The number of WT cells arresting in
G1 peaked with 843% of the population containing a 1C of DNA by 8 h. After this time,
cells began to recover (as a reduction in the number of G1 arrested cells was observed)
reaching a global minimum of 635% by 16 h, before tending towards a plateau of 67%
(oscillating around this value until 36 h). This behaviour was also observed in cki1 and
cki2 strains over the 36 h period (Figure 4.18 and 4.19).
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Figure 4.18: cki3 cells do not contain one complement of DNA following
treatment with P-factor for 20 h. WT (JY544), cki1 (JY1731), cki2 (JY1722) and
cki3 (JY1600) strains strains were grown to mid-exponential growth phase and treated
with 10 µM P-factor for periods up to 36 h. Cell cycle position (or DNA complement) was
analysed every 4 h from 0 h to 36 h (as described in section 2.2.15.1). The two dotted red
lines highlight the gating used to identify the number of cells with one complement (1C)
of DNA.
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Figure 4.19: G1 arrest was not maintained in cki3 cells following P-factor
treatment from 16 h. WT (JY544), cki1 (JY1731), cki2 (JY1722) and cki3
(JY1600) strains were grown to mid-exponential growth phase and treated with 10 µM P-
factor for periods up to 36 h. Cell cycle position (or DNA complement) was analysed every 4
h from 0 h to 36 h (as described in section 2.2.15.1). Data shown are the average for three
independent determinants SEM. Statistical signicance was calculated using two-way
ANOVA with a Dunnett's multiple comparison test, p<0.05, p<0.01 and   p<0.001.
Strains disrupted in cki3 initially followed the same trend as WT strains, displaying a
shift from predominately G2 to G1 between 0 h to 4 h, reaching a maximal peak of 874% in
G1 phase by 8 h. However, following 8 h treatment with P-factor cki3 cells showed a shift
from predominantly 1C to predominantly 2C DNA content reaching a global minimum of
162% (with 1C of DNA) by 24 h, before tending towards a plateau of 20% (until 36 h).
The population of cki3 cells in a G1 arrest was signicantly reduced following treatment
with P-factor from 20 h onwards in comparison to WT strains (all p<0.0001 when n=3,
one-way ANOVA with a Dunnett's multiple comparison test, Figure 4.19).
The propidium iodide peaks for cki3 cells displayed no dened G1 peak from 20 h,
suggesting that cells had recovered from a G1 arrest. However, a dened G2 was not
observed either (as seen at 0 h), instead the peaks became progressively dispersed from 20
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h. The dispersion of propidium iodide peaks suggested that dierent sub-populations of
cells contained a varied number DNA complements, not just 1C or 2C (Figure 4.18, 24 h
to 36 h).
To assess whether the dispersion of propidium iodine peaks observed in cki3 strains
following treatment with 10 µM P-factor for a prolonged (>20 h) time was also observed
in strains treated with lower (<10 µM) concentrations of P-factor, WT (JY544) and cki3
(JY1600) cells were grown to mid-exponential growth phase and treated with a 1 nM, 100
nM and 10 µM P-factor for periods of up to 36 h. DNA content was determined every 4 h
from 0 h to 36 h (as detailed in section 2.2.15.1). In addition to the DNA content proles,
the ow cytometer also measured the forward scatter (FSC) (which correlates to the cell
volume) and side scatter (SSC) (which relates to the inner complexity of the cell) of each
individual cell.
Following 4 h of treatment with 1 nM P-factor, WT and cki3 cells showed a reduc-
tion in the number of G1 arrested cells (Figure 4.20 and Figure 4.21a). An increase in
the population in G1 was observed in both strains following 4 h treatment with P-factor,
reaching a global maximum of 443% after 28 h treatment (4.21a). Importantly, these
data illustrated that at low (1 nM) P-factor concentrations disruption of cki3 did not aect
cell cycle progression.
WT strains displayed a shift from predominantly 2C (G2 phase) to predominantly 1C
(G1 phase) DNA content between 8 h and 12 h following treatment with 100 nM P-factor
(Figure 4.20). cki3 strains responded quicker to 100 nM P-factor displaying a shift from
predominantly 1C to 2C DNA content between 4 h and 8 h (Figure 4.21b). WT strains
reached a global maximum (812% G1 arrested cells) at 16 h in comparison to cki3
strains, which reached a global maximum (744% G1 arrested cells) by 12 h (Figure 4.21b).
After reaching the maximal peaks both WT strains and cells disrupted in cki3 showed a
reduction in the population of cells showing a G1 arrest tending towards a plateau of 60%
(oscillating around this value) (Figure 4.21b). Following 28 h of treatment with 100 nM
P-factor, a greater spread in the SSC and FSC of cki3 cells was observed in comparison
to WT cells (Figure 4.20).
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Figure 4.21: The reduction in G1 arrested cells only occurs at high (10 µM) P-
factor concentrations. WT (JY544) and cki3 strains were grown to mid-exponential
growth phase before treated with 1 nM, 100 nM and 10 µM P-factor for a period of 36 h.
Cell cycle arrest was determined every 4 h from 0 h to 36 h using propidium iodide staining
and ow cytometry. Data shown are the average for two independent determinants SEM.
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As discussed above, strains lacking cki3 showed a signicant reduction in the population
of G1 arrested cells (in comparison to WT cells) following treatment with 10 µM P-factor for
20 h (Figure 4.21c). After 12 h of treatment (with 10 µM P-factor) cki3 cells exhibited
a greater spread in FSC in comparison to WT cells that became increasingly dispersed
with time (Figure 4.20). The spread in FSC suggested that cell volume increased following
treatment with P-factor, which was also demonstrated by the time-course cell volume assay
(Figure 4.13). It should be noted that the cki3 cells, which showed a greater FSC also
displayed an increase in SSC (greater internal complexity) (Figure 4.20). The increase
in internal complexity (represented by the SSC) was consistent with the idea that cells
lacking cki3 attempted to divide and hence replicated internal structures, yet were unable
to complete division, resulting in an increased cell volume (represented by FSC).
4.5.8 cki3 cells that display septa also display multiple nuclei
In response to a high (10 µM) concentration of P-factor cki3 strains displayed septa
(Figure 4.17), an increase in the frequency of cells displaying a high internal complexity
(measured by SSC), an increased cell volume (measured by FCS) (Figure 4.20) and a
reduction in the percentage of cells displaying 1C of DNA following 20 h of treatment
(Figure 4.21c). Together, these data suggest that in response to P-factor, cki3 strains
attempt to divide as the cells progressed from G1 arrest into S phase (replicating DNA)
and entered mitosis (indicated by the formation of the medial ring or septum). However,
these cells could not successfully complete cytokinesis, yet still entered into further rounds
of division as 2 septa were displayed in 50% of the population following 36 h treatment
(Figure 4.15).
Formation of the septum occurs in tandem with anaphase B (separation of DNA into
daughter cells). To determine whether cells had successfully completed anaphase B by
separating the nuclei, the uorescent stain DAPI, which binds A-T rich regions within
DNA was utilised to visualise the nuclei of S. pombe. WT (JY544) and cki3 (JY1600)
strains were grown to mid-exponential growth phase, treated with 10 µM P-factor and
after 36 h cells were stained with DAPI and imaged (as described in section 2.2.13). cki3
cells, which displayed septa also displayed multiple-nuclei (Figure Figure 4.22). This was
shown in the pseudocoloured DAPI images (which were used to aid the visualisation of
the staining), where DNA is highlighted in yellow (Figure 4.22, arrows highlight multiple
nuclei). Multiple-nuclei were not observed in WT cells (Figure 4.22). Together these data
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suggest that cells which commit to cell-cycle progression complete anaphase B, indicating
that Cki3 is required for cytokinesis.
!   
Merge
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field
WT Δcki3
Figure 4.22: cki3 cells that display septa contain multiple nuclei. WT (JY544)
and cki3 (JY1600) strains were grown to mid-exponential growth phase before treated
with 10 µM P-factor for 36 h. Cells were stained with DAPI to visualise the DNA and
imaged with UV light (as described in section 2.2.13). ImageJ software was used to trans-
form the DAPI images into re scale for the ease of the reader (this highlights the stained
DNA in yellow). Arrows highlight multiple nuclei. Scale bar represents 10 µm.
4.5.9 Constitutive expression of Cki1, Cki2 and Cki3 on the pheromone-
response pathway in S. pombe
Deletion of the kinases' highlighted a role for Cki1 and Cki3 in regulating signal transduction
of the pheromone-responsive pathway (section 4.5). Moreover, Cki2 was shown to play a
role in mating (Figure 4.4). Constitutive expression of proteins (by utilising expression
plasmids) can provide further information about their role within the mating-response in
S. pombe [173, 223, 228]. First Cki1, Cki2 and Cki3 were cloned into the expression vector
pREP3x (as described in section 2.3.2.1), which allows constitutive expression of exogenous
genes at high levels [235].
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4.5.9.1 Overexpression of Cki1 partially rescued P-factor-directed responses
in strains lacking Cki1
To further investigate the role of Cki1 in pheromone-directed responses, WT (JY544;
sxa2>lacZ ) and cki1 (JY1731; sxa2>lacZ, cki1::ura4+) strains were transformed with
pREP3x (JD3386) and pREP3x-Cki1 (JD3893: pCki1) to increase the cellular concentra-
tion of Cki1. The strains were grown to mid-exponential growth phase in the absence of
thiamine to induce full plasmid expression and following 16 h of treatment with a range
of P-factor concentrations (0 µM - 100 µM P-factor) cells were assayed for b-galactosidase
activity and cell volume (as described in section 2.2.8.1 and section 2.2.7, respectively).
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Figure 4.23: Expression of Cki1 in cki1 cells reduced gene transcription and
cell volume. WT (JY544) and cki1 (JY1731) strains expressing pREP3x (JD3386)
and pREP3x-Cki1 (JD3893: pCki1) were grown to mid-exponential growth phase before
treatment with a range of P-factor concentrations (from 0 µM to 100 µM). After 16 h cells
were assayed for (a) b-galactosidase activity and (b) cell volume (as described in section
2.2.8.1 and section 2.2.7, respectively). Scale bar represents 10 µm.
The b-galactosidase and cell volume assay demonstrated that Cki1 overexpression in the
WT strain JY544 did not aect the transcription of lacZ or conjugation tube formation, as
the basal, maximal and pEC50 values were not signicantly dierent to WT cells expressing
pREP3x (p>0.05 when n=3, Student's t-test) (Figure 4.24). However, Cki1 overexpression
in cki1 strains signicantly but partially reduced maximal b-galactosidase activity (from
401 lacZ units to 321 lacZ units, p=0.0048 when n=3, Student's t-test) and cell volume
(from 1042 µm3 to 922 µm3, p=0.0132 when n=3, Student's t-test) (Figure 4.24). These
data suggest the cellular concentration of Cki1 is not a limiting factor in the S. pombe
pheromone-response transcriptional pathway.
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Figure 4.24: The cki1 hyper-elongated conjugation tube phenotype is rescued
with expression of Cki1. WT (JY544) and cki1 (JY1731) strains expressing pREP3x
(JD3386) and pREP3x-Cki1 (JD3893: pCki1) were grown to mid-exponential growth phase
before treated with 0 µM and 10 µM P-factor. After 16 h cells were stained with calcouor
white and imaged with bright eld and UV light (as described in section 2.2.12). Scale bar
represents 10 µm.
The same strains used in the b-galactosidase assay were stained with calcouor white and
imaged to visualise the aect of overexpression of Cki1 on cell size, shape and integrity of the
membranes (as described in section 2.2.12). The partial rescue of cell volume observed when
overexpresing Cki1 in cki1 strains, in comparison to WT cell volume (Figure 4.23b) was
also demonstrated by the reduction in conjugation tube length in the microscopy analysis
(Figure 4.24). There was no observed dierence in cell elongation following enhanced Cki1
expression in WT cells. The microscopy analysis in combination with the quantitative
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cell volume assay suggests that endogenous Cki1 expression levels are not limiting when
inuencing the morphological response.
4.5.9.2 Overexpression of Cki2 does not aect P-factor-directed responses
A previous study demonstrated that overexpression of Cki2 during vegetative cell growth
lead to a pear-shaped cell morphology [272]. To determine the role of Cki2 during the
morphological response, WT (sxa2>lacZ ) and cki2 (JY1722; sxa2>lacZ, cki2::ura4+)
strains expressing pREP3x (JD3386) and pREP3x-Cki2 (JD3766: pCki2) were grown to
mid-exponential growth phase before treatment with 0 µM and 100 µM P-factor. After 16
h cells were then stained with calcouor white and imaged (as described in section 2.2.12).
Contrary, to previous observations, overexpression of cki2 in WT strains in both treated
and untreated cells was indistinguishable from WT+pREP3x (Figure 4.26).
To quantify how expression of Cki2 inuences the transcriptional and morphological
response, WT+pREP3x, WT+pCki2, cki2+pREP3x and cki2+pCki2 were grown to
mid-exponential growth phase before treatment with a range of P-factor concentrations
(from 0 µM to 100 µM). Following 16 h, cells were assayed for b-galactosidase activity and
cell volume (as described in section 2.2.8.1 and section 2.2.7, respectively). Expression of
Cki2 in WT andcki2 cells did not inuence the the transcriptional b-galactosidase expres-
sion of cell volume proles in comparison to cells expressing pREP3x (Figure 4.25). These
data provide further evidence that Cki2 does not inuence P-factor-directed responses.
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Figure 4.25: Expression of Cki2 did not aect gene transcription or cell volume.
WT (JY544) and cki2 (JY1722) strains expressing pREP3x (JD3386) and pREP3x-Cki2
(JD3766: pCki2) were grown to mid-exponential growth phase before treatment with a
range of P-factor concentrations (from 0 µM to 100 µM). After 16 h cells were assayed for
(a) b-galactosidase activity and (b) cell volume (as described in section 2.2.8.1 and section
2.2.7, respectively). Data shown is the average of three independent experiments SEM.
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Figure 4.26: Expression of Cki2 did not inuence cell morphology. WT (JY544)
and cki2 (JY1722) strains expressing pREP3x (JD3386) and pREP3x-Cki2 (JD3766:
pCki2) were grown to mid-exponential growth phase before treated with 0 µM and 10 µM
P-factor. After 16 h cells were stained with calcouor white and imaged with bright eld
and UV light (as detailed in section 2.2.12). Scale bar represents 10 µm.
4.5.9.3 Overexpression of Cki3 partially rescued P-factor-directed responses
in cki3 strains
To further investigate the role of Cki3 in pheromone-directed responses, WT (JY544;
sxa2>lacZ ) and cki1 (JY1600; sxa2>lacZ, cki3::ura4+) strains were transformed with
pREP3x (JD3386) and pREP3x-Cki3 (JD3782: pCki3) to increase the cellular concentra-
tion of Cki3. The strains were were grown to mid-exponential growth phase in the absence
of thiamine to induce full plasmid expression and following 16 h of treatment with a range of
Chapter 4: The Role of Cki1, Cki2 and Cki3 141
P-factor concentrations (0 µM - 100 µM P-factor) the cells were assayed for b-galactosidase
activity and cell volume (as described in section 2.2.8.1 and section 2.2.7, respectively).
The b-galactosidase and cell volume assay demonstrated that Cki3 overexpression in the
WT strain JY544 did reduce the maximal transcription of lacZ and the cell volume of
strains, however this was not considered statistically signicant in comparison to WT cells
expressing pREP3x (p>0.05 when n=3, Student's t-test) (Figure 4.27). Cki3 overexpression
in cki3 strains did however show a signicant partial rescue in maximal b-galactosidase
activity (from 582 lacZ units to 402 lacZ units, p=0.0048 when n=3, Student's t-test)
and cell volume (from 1455 µm3 to 1154 µm3, p=0.0094 when n=3, Student's t-test)
(Figure 4.27). These data suggest the cellular concentration of Cki3 is a limiting factor in
S. pombe pheromone-response pathway.
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Figure 4.27: Gene transcription and cell volume is reduced following expression
of Cki3 in cki3 cells. WT (JY544) and cki3 (JY1600) strains expressing pREP3x
(JD3386) and pREP3x-Cki3 (JD3782: pCki3) were grown to mid-exponential growth phase
before treatment with a range of P-factor concentrations (from 0 µM to 100 µM). After
16 h cells were for (a) b-galactosidase activity and (b) cell volume (as described in section
2.2.8.1 and section 2.2.7, respectively). Data shown is the average of three independent
experiments SEM.
The strains were also stained with calcouor white and imaged (as described in section
2.2.12) to visually assess the aect of overexpression of Cki3 on cell size, shape and in-
tegrity of the membranes. The partial rescue of cell volume observed when overexpresing
Cki3 observed in cki3 strains, in comparison to WT cell volume (Figure 4.27b) was also
demonstrated by the reduction in conjugation tube length in the microscopy analysis (Fig-
ure 4.28). In addition, overexpression of Cki3 prevented the dominant septa phenotype
that was observed in cki3 strains (Figure 4.28).
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The cell volume assay displayed the same dose-dependent behaviour as the transcrip-
tional assay for all strains; showing that expression of Cki3 in WT and cki3 cells results
in no dierence and a reduction in cell volume size, respectively.
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Figure 4.28: The septa phenotype shown in cki3 cells is rescued with expres-
sion of Cki3. WT (JY544) and cki3 (JY1600) strains expressing pREP3x (JD3386)
and pREP3x-Cki3 (JD3782: pCki3) were grown to mid-exponential growth phase before
treated with 0 µM and 10 µM P-factor. After 16 h cells were stained with calcouor white
and imaged with bright eld and UV light (as detailed in section 2.2.12). Composite im-
ages were collated for cki3+pREP3x and are highlighted by a separate box. Scale bar
represents 10 µm.
Chapter 4: The Role of Cki1, Cki2 and Cki3 143
4.6 Summary
This chapter has described the role of Cki1, Cki2 and Cki3 in the pheromone-response
pathway of S. pombe. To date only two papers have explored these proteins contribution to
the pheromone-response, solely via the use of mating assays [273], which has demonstrated a
role of Cki2 in regulating the pathway [278]. Deletion strains and constructs for constitutive
expression of Cki1, Cki2 and Cki3 were examined (see chapter 2) and four standard mating-
response assays were performed. These included quantication of transcription of mating-
responsive genes, the measurement of conjugation tube formation, quantication of the
population in G1 and the measurement of successful mating by quantifying the production
of ascospores. A summary of the results obtained in this chapter is provided in Table 4.1.
10 µM P-factor
Strain Successful Gene Conjugation Defects in G1
mating transcription tube formation morphology arrest
WT - 3 3 3 5 3
+ pCki1 - 3 3 5 -
+ pCki2 - 3 3 5 -
+ pCki3 - 3 3 5 -
cki1 - 3 33 33 5 3
+ pCki1 - 53 53 5 -
cki2 - 53 3 3 5 3
+ pCki2 - 3 3 5 -
cki3 - 33 33 33 3 5
+ pCki3 - 53 53 5 -
Table 4.1: A summary of pheromone-induced responses in WT, cki1, cki2
and cki3 strains. mating-response, gene transcription, conjugation tube formation,
morphological defects (such as multiple projection tips, septa and cell wall deposition)
and G1 arrest following stimulation with 10 µM pheromone are summarised. 3is used to
denote a response, 33indicated an increased response, 53= reduced response and 5= no
response.
Deletion of cki1 increased transcriptional response and conjugation tube elongation fol-
lowing treatment with >1 µM P-factor. This behaviour was similar to the phosphatase
Pmp1, which is thought to negatively regulate the expression of Spk1 [11, 221] and this
therefore indicated that Cki1 could be a negative regulator of the pheromone-response in
S. pombe. Strains lacking cki1 arrest in G1 phase of the cell cycle following treatment with
P-factor and were successful at mating since no quantiable dierence in CFU recovery
(ascospores) following heat inactivation was observed in comparison to WT strains, sug-
gesting that deletion of cki1 does not change the cells' ability to mate. This is dierent to
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other known negative regulators of signalling such as Rgs1 [87] and Gap1 [86], which are
required for a successful WT mating-response. Constitutive expression of Cki1 in WT S.
pombe strains did not aect signalling behaviour, however, a partial phenotypic recovery
was observed following expression of Cki1 in cki1 cells. Together these data suggested a
role for Cki1 in regulating the signalling events prior to conjugation in S. pombe.
Previously, Cki2 was shown to be required for successful mating in S. pombe [273].
This result was conrmed as cki2 cells showed only a partial increase in CFU recovery
when compared to WT cells. Despite this, deletion of cki2 did not aect transcriptional
response, conjugation tube formation or the ability for cells to arrest in G1 and recover
following prolonged treatment with P-factor. However, deletion of cki2 did signicantly
increase both the cell area and cell volume during vegetative cell growth. Together these
data indicate that Cki2 is required for controlling cell size during vegetative cell growth but
is not required for GPCR signalling events prior to agglutination and conjugation, but may
be required for the later mating events as the signalling events upstream were unaected
in cki2 cells.
During vegetative cell growth, cki3 cells grow and divide at a normal rate displaying
typical morphology. Only in response to P-factor was an increase in transcriptional response
and hyper-elongated conjugation tubes observed, displaying multiple-projection tips and
septa. In addition to the aberrant morphologies displayed in cki3 disruption strains, the
use of the cell wall marker, calcouor white, highlighted defects in cell wall biogenesis.
Additional DNA complement assays were performed withcki3, the resulting propidium
iodide peaks (which indicate the DNA complement of cells' within the population) became
dispersed following prolonged (from 20 h to 36 h) treatment with P-factor, suggesting
that the number of cells containing various complements of DNA, not just one or two
complements, increased. Further analysis revealed that the number ofcki3 cells displaying
septa increased with time in response to high (10 µM) concentrations of P-factor, suggesting
that cells attempted to divide yet were unable to complete the process of cytokinesis, as
nuclei were observed between septa. Together these data suggest that Cki3 has a negative
regulatory role on the pheromone pathway of S. pombe and interestingly, Cki3 has an
essential role for the progression of cells to complete cytokinesis but only in a P-factor
dependent manner.
Chapter 5
The role of Cki1, Cki2 and Cki3 in
Mam2 internalisation
5.1 Background
GPCRs are often internalised from the plasma membrane in response to ligand-binding.
These internalisation events are typically initiated via phosphorylation of the intracellular
receptor domains. Mam2, the M-type S. pombe pheromone receptor, is internalised in
response to P-factor [173]. However, the specic kinase(s) that promote this process have
not yet been described. Chapter 4 identied three kinases that potentially promote inter-
nalisation of Mam2: Cki1, Cki2 and Cki3 and investigated their role in P-factor-directed
responses. This chapter seeks to elucidate whether these kinases initiate the internalisation
of Mam2 in response to treatment with P-factor.
5.2 Mam2 does not interact with Cki1, Cki2 or Cki3
To establish whether Cki1, Cki2 and Cki3 interacted with the C-terminal tail of Mam2,
a yeast 2-hybrid analysis, which detects a physical interaction between two proteins was
performed [280]. The yeast 2-hybrid system utilises the GAL4 transcription factor from
S. cerevisiae, which is typically involved in the regulation of galactose metabolism [280].
GAL4 consists of two domains; a DNA binding domain (BD) and a DNA activation domain
(AD). These domains act in concert to induce the transcription of GAL4 controlled genes.
Both the DNA BD and the DNA AD can be fused to two potentially interacting proteins,
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with an interaction leading to the reconstitution of the complete functional GAL4 domain
and subsequent transcriptional activation of reporter genes.
The S. cerevisiae strain AH109 contains three yeast reporter genes HIS3, ADE2, MEL1
(which encodes a-galactosidase) and a bacterial reporter gene lacZ (which encodes b-
galactosidase), all under the control of the GAL4 promoter. Reconstitution of the GAL4
transcription factor by two interacting proteins, enables cell proliferation in the absence of
histidine and adenine [281].
5.2.1 Plate-based yeast 2-hybrid assay
To determine whether the kinases interacted with the last 45-residues of Mam2 (the
Mam2tail) [173], Cki1, Cki2 and Cki3 were rst cloned into the yeast 2-hybrid expres-
sion vector pGADT7, which fuses the kinase with the DNA AD (as described in section
2.3.2.2). A yeast 2-hybrid assay was then performed with S. cerevisiae strain AH109 trans-
formed with the AD vectors and co-transformed with each BD vector described in Table
5.1. Transformants were grown to mid-exponential growth phase, spotted onto SD-leu-trp
plates to conrm the presence of both plasmids and SD-leu-trp-his-ade plates to indicate a
protein-protein interaction.
Activating domain (AD) Binding domain (BD)
pGADT7 (JD2320) pGBKT7 (JD1170)
pGADT7-Rgs1 (JD3180) pGBKT7-Mam2tail (JD3221)
pGADT7-Cki1 (JD3770) pGBKT7-Map3tail (JD3280)
pGADT7-Cki2 (JD3771) pGBKT7-STE2tail (JD3284)
pGADT7-Cki3 (JD3763) pGBKT7-Rgs1 (JD3182)
Table 5.1: The vectors used in the yeast 2-hybrid assay. The S. cerevisiae strain
AH109 was transformed with the activating domain vectors and co-transformed with the
binding domain vectors.
Vector alone (negative) controls were included to conrm the absence of auto-activation
of the promoter and an Rgs1 (positive) control was included as Rgs1 has previously been
shown to interact with the last 45-residues of Mam2 [173] (Figure 5.1). The last 54-residues
of the P-type GPCR Map3 (Map3tail) [282] was also included in the yeast 2-hybrid assay
to identify an interaction between Map3 and the kinases. As Cki1, Cki2 and Cki3 are
homologous to YCK1 and YCK2, the kinases that phosphorylate the C-terminal domain of
STE2 [112], they may confer similar properties. Therefore, the last 133 residues of STE2
(STE2tail) [180] were included in the assay to identify if the kinases interacted with STE2.
Chapter 5: Internalisation of Mam2 147
SD-leu-trp SD-leu-trp-his-ade 
 
Vector / Vector 
 
Vector / Mam2tail 
 
Vector / Map3tail 
 
Vector / STE2tail 
 
Vector / Rgs1 
 
Rgs1 / Vector 
 
Rgs1 / Mam2tail 
 
Rgs1 / Map3tail 
 
Rgs1  / STE2tail 
 
 
 
Cki1 / Vector 
 
Cki1 / Mam2tail 
 
Cki1 / Map3tail 
 
Cki1 / STE2tail 
 
Cki1 / Rgs1 
 
Cki2 / Vector 
 
Cki2 / Mam2tail 
 
Cki2 / Map3tail 
 
Cki2 / STE2tail 
 
Cki2 / Rgs1 
 
Cki3 / Vector 
 
Cki3 / Mam2tail 
 
Cki3 / Map3tail 
 
Cki3 / STE2tail 
 
Cki3 / Rgs1 
Cell number 
Negative 
control
Positive 
control
106  103 102105 104 106  103 102105 104
Figure 5.1: Mam2 does not interact with Cki1, Cki2 or Cki3. S. cerevisiae strains
AH109 were transformed with control vector pGADT7 (JD2320), pGADT7-Rgs1 (JD3180),
pGADT7-Cki1 (JD3770), pGADT7-Cki2 (JD3771) and pGADT7-Cki3 (JD3763) and were
co-transformed with vector pGBKT7 (JD1170), pGBKT7-Mam2tail (JD3221), pGBKT7-
Map3tail (JD3280), pGBKT7-STE2tail (JD3284) and pGBKT7-Rgs1 (JD3182). Trans-
formants were grown to mid-exponential growth phase and spotted onto SD-leu-trp (to
conrm the presence of both plasmids) and SD-leu-trp-his-ade plates (to indicate a protein-
protein interaction). Negative and positive controls (as indicated) were included to conrm
the absence of auto-activation of the GAL4 promoter and positive interactions with the
the C-terminal tail of Mam2, respectively.
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Strains expressing the Mam2tail with Cki1 and Cki2 did not produce colonies on the
SD-leu-trp-his-ade plates (Figure 5.1), suggesting that the C-terminal domain of Mam2
does not interact with either kinase. Colony formation was observed on SD-leu-trp-his-ade
plates for strains expressing the Mam2tail with Cki3, indicating a potential interaction
between these proteins. However, colonies were also observed on the SD-leu-trp-his-ade
plates when Cki3 was expressed with the vector control pGBKT7 (Figure 5.1), suggesting
that auto-activation of the GAL4 promoter had occurred and hence, it is unlikely that
Cki3 interacts with the Mam2tail. Interestingly, colony formation was observed on the
SD-leu-trp-his-ade plates between the kinases and STE2 and Rgs1, suggesting a positive
interaction between these proteins (Figure 5.1).
5.2.2 Quantitative yeast 2-hybrid assay
lacZ is one of the reporter genes under the control of the GAL4 promoter. lacZ encodes b-
galactosidase, production of which can be used to quantify the strength or likelihood of any
detected interactions between proteins. The plate-based yeast 2-hybrid assays indicated
that the kinases did not interact with Mam2 but did interact with S. pombe Rgs1 (Figure
5.1). To verify and quantify the results from the growth plate-based experiment the S.
cerevisiae strain AH109 was transformed with pGADT7-Rgs1, pGADT7-Cki1, pGADT7-
Cki2 and pGADT7-Cki3 and co-transformed with vector pGBKT7, pGBKT7-Mam2tail
and pGBKT7-Rgs1, grown to mid-exponential growth phase and assayed for b-galactosidase
activity as described in section 2.2.8.2. In agreement with the plate-based yeast 2-hybrid
experiment, the b-galactosidase assay did not display a dierence in reporter activity be-
tween strains expressing either kinase with the vector control or Mam2tail (p>0.05 when
n=3 (where n represents the number of independent experiments performed) when calcu-
lating one-way ANOVA) (Figure 5.2a). In contrast, a signicant increase in b-galactosidase
activity was observed between strains expressing Rgs1 with the vector control pGADT7
(0.20.1 lacZ units) and Rgs1 with Cki1 (1.90.4 lacZ units), Rgs1 with Cki2 (2.40.4
lacZ units) and Rgs1 with Cki3 (2.30.3 lacZ units) (Cki1: p = 0.0053, Cki2: p=0.0006,
Cki3: p=0.0008 when n=3, one-way ANOVA) (Figure 5.2b). These results suggested that
the kinases did not interact with the C-terminal domain of Mam2, but did interact with
Rgs1.
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Figure 5.2: Rgs1 interacts with Cki1, Cki2 and Cki3. The S. cerevisiae strain
AH109 was transformed with control pGADT7-Rgs1 (JD3180), pGADT7-Cki1 (JD3770),
pGADT7-Cki2 (JD3771) and pGADT7-Cki3 (JD3763) and were co-transformed with vec-
tor pGBKT7 (JD1170) and pGBKT7-Mam2tail (JD3221). Transformants were grown to
mid-exponential growth phase and a b-galactosidase assay (as described in section 2.2.8.2)
was performed. Data shown is the average of three independent experiments SEM.
Statistical signicance was calculated using one-way ANOVA, p<0.05, p<0.01 and
  p<0.001.
G protein-coupled receptor kinases (GRKs) often phosphorylate ligand-bound GPCRs
to initiate the binding of a b-arrestin protein and the subsequent internalisation of the
receptor from the plasma membrane (reviewed in [104]). Interestingly, GRKs contain an
RGS-like binding domain in their N-terminus and in some instances GRKs have been shown
to interact with Ga proteins [132]. An equivalent GRK protein has not yet been identied
in S. pombe (or any yeast system). As Cki1, Cki2 and Cki3 potentially perform similar roles
to GRKs in mammalian cells, it may not be surprising that a positive interaction between
these kinases with Rgs1 was observed. However, it should be noted that an RGS-like
binding domain has not been identied in Cki1, Cki2 or Cki3.
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5.3 Mam2-mCherry could not be utilised to quantify plasma
membrane uorescence
The yeast 2-hybrid assays demonstrated that Cki1, Cki2 and Cki3 did not interact with
the C-terminal domain of Mam2. When the C-terminus is transcribed, it would most likely
form a conformation that replicates an inactive receptor, as P-factor is not bound promoting
the active receptor conformation. If the role of the kinases was to phosphorylate Mam2
in response to P-factor binding, then it is intuitive that if the receptor is in an inactive
conformation then the kinases would not interact with Mam2. Therefore, these kinases
may still promote Mam2 internalisation in response to P-factor even though an interaction
between themselves and the GPCR was not observed.
Some studies, such as in S. cerevisiae have quantied GPCR internalisation utilising a
radio-labelled ligand [269]. Unfortunately, radio-labelled P-factor was unavailable for this
study. The localisation and tracking of GPCRs can be visualised and also quantied
via the addition of a uorescent protein to the C-terminus of the receptor in combination
with confocal microscopy. Previous studies in S. pombe have adopted this approach by
the addition of a green uorescent protein (GFP) or mCherry uorescent protein to the C-
terminal tail of Mam2 and have successfully observed the receptor at the plasma membrane
and within intracellular vesicles [173, 184]. Therefore, the internalisation of Mam2 was
measured in this study by utilising uorescently labelled Mam2 in combination with cell
segmentation software QuimP, which can quantify the cortical uorescence of individual
cells.
5.3.1 Mam2-mCherry was internalised in response to P-factor
The localisation of Mam2 was investigated via the addition of mCherry to the C-terminal
domain and expressing this from an inducible plasmid (pREP3x) in combination with confo-
cal microscopy. Visualisation of Mam2 was achieved by utilising an S. pombe strain lacking
endogenous mam2 (JY1169; mam2 , sxa2>lacZ ), which was transformed with pREP3x-
mCherry (JD3514, pmCh) as a control and pREP3x-Mam2-mCherry (pMam2mCh, JD3590).
Strains were grown to mid-exponential growth phase treated with 0 µM and 10 µM P-factor
and imaged after 16 h treatment (as described in section 2.2.14).
When untreated Mam2-mCherry was localised in vacuole-like structures within the cell
interior (Figure 5.3, red spheres in the cell interior) and at the cell periphery, specically at
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the cell tips (Figure 5.3, arrows). Following treatment with P-factor, cells formed conjuga-
tion tubes and Mam2-mCherry was localised within vacuole-like structures in the cytosol,
but no longer observed at the cell periphery (Figure 5.3). The lack of visible Mam2-mCherry
at the plasma membrane following treatment, suggested the receptor had been internalised
(Figure 5.3), in agreement with previous observations [173, 184].
[P-factor] 
mam2 + 
pMam2mCh 
10 µM 0 µM 
mam2 + 
pmCh 
x
Figure 5.3: Mam2-mCherry is internalised following treatment with P-factor.
mam2 (JY1169) strains were transformed with pREP3x-mCherry (pmCh, JD3514) and
pREP3x-Mam2-mCherry (pMam2mCh, JD3590) were grown to mid-exponential growth
phase before treatment with a range of P-factor concentrations (from 0 µM to 100 µM).
Following 16 h treatment cells were imaged in the mCherry channel (section 2.2.14). Scale
bar represents 10 µm. Arrows highlight the receptor is localised to the cell periphery,
which we assume is the plasma membrane. The cross highlights that plasma membrane
localisation is dicult to identify on some cells.
5.3.2 The mCherry protein did not aect signal transduction via Mam2
The formation of conjugation tubes observed in S. pombe strains expressing Mam2-mCherry
(Figure 5.3), suggested the addition of the mCherry protein to the C-terminal domain of
Mam2 did not hinder signal transduction via the G protein. This was conrmed in vitro by
performing a b-galactosidase assay. mam2 S. pombe cells (JY1169) were transformed with
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pmCh (JD3514) and pMam2mCh (JD3590) and in addition to the wild type (WT) strain
(JY544; mam2+, sxa2>lacZ ) were grown to mid-exponential growth phase, treated with a
range of P-factor concentrations (0 µM to 100 µM) for 16 h and assayed for b-galactosidase
activity (as described in section 2.2.8.1).
WT strains containing endogenous Mam2 reached a maximum response of 241 lacZ
units (Figure 5.4). Expressing Mam2mCh in mam2 strains from the inducible plasmid
pREP3x resulted in a reduction in maximal b-galactosidase activity to 211 lacZ units (in
comparison to WT). However, the reduction in response was not statistically signicant
(p=0.0779 when n=3, Student's t-test). In addition, no signicant change in the potency
of P-factor was observed between strains containing endogenous Mam2 and Mam2mCh
(Mam2 pEC50: 7.50.08 and Mam2mCh pEC50: 7.50.13, p=0.7597 when n=3, Student's
t-test). Together, the conjugation tube formation observed during the microscopy analysis
and similar signalling characteristics exhibited by the b-galactosidase assays suggested that
the addition of the mCherry protein to the C-terminal domain of Mam2 did not aect
signal transduction via Gpa1 (the G protein) (Figure 5.4).
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Figure 5.4: Signalling is rescued in mam2 strains expressing Mam2-mCherry.
mam2 (JY1169) strains expressing pmCh (JD3514) and pMam2mCh (JD3590) and the
WT strain (JY544, mam2+) were grown to mid-exponential growth phase and treated
with a range of P-factor concentrations from 0 µM to 100 µM for 16 h before being assayed
for b-galactosidase activity (as described in section 2.2.8.1). Data shown is the average of
three independent experiments SEM.
If Cki1, Cki2 or Cki3 promoted P-factor-induced internalisation of Mam2, then loss of
these proteins would retain the receptor at the plasma membrane for longer. To determine
whether deletion of the kinases reduces Mam2 internalisation, rstM-type S. pombe strains
lacking the endogenous receptor and either Cki1, Cki2 or Cki3 were created (as described in
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section 2.3.1). The double knockout strains cki1mam2 (JY1727; sxa2>lacZ, mam2,
cki1::ura4+), cki2mam2 (JY1734; sxa2>lacZ, mam2, cki2::ura4+) and cki3mam2
(JY1720; sxa2>lacZ, mam2, cki3::ura4+) had typical cellular morphology and did not
respond to P-factor (see Appendix D).
Removing Cki1 and Cki3 from S. pombe strains containing endogenous Mam2 exhib-
ited a signicant increase in maximal b-galactosidase activity and cell volume following
treatment with P-factor (Chapter 4; Figure 4.9 and Figure 4.10, respectively). To ver-
ify that these signalling characteristics were maintained with the double-deletion strains
expressing Mam2-mCherry, b-galactosidase and cell volume assays were performed. The
double deletion strains (cki1mam2, cki2mam2 and cki3mam2 ) and mam2
cells were transformed with pMam2mCh, grown to mid-exponential growth phase, treated
with a range of P-factor concentrations (from 0 µM to 100 µM) for 16 h and assayed for
b-galactosidase activity and cell volume (as described in section 2.2.8.1 and 2.2.7, respec-
tively).
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Figure 5.5: The localisation of Mam2-mCherry does not dier in strains lack-
ing Cki1, Cki2 or Cki3. mam2 (JY1169), cki1mam2 (JY1727), cki2mam2
(JY1734) and cki3mam2 (JY1720) strains expressing pMam2mCh (JD3590) were
grown to mid-exponential growth phase and treated with a range of P-factor concentra-
tions from 0 µM to 100 µM for 16 h before being assayed for (a) b-galactosidase activity
(section 2.2.8.1) and (b) cell volume (section 2.2.7). Data shown is the average of three
independent experiments SEM.
Loss of Cki1 and Cki3 in strains expressing Mam2mCh demonstrated a signicant in-
crease in b-galactosidase activity, in concert with the previous observations from chap-
ter 4 (Figure 5.5a). Specically, mam2+pMam2mCh cells displayed 251 lacZ units,
whereas loss of cki1 and cki3 exhibited an increase in maximal response to 331 lacZ
units and 492 lacZ units, respectively (cki1 : p=0.0048 and cki3 : p=0.0004 when
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n=3, Student's t-test) (Figure 5.5a). In addition, cki1mam2 and cki3mam2 strains
expressing Mam2mCh demonstrated a signicant increase in maximal cell volume (Figure
5.5b). cki1+,cki3+ cells displayed a cell volume of 821 µm3, whereas loss of cki1 and
cki3 demonstrated an increase in cell volume of 1033 µm3 and 1595 µm3, respectively
(cki1 : p=0.0027 and cki3 : p=0.0001 when n=3, Student's t-test) (Figure 5.5b).
These data illustrate that the signalling characteristics were maintained between strains
containing endogenous Mam2 and strains expressing Mam2-mCherry when the kinase
ORF's were disrupted (compare Figure 4.9 and Figure 4.10 with Figure 5.5). Therefore,
Mam2mCh was utilised to quantify how deletion of Cki1, Cki2 and Cki3 aect plasma
membrane localisation of Mam2 in response to P-factor treatment.
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5.3.3 Insucient Mam2 localisation at the plasma membrane
To quantify plasma membrane uorescence using Mam2-mCherry its expression at the
plasma membrane was required to be sucient enough for the QuimP software to segment
the cell periphery. Unfortunately, cells expressing Mam2mCh often did not show a strong
association with the cell membrane (as seen in gure 5.3, the cross illustrates a cell with
poor receptor membrane expression) and therefore, for many cells the QuimP software was
unable to segment the cell perimeter and hence, quantify cortical uorescence (see Figure
5.6 for an example). The images displayed in Figure 5.6 were achieved using mam2 S.
pombe cells transformed with pMam2mCh, grown to mid-exponential growth phase, treated
with 10 µM P-factor for 8 h and imaged every 2 h from 0 h to 8 h (as detailed in section
2.2.14). The uorescent images were loaded into the QuimP software and an individual cell
was selected at random and segmented.
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pMam2mCh  
DIC  
Figure 5.6: Mam2 tagged mCherry did not localise to the plasma membrane
enough for QuimP to segment the cell periphery. mam2 (JY1169) strains express-
ing pMam2mCh (JD3590) were grown to mid-exponential growth phase before treatment
with 10 µM P-factor for 8 h. Cells were then imaged every 2 h from 0 h to 8 h in the
mCherry and dierential interference contrast (DIC) channel (or bright eld) (as detailed
in section 2.2.14). The uorescent images were loaded into QuimP to segment and mea-
sure the plasma membrane uorescence over time(highlighted by the outer red and inner
yellow contours). The DIC channel was shown to illustrate that the software was unable
to identify the cell periphery. Scale bar represents 10 µm.
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5.4 Characterising the C-terminal domain of Mam2
5.4.1 The C-terminal domain of Mam2 is essential for internalisation
Mam2-mCherry did not associate strongly with the plasma membrane and thus, the QuimP
software could not segment the cell periphery. A previous study showed that removing the
last 45-residues of Mam2 (as shown in Figure 5.7a) increased receptor plasma membrane
concentration [173]. Therefore, mam2 (JY1169) cells expressing pREP3x-Mam2tail-
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Figure 5.7: QuimP is able to identify Mam2tailmCh at the plasma membrane.
(a) A schematic representation of of the last 45 amino-acid residues of Mam2, highlighting
the truncation point directly downstream of the glutamine (Q) residue used to create
pREP3x-Mam2tail-mCherry (pMam2tailmCh, JD3621). (b) mam2 (JY1169) cells
transformed with pMam2tailmCh were grown to mid-exponential growth phase before
treatment with 10 µMP-factor for 8 h. Cells were imaged every 15 min from 0 h to 8 h in the
mCherry channel (as described in section 2.2.14). (c) The uorescent images were loaded
into QuimP to segment and measure the plasma membrane uorescence of individual cells
(highlighted by the outer red and inner yellow contours). Scale bar represents 10 µm.
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mCherry, which had the last 45-residues removed (Mam2tailmCh, JD3621) were grown to
mid-exponential growth phase, treated with 10 µM P-factor and imaged every 15 min from
0 h to 8 h (as described in section 2.2.14). The resulting images were loaded into QuimP
to determine whether the concentration of Mam2tailmCh at the plasma membrane was
sucient to segment the cell periphery and hence, quantify cortical uorescence.
Removing the last 45-residues of Mam2 resulted in a uniform localisation of the receptor
at the plasma membrane (Figure 5.7b). As a result, the QuimP software was able to
segment the cell periphery and quantify plasma membrane uorescence over time (Figure
5.7b-c). However, loss of the C-terminal domain prevented both constitutive and ligand-
induced internalisation (Figure 5.7b, this can be seen clearly in Figure 5.8a where cells had
been treated with P-factor for 16 h, as the receptor was not observed in the vacuole-like
structures). Although a reduction in plasma membrane uorescence was observed between
0 h and 8 h (from 54 % to 47 %) for the cell highlighted in Figure 5.7b, this reduction was
most likely the result of continued light exposure during the time-lapse experiment, which
causing photobleaching of the uorescent molecule and hence, a reduction in signal (Figure
5.7c).
Strains expressing Mam2tailmCh did form conjugation tubes in response to P-factor
(Figure 5.8). This morphological response (conjugation tube formation) indicated that the
C-terminal domain of Mam2 was not essential for signal transduction via the G protein. b-
galactosidase assays conrmed the C-terminal tail of Mam2 was not essential for G protein
activation. However, it was required for maximal WT (mam2+) signalling response (Figure
5.8b). Maximal response was signicantly reduced in cells expressing Mam2tailmCh in
comparison to strains transformed with pMam2mCh (reduction from 200.5 lacZ units to
81 lacZ units , p=0.0001 when n=3, Student's t-test). In addition to the reduction in
response, a signicant shift in pEC50 from Mam2mCh at 6.40.1 to Mam2tailmCh at
80.2 was observed (p=0.0028 when n=3, Student's t-test).
It has been shown that the C-terminal domain of Mam2 acts as a scaold for Rgs1
[173]. When the tail is absent Rgs1 is not localised to the plasma membrane and hence,
is unable to hydrolyse GTP-bound Gpa1 (a G protein), which is required for a maximal
signalling response. The data collected in this section (5.4.1) are in agreement with previous
observations [173].
Although removing the C-terminal domain of Mam2 increased plasma membrane locali-
sation such that the QuimP software could segment and quantify cortical uorescence, the
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signalling behaviour was signicantly altered and receptor internalisation was prevented
(Figure 5.8). Therefore, Mam2tailmCh was not an appropriate receptor to quantify the
internalisation of Mam2 in strains lacking Cki1, Cki2 and Cki3. The generation of a receptor
that when expressed in untreated cells resembled that of Mam2tailmCh, but internalised
and signalled like full length Mam2 would provide a system to enable the quantication of
how loss of the kinases aects receptor internalisation.
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Figure 5.8: The C-terminal tail of Mam2 is essential for internalisation and
maximal signalling. mam2 (JY1169) strains transformed with pMam2mCh (JD3590)
and pMam2tailmCh were grown to mid-exponential growth phase before treatment with
a range of P-factor concentrations (from 0 µM to 100 µM). Following 16 h (a) cells treated
with 0 µM and 10 µM P-factor were imaged in the mCherry channel (as detailed in section
2.2.14) and (b) cells were assayed for b-galactosidase (as described in section 2.2.8.1). Scale
bar represents 10 µm. Data shown is the average of three independent experiments SEM.
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5.4.2 Truncating Mam2 aects receptor localisation and sorting
Truncating the C-terminal tail of Mam2 highlighted that residues within the 45-residue
sequence where essential for internalisation and tracking of the receptor to the vac-
uoles (Figure 5.8). A previous study suggested that removal of an 8-residue sequence
(YSISDESE) from the C-terminal tail of Mam2 increased plasma membrane localisation
in untreated cells, yet maintained a maximal signalling response following treatment with
P-factor [173]. However, the microscopy images used to make these conclusions were of
low-resolution and the localisation and sorting of the receptors in response to treatment
with P-factor was not analysed (E. McCann, PhD thesis, 2010).
The localisation and internalisation of Mam2 can now be investigated in greater detail
with the aid of higher-resolution microscopy. The sorting of the receptor to the vacuole can
be assessed using a lipophilic styryl vacuole dye FM4-64, which binds the plasma membrane
of living cells and is endocytosed and tracked to the vacuole, thereby highlighting the
vacuola membranes [283]. FM4-64 is a red uorescent dye (excitation/emission maxima
515/640 nm), which can be visualised in the mCherry channel of a DeltaVision system
wide-eld deconvolution microscope. Therefore, a dierent coloured uorescent dye other
than mCherry was required for visualising the receptor to co-visualise the receptor with the
vacuole dye. A number of truncated versions of Mam2-GFP had previously been created by
E. McCann in the inducible plasmid pREP3x and hence, were used to assess the localisation
and sorting of the receptors with the vacuole dye (see Figure 5.9 for a list of receptors used
in this section).
QSMKTSSAQGETTEVSIRVDRTFDIKHTPSDDYSISDESETKKWTMam2tail 
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Figure 5.9: Sequential truncations of the C-terminal tail of Mam2. Schematic
representation of the last 45-amino acid residues of Mam2. The diagram highlights
the sequential truncations of Mam2. The resulting DNA fragments were cloned
into pREP3x-GFP (pGFP, JD2261) to create pREP3x-Mam25-GFP (pMam25GFP,
JD2999), pREP3x-Mam213-GFP (pMam213GFP, JD3001), pREP3x-Mam221-GFP
(pMam221GFP, JD3003), pREP3x-Mam237-GFP (pMam237GFP, JD3007) and
pREP3x-Mam2tail-GFP (pMam2GFP, JD3317) (E. McCann, PhD thesis, 2010).
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Figure 5.10: The last 13 residues of Mam2 are essential for consti-
tutive internalisation into the vacuoles. mam2 strain (JY1169) express-
ing pMam2GFP (JD2885), pMam25GFP (JD2999), pMam213GFP (JD3001),
pMam221GFP (JD3003) and pMam237GFP (JD3007) were grown to mid-exponential
growth phase containing 50 µM of FM 4-64 vacuole staining protein for 16 h [283]. Cells
were then imaged in the mCherry and GFP channel as described in section 2.2.14 and the
middle 8 stacks were maximally projected to show the cross section of each cell (include
vacuole cross section). White arrows highlight the receptor on the plasma membrane, aster-
isk's indicate cells, which display receptor within the vacuoles and yellow arrows highlight
endosomal structures. Composite images were collated into one image for visualisation
(marked with a white boarder). Scale bar represents 10 µm.
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The mam2 S. pombe strain JY1169 was transformed with pREP3x-Mam2-GFP
(pMam2GFP, JD2885) and those receptors described in Figure 5.9 (each of which contained
one GFP molecule at their C-terminus). These strains were grown to mid-exponential
growth phase in minimal medium containing 50 µM FM4-64 (vacuole staining protein) for
16 h and imaged as described in section 2.2.14. A previous study illustrated that following
growth of S. pombe to 5x106 cells/ml and treatment with 50 µM FM4-64 for 1 h was
sucient to identify the vacuola membranes [283]. Therefore, growth with the FM4-64 dye
for 16 h was assumed to identify vacuoles (Figure 5.10, FM4-64 panel).
Full length Mam2 (Mam2GFP) and Mam5GFP was observed at the plasma membrane,
but predominantly within spherical structures in the cell interior (Figure 5.10, arrows).
The merged images displayed some green spheres conned by a ring of red FM4-64 staining
(Figure 5.10, shown by asterisk's), suggesting that these receptors were contained within
the vacuoles. Additional green spherical structures are also observed, but were not encased
by FM4-64 staining (Figure 5.10, yellow arrows).
Mam213GFP was visible at the plasma membrane, predominantly at the cell tips
and within internal structures in the cytosol (Figure 5.10). The merged image did not
show Mam213GFP encased by the red vacuole dye (in comparison to Mam25GFP),
suggesting that the last 13-residues of Mam2 were required for receptor sorting to the
vacuoles.
Strains expressing Mam221GFP and Mam237GFP exhibited the receptor uniformly
distributed at cell perimeter (Figure 5.10), rather than just the cell tips (in comparison
to the Mam213GFP receptor). The merged images did not demonstrate any receptors
within vacuoles and fewer receptors were observed within internal structures. Truncating
the last 21 and 37 residues of Mam2 appeared to increase plasma membrane concentration
of the receptor and reduce receptor internalisation.
To investigate the localisation and tracking of the receptors in response to P-factor,
mam2 (JY1169) strains transformed with pMam2GFP, pMam25GFP, pMam213GFP,
pMam221GFP and pMam237GFP were grown to mid-exponential growth phase con-
taining 50 µM FM4-64 (vacuole staining protein), treated with a 10 µM P-factor and
imaged following 16 h (as detailed in section 2.2.14). The sequential truncations of Mam2
appeared to reduce conjugation tube elongation (Figure 5.11), highlighting that the recep-
tor tail is required for a WT response [173]. This is most likely the result of the predicted
Rgs1 binding domain contained within the 16 residue sequence between Mam25GFP
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and Mam221GFP, as Rgs1 interacts with the C-terminal domain stabilising its plasma
membrane localisation and G protein hydrolysis [173].
Mam2GFP was not visible at the plasma membrane following treatment with P-factor,
instead the receptor was displayed within two types of intracellular spherical structures
within the cytosol. One of the spherical structures was encased by the FM4-64 staining
(Figure 5.11, merge), suggesting that Mam2 had been internalised and tracked to the
vacuoles. The other structures were not encased by FM4-64 but resided near the cell pe-
riphery. Removing the last 5-residues of Mam2 increased plasma membrane localisation as
the receptor was observed at the cell periphery following treatment with P-factor in compar-
ison to Mam2GFP (Figure 5.11). Similarly to Mam2GFP, Mam25GFP was internalised
into the cell interior, displaying green spheres encased by FM4-64 staining (vacuoles) and
smaller spherical vesicles not encased by the vacuola staining (Figure 5.11, merged).
Removing the last 13 and 21 residues of Mam2 did not increase plasma membrane lo-
calisation and these receptors were observed in intracellular compartments that were not
vacuoles, as they were not encased by FM4-64 staining (Figure 5.11, merged). Strains ex-
pressing Mam237GFP displayed the receptor predominantly in large intracellular struc-
tures positioned near the cell tips and in some cells at the plasma membrane (Figure 5.11).
Loss of the 37-residues of Mam2 prevented receptor sorting to the vacuole however, small
intracellular structures not encased by FM4-64 were observed near the cell periphery.
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Figure 5.11: The last 13 residues of Mam2 are essential for track-
ing to the vacuoles following endocytosis. mam2 strain (JY1169) ex-
pressing pMam2GFP (JD2885), pMam25GFP (JD2999), pMam213GFP (JD3001),
pMam221GFP (JD3003) and pMam237GFP (JD3007) were grown to mid-exponential
growth phase containing 50 µM of FM 4-64 vacuole staining protein before treatment with
10 µM P-factor. After 16 h cells were then imaged in the mCherry and GFP channel as
described in section 2.2.14 and the middle 8 stacks were maximally projected to show a
cross section of the cell (to include vacuole cross section). Scale bar represents 10 µm.
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5.4.3 Truncating Mam2 alters signal transduction in response to P-factor
Mam221 was uniformly distributed at the cell periphery in untreated cells, yet internalised
in response to P-factor (section 5.4.2). Hence, in terms of quantifying plasma membrane
uorescence using QuimP, Mam221GFP appeared to be an ideal receptor for assessing
how loss of Cki1, Cki2 and Cki3 in S. pombe strains aects receptor internalisation.
Deleting the last 45-residues of Mam2 reduces maximal signalling response and in-
creases the potency of P-factor (Figure 5.8b). To assess which regions of the tail are
essential for a WT (full length Mam2) P-factor-directed transcriptional response and to
specically determine how loss of the 21-residues from the C-terminus of Mam2 changes
the signalling characteristics, b-galactosidase assays were performed with the truncated
versions of Mam2. mam2 (JY1169; mam2 , sxa2>lacZ ) S. pombe cells were trans-
formed with pGFP, pMam2GFP, pMam25GFP, pMam213GFP, pMam221GFP and
pMam237GFP, grown to mid-exponential growth phase, treated with a range of P-factor
concentrations (from 0 µM to 10 µM P-factor) and assayed for b-galactosidase activity after
16 h (as described in section 2.2.8.1).
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Figure 5.12: Truncating Mam2 caused an increased basal and reduced maximal
response following P-factor treatment. mam2 cells (JY1169) were transformed
with pGFP (JD2261), pMam2GFP (JD2885), pMam25GFP (JD2999), pMam213GFP
(JD3001), pMam221GFP (JD3003) and pMam237GFP (JD3007) were grown to mid-
exponential growth phase before treated with a range of P-factor concentrations from 0
µM - 100 µM. Following 16 h cells were assayed for b-galactosidase activity (as detailed in
section 2.2.8.1). Data shown is the average of three independent experiments SEM.
Truncation of the last 5 or 13 residues of Mam2 did not signicantly alter the maximal
or basal transcriptional signalling responses (Figure 5.12) (p>0.05, Student's t-test). How-
ever, Mam213GFP was signicantly more potent to P-factor, displaying an increase in
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pEC50 from 6.80.1 to 7.50.1, in comparison to full length Mam2 (p=0.0029 when n=3,
Student's t-test). Truncating 21 and 37 residues from the C-terminal domain of Mam2
demonstrated an increase in potency of P-factor and basal b-galactosidase activity and a
reduction in maximal response (Figure 5.12). Specically, Mam221GFP displayed a sig-
nicant reduction from 201 lacZ units to at 151 lacZ units in comparison to full length
Mam2 (p=0.0241 when n=3, Student's t-test).
The receptor Mam213GFP reached the same maximal signalling level as full length
Mam2 in response to P-factor (Figure 5.12). However, the receptor did not localise uni-
formly at the membrane during vegetative growth (only at the tips) (Figure 5.10). In
contrast, the receptor Mam221GFP did localise uniformly at the cell periphery when un-
treated and would therefore be suitable for segmentation using QuimP (Figure 5.10) but a
signicant reduction in maximal signalling response was exhibited (Figure 5.12). Together,
these data suggest that neither Mam213GFP or Mam221GFP are appropriate receptors
to access how loss of Cki1, Cki2 and Cki3 aects internalisation of Mam2.
5.5 Characterisation of the lysine decient C-terminal do-
main of Mam2
Monoubiquitination of a single lysine residue within the SINNDAKSS sequence of the C-
terminal domain of S. cerevisiae STE2 is essential for both constitutive and ligand-induced
internalisation [174, 284]. However, the investigation of many mammalian GPCRs has
revealed that ubiquitination is not required for ligand-induced endocytosis. Some examples
are the chemokine CXCR4, b2AR, DOR and neurokinin (NK1R) receptors [159, 285{288].
Arginine scanning of lysine residues in the S. cerevisiae STE3 C-terminal domain pre-
vents ubiquitination-dependent constitutive internalisation of the GPCR, resulting in an
increase in plasma membrane concentration, yet the receptor remains sensitive to ligand-
induced internalisation [289]. This mechanism of arginine scanning was exploited in order to
increase the plasma membrane concentration of Mam2 without altering the ligand-induced
internalisation characteristics of the receptor, allowing the QuimP software to successfully
segment the cell periphery.
Mam2 contains 4 lysine residues at positions 307, 329, 345 and 346 relative to the ATG
(position 1) codon (Figure 5.13). The two latter lysines (345 and 346) are contained within
the last 5-residues of Mam2, with truncation of these residues exhibiting no defects in
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receptor localisation when compared to full length Mam2 (Figure 5.10 and 5.11). Two
potential ubiquitination decient mCherry tagged receptors were created in plasmids for
the expression of proteins under the control of the nmt1 promoter of pREP3x [235] (for de-
tails see section 2.3.2.3 and 2.3.2.4): pREP3x-Mam22K-mCherry (pMam22KmCh, JD3802)
contains a version of Mam2 with the lysine residues at position 345 and 346 (situated
in the last 5-residues) remaining intact but the other lysine residues mutated to arginine
and pREP3x-Mam24K-mCherry (pMam24KmCh, JD3804) contains a receptor with all four
lysine residues either mutated to arginine of deleted (Figure 5.13).
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Figure 5.13: Schematic illustration of the lysine mutations of Mam2. Schematic
representation of the last 45-amino acid residues of Mam2 (Mam2), pREP3x-Mam22K-
mCherry (Mam22K, JD3802) minus the mCherry tag and pREP3x-Mam24K-mCherry
(Mam24K, JD3804) minus the mCherry tag. The diagram highlights the lysine (K) residues
in blue and the mutation of the lysine to arginine (R) in red. For details on how these
Mam2 mutations were created see section 2.3.2.3 and 2.3.2.4.
5.5.1 Mutating the lysine residues of Mam2 does not aect mating in S.
pombe
Previous studies in S. pombe has shown that truncating regions of the C-terminal domain of
Mam2 and point mutations within other proteins such as Ras1, can aect the cells' ability to
mate ([173]; M. Bond, PhD thesis, 2012). Therefore, mating was assessed for cells expressing
the receptors Mam22KmCh and Mam24KmCh to verify that mutation of the lysine residues
did not aect the cells' ability to mate. mam2 , sxa2+ S. pombe M-type cells (JY1353) were
transformed with pmCh, pMam2mCh and pMam2tailmCh as controls for pMam22KmCh
and pMam24KmCh. In addition, the strain JY1353 was transformed with pREP3x-GFP
(pGFP, JD2261), pMam2GFP and pMam25GFP plasmids for comparison. Strains were
mixed with mating-type stable P-cells (JY1025: sxa2+), grown to mid-exponential growth
phase and mating was assessed via an iodine staining assay (as described in section 2.2.11.1).
The assay utilises the property that iodine binds the starch within the ascospore cell
wall and therefore the production of a brown/black colony colouration indicates a successful
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mating event [220]. Cells expressing Mam2mCh, Mam22KmCh, Mam24KmCh, Mam2GFP
and Mam25GFP displayed a qualitative dierence in colour intensity between the un-
mated and mated cells (Figure 5.14a), suggesting that strains expressing these receptors
were able to mate.
Following these qualitative results, the same strains were assayed for ascospore produc-
tion by measuring the percentage of colony forming units (CFU) or spore formation after a
heat shock step at 50C for 10 minutes (as detailed in section 2.2.11.2). This quantitative
assay utilises the heat resistant property of the spores. A signicant dierence in CFU re-
covery was not observed between strains expressing Mam2mCh (358%) and Mam22KmCh
(334%) or Mam24KmCh (357%) (Figure 5.14b). These data indicate that mating is not
aected by the removal or mutation of lysine residues in the C-terminal domain of Mam2
(p>0.05, one-way ANOVA) and therefore, further analysis with these receptors could be
performed.
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Figure 5.14: CFU recovery is unaected when removing lysine residues
from Mam2. mam2  sxa2+ S. pombe M-cells (JY1353) were transformed with pmCh
(JD3514), pMam2mCh (JD3590), pMam22KmCh (JD3802), pMam24KmCh (JD3804),
pMam2tailmCh (JD3621), pGFP (JD2261), pMam2GFP (JD2885), pMam25GFP
(JD2999) and mixed with mating-type stable P-cells (JY1025: sxa2 ). These strains
were then grown to mid-exponential growth phase in minimal medium and mating was
assessed using an (a) iodine staining assay (brown/black yeast colonies are formed when
mating is successful) as described in section 2.2.11.1 and a (b) quantitative sporulation
assay, which measures the percentage of colony forming units (CFUs) / spore formation
following 10 minutes of heat inactivation at 50C (for details see section 2.2.11.2). Data
shown is the average of three independent experiments SEM. Statistical signicance was
calculated using one-way ANOVA, p<0.05, p<0.01 and   p<0.001.
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5.5.2 Constitutive internalisation of Mam2 is prevented upon removal of
all four lysine residues from its C-terminus
As the lysine decient receptors did not aected the ability of S. pombe cells to mate
(Figure 5.14), the localisation of these receptors was investigated. The strain JY1169
(mam2 , sxa2>lacZ ) was transformed with the lysine decient receptors pMam22KmCh,
pMam24KmCh and pMam2mCh and pMam2tailmCh as controls. Cells were grown to
mid-exponential growth phase, treated with 0 µM and 10 µM P-factor and imaged following
16 h of treatment (as described in section 2.2.14).
When untreated Mam22KmCh was localised uniformly at the plasma membrane, yet
was still observed in vacuole-like structures in the cytosol (Figure 5.15). Cells expressing
Mam22KmCh responded to P-factor as conjugation tubes were observed (Figure 5.15).
Following treatment, the receptor was localised within intracellular compartments in the
cytosol and was not observed at the plasma membrane (Figure 5.15).
Mam24KmCh was distributed uniformly at the plasma membrane, but was not observed
within intracellular compartments in the cytosol, similar to removing the entire C-terminus
(Mam2tailmCh) (Figure 5.15). In contrast to Mam2tailmCh P-factor treated receptor,
which was localised at plasma membrane only, Mam24KmCh was observed at the plasma
membrane but also within intracellular compartments in the cytosol (Figure 5.15). Cells
expressing Mam24KmCh also formed conjugation tubes in response to treatment.
These microscopy analyses suggest that ligand-induced internalisation of Mam2 is not
dependent on ubiquitination. The receptor was internalised and observed in vacuole-like
structures in the cytosol when removing of all four lysine residues and thus, sites of ubiq-
uitination in the C-terminal domain of Mam2. The analysis also suggested that remov-
ing two lysine residues from the C-terminus of Mam2 (Mam22KmCh) increased receptor
plasma membrane concentration (as the receptor was localised around the cell perime-
ter). Additional loss of all four lysine residues appeared to enhance receptor membrane
association even further (observed by a greater intensity of cortical uorescence). Quanti-
cation of plasma membrane uorescence using QuimP conrmed that removing the lysine
residues from Mam2 increased plasma membrane uorescence. mam2 S. pombe (JY1169;
mam2 , sxa2>lacZ ) strains expressing mCh, Mam2mCh, Mam22KmCh, Mam24KmCh and
Mam2tailmCh (Figure 5.16). Strains were grown to mid-exponential growth phase im-
aged and QuimP was used to determine cortical uorescence (as detailed in section 2.2.14
and 2.2.18, respectively).
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Figure 5.15: Mam24KmCh is visible at the plasma membrane following P-factor
treatment. mam2 (JY1169) strains were transformed with pMam2mCh (JD3590),
pMam22KmCh (JD3802), pMam24KmCh (JD3804) and pMam2tailmCh (JD3621) were
grown to mid-exponential growth phase and treated with 0 µM and 10 µM P-factor and
imaged in the mCherry channel as described in section 2.2.14. Scale bar represents 10 µm.
The videos 3.1 and 3.2 demonstrate that the receptor Mam24KmCh was internalised into
vacuole-like structures.
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Figure 5.16: Removing lysines from Mam2 increases plasma membrane uores-
cence in untreated cells. mam2 S. pombe (JY1169) cells were transformed with pmCh
(JD3514), pMam2mCh (JD3590), pMam22KmCh (JD3802), pMam24KmCh (JD3804) and
pMam2tailmCh (JD3621), then grown to mid-exponential growth phase before imaging
in the mCherry channel. Individual cells (pmCh: m=6, pMam2mCh: m=20 and all others:
m=30, where m represents the number of individual cells analysed) were selected at ran-
dom and their plasma membrane uorescence was quantied using QuimP (as detailed in
section 2.2.18). Statistical signicance was determined using one-way ANOVA, p<0.05,
p<0.01 and   p<0.001.
A signicant increase in plasma membrane uorescence was observed between Mam2mCh
at 12% (m=20) and Mam22KmCh at 27% (m=30, where m represents the number of in-
dividual cells analysed) (p<0.0001, one-way ANOVA). Removing all four lysine residues
increased plasma membrane uorescence even further to 59% (m=30) of uorescence (of
the total cell) was situated at the membrane, similar to the amount observed when re-
moving the last 45-resides of Mam2 (Mam2tail) (58%, when m=30) (p<0.0001, one-way
ANOVA) (Figure 5.16). Together, these data present Mam24KmCh as an ideal receptor
for assessing how loss of Cki1, Cki2 and Cki3 aects the rate of receptor internalisation.
Mainly as its plasma membrane concentration is greatly increased in comparison to Mam2
and hence, QuimP will successfully segment the cell periphery, yet receptor will still remain
sensitive to ligand-induced internalisation.
5.5.3 Lysine decient Mam2 showed an initial sigmodial P-factor-induced
transcriptional response like Mam2
Before utilising Mam24KmCh to measure how loss of the kinases aects receptor internali-
sation, its signalling behaviour was analysed to ensure that removal of the lysine residues
did not alter its signalling characteristics in comparison Mam2. A b-galactosidase as-
say was performed with mam2 (JY1169; mam2 , sxa2>lacZ ) strains transformed with
pMam2mCh, pMam22KmCh and pMam24KmCh, grown to mid-exponential growth phase
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and treated with a range of P-factor concentrations (0 µM-10 µM) for 16 h (as detailed in
section 2.2.8.1). Both lysine decient receptors signalled in a similar fashion to Mam2mCh
showing a sigmodial dose-response when treated with 0 µM to 1 µM P-factor (Figure
5.17). However, following treatment with >1 µM P-factor cells expressing Mam22KmCh
and Mam24KmCh exhibited a reduction in signalling response observed by the bell-shaped
(non-monotonic) curves (Figure 5.17).
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Figure 5.17: Cells expressing lysine decient Mam2 showed a reduction in
b-galactosidase activity when treated with >1 µM P-factor. mam2 S. pombe
(JY1169) strains were transformed with pMam2mCh (JD3590), pMam22KmCh (JD3802),
pMam24KmCh (JD3804) and were grown to mid-exponential growth phase before treat-
ment with a range of P-factor concentrations (0 µM - 100 µM). Cells were assayed for
b-galactosidase activity after 16 h as described in section 2.2.8.1. Data shown are the
mean of ve independent determinants SEM.
5.5.4 Lysis is increased in cells expressing C-terminal lysine decient
Mam2 in response to high concentrations of P-factor
Similar bell-shaped b-galactosidase responses have been observed previously, both in this
study (Figure 3.11) and in the literature [223]. It has been shown that the reduction
in b-galactosidase response was the result of increased cell lysis in response to prolonged
(>8 h) treatment with high (>1 µM) concentration of P-factor [223]. In these studies
the percentage of non-viable cells in a population was determined using a cell viability
assay as described in section 2.2.16, which measures the Forster resonance energy transfer
(FRET) signal between two uorophores, propidium iodide and SYTO®9 [230]. Both dyes
are excited using a 488 nm laser on a ow cytometer and emission detected using a 550 nm
long pass lter with a 575/26 nm band pass lter for propidium iodide and a 505 nm long
pass lter with a 530/30 nm band pass lter for SYTO®9.
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A cell viability assay could not be performed with mam2 cells transformed with
pMam24KmCh as the mCherry uorophore can be excited within the same spectrum of
light and hence would aect the results. Instead, cell viability was determined visually
from time-lapse microscopy images. mam2 cells were transformed with pMam2mCh and
pMam24KmCh, grown to mid-exponential growth phase, treated with 10 µM P-factor and
imaged every 2 h from 0 h to 16 h as described in section 2.2.14. Each cell within the frame
was tracked with time to determine its viability (for examples of time-lapse images used to
determine cell viability please see the representative images in Appendix F).
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Figure 5.18: Expression of Mam24KmCh reduces cell-viability with pro-
longed P-factor treatment. mam2 S. pombe cells (JY1169) were transformed with
pMam2mCh (JD3590) and pMam24KmCh (JD3804) grown to mid-exponential growth
phase and treated 10 µM P-factor. A randomly selected eld of cells (containing 30 cells)
were chosen and imaged in the mCherry channel every 2 h from 0 h to 16 h as detailed
in section 2.2.14. The percentage of non-viable cells in each frame were determined by
eye and plotted in a Kaplan-Meier plot. Data shown are the mean of three independent
determinants SEM.
Mam2 tagged mCherry (Mam2mCh) displayed a 4% reduction in survival following 16 h
of treatment (Figure 5.18), whereas Mam24KmCh showed a 15% reduction in survival from
0 h (100%) to 16 h (854%). The dierence in survival after 16 h of P-factor treatment
between Mam2mCh and Mam24KmCh was signicant (p=0.0135, two-way ANOVA using a
Sidak test). These data suggest that removal of all four lysines from the C-terminal domain
of Mam2 promotes cell lysis in response to P-factor treatment for periods up to 16 h and
hence, provides a possible explanation for the reduction in b-galactosidase activity observed
in the transcriptional assay.
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5.5.5 Lysine decient Mam2 alters conjugation tube formation
Cells expressing Mam24KmCh became increasingly non-viable with time following treat-
ment with 10 µM P-factor (Figure 5.18). Visual analysis of the time-lapse microscopy
images exhibited some cells elongating from both tips (rather than one end) to form conju-
gation tubes in response to treatment. A series of time-lapse images were taken of mam2 
S. pombe cells (JY1169) expressing mCh, Mam2mCh and Mam24KmCh following treat-
ment with 10 µM P-factor for 16 h. Each cell that responded to P-factor was categorised
by whether it had elongated from a single tip or both tips.
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Figure 5.19: Expression of Mam24KmCh increases the number of cells form-
ing conjugation tubes from both tips. (a) mam2 (JY1169) and (b) mam2+
(JY544) S. pombe cells were transformed with pmCh (JD3514), pMam2mCh (JD3590)
and pMam24KmCh (JD3804) and were grown to mid-exponential growth phase before
treatment with 10 µM P-factor. A frame of cells was selected at random and imaged
under bright eld light every 15 minutes from 0 h to 16 h. Each cell (that formed con-
jugation tubes) within that image was then categorised into whether it elongated from a
single or both ends. Data shown the average of two independent determinants SEM, the
total number of cells counted is denoted n. Statistical signicance was determined using
one-way ANOVA. p<0.05, p<0.01 and   p<0.001. The videos 3.3 and 3.4 are rep-
resentative time-lapse videos showing cells that elongate from a single tip and from both
tips, respectively.
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463% (m=68) of cells expressing Mam24KmCh formed conjugation tubes from both
tips was signicantly increased in comparison to 71% (m=86) of cells exhibited when ex-
pressing Mam2mCh (p<0.0001, one-way ANOVA) (Figure 5.19a). Interesting an increase
in the number of cells elongating from both tips was also observed in strains express-
ing both endogenous Mam2 (JY544) and pMam24KmCh (Figure 5.19b). Indicating that
Mam24KmCh was dominant in terms of signalling preference than endogenous Mam2.
5.5.6 Active Cdc42 was observed at both tips in some cells that formed
conjugation tubes from both tips
The G protein Cdc42 is concentrated at the growing tip in S. pombe cells [83]. A uorescent
fusion protein Cdc42/Rac interactive binding (CRIB)-GFP binds specically to activated
GTP-bound Cdc42 and can be used as a marker to assess the growing tip of S. pombe cells
[85, 290, 291]. The strain JY1689 which expresses CRIB-GFP under the control of the
Shk1 promoter (a downstream eector of Cdc42) and contains endogenous Mam2, when
expressed with additional Mam2-mCherry from the pREP3x vector (pMam2mch, JD3950)
was grown to mid-exponential growth phase, plated onto agarose pads contains 10 µM
P-factor and imaged every 15 minutes (as described in section 2.2.14) to elucidate the
growing tip. Cells transformed with Mam2mCh illustrated that CRIB-GFP was localised
to a single elongating tip in response to P-factor (Figure 5.20), consistent with previous
studies [223, 290]. Images are shown from 4 h as conjugation tubes are typically observed
following 4 h of P-factor treatment and images are shown until 8 h as the direction of
growth would be clear by this time.
50 % of cells containing endogenous Mam2 and expressing additional Mam24KmCh
elongated from both tips in response to P-factor (Figure 5.19). This elongation from both
tips suggested that the receptor Mam24KmCh was dominant in terms of signalling prefer-
ence over endogenous Mam2. Therefore, the C-terminal tail lysine decient receptor was
expressed in CRIB-GFP strains (which are mam2+) to investigate the localisation of active
Cdc42. The CRIB-GFP strain JY1689 was transformed with pMam24KmCh, grown to mid-
exponential growth phase, plated onto agarose pads containing 10 µM P-factor and imaged
every 15 min from 4 h (as described in section 2.2.14). Some cells expressing Mam24KmCh
that elongated from both ends in response to P-factor exhibited CRIB-GFP at both tips
(Figure 5.20). The CRIB-GFP+pMam24KmCh panel in Figure 5.20 is a representative
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Figure 5.20: Cells expressing Mam24KmCh elongate from both tips following
P-factor treatment. mam2+ strains containing a CRIB-GFP marker for Cdc42-GTP
(JY1689) were transformed with pMam24KmCh (JD3804) and grown to mid-exponential
growth phase before treatment with 10 µM P-factor. A randomly selected eld of cells
were imaged in the GFP channel every 15 minutes from 0 h to 8 h (as described in section
2.2.14). Only 4 h to 8 h are shown here as the majority of cells begin to form conjugation
tubes following 4 h of treatment with P-factor. Yellow arrow heads highlight CRIB-GFP
at the cell tips. Scale bar represents 10 µm. The video 3.5 is a representative time-lapse
image showing that CRIB-GFP was observed at both tips in some cells that elongate from
both tips.
image. Not all cells that appeared to elongate from both ends exhibited CRIB-GFP at
both tips (see video 3.5).
In mitotically growing cells, following cell division, the daughter cells grow from the tip
that existed prior to separation (the `old' tip). When a minimal size threshold is reached
growth is initiated from the opposite tip and period of bipolar growth is established, a
process termed new end take o (NETO) [292]. In mitotically growing cells CRIB-GFP
has been shown to oscillate by a period of 2 minutes during bipolar growth [85]. To obtain
time-lapse images of cells every 2 minutes, many factors need to be controlled, such as the
photobleaching of the uorophores and the drift from the microscope. These factors make
it incredibly challenging to image these cells over the period of 2 minutes and to observe
the conjugation tube formation which can take hours. The images obtained during this
study were taken every 15 minutes over a period of 5 hours before photobleaching was
observed (see video 3.5) and oscillations of CRIB-GFP between each tip was exhibited.
These images therefore suggest that conjugation tube formation from both tips may be a
result of Cdc42 activation at both tips, suggesting that the Mam24KmCh inuences Cdc42
activation in response to treatment with P-factor.
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5.6 Loss of Cki2 reduces receptor internalisation
Cells expressing Mam24KmCh exhibited an increase in receptor plasma membrane concen-
tration (in comparison to Mam2mCh), as constitutive internalisation was prevented, yet
the receptor remained sensitive to P-factor-induced internalisation (Figure 5.15). Strains
expressing Mam24KmCh also demonstrated similar sigmodial responses to P-factor as ob-
served with full length Mam2 when treated with <1 µM P-factor (Figure 5.17). As dis-
cussed, cells expressing Mam24KmCh showed a reduction in b-galactosidase activity as a
consequence of the cells becoming increasingly non-viable in response to P-factor. However,
this was only signicant following 12 h of treatment (Figure 5.18).
These data suggested that the receptor Mam24KmCh could be utilised to investigate how
loss of Cki1, Cki2 and Cki3 alters the rate of receptor internalisation, as the receptor was
strongly localised to the cell periphery and could be quantied (prior to the signicant cell
lysis observed after 12 h of treatment). Therefore, mam2 (JY1169; mam2 , sxa2>lacZ ),
cki1mam2 (JY1727; mam2 , cki1::ura4+, sxa2>lacZ ),cki2mam2 (JY1734; mam2 ,
cki2::ura4+, sxa2>lacZ ) and cki3mam2 (JY1720; mam2 , cki3::ura4+, sxa2>lacZ ) S.
pombe strains were transformed with pMam24KmCh, grown to mid-exponential growth
phase, treated with 0 µM and 10 µM P-factor for 16 h and imaged to assess cell morphol-
ogy and receptor localisation (as described in section 2.2.14).
When untreated, Mam24KmCh was predominantly localised to the cell membrane. Vacuole-
like structures in the cytosol were observed in cki1mam2 and cki3mam2 strains
(Figure 5.21). In response to P-factor, all strains formed conjugation tubes, localising the
receptor at the plasma membrane and within vacuole-like structures within the cytosol, sug-
gesting that some Mam24KmCh had been internalised from the plasma membrane (Figure
5.21).
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Figure 5.21: P-factor-induced internalisation of Mam24KmCh was not pre-
vented by disruption of cki1, cki2 or cki3. mam2 (JY1169), cki1mam2
(JY1727), cki2mam2 (JY1734) and cki3mam2 (JY1720) cells transformed with
pMam2Mam24KmCh (JD3804) were grown to mid-exponential growth phase before treat-
ment with 0 µM and 10 µM P-factor. After 16 h of cells were imaged in the mCherry
channel as described in section 2.2.14. Scale bar represents 10 µm.
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QuimP was used to analyse the plasma membrane uorescence of mam2 (JY1169)
strains expressing Mam24KmCh and Mam2tailmCh following treatment with P-factor.
Strains were grown to mid-exponential growth phase, plated onto agarose gels containing
10 µM P-factor and imaged every 30 minutes from 0 h to 8 h (as described in section 2.2.14).
QuimP was used to measure the percentage plasma membrane uorescence (of the total cell
uorescence) of each cell in every time-lapse frame. Strains expressing Mam24KmCh and
Mam2tail displayed a reduction in plasma membrane uorescence over time (Figure 5.22).
However, the reduction displayed by Mam2tail (100% to 86%) was not as prominent as
Mam24KmCh (100% to 46%).
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Figure 5.22: Quantifying plasma membrane uorescence using QuimP. mam2
(JY1169) cells transformed with pMam24KmCh (JD3804) and pMam2tailmCh (JD3621)
were grown to mid-exponential growth phase and plated onto agarose pads containing 10
µM P-factor. Cells were imaged in the mCherry channel every 30 minutes from 0 h to 8 h
as detailed in section 2.2.14. QuimP was used to (a) segment the plasma membrane (red
and yellow contours dene the outer and inner bounds of the membrane, respectively) of a
single cell and (b) quantify the the plasma membrane uorescence as a percentage of the
total cell uorescence (normalised data presented).
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To quantify receptor endocytosis following treatment with P-factor in cells disrupted
in cki1, cki2 and cki3 relative to a WT (cki1+, cki2+ and cki3+) strain a combina-
tion of microscopy and QuimP analysis was employed. mam2 (JY1169), cki1mam2
(JY1727), cki2mam2 (JY1734) and cki3mam2 (JY1720) strains transformed with
pMam24KmCh were grown to mid-exponential growth phase, plated onto agarose pads con-
taining 10 µM P-factor and a randomly selected eld of cells were imaged every 30 minutes
from 0 h to 16 h (As described in section 2.2.14). The uorescent images were loaded into
QuimP to determine the plasma membrane uorescence as a percentage of the total cell
uorescence. Cells were selected provided they did not divide over the time-course or once
it had completed a round of division. Each cell was tracked with time and QuimP was used
to measure plasma membrane uorescence every 1 h (from the initial measurement frame)
up to 8 h. Individual cell analyses can be found in Appendix E.
Strains lacking functional cki1 displayed a similar internalisation behaviour to WT cells,
where plasma membrane uorescence decreases following treatment with P-factor over time
(Figure 5.23). No signicant dierence in Mam24KmCh plasma membrane uorescence
was observed after 8 h of treatment between WT (404%, m=21) and cki1mam2 cells
(472%, m=18), where p=0.3598 calculated using two-way ANOVA.
A signicant increase in Mam24KmCh plasma membrane uorescence was observed
in cki2mam2 strains following 5 h treatment with P-factor in comparison to cki2+
(mam2+pMam24KmCh) cells (Figure 5.23). After treatment for 8 h WT strains dis-
played 472% (m=18) whereas cki2mam2 cells displayed 655% (m=18), which was
a signicant increase (p=0.0002 calculated using two-way ANOVA).
Strains lacking cki3 displayed a signicant decrease in plasma membrane uorescence
from 4 h to 8 h of treatment (Figure 5.23c), whereas at 8 h WT strains displayed 472%
(m=18) Mam24KmCh plasma membrane uorescence in comparison to cki3mam2 cells,
which displayed 333% (m=16) (p=0.0170 calculated using two-way ANOVA).
These data suggest that Cki2 positively regulates receptor internalisation in response to
P-factor, whereas Cki1 and Cki3 did not. In addition, the data collected for cki3 strains
indicate that Cki3 may even prevent internalisation, as plasma membrane uorescence was
reduced in comparison to cki3+ strains (Figure 5.23).
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Figure 5.23: Loss of cki2 reduces the amount of plasma membrane uores-
cence over time mam2 (JY1169) cells transformed with pMam24KmCh (JD3804)
and pMam2tailmCh (JD3621) together with cki1mam2 (JY1727), cki2mam2
(JY1734) and cki3mam2 (JY1720) cells transformed with pMam24KmCh were grown
to mid-exponential growth phase before treatment with 10 µM P-factor. A randomly se-
lected eld of cells were imaged in the mCherry channel every 30 minutes from 0 h to 8 h
as detailed in section 2.2.14. 16 cells or more were quantied for their plasma membrane
uorescence using QuimP (as detailed in section 2.2.18, for exact n numbers see text).
The gure displays the (a) mean raw and normalised data SEM, (b) the normalised data
including statistical signicance p<0.05, p<0.01 and   p<0.001, following two-way
ANOVA (comparing all strains tomam2 + pMam24KmCh) and (c) the normalised values
at each time point.
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5.7 Summary
This chapter sought to determine whether Cki1, Cki2 and Cki3 promoted ligand-induced
endocytosis of Mam2. Yeast 2-hybrid analysis did not indicate an interaction between
Mam2 with either of the kinases however, an interaction with Rgs1 (the RGS protein)
was observed (Figure 5.2). Following this, a combination of uorescent protein markers
(mCherry and GFP), microscopy analysis and cell segmentation software was employed to
quantify internalisation of Mam2.
Deletion strains that contained the double disruption mam2 with either cki1, cki2 and
cki3 were created (section 2.3.1) and microscopy analysis and b-galactosidase assays were
used to access the localisation and signalling behaviour of Mam2-mCherry expressed from
the pREP3x vector (pMam2mCh). Unfortunately, a weak plasma membrane association of
Mam2mCh prevented the QuimP software from segmenting the cell periphery and quan-
tifying membrane uorescence (Figure 5.6). The lack of Mam2 tagged mCherry at the
plasma membrane prompted the investigation to create a version of Mam2 that increased
the concentration of the receptor at the membrane, yet internalised following treatment
with P-factor.
A previous study suggested that sequential truncation of the C-terminal domain of
Mam2 increased plasma membrane localisation (E. McCann, PhD thesis, 2010). However,
the microscopy images used to make these conclusions were of low-resolution and these
receptors localisation had not been investigated in response to P-factor. Previously created
truncated versions of Mam2 (5, 13, 21 and 37) tagged with GFP were analysed
using high-resolution microscopy in combination with a vacuole staining dye (FM4-64) to
assess the receptors localisation and sorting to the vacuole.
Loss of the last 21-residues of Mam2 increased plasma membrane localisation uniformly
at the cell perimeter in untreated cells (Figure 5.10) and yet the receptor internalised from
the plasma membrane into intracellular structures that were not vacuoles in response to
P-factor (Figure 5.11). Therefore, the Mam221-GFP appeared an ideal receptor for ac-
cessing the rate of receptor endocytosis using QuimP. b-galactosidase assays indicated that
Mam221GFP did not signal like full length Mam2 (Mam2GFP) (Figure 5.12), most likely
as those residues that were truncated are potential docking sites for Rgs1, an interaction
which is essential for a maximal signalling response [173]. As a result of Mam221-GFP
was not used to access internalisation. A summary of the Mam2tail mutant microscopy
analysis and b-galactosidase assay results are presented in Table 5.2.
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No P-factor P-factor
Plasma Internal Vacuole Basal Plasma Internal Vacuole Maximal
membrane structures signalling membrane structures signalling
Mam2 35 3 3 5 3 3
Mam25 3 3 3 - 5 3 3 -
Mam213 3 3 35 - 5 3 5 -
Mam221 3 5 5 " 5 3 5 #
Mam237 3 5 5 " 35 3 5 #
Mam2tail 3 5 5 " 3 5 5 #
Mam22K 3 3 3 - 5 3 3 - #
Mam24K 3 5 5 - 3 3 3 - #
Table 5.2: A table summarising the microscopy and b-galactosidase analysis
from Chapter 5. The versions of Mam2 used in this study were analysed using mi-
croscopy and b-galactosidase assays to determine whether these receptors were localised
to the plasma membrane, internalised and subsequently tracked to the vacuole and their
signalling behaviours, respectively in both a P-factor independent and dependent envi-
ronment. A 3 means that this was observed, a 5 if this was not observed and 35 if
this was observed occasionally. An " indicates an increase, a # indicates a decrease in
b-galactosidase signalling compared to Mam2 and a -# indicates a reduction in signalling
due to cell lysis.
Monoubiquitination of a single lysine residue within C-terminal domain of S. cerevisiae
STE2 is essential for both constitutive and ligand-induced internalisation [284]. However,
for many mammalian GPCRs and the pheromone-type S. cerevisiae STE3 ligand-induced
endocytosis is not dependent on ubiquitination [287{289]. Therefore, Mam2's dependency
on ubiquitination was investigated by mutating the four lysine residues (and hence sites of
ubiquitination) contained in the C-terminal tail of Mam2. Two of the four lysine residues
were contained within the last ve residues of Mam2, which were shown to not be essential
for signalling response, internalisation or subsequent receptor sorting to the vacuoles (Table
5.2, see Mam25GFP). To investigate the involvement of the other two lysine residues
(not contained within the last ve amino acid residues of Mam2) mutation of the lysine
residues to arginine was performed on both Mam2 and Mam25 (section 2.3.2.3 and 2.3.2.4,
respectively).
Mutation of the rst two lysine residues with the other two remaining within the last ve
residues of the Mam2 (Mam22K) increased plasma membrane uorescence in untreated cells,
but did not appear to prevent internalisation and tracking to the vacuoles. The removal
of all four lysine residues (Mam24K) prevented constitutive internalisation and yet receptor
endocytosis into the vacuole-like structures was observed in response to P-factor (Figure
5.15). The result suggested that ubiquitination is essential for constitutive internalisation,
but not required for P-factor-induced internalisation of Mam2. The C-terminal domain
lysine mutated Mam2 receptors b-galactosidase signalling and localisation behaviour are
summarised in Table 5.2.
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Mam24KmCh b-galactosidase signalled like full length mam2 (Mam2mCh) following
treatment with 0 µM to 1 µM P-factor. However, a reduction of signalling was observed
following treatment with >1 µM P-factor. Visual cell viability analysis showed that cells
expressing Mam24KmCh became increasingly non-viable following prolonged (>12 h) treat-
ment with P-factor (Figure 5.18). Further analysis of the microscopy time-lapse images
revealed that some cells expressing Mam24KmCh tended to elongate from both tips than
the typical one tip shown by Mam2mCh (Figure 5.19).
Despite the reduction in cell viability following prolonged treatment with P-factor, the
receptor was strongly localised at the cell periphery in cells expressing the lysine decient
receptor Mam24KmCh. Providing the QuimP analysis was performed on cells before the
10 h period (where the percentage of non-viable cells increased), this receptor seemed ideal
to access whether Cki1, Cki2 and Cki3 aected P-factor induced internalisation. QuimP
analysis on strains lacking cki1, cki2 and cki3 and expressing Mam24KmCh suggested that
Cki2 promoted receptor internalisation in response to P-factor, where as Cki1 and Cki3
did not. In addition, the data collected for cki3 strains indicate that Cki3 may even
prevent internalisation in a P-factor-dependent manner, as plasma membrane uorescence
was reduced in comparison to cki3+ strains (Figure 5.23).
Chapter 6
Discussion
6.1 Overview
The internalisation of GPCRs has been studied extensively over the last 30 years. The
pharmaceutical industry invests billions of dollars each year to discover therapeutic com-
pounds for GPCRs that give desired physiological eects (reviewed in [5]). Many long-term
treatments that target these receptors result in the patient becoming tolerant to the drug
[293]. This tolerance often results in having to increase the dosage to deliver the same
physiological outcome, which can be debilitating for the patient and lead to undesirable
side eects. Understanding how these receptors are regulated at the plasma membrane is
key to developing appropriate treatments for diseases. In higher eukaryotes, the number of
dierent receptor types expressed on the cell surface at any one time depends on the cell
type and as such the cross-talk between these pathways makes it dicult to dissect the role
of individual GPCRs in a cellular response.
Despite decades of research on the pheromone-response pathway in ssion yeast, the
combinatorial process of signal regulation and specically GPCR internalisation are still
unknown. With a greater understanding of GPCR signal regulation in these single celled
eukaryotes, this may help to uncover overall processes in higher multi-cellular organisms so
that more selective treatments can be designed. This study has identied three potential
candidates (Cki1, Cki2 and Cki3) that could promote pheromone-induced internalisation
of the M-type receptor Mam2 and in doing so has lead to the highly probable discovery
that two distinct internalisation pathways exist in ssion yeast.
184
Chapter 6: DISCUSSION 185
6.2 Development of the KR model
Chapter 3 describes the creation of a fully descriptive model of the pheromone-response
pathway in S. pombe (called the KR model). The KR model is extended from the pre-
existing Croft et al. (2013) model [173] to include the downstream signalling components
and known regulatory mechanisms of the P-factor-induced S. pombe signal transduction
pathway. The KR model contains 39 species, 54 reactions and 54 rate constants, which
have been heuristically determined to t the experimental data. Despite the large number of
reactions and species, the KR model can qualitatively recapitulate all of the current exper-
imental end-point data (collated form the literature and collected in this study), providing
the cells were viable during the assays.
Our condence in the model reactions prompted its use as a predictive tool for systems
level behaviour. Rgs1 (the RGS for Gpa1, the Ga subunit) has previously been shown to
have a dual positive and negative role on signalling response [190]. However, upon deletion
of Gap1 (the GAP for Ras1) from S. pombe the KR model predicts that Rgs1 would now
act as a sole negative regulator. The prediction was validated by a series of transcriptional
reporter assays [11].
6.2.1 Rgs1 acts as a negative regulator in Gap1 deletion strains
When referring to the model components, GAP represents Gap1 and RGS represents Rgs1.
The KR model predicts that setting the initial concentration of GAP to 0 nM ([GAP] =
0 nM) in silico results in RGS acting as a negative regulator of signalling (Figure 3.26),
i.e. increasing the concentration of RGS decreases the maximal system level output. This
was veried in vitro by expressing dierent levels of Rgs1 in Gap1 deletion strains (Figure
3.27.b).
Strains lacking endogenous Rgs1 (rgs1 ) exhibit an elevated basal activity [190] (Figure
3.27.b). This increase in basal response suggests that a larger pool of Gpa1 are GTP-bound
in comparison to rgs1+ strains. The rise in active Gpa1 therefore increases signal transduc-
tion to downstream eectors, resulting in an increase in transcription of mating-responsive
genes (Figure 3.27.a). Strains lacking endogenous Rgs1 still exhibited a dose-dependent in-
crease in transcriptional response to P-factor, reaching an 12 maximal signalling response
in comparison to rgs1+ strains [190] (Figure 3.27.a, compare red and blue maximal response
levels). Hence, Rgs1 is required for cells to reach a maximal signalling response.
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Deleting Gap1 in a rgs1+ strain displayed an elevated transcriptional response that did
not respond in a dose-dependent manner to P-factor (Figure 3.27.b). Importantly, the level
of response ingap1 cells is 12 maximal signalling response of wild type (WT; rgs1+gap1+)
strains and equivalent to the maximal response of rgs1 strains (Figure 3.27, compare the
red curves). Therefore, the concentration of GTP-bound Gpa1 becomes a limiting factor
in signal transduction in strains lacking gap1, i.e. for rgs1gap1 the pool of active Gpa1
is already at a maximal level, illustrated by the same transcriptional response level rgs1
in response to P-factor, thus increasing Rgs1 can only have a negative inuence on signal
transduction.
Thergs1gap1 strains created and used in this study are dicult to grow and maintain
(data not available). For example, these strains needed to be restricted onto fresh medium
plates every week otherwise growth was not observed in liquid culture. In addition, these
strains also took longer to reach mid-exponential growth phase than other strains (data not
available). The rgs1gap1 strains used in the study are cyr1 . Deletion of cyr1 allows
S. pombe to undergo sexual dierentiation during mitotic growth by mimicking nutrient
starvation [53]. It is known that nutrient starvation also induces a G1 arrest [294].
The WT strain JY544 used in this study showed that 29% of S. pombe cells were
arrested in G1 phase of the cell cycle prior to treatment with P-factor (Figure 4.19, see
the WT strain at 0 h), which is consistent with previous studies (M. Bond, PhD Thesis,
2012; C. Weston, PhD thesis, 2013). In combination with 29% of the population in G1
arrest plus the deletion of rgs1 and gap1 which enhances basal signalling to 12 maximal
response of wild type (WT; rgs1+gap1+) strains (Figure 3.27), it is most likely that these
strains are predominantly in G1 phase of the cell cycle and hence, growth was signicantly
reduced. This could be a reason why a dose-dependent response is not observed following
treatment with P-factor (Figure 3.27.b), because the cells are already in G1 phase of the
cell cycle. DNA complement could be measured in these strains to assess whether they are
predominantly in G1 phase prior to pheromone stimulation.
6.2.2 Further improving the KR model to show quantitative agreement
with empirical data
The KR model is the rst model that signals via the Ga subunit, which includes downstream
signalling molecules such as the G protein, GAP, a MAPK kinase cascade and phosphatase.
Although the KR model can qualitatively recapitulate the vast majority of the experimental
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data currently available, a limitation of this work is that it lacks experimentally determined
parameters and initial species concentrations.
Many of the initial species concentrations described in the KR model were estimated
from known protein expression levels of the components of the S. cerevisiae mating-response
pathway [241]. It is assumed that the species concentrations or the ratios between the
mating-response pathway components were conserved between the two yeasts. To improve
the KR model, the protein expression levels of the species involved the S. pombe mating-
response pathway need to be determined. One study has quantied the protein expression
levels of the species in the mating-response pathway of quiescent S. pombe cells [295]. S.
pombe cells arrest in G1 phase of the cell cycle in response to pheromone stimulation.
During the G1 arrest phase, S. pombe cells are in a period of inactivity in terms of cell
cycle progression and at this point are most similar to quiescent cells. Therefore, the KR
model could be improved by incorporating the potentially more realistic initial species
concentrations determined for quiescent S. pombe cells.
The KR model is complete in terms of known signalling regulatory mechanisms and is
able to reproduce the temporal data (Figure 3.30), however including a term for internal-
isation into the model hindered the qualitative ability of the model to t the end-point
experimental data as well as it had before. This is most likely because the parameters used
in the model are not true parameter values, rather they have been heuristically determined
to best t the experimental data. Although a qualitative agreement is observed between
simulations and experimental dose-response data, quantitative agreement is lacking, most
likely due to the absence of true parameter values.
Future work should focus on developing the KR model to improve its quantitative ac-
curacy. For example, parameter sensitivity analysis could be performed as a means of
improving accuracy. Dierent parameter values can result in the same model behaviour.
Hence it is crucial to estimate the parameter values that are relevant for GPCR signalling
in S. pombe. One possibility as discussed previously is to experimentally measure each pa-
rameter for a specic reaction, however it is often dicult to do such measurements within
a biological organism. Another approach is reverse engineering, where model parameters
are estimated by tting model output to available experimental data. This type of analysis
is often used to assess how changes in model parameters aect the model output and can
provide valuable information on which parameters are crucial to determine experimentally
and which, if any, can be discarded. In addition, by tting a model to the experimental
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data, a set of parameter values can be determined, which do not need to be measured
experimentally. The disadvantage with tting such a model is that it may not oer any
explanatory power; for example, a high order polynomial can be tted to almost any data
set, however this is not biologically accurate.
6.3 Characterisation of Cki1, Cki2 and Cki3
The yeast casein kinase proteins YCK1 and YCK2 are required for the phosphorylation
of serine residues within the C-terminal tail of the S. cerevisiae pheromone receptor STE2
and its subsequent internalisation in response to treatment with pheromone [112, 269, 270].
The aim of chapter 4 was to identify and characterise the role of the proteins homologous
to YCK1 and YCK2 in the S. pombe mating-response pathway, Cki1, Cki2 and Cki3.
Four standard mating-response assay were employed, with the kinase disruption strains or
overexpression plasmids, which indicated a role of each kinase (Cki1, Cki2 and Cki3) within
the mating-response of S. pombe (discussed in more detail below).
6.3.1 Cki1 negatively regulates the pheromone-response pathway in S.
pombe
This thesis provides evidence that Cki1 negatively regulates the transcriptional and mor-
phological response of the pheromone-response pathway in S. pombe. Disruption of Cki1
showed a signicant increase in maximal transcriptional reporter activity (Figure 4.9), cell
volume (Figure 4.10) and hyper-elongated conjugation tubes (Figure 4.6). Removing a neg-
ative regulator of pheromone-signalling typically results in an increase in P-factor-directed
responses. For example, Pmp1, the phosphatase that is thought to negatively regulate the
action of the MAPK Spk1, when deleted also displays elongated-conjugation tubes, an in-
crease in transcriptional response and an increase in cell volume following 16 h treatment
with P-factor [11, 221] (Figure 4.12).
A signicant increase (in comparison to WT) in transcriptional activity is only observed
in Cki1 deletion strains following 14 h treatment with P-factor (Figure 4.11). This de-
lay in the increase of transcriptional activity suggests that Cki1 may not directly regulate
the components of the transcriptional pathway (described in Figure 1.7), but may inu-
ence pheromone-signalling by a feedback mechanism initiated by pheromone activation.
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Additional evidence to support this, is that unlike other negative regulators of pheromone-
signalling, such as Rgs1 [87] and Gap1 [86], deletion of Cki1 does not reduce the number
of successful mating events (CFU recovery) (Figure 4.4).
It is known that Cki1 phosphorylates and inactivates phosphatidylinositol 4-phosphate
5-kinase (PIP5K), a protein kinase that catalyses the last step in the synthesis of PIP2 [296].
As discussed in the introduction, PIP2 is a precursor of DAG and IP3 (second messenger
signalling molecules) and is involved in the regulation of actin cytoskeleton remodelling,
membrane tracking [297] and vesicle transport [298]. PIP2 has a specic role in bind-
ing Sec3 and Exo70 components of the exocyst complex (which is transported along actin
cables in a myosin V manner) and provides positional information for localisation of the
entire complex at the cell tip [80, 299, 300]. A previous study has shown that overexpres-
sion of Cki1 reduces plasma membrane localisation and activity of PIP5K (by 48% [296]),
ultimately reducing the synthesis of PIP2. Overexpression of Cki1 in this study did not
alter cell morphology or inuence pheromone-signalling suggesting that despite the poten-
tial reduction and inactivation of PIP2 at the plasma membrane, this was not a limiting
factor for cellular processes, even if overexpression of Cki1 reduced its localisation at the
membrane.
Further work investigating Cki1's role in pheromone-signalling should be investigated,
as this may reveal an additional feedback mechanism/regulation that has not yet been
identied. Casein kinases have numerous roles within the cell and can target many regu-
latory proteins [110, 301]. Therefore, to uncover which proteins Cki1 is targeting and to
understand how this feedback eects pheromone signalling, a yeast 2-hybrid screen could
be performed to identify proteins that potentially interact with Cki1.
6.3.2 Cki2 plays a role in regulating cell size during vegetative growth
A previous study has shown that overexpression of Cki2 causes pear-shaped cells that
separate poorly following septation, suggesting a potential role of Cki2 in regulating cell
morphology [272]. Pear-shaped cells or cells that were unable to separate following septation
were not observed in this study, instead the results show that deletion of Cki2 increases cell
size during vegetative growth, yet not in response to P-factor.
Previous studies have coupled vegetative cell size to entry into mitosis, through a spatial
intracellular gradient of Pom1, a dual-specicity Yak-related kinase (DYRK) [302]. DYRKs
self-catalyse via multiple autophosphorylation reactions within their activation loop [303].
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When the cells are small, Pom1 is located across the entire cell and inhibits transition
into mitosis (via inhibition of the kinase Cdr2, enabling the M phase inhibitor protein
kinase Wee1 to inhibit Cdc2, thereby preventing cell cycle progression), but as the cells
elongate the source of the Pom1 gradient at cell tips is moved further apart and thus the
concentration of Pom1 in the cell centre is reduced, removing inhibition of mitosis, resulting
in cell division [304] (Figure 6.1).
Pom1
Cdr2
Wee1
Cdc2
Pom1
Cdr2
Wee1
Cdc2
Cell cycle delay
Cell cycle pregression
Figure 6.1: A model describing how S. pombe cells monitor their length to
control entry into mitosis. A gradient of Pom1 from cell tips overlaps signicantly
with Cdr2 at the centre of small cells, leading to Cdr2 inhibition and cell cycle delay. As
the cells grow and become longer in size, the concentration of Pom1 at the cell centre is
no longer sucient for signicant Cdr2 inhibition, allowing cell cycle progression. Figure
adapted from [302].
The Pom1 gradient is maintained by microtubules, which amongst other proteins such as
Tea1 [305] and Tea4 [306], trac Pom1 to the cell tips to mark the sites of actin nucleation
and consequently cell growth [307]. A basic domain within Pom1 associates with lipids in
the plasma membrane and this anity is lost with increasing autophosphorylation, which
ultimately results in Pom1's release into the cytoplasm. Concomitantly to this process of
Pom1 autophosphorylation and cytoplasmic release, Tea4 recruits the protein phosphatase
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Dis2 [308], which dephosphorylates Pom1 at cell tips leading to a greater membrane asso-
ciation [309].
Cki2 may regulate the association of Pom1 with the plasma membrane, for example by
modulating the activity of Dis2, such that loss of Cki2 would result in a reduction in Dis2
phosphatase activity, leading to an increase in cytoplasmic Pom1. Dis2 has been shown
to have multiple phosphorylation sites [310]. As a result, the cells would grow to a larger
size before the reduction in Pom1 in the center of the cell would be reduced enough to
promote cell cycle progression (Figure 6.2). In response to P-factor the Pom1 gradient
sensing machinery is overridden by Cdc42 activation, which promotes elongation from a
single tip and therefore, would explain why loss of Cki2 only increases vegetative cell size
and not conjugation length/cell volume in response to P-factor.
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Figure 6.2: A model for the modulation of intracellular Pom1 gradients. Tea4
tracs Dis2 upto the cell tips via microtubules. Dephosphorylation of Pom1 is mediated via
the phosphatase Dis2 and results in a strong membrane association. Autophosphorylation
of Pom1 reduces its anity for the cell membrane, which increase the probability of Pom1
detaching from the membrane. Cki2 may be acting, by phosphorylation of Dis2, to regulate
Dis2's activity. Figure adapted from [309].
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6.3.3 Cki3 is a negative regulator of the pheromone-response in S. pombe
A previous study has shown that deletion or overexpression of Cki3 exhibit no characteristic
phenotypes during vegetative growth [273]. This thesis conrms that overexpression or
deletion of Cki3 does not result in cell morphological defects however, an increase in cell
area was observed with loss of Cki3 (Figure 4.2). This result could be an experimental
outlier because a cell volume assay was also performed on these strains but did not exhibit
a signicant increase in cell volume.
The results indicate that loss of Cki3 increases P-factor-directed transcriptional and
morphological responses. Specically, an increase in cell volume (Figure 4.9 and 4.10) mea-
sured by a quantitative assay and hyper-elongated conjugation tubes determined visually
from the microscopy analysis (Figure 4.8) were observed. The increase in transcriptional
response and cell volume displayed by cki3 cells is observed following 4 h of P-factor
treatment (Figure 4.11 and Figure 4.13, respectively), suggesting that Cki3 may directly
regulate the morphological and transcriptional response in S. pombe.
Ras1 mediates both the morphological and transcriptional pathway in response to P-
factor. Therefore, Cki3 may act to regulate Ras1 activation or the components of the
pathway directly upstream of Ras1. The YCK1 and YCK2 S. cerevisiae kinases were
shown to phosphorylate STE2 (the pheromone GPCR) in response to a-factor, to promote
its internalisation from the plasma membrane [112]. Cki3 is 67-69% homologous to YCK1
and YCK2 (Figure 4.1) and therefore, may perform a similar cellular role in S. pombe.
Given Mam2 (the pheromone GPCR in S. pombe) acts upstream of Ras1 and that loss of
Cki3 enhances signal propagation via Ras1, the data collected in this study may suggest
that Cki3 is phosphorylating Mam2 to promote its internalisation.
6.3.4 Cki3 is required for the completion of cytokinesis, but only in S.
pombe cells that have responded to P-factor
Loss of the negative regulators Rgs1 and Gap1 in S. pombe reduces the cells' ability to
mate successfully [86, 87]. This study identied Cki3 as a negative regulator of signalling
however, rather than exhibiting a reduction in successful mating events, loss of Cki3 shows
an increase in CFU recovery/successful mating events (Figure 4.4).
Deletion of other proteins such as the cyclin Cig2 [311] and Cpc2 (the receptor for acti-
vated C kinase 1 (RACK1) orthologue) [221] have also been shown to exhibit an increase in
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successful mating events. Interestingly, both Cig2 and Cpc2 proteins have been implicated
in regulating cell cycle progression [312, 313]. It is clear that Cki3 also plays a role in cell
cycle progression as septa were found in cki3 cells following treatment with P-factor.
As previously discussed, during mitotic growth, S. pombe cells spatially sense their size
through an intracellular gradient of Pom1 [302]. In response to P-factor, Cdc42 activation
is enhanced and this is thought to override this sensing machinery and initiate elongation
from a single tip forming conjugation tubes towards a mating partner [223]. Following pro-
longed (8 h) treatment with P-factor S. pombe cells can undertake two successive rounds
of divisions and then continue to respond to P-factor forming conjugation tubes (W. Croft,
Doctoral thesis). This novel mechanism of cell division in response to prolonged treat-
ment suggests that either the gradient sensing machinery overrides the Cdc42 activation
mechanism to promote cell division or another mechanism that has not yet been described
initiates this cell division process.
The septa and multi-nucleated cki3 cells observed in this study suggest that cells are
able to complete anaphase B; the event of segregating nuclei into daughter cells, yet are
unable to separate the daughter cells. Although strains lacking cki3 are unable to complete
cell separation, they still enter into additional rounds of division, as more than two septa
were displayed in 50% of cells following 36 h of P-factor treatment. To further support
the theory that Cki3 is involved in cell cycle progression, the dispersion of propidium
iodide peaks, FCS and SSC scatter plots collected during this study all indicate that a
sub-population of cells contain more than two complements of DNA.
The septa and multiple projection phenotype observed in cki3 cells in response to P-
factor are similar to those observed for the temperature-sensitive YCK1 and YCK2 mutant
strain in S. cerevisiae. The double mutant cells yckts (yck1 -1::ura3 yck2 -2ts) are viable
at the permissive temperature of 24 C but become lethal at the restrictive temperature of
36 C, which after several aberrant rounds of cell division form multiple elongated septated
buds containing multiple nuclei [314, 315]. At the permissive temperature yckts cells grow
and divide normally however, in response to pheromone cells become hyper-elongated and
form conjugation tubes which display morphological abnormalities that become exaggerated
over time, eventually resembling the morphologies of vegetative cells at at the restrictive
temperature [316].
S. cerevisiae a-cells that have a reduction in YCK1 and YCK2 activity also exhibit elon-
gated conjugation tubes in response to treatment with a-factor [316], similar to the loss of
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Cki3 in S. pombe illustrated in this study. The localisation of YCK2 also changes through-
out the cell cycle. YCK2 is situated at the growing tip during conjugation tube formation
and vegetative growth, but is then positioned at the bud neck. This data suggested that
YCK1 and YCK2 proteins are involved in cell polarity [316]. As cells lacking Cki3 exhibit
similar behaviours to the YCK1 and YCK2 mutant cells this may suggest that Cki3 is also
involved in cell polarity in S. pombe.
6.3.4.1 A potential role for Cki3 in regulating septins
To understand the relevance of the Cki3's potential role for regulating septin organisation
during cytokinesis, an overview of the S. pombe cell cycle is described here. The onset of
mitosis is characterised by a rearrangement of the actin cytoskeleton. F-actin patches delo-
calise from cell tips and reorganise in the centre by forming an actomyosin-based contractile
ring overlying the nucleus. Once formed, four S. pombe septin proteins (Spn1, Spn2, Spn3
and Spn4) organise to the cell centre forming a septin ring adjacent to the actomyosin ring.
Septins are conserved GTP-binding proteins that form hetero-oligomeric complexes, which
assemble into higher-order structures, such as laments and rings [317]. Septin complexes
provide a scaold to which many proteins bind (reviewed in [318]) and/or diusion bar-
riers to aect a range of cellular functions, including: cytokinesis, mitosis, exocytosis and
apoptosis [319].
As the nuclei are segregated during anaphase B, the actomyosin ring constricts guiding
the closure of the plasma membrane. Concomitant with this process, the primary septum
anked by two secondary septa develops behind the constricting ring, which splits the
septin ring in two. The association of the septin ring with a protein Mid2, maintains the
integrity and stability of the septin ring during the contractile ring closure [320]. Formation
of the septin-Mid2 ring guides a multi-protein exocyst complex, which transports vesicles
in a myosin V dependent-manner via actin cables to the cell centre [321]. The exocyst
complex is thought to transport and secrete the enzymes Eng1 and Agn1, to cleave the
primary septum and the cell wall [322], thereby separating the two daughter cells (reviewed
by [323]).
Loss of any or all of the septins or Mid2 in S. pombe causes a chained cell phenotype
[317, 320, 324, 325]. In S. cerevisiae, the septin CDC12 was mislocalised in yckts mutant
cells [316], suggesting that YCK1 and YCK2 activity could regulate the site or process
of assembling the septins at the bud neck. The S. cerevisiae mutant yckts and cki3 S.
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pombe cells show a similar phenotypic behaviour in response to pheromone stimulation and
therefore, Cki3 may function in a similar role in S. pombe by regulating septin assembly
during the cell cycle.
In S. cerevisiae the septin ring is regulated via phosphorylation of the septins, by several
protein kinases, including CDK1 and CLA4 [326, 327]. Specically, loss of CLA4 resulted
in elongated cells and mislocalisation of the septins to the cell tips rather than the bud
neck [328]. This study also suggests that CLA4 is activated by CDC42, to phosphorylate
the septins at the division site, stabilising the septin ring formation [328]. The CDK1
and CLA4 homologues in S. pombe are Cdr1 and Cdr2, however these proteins have not
been shown to phosphorylate Spn1, Spn2, Spn3 or Spn4 [329] or have not been identied
in inuencing septin ring formation. The data collected in this study suggests that Cki3
kinase is required for cell division in response to P-factor. Given that CLA4 may be
activated in a CDC42-dependent manner in S. cerevisiae and given that CDC42 is assumed
to perform an equivalent role to Cdc42 in S. pombe, which is activated in response to P-
factor, Cki3 activity could be enhanced by activation of Cdc42 and could be the kinase
that phosphorylates the septins to promote their organisation during cytokinesis.
6.4 Cki1, Cki2 and Cki3 as potential targets for pheromone-
induced internalisation of Mam2
Chapter 5 investigated and discussed the role of Cki1, Cki2 and Cki3 in the internalisation
of Mam2. Microscopy analysis of mCherry-tagged Mam2 in combination with the QuimP
software to allow the analysis of cortical uorescence [231, 232] was employed to quantify the
levels of plasma membrane localisation in strains lacking either Cki1, Cki2 and Cki3. Due
to the weak plasma membrane expression levels of WT mCherry-tagged Mam2 the QuimP
software was unable to segment the cell periphery. A receptor lacking all four lysines within
the 45 residue C-terminal tail was created, which enhanced plasma membrane localisation
as a result of preventing constitutive internalisation, yet still internalised in response to
treatment with pheromone. The QuimP segmentation and uorescence software was used
to quantify plasma membrane uorescence following treatment with P-factor in strains
lacking Cki1, Cki2 and Cki3.
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6.4.1 Sorting of Mam2 following its internalisation
Microscopy analysis of the GFP tagged truncated Mam2 receptors showed that the last
ve residues of Mam2 were not essential for constitutive and pheromone-induced internal-
isation, or subsequent tracking of the receptor to the vacuoles, as the localisation of the
receptor was indistinguishable from full length Mam2. The FM4-64 vacuole staining dye in
combination with the loss of the ve residues of GFP tagged Mam2 revealed two pockets of
receptors: ones that were encased by the red dye indicating that these receptor were in the
vacuoles and ones that were not encased by the dye. There are two possible explanations
for these vesicles of receptors not encased by the vacuole dye. They could either be newly
synthesised receptors that are being tracked to the plasma membrane or they could have
been recently endocytosed from the plasma membrane into the endosomes/MVBs and have
yet to be tracked to the vacuoles.
Mam2Δ21: QSMKTSSAQGETTEVSIRVDRTFDIKHTPSDDYSISDESETKKWT
Mam2Δ37: QSMKTSSAQGETTEVSIRVDRTFDIKHTPSDDYSISDESETKKWT
Endosome
Vacuole
Mam2
Mam2Δ5:   QSMKTSSAQGETTEVSIRVDRTFDIKHTPSDDYSISDESETKKWT
Mam2Δ13: QSMKTSSAQGETTEVSIRVDRTFDIKHTPSDDYSISDESETKKWT
Mam2:       QSMKTSSAQGETTEVSIRVDRTFDIKHTPSDDYSISDESETKKWT
Deleted residues
Available residues
Required for 
sorting to vacuole
Figure 6.3: Specic regions within the C-terminal domain of Mam2 control its
internalisation and subsequent sorting. A model that illustrates how truncation of
specic regions of Mam2 alters its internalisation and subsequent tracking to the vacuole.
Loss of the 13 residue sequence (YSISDESETKKWT) signicantly reduced receptor
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tracking to the vacuoles and further truncation of the Mam2 removing 21 residues pre-
vented receptor sorting into the vacuoles (Figure 6.3). Ubiquitination of lysine residues
typically targets proteins to the vacuoles/lysosome as ESCRT proteins contain ubiquitin
binding domains that recognise the ubiquitinated receptors and mediate there invagination
into MVBs and transport to the vacuole [160]. Loss of the last 5-residues (TKKWT), which
contain two (Lys345 and Lys346) of the four (Lys307, Lys329, Lys345 and Lys346) lysines
within the C-terminal tail of Mam2, did not prevent sorting to the vacuole. This therefore
suggests that specic residues within the 16-residue sequence IKHTPSDDYSISDESE (be-
tween the 21 and 5 Mam2 truncations) are essential for receptor vacuole localisation.
Signicantly, Lys329 is contained within the 16-residue sequence however, the lysine de-
cient mutant Mam22K-mCherry receptor where Lys307 and Lys329 are mutated to arginine
but still contain intact Lys345 and Lys346 (from TKKWT 5) appeared to be tracked to
vacuoles following internalisation (Figure 5.15). This suggests that receptor sorting to the
vacuole is not lysine specic, i.e. it does not matter which lysine residue is ubiquitinated
to promote tracking to the vacuole.
Mutation of the lysine residues (Lys307, Lys329, Lys345 and Lys346) prevents con-
stitutive receptor internalisation, yet in response to P-factor the receptor is internalised
and appears to be tracked to the vacuole-like structures. Some GPCRs are sorted to
the lysosome independently of ubiquitination. For example, the d-opioid receptor (DOR)
is tracked to the lysosome in response to ligand-binding, like WT DOR even when all
intracellular lysine residues are mutated to arginine [287].
The last 37-residues of Mam2 appear essential for constitutive internalisation, as the
receptor was only observed at the plasma membrane (Figure 5.10). Whereas the last 37-
residues of Mam2 did not appear essential for P-factor-induced Mam2 internalisation as the
receptors were observed within the cytosol, in large structures positioned at the cell tips
and within smaller spheres situated in close proximity to the cell periphery (Figure 5.11).
This suggests that there are two distinct internalisation pathways within S. pombe M-type
cells.
6.4.2 Two distinct receptor internalisation pathways in S. pombe
This study provides evidence that the receptor Mam2 can be internalised via two distinct
pathways. The removal of all four lysine residues from the C-terminal domain of Mam2
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(ubiquitination decient receptor) prevented constitutive internalisation yet remained sen-
sitive to ligand-induced internalisation. This is similar to observations made of STE3 (a
pheromone GPCR) [289] but dierent to STE2 (another pheromone receptor) where ubiq-
uitination is required for all internalisation mechanisms in S. cerevisiae [112]. This could
suggest that the pheromone-induced endocytotic pathway in S. pombe may be a more repre-
sentative pathway for studying the general principles of mammalian GPCR ligand-induced
internalisation, as most mammalian GPCRs can be internalised via distinct pathways.
Promoting pheromone-induced internalisation of Mam2, like mammalian cells and S. cere-
visiae is most likely the result of phosphorylation of the intracellular regions of the GPCR
following P-factor stimulation.
6.4.3 S. pombe cells elongate from both tips when expressing ubiquiti-
nation decient Mam2
During mitotic growth, Cdc42 is activated in a Ras1-independent manner (via Gef1, a
GEF [330]) and a Ras1-dependent manner (via Scd1). Following cell division, the daughter
cells grow from the tip that existed prior separation (the `old' tip). When a minimal size
threshold is reached growth is initiated from the opposite tip and period of bipolar growth
is established, a process termed new end take o (NETO). Gef1 establishes growth at the
`new' tip during NETO [330], potentially via regulation of myotonic dystrophy like-kinase
Orb6 [331], which spatial maintains Gef1 at the cell tips. Scd1 and Cdc42 have been
observed to have oscillatory behaviour during this period of bipolar growth [85]. Both
Gef1 and Scd1 are recruited to the cell centre at the end of growth phase where Cdc42
activity then directs the formation of the actomyosin ring. P-factor stimulation is thought
to seize control of this process, by increasing Ras1 activation and thus coordinating Cdc42
activation at a single tip.
In response to treatment with P-factor, some cells expressing the C-terminal tail lysine
decient Mam2 were shown to form conjugation tubes by initiating growth from both tips
(section 5.5.5). The use of CRIB-GFP marker for Cdc42 activation showed that Cdc42
activation was present at both tips in these cells rather than at the single growing tip in
typical S. pombe cells. Overexpression of Mam2 in S. pombe cells did not demonstrate a
signicant increase in the number of cells that elongate from both tips, whereas preventing
constitutive internalisation promoted elongation from both tips. This suggests that it is the
increase in receptor concentration at the membrane that causes Cdc42 activation at both
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tips. This could be investigated further by analysing the percentage of cells that elongate
from both tips when removing the C-terminal domain (45-residues) of Mam2.
6.4.4 Cki2 and Cki3 may both be required for Mam2 desensitisation
The results from Chapter 4 indicate that deletion of Cki3 enhances P-factor-directed sig-
nalling responses. One possible explanation for these results could be that when Cki3 is
absent the receptor Mam2 remains active at the cell membrane for longer and thus pro-
tracts signalling response. If this was the case it would suggest that Cki3 may regulate the
activity of Mam2 or its localisation in response to P-factor. The QuimP analysis performed
on cki3 strains in Chapter 5 revealed that rather than reducing receptor internalisation,
removal of Cki3 actually enhanced the ability of the receptor to be removed from the plasma
membrane. Interestingly, deletion of Cki2, which was shown to have no eect on signalling
responses, signicantly reduces the rate at which Mam2 was internalised from the plasma
membrane. Perhaps unexpectedly suggesting that Cki2 rather than Cki3 may positively
regulate the internalisation of Mam2 in response to treatment.
In S. cerevisiae both YCK1 and YCK2 are required to phosphorylate the C-terminal tail
of STE2 (a pheromone GPCR) to promote endocytosis and in fact deletion of both kinases
is lethal to the cell. A possible explanation for the results obtained in this study is that like
in S. cerevisiae, perhaps Cki2 and Cki3 are both required for ecient Mam2 desensitisation
in response to pheromone stimulation. Perhaps Cki3 is required to phosphorylate Mam2 to
prevent further G protein activation, whilst Cki2 is required to initiate the internalisation
of the receptor. The creation of a double deletion strain of Cki2 and Cki3 were attempted
in this study however it was unsuccessful, perhaps as this double deletion may be lethal to
S. pombe. To truly test this hypothesis a temperature sensitive mutant with Cki2 and Cki3
strains should be created and the localisation and internalisation of the receptor could be
investigated.
Another possible explanation that has not yet been considered for why deletion of Cki2
reduces Mam2 internalisation is that perhaps following internalisation, the receptor it is
being increasingly recycled back to the plasma membrane. Perhaps phosphorylation of
the receptor or the internalisation machinery by Cki2 is necessary for an interaction with
another protein of the degradation pathway. Hence when Cki2 is unavailable the receptor
is not being tracked into the degradation pathway and hence is being recycle back to the
plasma membrane. Recycling of yeast GPCRs has not yet been described, but this could
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still be occurring. In addition, Cki2 could have a role in the secretory pathway of newly
synthesis Mam2 and that perhaps when Cki2 is removed this enhances receptor tracking
to the membrane.
6.5 Limitations and Future work
This work investigates three potential candidates for promoting receptor internalisation.
Our analysis has revealed that Cki2 may play a role in pheromone-induced Mam2 internal-
isation. However, these ndings are not conclusive and further work needs to be undertaken
to clarify whether Cki1, Cki2 and/or Cki3 promote pheromone-induced desensitisation of
Mam2. Future study could explore the use of mass-spectrometry to identify whether loss
of Cki1, Cki2 or Cki3 would alter the amount of Mam2 phosphorylation in response to
P-factor. In addition, the use of two-dimensional gel electrophoresis can be used to iden-
tify dierent phosphorylation states of Mam2. Furthermore, quantitative Western blotting
could be used to clarify whether Cki1, Cki2 and Cki3 would aect receptor internalisation
from the plasma membrane. The QuimP analysis does not take into account the produc-
tion of tracking of newly synthesised receptors to the plasma membrane, therefore more
QuimP analysis should be performed using cycloheximide to inhibit new receptor synthesis.
This study identied novel roles of Cki1, Cki2 and Cki3 in the pheromone-response
pathway of S. pombe. It has demonstrated that deletion of Cki3 has severe aects on cell
morphology and for the rst time has implicated Cki3 in regulating cell cycle progression.
The morphologies displayed in Cki3 disrupted cells are similar to those observed upon dele-
tion of YCK2 from S. cerevisiae, which show a displacement of septin CDC12 localisation
during cell division [316]. Further investigation into the role of Cki3 in cell cycle progres-
sion and an investigation into its potential role in regulating septin localisation during cell
division should be performed. The use of uorescently tagged septin in Cki3 disrupted
strains would aid this investigation.
6.6 Advances and conclusions
Many challenges remain in understanding GPCR signal transduction and desensitisation
and specically the role of casein kinases in promoting internalisation, ubiquitination and
GPCR sorting following internalisation both in general and in the mating-response path-
way in S. pombe. This project has advanced the pre-existing mathematical models of the
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S. pombe pheromone-response to include all downstream components and regulatory mech-
anisms of GPCR signalling in S. pombe.
Novel roles for Cki1, Cki2 and Cki3 were identied in regulating the pheromone-response
in S. pombe, specically with regard to Cki3 in regulating cell cycle progression and Cki2
was shown to promote ligand induced internalisation in response to P-factor.
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ATG 
JO3078 JO3075 
10 -1 
 
ATG Stop 
cki1 ORF 
JO3125 JO3126  
XbaI  
ATG 
EcoRI  
pKS 
XbaI  EcoRI  
Digest with XbaI  and EcoRI  
Ligate 
-452 419 
  
-452 -1 6 419 
Ligate 
BamHI  
419 -452 
BamHI  
 
BamHI  
ATG   Stop 
ura4 cassette 
Digest with BamHI  
 
ATG   Stop 
XbaI   
-452 419 
 
JD3903 
pKS-5’Cki1 UTR-Cki1 
pKS-5’Cki1 UTR-Cki1 
gga tcc
EcoRI 
AmpR
AmpR
AmpR
AmpR
Ligate
AmpR
PCR amplification 
 
using FastStart polymerase
 
Inverse PCR amplification 
using FastStart polymerase
Oligonucleotide Sequence
JO3125 gggtctagaGACTGCAAAATGATTCTATTATTTAAGAATGCACCTTGCATATG
JO3126 cccgaattcGCCAAAGTCTACTACGTAGATCATATTAGCATTTTTACTGTTTGG
JO3075 tccTATCTTTGAACGATTTGTGCTGGAGATTTGTC
JO3078 tccCAAAACAATGTAGTCGGTGTCCACTACAAAGTTGGAAGAAGAATTGGCG
Figure A.1: Construction of cki1::ura4+ disruption cassette. To drive integration
of the ura4 cassette into the rst 9 bp region of the cki1 ORF (from position 1 from the
ATG) a 452 bp fragment containing the 5' UTR and the rst 419 bp of the cki1 ORF was
amplied to introduce XbaI and EcoRI restriction sites. The PCR product was ligated
into the pKS vector (JD1776) and inverse PCR performed to introduce a BamHI site
allowing insertion of the ura4 cassette to produce JD3903. An XbaI/EcoRI digest releases
a fragment suitable to generate cki1::ura4 strains through homologous recombination.
Restriction sites within oligonucleotides are highlighted in bold and non-endogenous bases
are denoted in lower case.
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-1 5 419 
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BamHI   
435 
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BamHI  
 
BamHI  
 
ATG   Stop 
ura4 cassette 
Digest with BamHI  
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ATG  Stop  
XbaI HindIII 
 
-469 
 
435 
 
pKS-5’Cki2 UTR-Cki2 
pKS-5’Cki2 UTR-Cki2 
JD3908 
gat
 
gga  tcc  
AmpR
AmpR
AmpR AmpR
AmpR
PCR amplification 
using FastStart polymerase
Inverse PCR amplification 
using FastStart polymerase
Oligonucleotide Sequence
JO3127 gggtctagaGTTTGTATAATCTATCGTATAGCCTCAGCTCCGACAACTCCGTTTT
TACGATGG
JO3128 cccaagcttCCTTATAGGAACAACTTAGGAAACTTACCATCTGTTTCGCCGTCAT
AGCCACC
JO3082 tccCCAAACGAGCGTAGTAGGGGTTCACTATCGCGTGGG
JO3088 tccGATAAATAACCCTGTCACAAGGAATTGACCG
Figure A.2: Construction of cki2::ura4 disruption cassette. To drive integration
of the ura4 cassette into the rst 8 bp region of the cki2 ORF (from position 1 from the
ATG) a 904 bp fragment containing a 469 bp 5' UTR and 435 bp of the cki2 ORF was
amplied to introduce XbaI and HindIII restriction sites. The PCR product was ligated
into pKS vector (JD1776) and inverse PCR performed to introduce a BamHI site allowing
insertion of the ura4 cassette to produce JD3808. XbaI/HindIII digest releases a fragment
suitable to generate cki2::ura4 strains through homologous recombination. Restriction
sites within oligonucleotides are highlighted in bold and non-endogenous bases are denoted
in lower case.
Appendix A: DNA construct design 205
ATG 
JO3132 
10 -1 
PCR amplification 
using FastStart polymerase
ATG Stop 
cki3 ORF 
JO3129 JO3130  
XbaI 
 
ATG 
HindIII 
pKS (JD1776) 
XbaI HindIII 
 Digest with XbaI and HindIII 
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Inverse PCR amplification 
using FastStart polymerase
-480 422 
  
-480 -1 6 422 
Ligate 
BamHI  
422 -480 
BamHI 
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ATG   Stop 
ura4 cassette 
Digest with BamHI 
 
Ligate 
ATG   Stop 
XbaI HindIII 
-480 422 
pKS-5’Cki3 UTR-Cki3 
JD3905 
pKS-5’Cki3 UTR-Cki3 
gga  tcc  
JO3131 
AmpR
AmpR
AmpR
AmpR
AmpR
Oligonucleotide Sequence
JO3129 gggtctagaACTTGCTATATTAGTATGTGTTTAAGTTGCGATACGATTTAACCTT
TATCTTAATC
JO3130 cccaagcttGCAATCATGGCAACGGTTTTAGGACTAAAACGTCTGCCACAATAA
TC
JO3032 tccCTTCGTCTCACTCCAACGTCGTTGGTGTTCATTACCG
JO3031 tccGATGGTCTTTTAAATATTCCACTATGTTAAATGC
Figure A.3: Construction of cki3::ura4 disruption cassette. To drive integration
of the ura4 cassette into the rst 9 bp region of the cki3 ORF (from position 1 from the
ATG), a 902 bp fragment containing 480 bp of the 5' UTR and 422 bp of the cki3 ORF was
amplied to introduce XbaI and HindIII restriction sites. The PCR product was ligated
into pKS vector (JD1776) and inverse PCR performed to introduce a BamHI site allowing
insertion of the ura4 cassette to produce JD3905. XbaI/HindIII digest releases a fragment
suitable to generate cki3::ura4 strains through homologous recombination. Restriction
sites within oligonucleotides are highlighted in bold and non-endogenous bases are denoted
in lower case.
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BamHI 
Digest with BamHI 
 
Ligate 
ATG Stop 
cki ORF 
Sense primer Antisense primer 
BamHI 
 
BamHI 
 
ATG Stop 
 
ATG                      Stop 
pREP3x-cki ORF 
BamHI BamHI 
nmt1  
nm
t1
 
LEU2
LEU2
cki ORF 
PCR amplification 
using  
FastStart polymerase  
 pREP3x 
(JD3386)
cki ORF Sense oligonucleotide Antisense oligonucleotide
cki1 ggggatccATGAGTGGACAAAACAATGT
AGTCGGT
ggggatccTCATGTGTCTTCATTGGAGC
CA
cki2 ggggatccATGAATTCCCAAACGAGCGT
AGTA
ggggatccCTAAGAAAAGCAACGACAGC
ATATCATATC
cki3 ggggatccATGTCAACTACTTCGTCTCA
CTCC
ggggatccCTATTCTTGTTTCGATATGCA
GCAAGAC
Figure A.4: Cloning of Cki1, Cki2 and Cki3 ORFs into pREP3x. The Cki1, Cki2
and Cki2 ORFs were amplied on a cDNA library using the oligonucleotides listed. This
introduced a BamHI site at either end of the PCR product, which along with pREP3x
(JD3386) vector were digested with BamHI and ligated to create pREP3x-Cki1 (JD3893),
pREP3x-Cki2 (JD3766) and pREP3x-Cki3 (JD3782). Restriction sites within oligonu-
cleotides are highlighted in bold and non-endogenous bases are denoted in lower case.
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 PCR amplification 
using  
FastStart polymerase  
pGADT7 
(JD2320)
 
Digest with BamHI 
 
Ligate 
ATG Stop 
cki ORF 
Sense primer Antisense primer 
 
ATG Stop 
 
ATG                      Stop 
pGADT7-cki ORF 
BamHI BamHI 
BamHI 
BamHI 
BamHI 
LE
U
2
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U
2
AmpR
AmpR
AD
AD
cki ORF 
cki ORF Sense oligonucleotide Antisense oligonucleotide
cki1 ggggatccATGAGTGGACAAAACAATG
TAGTCGGT
ggggatccTCATGTGTCTTCATTGGAG
CCA
cki2 ggggatccATGAATTCCCAAACGAGCG
TAGTA
ggggatccCTAAGAAAAGCAACGACAG
CATATCATATC
cki3 ggggatccATGTCAACTACTTCGTCTC
ACTCC
ggggatccCTATTCTTGTTTCGATATGC
AGCAAGAC
Figure A.5: Cloning of Cki1, Cki2 and Cki3 ORFs into pGADT7. The cki ORFs
were amplied using a cDNA library using the oligonucleotides listed. This introduced a
BamHI site at either end of the PCR product, which along with the pGADT7 (JD2320)
vector were digested with BamHI and ligated to create pGADT7-Cki1 (JD3770), pGADT7-
Cki2 (JD3771) and pGADT7-Cki3 (JD3763). Restriction sites within oligonucleotides are
highlighted in bold and non-endogenous bases are denoted in lower case.
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Digest with XhoI and BamHI 
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ATG ATG       Stop 
        ATG Stop 
PCR amplification 
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ATG       Stop 
Q 
JO2955 REP2 
pREP3x-Mam2-mCherry 
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PvuII 
ATG 
Q 
XhoI
I 
BamHI 
 
        ATG Stop 
pKS-Mam22K-mCherry 
ATG   
nm
t1
LEU2
AmpR
nm
t1
LEU2
K K
R R
R R
AmpR
LEU2
nm
t1
R R
     ATG
XhoI BamHI 
(JD3590)
 
(JD3374)
 
Q 
Q 
Oligonucleotide Sequence
JO2955 CAAAGCATGAgAACTTCATCTGCGCAAGGAGAAACCACCGAGGTTTCGA
TTAGAGTTGATAGAACGTTTGATATCAgACATACT
REP2 GCAGCTTGAATGGGCTTCC
Figure A.6: Creation of pREP3x-Mam22K-mCherry. Mam2 tagged mCherry was
amplied from pREP3x-Mam2-mCherry (JD3590) using a mutagenic sense oligonucleotide
and an antisense oligonucleotide (REP2) (grey region). This introduced a mutation at the
307th and 329th codons of Mam2 changing a lysine (AAA) to arginine (AgA). The product
was ligated into PvuII digested pKS-Mam2tail and the small fragment produced from a
XhoI/BamHI digest was ligated into XhoI/BamHI digested pREP3x (JD3386) to produce
pREP3x-Mam22K-mCherry (JD3802). Codon mutations are highlighted in bold and non-
endogenous bases are denoted in lower case.
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PCR amplification 
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AmpR
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R R
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BamHI XhoI 
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PvuII
XbaI 
REP1 
 
(JD3453)
 
 
(JD3374)
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Q 
Q 
Oligonucleotide Sequence
JO2955 CAAAGCATGAgAACTTCATCTGCGCAAGGAGAAACCACCGAGGTTTCGATT
AGAGTTGATAGAACGTTTGATATCAgACATACT
REP2 GCAGCTTGAATGGGCTTCC
REP1 ATCCGATTGTCATTCGGC
JO3038 TTCAGATTCATCAGAAATCG
Figure A.7: Creation of Mam24K-mCherry. The Mam25-tail was amplied using
a mutagenic sense (JO2955, initiated directly downstream of the Glutamate (Q) codon,
introducing a mutation at the 307th and 329th codons of Mam2) and antisense (REP2)
oligonucleotide and the product was ligated into PvuII digested pKs-Mam2tail. The stop
codon was removed through amplication of the resulting vector (pKS-Mam24K) with
sense (REP1) and antisense (JO3038) oligonucleotides. The product was digested with
XbaI and ligated into XbaI/PvuII digested pKS-mCherry. Finally, the small fragment pro-
duced from XhoI/BamHI digested pKS-Mam24K-mCherry was ligated into XhoI/BamHI
digested pREP3x. Codon mutations are highlighted in bold and non-endogenous bases are
denoted in lower case.
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Model reaction schemes developed
in Chapter 3
Species Initial concentration (nM)
L 0 - 100,000
R 205
GGDP 205
G 205
RGSc 60
GEF 205
RASGDP 205
GAP 205
All other species were set to 0 nM
Table B.1: Initial concentrations for species in the RAS model. For simulation
of WT cells when simulated with the RAS model from Table B.2.
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Ligand / G protein signalling
L + R ! LR k1 0.0025 nM 1h 1
G + R ! RG k2 0.005 nM 1h 1
G + LR ! LRG k3 0.02 nM 1h 1
L + RG ! LRG k4 0.005 nM 1h 1
L + RRGSm ! LRRGSm k5 0.005 nM 1h 1
G + RRGSm ! RRGSmG k6 0.005 nM 1h 1
G + LRRGSm ! LRRGSmG k7 0.02 nM 1h 1
L + RRGSmG ! LRRGSmG k8 0.005 nM 1h 1
G protein activation
LRG ! GGTP + G + LR k9 50 h 1
G ! GGTP + G k10 0.2 h 1
LRRGSmG ! GGTP + G + LRRGSm k11 40 h 1
RGS tracking
RRGSc ! RRGSm k12 0.0005 h 1
RRGSm ! RRGSc k13 0.005 h 1
R + RRGSc ! RRGSm k14 0.1 nM 1h 1
RRGSm ! R + RRGSm k15 100 h 1
LR + RRGSc ! LRRGSm k16 0.1 nM 1h 1
LRRGSm ! LR + RRGSm k17 100 h 1
RG + RRGSc ! RRGSmG k18 0.1 nM 1h 1
RRGSmG ! RG + RRGSm k19 0.1 h 1
LRG + RRGSc ! LRRGSmG k20 0.1 nM 1h 1
GGTP + RRGSc ! RRGSmGGTP k21 60 nM 1h 1
RRGSmGGTP ! GGTP + RRGSc k22 0.05 h 1
Switching o / recycling G protein
GGTP ! GGDP k23 0.005 h 1
GGTP + RRGSm ! RRGSmGGTP k24 500 nM 1h 1
RRGSmGGTP ! GGDPP + RRGSc k25 2.5 h 1
GGTP + LRRGSm ! LRRGSmGGTP k26 100 nM 1h 1
LRRGSmGGTP ! GGDPP + LRRGSm k27 2.5 h 1
GGTP + RRGSm ! RRGSmGGTP k28 0.5 nM 1h 1
RRGSmGGTP ! GGDPP + RRGSm k29 0.5 h 1
GGDPP ! GGDP + P k30 1000 h 1
GGDP + G ! G k31 1000 nM 1h 1
P ! ; k32 10 h 1
RAS activation
GEF + GGTP ! GGTPGEF k33 13 nM 1h 1
GGTPGEF + RASGDP ! inertGGTPGEFRASGTP k41 50 nM 1h 1
inertGGTPGEFRASGTP ! inertGGTPGEF + RASGTP k42 4 h 1
GGTP + RASGDP ! GGTP + RASGTP k50 0.00034 nM 1h 1
Recycling of G protein / GEF complex
inertGGTPGEF + RRGSc ! RRGSminertGGTPGEF k34 0.0001 nM 1h 1
inertGGTPGEF ! GGDPP + GEF k36 0.005 h 1
inertGGTPGEF + RRGSm ! RRGSminertGGTPGEF k37 0.3 nM 1h 1
RRGSminertGGTPGEF ! RGGDPP + RRGSc + GEF k38 0.3 h 1
inertGGTPGEF + LRRGSm ! LRRGSminertGGTPGEF k39 50 nM 1h 1
LRRGSm inertGGTPGEF ! GGDPP + LRRGSm + GEF k40 0.3 h 1
Regulation of RAS by GAP
RASGTP + GAP ! RASGTPGAP k44 4.2 nM 1h 1
RASGTPGAP ! RASGDPP + GAP k45 8 h 1
RASGTP ! RASGDPP k48 10 h 1
RASGDPP ! RASGDP + P k49 1000 h 1
Table B.2: RAS model. Includes reactions for activation of RAS via GEF and GGTP,
and regulation of RAS by GAP. to be simulated with initial conditions displayed in Table
B.1.
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Figure C.1: Model testing: Dependence on Gpa1 concentration. (a) The WT
strain was transformed with pREP3x (JD3386) and pREP3x-Gpa1 (JD2332) to create
Rgs1 and Rgs1+pGpa1, respectively. Also, the rgs1 (JY630) strain was transformed
with pREP3x (JD3386) and pREP3x-Gpa1 (JD2332) to create Rgs1 and Rgs1+pGpa1
respectively. Cells were grown to mid-exponential growth phasebefore treatment with a
range of P-factor concentrations (from 0 µM to 100 µM). After 16 h cells were assayed
for b-galactosidaseactivity (as described in section 2.2.8.1). Data shown is the average
of three independent experiments SEM. Data adapted from Smith et al. (2009) [190].
(b) The equivalent in silico experiment was simulated using the KR model (Table 3.9).
Simulations are of an unmodied system (RGS), when G concentration is doubled to
410 nM (RGS+G), when the concentration of RGS is 0 nM (No RGS) and simulating a
system when the concentration of RGS=0 nM and the concentration of G was doubled
to 420 nM (No RGS+G). The concentration of ligand was varied over the range 0 to 100
µM following 16 h simulated induction. Output from the model shows the accumulation
Spk1P complexes over the duration of the simulated assay.
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Figure C.2: Model testing: Overexpression of Mam2. (a) The WT strain (JY544),
which contains endogenous Mam2 was transformed with pREP3x (JD3386) and pREP3x-
Mam2 (JD2880) to create Mam2 and Mam2+pMam2 respectively. Cells were grown to
mid-exponential growth phasebefore treatment with a range of P-factor concentrations
(from 0 µM to 100 µM). After 16 h cells were assayed for b-galactosidaseactivity (as de-
scribed in section 2.2.8.1). Data shown is the average of three independent experiments
SEM. Data was adapted from W. Croft, PhD thesis, 2012. (b) The equivalent in silico
experiment was simulated using the KR model (Table 3.9). Simulations are of an unmod-
ied system (1xGPCR) and a system initialised with double the concentration of receptor
(2xGPCR). The concentration of ligand was varied over the range 0 to 100 µM following 16
h simulated induction. Output from the model shows the accumulation Spk1P complexes
over the duration of the simulated assay.
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Figure C.3: Model testing: Overexpression of Mam2. ((a) WT (JY544),
which contains endogenous Rgs1 (Rgs1), rgs1 strain (JY630), which lacks endoge-
nous Rgs1 (Rgs1) and gpa1 (JY1285) transformed with pREP3x-Gpa1G223S (JD2673)
(Gpa1G223S) were grown to mid-exponential growth phasebefore treatment with a range
of P-factor concentrations (from 0 µM to 100 µM). After 16 h cells were assayed for
b-galactosidaseactivity (as described in section 2.2.8.1). Data shown is the average of
three independent experiments SEM. Data was adapted from Smith et al. (2009) [190].
(b) The equivalent in silico experiment was simulated using the KR model (Table 3.9).
Simulations are of an unmodied system (RGS), a system initialised with the concentra-
tion of RGS=0nM (No RGS) and a system where all G-RGS interactions are blocked
(GRGSinsensitive). The concentration of ligand was varied over the range 0 µM to 100
µM following 16 h simulated induction. Output from the model shows the accumulation
Spk1P complexes over the duration of the simulated assay.
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Figure D.1: Mam2 is essential for P-factor induced transcriptional re-
sponse and cell elongation. WT (mam2+, JY544), mam2 (JY1169), cki1mam2
(JY1727), cki2mam2 (JY1734) andcki3mam2 (JY1720) strains were grown to mid-
exponential growth phasebefore treatment with a range of P-factor concentrations (from
0 µM to 100 µM). After 16 h cells (a) treated with 0 µM and 10 µM P-factor were imaged
under brighteld light as described in section 2.2.14 and (b) assayed for b-galactosidase
activity as detailed in section 2.2.8.1. Scale bar represents 10 µm. Data shown is the
average of three independent experiments SEM.
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Figure E.1: Mam24KmCh and Mam2tailmCh plasma membrane uorescence
data from QuimP. mam2 (JY1169) cells transformed with pMam24KmCh (JD3804)
and pMam2tailmCh (JD3621) were grown to mid-exponential growth phasebefore treat-
ment with 10 µM P-factor. Cells were imaged in the mCherry as described in section
2.2.14. A single cell was selected at random and quantied for their plasma membrane
uorescence using QuimP (as detailed in section 2.2.18). The gure shows the raw and
normalised (a) individual data and (b) mean data SEM. The mean data for cells ex-
pressing Mam24KmCh was tted using an exponential decay model t and cell expressing
Mam2tailmCh was tted using linear regression.
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Figure E.2: Raw and normalised plasma membrane uorescence data from
QuimP for cki1, cki2 and cki3 disruption strains. mam2 (JY1169), cki1mam2
(JY1727), cki2mam2 (JY1734) and cki3mam2 (JY1720) Sz. pombe transformed
Mam24K-mCherry and mam2 (JY1169) transformed Mam2tail were grown to mid-
exponential growth phasebefore treatment with 10 µM P-factor. Cells were imaged in the
mCherry as described in section 2.2.14. A single cell was selected at random and quantied
for their plasma membrane uorescence using QuimP (as detailed in section 2.2.18).
Appendix F
Determining cell lysis
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Figure F.1: Time-lapse images of Mam2-mCherry. mam2 cells were transformed
with pMam2mCh, grown to mid-exponential growth phase, treated with 10 µM P-factor
and imaged every 2 h from 0 h to 16 h as described in section 2.2.14. Each cell within
the frame was tracked with time to determine its viability heuristically. Yellow asterisk's
indicate the lysed cells in each frame.
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Figure F.2: Time-lapse images of C-terminal lysine decient Mam2. mam2
cells were transformed with pMam24KmCh, grown to mid-exponential growth phase,
treated with 10 µM P-factor and imaged every 2 h from 0 h to 16 h as described in
section 2.2.14. Each cell within the frame was tracked with time to determine its viability
heuristically. Yellow asterisk's indicate the lysed cells in each frame. For the actual video
see video 3.1 (this is a representative video used to determine the percentage of lysed cell
in each frame following treatment with P-factor for 16 h).
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Abstract
The detection and amplification of extracellular signals requires the involvement of multiple protein components. In
mammalian cells the receptor of activated C kinase (RACK1) is an important scaffolding protein for signal transduction
networks. Further, it also performs a critical function in regulating the cell cycle by modulating the G1/S transition. Many
eukaryotic cells express RACK1 orthologs, with one example being Cpc2p in the fission yeast Schizosaccharomyces pombe. In
contrast to RACK1, Cpc2p has been described to positively regulate, at the ribosomal level, cells entry into M phase. In
addition, Cpc2p controls the stress response pathways through an interaction with Msa2p, and sexual development by
modulating Ran1p/Pat1p. Here we describe investigations into the role, which Cpc2p performs in controlling the G protein-
mediated mating response pathway. Despite structural similarity to Gb-like subunits, Cpc2p appears not to function at the G
protein level. However, upon pheromone stimulation, cells overexpressing Cpc2p display substantial cell morphology
defects, disorientation of septum formation and a significantly protracted G1 arrest. Cpc2p has the potential to function at
multiple positions within the pheromone response pathway. We provide a mechanistic interpretation of this novel data by
linking Cpc2p function, during the mating response, with its previous described interactions with Ran1p/Pat1p. We suggest
that overexpressing Cpc2p prolongs the stimulated state of pheromone-induced cells by increasing ste11 gene expression.
These data indicate that Cpc2p regulates the pheromone-induced cell cycle arrest in fission yeast by delaying cells entry
into S phase.
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Introduction
Eukaryotic cells are constantly exposed to different stimuli and
are therefore required to both interpret and integrate their
response to these signals in order to modulate their behavior.
Many external signals are detected through cell surface G protein-
coupled receptors (GPCRs), which couples to heterotrimeric G
proteins consisting of a Ga, Gb and a Gc. In the inactive state, a
Ga subunit is bound to a molecule of GDP. Upon agonist
stimulation of a GPCR, nucleotide exchange occurs upon the Ga
subunit such that GDP is lost and replaced by GTP. This
promotes disassociation of Ga-GTP from the Gbc dimer. Each
can then regulate the activity of effector proteins thereby bringing
about changes in cellular behavior [1]. Signaling is terminated
when Ga-GTP is hydrolyzed to GDP through the intrinsic
GTPase activity of the Ga subunit leading to the re-association of
the heterotrimer.
The Gbc-dimer can function at different levels to regulate G
protein signaling. Most Gbc-dimers recruit Ga-subunits to the
plasma membrane facilitating interactions with agonist-bound
receptors. However, they can also act as guanine nucleotide
disassociation inhibitors (GDIs) by blocking the spontaneous
exchange of GTP for GDP on the Ga subunit. Finally, Gba-
subunits can act as signal transducers within their own right by
activating proteins such as adenylate cyclases and specific G
protein-inward rectifying potassium channels [2]. A number of
specific Gbc-modulating/activating proteins have been identified
including the activator of G protein signaling (AGS) superfamily
[3–5].
In recent times it has become evident that G protein-mediated
signaling cascades do not always require classical Gbc-subunits.
One such example is the glucose-sensing pathway in the budding
yeast Saccharomyces cerevisiae where a number of Gb-structural
mimics have been reported. These include two kelch-repeat
containing proteins Krh1p/Gpb1p and Krh2p/Gpb1p (however
these proteins are now known to act further downstream of the Ga
subunit [6–9]) and more recently a WD-repeat protein, Asc1p [10]
an ortholog of mammalian receptor of activated protein C kinase
(RACK1). It has been speculated that Ga subunits in other
GPCR-mediate systems may interact with non-classical Gbc-like
proteins, and one such example is the pheromone-response
pathway of fission yeast [11].
During the mating response Schizosaccharomyces pombe cells
exchange pheromones that bind to cell surface GPCRs [12],
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and transduce their signals via Gpa1p (Ga subunit) through a
classical mitogen-activated protein (MAP) kinase cascade, resulting
in activation of the transcription factor Ste11p. Critical for efficient
mating of the cells, is their resultant entry into a transient G1 arrest
following pheromone stimulation [13]. Based upon sequence and
structural comparison of typical G protein subunits within the S.
pombe genome, there appears to be only one canonical Gbc-
subunit (Git5p/Git11p). Early research suggested that Git5p/
Git11p could function on the pheromone cascade [14], however
this now appears to be incorrect [15]. We have recently reported,
through the use of a yeast 2–hybrid screen to identify interacting
partners of Gpa1p, the isolation of a Gb-like subunit, Gnr1p [16].
Both disruption and overexpression of Gnr1p demonstrated its
role as a negative regulator of Gpa1p but it was not required for
signaling [16]. As part of the same screen, we identified a second
weak interacting partner of Gpa1p, Cpc2p.
Cpc2p is a Trp-Asp (WD)-repeat protein, and is the S. pombe
ortholog of both RACK1 and Asc1p [17,18]. RACK1 is highly
conserved among eukaryotic species [18,19], and it was originally
described for its ability to interact with specific protein kinase C
isoforms. In addition, it has become apparent that RACK1 is
involved in complex cellular signal transduction pathways and
chromatin organization [18,19]. Further, it also plays a role in
mitotically growing cells by delaying entry into S phase [20,21].
Analogous to RACK1, Cpc2p appears to regulate a wide range
of responses within S. pombe. It has also been suggested that Cpc2p
modulates sexual development though its action on Ran1p/Pat1p,
so regulating the transition from mitosis to meiosis [17,22]. In
addition, Cpc2p controls the stress response pathway through
regulation of Atf1p via an interaction with Msa2p [18] although
the precise nature of this modulation remains unknown. It has
however, been demonstrated that deletion of cpc2 is epistatic to an
msa2 deletion suggesting that Msa2p may negatively regulate
Cpc2p [22]. Further, Msa2p performs a number of cellular roles
including modulating the stability of cdc4 mRNA, (Cdc4p encodes
an essential light chain of myosin and plays a crucial role in
cytokinesis) [23], and regulates the onset of sexual differentiation
by repressing Ste11p-regulated genes [24]. The interplay between
Msa2p and Ste11p regulated genes appears complex since, Msa2p
is itself, negatively regulated by pheromone. Upon pheromone-
stimulation activated Spk1p (the MAP kinase of the mating
response) reduces Msa2p activity, allowing an increase in Ste11p
translation [25]. Cpc2p appears to have a number of other cellular
roles including; modulating the cell cycle of mitotically growing
cells by regulating the G2/M transition [26] and a documented
association with the 40S ribosomal subunit [27], that suggests a
role in modulating the level of translation for many other genes.
Here we describe a novel and distinct role for Cpc2p within the
S. pombe pheromone-response pathway. Despite initially isolating
Cpc2p as a structural Gb-mimic for Gpa1p, we now suggest that,
Cpc2p also performs an important role in modulating S. pombe cells
entry into S phase following pheromone-induced cell cycle arrest.
We attempt to provide a molecular explanation for this data by
linking Cpc2p modulation of Ran1p/Pat1p to pheromone
signaling and also highlight a potential role for Msa2p in this
process.
Results
Sequence and structural comparisons of typical G protein
subunits within the fission yeast genome have identified a single
canonical Gbc (Git5p/Git11p). Evidence has been presented
suggesting that Git5p and Git11p do not function on the
pheromone-response pathway but solely act to module Gpa2p
from the glucose-sensing pathway [15]. In a previous study, we
described our use of the yeast-2 hybrid system to identify Gpa1p-
binding partners [16]. From this screen we isolated a number of
interactants, including the WD-repeat protein, Gnr1p. Quantita-
tive characterization (Figure S1) [16] using previously described
reporter strains (JY546; h2, cyr12, sxa2.lacZ) where the bacterial
enzyme b-galactosidase transcription is linked to the promoter of
the Ste11p-regulated pheromone-responsive gene sxa2 (Sxa2p is a
carboxypeptidase that is only expressed after pheromone stimu-
lation [28,29]) confirmed Gnr1p as a negative modulator of the
pheromone-response pathway in fission yeast.
A second Gpa1p-binding partner identified in our yeast-2
hybrid screen [16], but not extensively characterized was Cpc2p.
Deletion of the cpc2 ORF from our Ste11p-regulated pheromone-
responsive sxa2.lacZ reporter strains (JY1628; h2, cyr12,
sxa2.lacZ, cpc22) resulted in cells displaying a reduced sensitivity
to pheromone (Wild type (JY546) - pEC50 = 7.360.07; cpc2
2
(JY1628) - pEC50 = 6.960.03) and a two-fold decrease in the
extent of the maximal response (Wild type (JY546) - Emax
= 24.4560.73 units; cpc22 (JY1628) - Emax = 10.8260.22 units)
(Figure 1A). These defects were rescued upon expression of Cpc2p
from an inducible plasmid. Overexpression of Cpc2p in cells
containing an endogenous copy of cpc2, did not significantly alter
their sensitivity or maximal response to pheromone. These results
are in contrast to that observed for Gnr1p (Figure S1), and suggest
that Cpc2p is not a negative modulator of pheromone signaling,
despite its potential interaction with Gpa1p. Attempts to validate a
potential in vivo interaction between Gpa1p and Cpc2p using co-
immunoprecipitation have proven to be unsuccessfully (data not
shown) and indicate a potential weak interaction between these
two proteins. Subsequent mutational analysis of the N-terminal 40
amino acids of Gpa1p suggested that these residues alone are
necessary and sufficient to enable Gpa1p association with plasma
membrane structures in the absence of either Cpc2p or Gnr1p
(Figure S2). These results would suggest that Gpa1p does not
directly require the presence of a classical Gb-like subunit for its
regulation.
Cpc2p is a WD-repeat protein and an ortholog of the S. cerevisiae
protein Asc1p. cpc2 encodes a 314 amino acids peptide, with a
predicted molecular mass of 34.6 kDa and, analogous to Asc1p
and Gnr1p, contains 7 predicted WD-repeats. Using EMBOSS
Needle [30], we determined that Cpc2p-Asc1p share 67%
similarity, while Cpc2p-Gnr1p only share 28%. Further, relatively
high sequence alignment (64%) was also identified between Cpc2p
and mammalian RACK1. For a more detailed structural analysis,
we used SWISS-MODEL Repository [31,32] to illustrate the multi-
domain nature of the Cpc2p peptide, highlighting the 7 WD
repeats (Figure 1B). Interestingly, many WD-repeat proteins
contain a specific (up to 600 amino acids) C-terminal extension
[33] although this motif does not seem to be present in Cpc2p.
Despite Cpc2p not appearing to be a negative regulator of
pheromone signaling, it clearly performs a role in modulating the
response. We therefore sought to determine what role Cpc2p may
play upon both mitotically growing wild type (JY448; cyr1+, sxa22)
and pheromone-responsive (JY546; h2, cyr12, sxa2.lacZ) cells. It
should be noted that to enable quantitative characterization of the
extent of pheromone-responsiveness we use strains defective for
Cyr1p, which generates a genotype that mimics starvation and
produces a more diminished cell size [34,35] (Figure 1C).
For wild type mitotically growing Cyr1p expressing cells,
disruption of the cpc2 ORF resulted in cells displaying a slightly
decreased size at the point of cell division (Wild type (JY448)
= 12.1660.44 mm; cpc22 (JY1712) = 11.3260.21 mm) although
this was not statistically significant (p.0.5; n = 400). A more
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Figure 1. Characterization of potential Gb-subunit mimic in the pheromone-response pathway. (A) Pheromone-dependent transcription
for the strains JY546 (h2, cyr12, sxa2.lacZ), JY1578 (h2, cyr12, sxa2.lacZ+oe-cpc2+), JY1628 (h2, cyr12, sxa2.lacZ, cpc22) and JY1713 (h2, cyr12,
sxa2.lacZ, cpc22+oe-cpc2+) was determined using the sxa2.lacZ reporter. Values are means of triplicate determinations 6 S.E.M. (B) Molecular
structure as determined using the SWISS-MODEL Repository for Cpc2p. Cpc2p contains seven WD-40 repeat domains with positions of residues as
indicated by colors on the molecular structure. (C) Cell morphology and size, at division (micrometers 6 S.D.) for strains JY448 (h2, cyr12, sxa22),
JY1711 (h2, sxa22+oe-cpc2+), JY1712 (h2, sxa22, cpc22), grown in minimal medium at 29uC and stained with calcofluor white (top panel) or imaged
Cpc2p Control of G1 Arrest
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significant effect (p,0.1, n = 400) was observed upon overexpres-
sion of Cpc2p (oe-cpc2p+) with cells displaying a decreased size at
the point of cell division (oe-cpc2+ (JY1711) = 10.860.11 mm). As
mentioned above cells lacking Cyr1p display a smaller size at
division (Figure 1D). Both the deletion or overexpression of the
cpc2 ORF from these strains increased the overall cell size (Wild
type (JY546) = 9.2660.29 mm; cpc22 (JY1628) = 10.660.64 mm;
oe-cpc2+ (JY1578) = 10.3860.10 mm) however these changes were
not found to be statistically significant (cpc22 (JY1628) = p.0.5, n
= 400; oe-cpc2+ (JY1578) = p.0.5, n = 400). Some of these sizes
are different to what maybe predicted from previous studies [18]
but may arise due to the genetic backgrounds we have used
compared to others. Indeed while all of the cell sizes at division in
this study appear to be slightly smaller than accepted within the
field (S. pombe cells generally undergo cell division at a size of
between 13-14 mm), it should be noted that the growth media used
in our assays is a variant of the classical EMM as described by
Davey et al., 1995 [36]. This media places a higher nutritional
demand on the cells and as a result causes the cells to undergo
division at a smaller size. Indeed it has been documented that
nutritional reduction of growth rate results in decreased cell size
[37].
We next sought to determine the effects upon the cell cycle of
deleting, or overexpressing Cpc2p, using the previously described
strains (Figure 1E). Deletion of Cpc2p slightly increased the
percentage of cells within a population contain multiple-septa
(regardless of the presence or absence of Cyr1) and is consistent
with previous reports [26]. Interestingly, and somewhat counter-
intuitive, this effect was more pronounced upon overexpression of
Cpc2p regardless of the presence (Wild type (JY448) =,0.1%; oe-
cpc2+ (JY1711) = 1060.2% - p =,0.0001, n = 4) or absence of
Cyr1p (Wild type (JY546) =,0.1%; oe-cpc2+ (JY1578)
= 1060.15% - p =,0.0001, n = 4). These results are consistent
with Cpc2p inhibiting the activity of Ran1p/Pat1p resulting in an
increase in Ste11p activity. Further, Cpc2p and Msa2p activity are
tightly coordinated and thus increased Cpc2p expression may
reduce the ability of Msa2p to stabilize cdc4 mRNA, causing
defects in cell division.
Deletion of cpc2 renders cells of both mating types sterile
(Figure 1F). It should be noted that all strains used in the
quantitative mating assays express sxa2 since strains lacking Sxa2p
are sterile [28]. Significantly, increasing Cpc2p expression leads to
a,1.5 fold increase in mating efficiency (observed for both mating
types).
Having established a role for Cpc2p during the mating
response, we next sought to provide a molecular explanation for
these effects. During mating cells undergo a unidirectional
elongation towards a potential partner (termed a shmoo) [38].
Our strains (either expressing or deleted for cyr1) lack Sxa2p and
therefore display abnormally long conjugation tubes following
prolonged exposure (.8 h) to high pheromone concentrations
(10 mM) in the absence of a sufficient nutrient source (Figure 2A)
[28]. After approximately 10-12 h these cells appear to resume
mitotic division, before generating a second pheromone depen-
dent-response. Strains deleted for cpc2 failed to generate any
morphological response to the presence of the pheromone and
continued mitotic growth (Figure 2B). Strains overexpressing
Cpc2p, when grown in the absence of nitrogen and treated with
pheromone, initially generated conjugation tubes of equivalent size
to wild type cells however, they failed to undergo division. Instead,
after .16 h, cells displayed very specific cell branching activity
(Figure 2C - arrows) but did not appear to lose viability. Moreover,
following prolonged pheromone exposure (.30 h) many cells
contained an increased number of septa, suggesting an inability to
efficiently divide. As described previously, these data are consistent
with Cpc2p having pleiotropic effects on the ability of Msa2p to
regulate cdc4 mRNA.
The observation that cells overexpressing Cpc2p appear to
elongate from multiple tips when exposed, for prolonged periods
to pheromone, led us to hypothesize that these strains may exhibit
a protracted pheromone-induced G1 cell cycle arrest. To address
this, we used flow cytometry to analyze the response of cells when
stimulated with pheromone. As mentioned previously, the strain
JY546 lacks adenylate cyclase [34], and this results in an increased
number of cells, within a population (,20-25%) containing a
single 1C content of DNA when analyzed using flow cytometry
reflecting modification of the mitotic cell cycle in these strains
(Figure 3C). Deletion of cpc2 from strains lacking cyr1 reduces the
percentage of cells within a population containing a single 1C
content of DNA, while overexpression did not have a significant
effect (p.0.5, n = 3).
Following exposure to 10 mM pheromone, the proportion of
wild type (JY546) cells with a 1C content of DNA steadily
increased reaching a maximum (after 8 h) before decreasing over
the subsequent 8 h time-frame. This cycle was repeated for the
following 16 h time period. These two phases reflect the
morphological images shown in Figure 2A and confirm that cells
lacking Cyr1p only respond for a fixed period (,10–12 h) before
resuming mitotic division. In contrast, overexpression of Cpc2p
results in an accelerated (compared to wild type) increase in the
percentage of cells exhibiting a 1C content of DNA (90%, n = 3)
following exposure to pheromone (Figure 3B and 3C). Consistent
with the morphological data presented in Figure 2C, these cells
failed to regain a 2C DNA content over the time frame analyzed.
Interestingly, the strain lacking cpc2 (JY1628) did show an increase
(from 10% to 55%) in the percentage of cells containing a single
1C content of DNA following pheromone stimulation. This did
not however coincide with an increase in cell size (Figure 2B)
suggesting these cells can detect the presence of the pheromone,
undergo an arrest but fail to initiate shmoo formation.
We next sought to observe if similar effects upon cell cycle
regulation was observed for strains expressing Cyr1p, when
nitrogen starved and exposed to pheromone (Figure 3D). Signif-
icantly, cells overexpressing Cpc2p appeared to increase the
number of cells entering and remaining in a G1 arrest. Unlike the
strains lacking cyr1, nitrogen starvation prevents cells from
regaining their 2C complement and therefore they remain arrested
in G1 (reviewed [13]). Overexpression of Cpc2p increased the
percentage of cells within the population that contained a single
1C content following pheromone stimulation. Interestingly how-
ever, strains lacking cpc2 did not appear to display any significant
arrest in G1. This is in contrast to the data observed with cyr1
2
through using bright field microscopy on agar pads (bottom panel). Scale bars 10 mm. (D) As for C except strains JY546 (h2, cyr12, sxa2.lacZ),
JY1578 (h2, cyr12, sxa2.lacZ+oe-cpc2+), and JY1628 (h2, cyr12, sxa2.lacZ, cpc22) were used. (E) Numbers of non-septated, septated and multiple
septa containing cells for the strains in C and D were determined from 400 individual cells. Values shown correspond to the percentages of the total
population. Cells were stained with calcofluor white, to enable visualization of septum material. (F) Mating efficiency was quantitated for cells
overexpressing (JY1634, h2, +oe-cpc2+; JY1633 h+, +oe-cpc2+) or lacking Cpc2p (JY1636, h2, cpc22; JY1635 h+, cpc22) compared to M (JY402, h2)
and P (JY383, h+) control cells. Statistical significance determined compared to M (h2) and P (h+) using a one-way Anova with a tukey multiple
comparison post test where www represents p#0.001, ww represents p#0.01, and w represents p#0.1.
doi:10.1371/journal.pone.0065927.g001
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strains and highlights potential differences that this nutritional
selection may enforce on S. pombe cells. Moreover the data would
suggest that the regulatory mechanism utilized by Cpc2p and
Cyr1p to control G1 arrest are different. It is entirely probable that
the increased percentage of cells that initially contain a 1C content
in a cyr12 background amplifies any potential arrests observed for
strains following pheromone stimulation.
Overall, these data suggest that Cpc2p proactively induces the
pheromone-dependent G1 arrest and following prolonged expo-
sure, cells overexpressing Cpc2p are unable to become desensi-
tized to pheromone and remain arrested in the G1 phase of the cell
cycle although the precise mechanism for this protracted G1 arrest
is unknown but maybe due, in part, to Cpc2p partially inhibiting
Ran1p/Pat1p. Cells lacking cpc2 do not appear to generate a
typical pheromone-induced G1 arrest and this is consistent with
the lack of shmoo formation observed previously (Figure 2B).
Mammalian RACK1 has been reported to, in mitotically
growing cells mouse NIH3T3 cells, delay their entry into S phase
[21,39]. Further, it has been suggested that RACK1 suppresses
cpc2 defects in S. pombe cells [17]. We therefore sought to determine
the effects on pheromone-induced responses in our strains
expressing mammalian RACK1. Cells lacking an endogenous
copy of the cpc2 were transformed with an inducible plasmid
expressing mammalian RACK1 and their dose-dependent re-
sponse to pheromone determined using the sxa2.lacZ reporter. As
has previously been suggested [17], mammalian RACK1 was able
to functionally complement for the loss of Cpc2p, with cells
generating a near normal pheromone-dependent response profile
(Figure S3A). Further, upon investigation of the DNA content of
cells expressing RACK1, when exposed to 10 mM pheromone, we
observed a prolonged G1 arrest (Figure S3B) analogous to that
described for increased Cpc2p expression (compare Figure 3C and
3D with Figure S3B). Taken together, these data highlight the
functional similarities between Cpc2p and RACK1 in modulating
the cells ability to exit pheromone-induced G1 phase of the cell
cycle.
Having established that pheromone treated cells overexpressing
Cpc2p display a protracted G1 arrest, we sought to determine if
this was as a direct result of cells failing to enter S phase. S. pombe
relies on a single cyclin-dependent kinase (CDK) Cdc2p, to
regulate and control mitotic cell-cycle events. Cdc2p is controlled
by association with B-type cyclins such that, Cdc2p-Cdc13p act as
the mitotic kinase [40,41], and Cdc2p-Cig2p the G1-S kinase [42].
In S. pombe cells, Rum1p, the sole cyclin-dependent kinase
inhibitor (CKI), plays an important role in regulating both
Cdc2p-Cig2p and Cdc2p-Cdc13p (over expression of Rum1p
induces polyploidy due to the bypass of M-phase [43]). During
anaphase, Rum1p starts to accumulate, becomes stable and
consistent during G1, and diminishes in S-phase [43]. In addition,
its expression is increased upon exposure to pheromone (http://
www.pombase.org/). Via its regulating activity of Cdc2p-Cig2p,
Figure 2. Cpc2p has profound morphological effects upon
pheromone-stimulated cells. The strains (A) JY448 (h2, sxa22) and
JY546 (h2, cyr12, sxa2.lacZ); (B) JY1712 (h2, sxa22, cpc22) and JY1628
(h2, cyr12, sxa2.lacZ, cpc22); (C) JY1711 (h2, sxa22+oe-cpc2+), JY1578
(h2, cyr12, sxa2.lacZ+oe-cpc2+), were grown to mid-exponential
phase over 32 h in minimal media. Cells were then imaged using
bright field microscopy on pads containing 10 mM of pheromone (see
methods). Cells were also stained with calcofluor white (lower panels A-
C) to visualize septation. Scale bars 10 mm. Prolonged exposure to
pheromone for cells overexpressing Cpc2p (oe-cpc2+) results in
multiple projection tips and a failure to undergo cytokinesis. Cells
lacking Cpc2p fail to generate the classical shmoo formation as
observed for control cells.
doi:10.1371/journal.pone.0065927.g002
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Figure 3. Cpc2p control the G1/S transition in pheromone-stimulated cells. (A) The strains JY546 (h2, cyr12, sxa2.lacZ), JY1578 (h2, cyr12,
sxa2.lacZ, +oe-cpc2+) and JY1628 (h2, cyr12, sxa2.lacZ, cpc22) were grown in minimal medium and (B) minimal media containing 10 mM of
pheromone for the times indicated. Cells were harvested and fixed prior to staining with propidium iodide prior to analysis using flow cytometry (see
methods). The proportion of cells exhibiting 1C or 2C DNA content was determined using FACSDiva v4.1 software for the assigned gates indicated by
the blue and red shapes. (C) The percentage of cells containing a 1C content (arrested in G1) as determined from B. Cells containing an additional
content of Cpc2 fail to desensitize following pheromone stimulation and remain arrested for the time frame analyzed. Cells lacking Cpc2p fail to
generate a significant arrest in G1 following exposure to 10 mM pheromone. (D) The percentage of cells from the strains JY448 (h
2, sxa22), JY1711
(h2, sxa22+oe-cpc2+), JY1712 (h2, sxa22, cpc22) containing a 1C content (arrested in G1) following nitrogen starvation and stimulation with 10 mM
pheromone.
doi:10.1371/journal.pone.0065927.g003
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Rum1p functions as the main controlling agent for maintaining
the G1 phase of the cell cycle [40-42,44]. We therefore generated a
pheromone-responsive reporter strain lacking Rum1p (JY1520;
h2, cyr12, sxa2.lacZ, rum12) capable of overexpressing Cpc2p.
Cells lacking Rum1p displayed a smaller size (irrespective of the
expression of Cyr1p) than wild type strains (Figure 4A), although
their morphology appeared normal. Further, there were no
observable defects in the levels of septation (Figure 4B) and/or
growth rates for the strain lacking Rum1p. Overexpression of
Cpc2p in strains lacking Rum1p resulted in a slight increase in cell
size (Figure 4A) and a 7-fold increase in the occurrence of multiple
septa (Figure 4B).
We next investigated the pheromone-dependent responses of
cells lacking Rum1p with and without additional Cpc2p
(Figure 4C). Cells lacking Rum1p failed to generate a dose-
dependent response to stimulation with pheromone and this was
not recovered by the overexpression of Cpc2p (JY1637). Flow
cytometry analysis revealed that both these populations (JY1520
(rum12) and JY1637 (rum12+oe-cpc2+)) contained a 2C content of
DNA regardless of the presence of 10 mM pheromone (Figure 4D),
suggesting that cells failing to reside in the G1 phase of the cell
cycle for an extended period, are not subjected to pheromone-
induced Cpc2p regulation of the G1/S transition.
Significantly, bright field microscopy images of our Rum1p
deleted strains overexpressing Cpc2p, following exposure to
10 mM pheromone (for 32 h) indicate the presence of elongated
cells compared to the non-stimulated populations (Figure 4E).
These effects were not observed in a strain lacking both Rum1p
and Cpc2p (JY1710; h2, cyr12, sxa2.lacZ, cpc22, rum12). The
pheromone-induced elongate cells in the rum1 deleted strain
overexpressing Cpc2p showed considerable similarity to the
classical shmoo morphology described in Figure 2A. The presence
of pheromone-induced elongated cells in a strain lacking Rum1p
strain suggests the possibility that S. pombe cells can generate a G1-
independent morphological response to pheromone. This data
would suggest that pheromone induces shmoo formation at the
same time as a G1 arrest. To the best of our knowledge, these
observations represent the first demonstration of a pheromone-
induced cell elongation for an S. pombe population that fails to enter
G1.
Following our observations that Cpc2p may play a role in
modulate cells passage into S phase, we sought to provide a
mechanistic interpretation to our data. The failure of cells lacking
Rum1p to enter a protracted G1 arrest suggests that Cpc2p
performs its role by over-activation of the Ste11p-regulated
pheromone-response pathway. Following pheromone activation
of cell surface receptors, Gpa1p propagates the response by
activating Ras1p. This leads to stimulation of a MAP kinase
cascade and activation of Ste11p. Further, Spk1p also phosphor-
ylates an unknown negative regulator of Msa2p [25], reducing it’s
activity leading to an increase in Ste11p translation therefore
reinforcing the response.
The promiscuous dual-specificity phosphatase Pmp1p, has
among other roles, been suggested to negatively modulate the
action of Spk1p [45]. Deletion of Pmp1p results in Spk1p
remaining activate for longer so prolonging Ste11p activation [45].
Thus, we sought to determine if similar cellular defects were
observed in Pmp1p deleted cells to that observed for cells
overexpressing Cpc2p. Morphological analysis of a strain lacking
Pmp1p, (JY948; h2, cyr12, sxa2.lacZ, pmp12 and JY1716; h2,
sxa22, pmp12) when stimulated with 10 mM pheromone for 32 h,
reveals cells that displayed extended conjugation tubes and
multiple projection tips (Figure 5A and 5B). Further, Pmp1p
depleted cells exhibit an elevated maximal response to pheromone
(Figure 5F), and flow cytometry analysis suggests that these cells
fail to exit from a pheromone-induced G1 arrest (Figure 5C).
These results are consistent with that observed for overexpression
of Cpc2p, and would suggest that Cpc2p could be acting to
increase MAP kinase/Ste11p activity in response to pheromone.
It is of interested to note that Cpc2p does not perform a direct
role in modulating the expression levels of Pmp1p but in contrast,
it has been reported that Cpc2p regulates the activity of two other
MAP kinase phosphatases Pyp1p and Pyp2p [18]. To date, little
information has been published relating to potential roles of Pyp1p
and Pyp2p in relation to pheromone signaling. Based upon our
results with deletion of pmp1 we sought to evaluate the role of
Cpc2p modulation of these two phosphatases with respect to
pheromone transduction. Unfortunately, despite numerous at-
tempts the concurrent deletion of pyp1 and cyr1 appears
synthetically lethal (Didmon and Davey unpublished). As a result
we have only been able to investigate the role of Pyp2p.
Cells lacking Pyp2p (JY709; h2, cyr12, sxa2.lacZ, pyp22) and
(JY710; h2, sxa2,2 pyp22) have a slightly reduced size (Figure 5D)
that is not significantly increase upon overexpression of Cpc2p.
Interestingly, and in contrast to all other strains tested within this
study, overexpression of Cpc2p did not induce an increase in septa
formation (Figure 5E). It has been reported that cells overexpress-
ing Pyp2p exhibit a delay in mitosis [46], and which appears
analogous to the overexpression of Cpc2p [18]. Since Cpc2p has
been documented to modulate the expression of Pyp2p, the
removal of pyp2 renders Cpc2p activity redundant. Finally,
irrespective of the presence of excess Cpc2p, cells lacking Pyp2p
fail to respond to pheromone (Figure 5F) and appear to contain a
2C DNA content at all times (Figure 5G and 5H). These results
are similar to the Rum1p disruption, however cells lacking Pyp2p
fail to generate a G1-independent morphological response to the
presence of the pheromone.
Discussion
The eukaryotic scaffold protein RACK1 (a WD-repeat protein)
is involved in a wide range of signal transduction pathways
including cell cycle progression. The fission yeast ortholog Cpc2p
has been reported to modulate the stress-response pathway and
positively regulates the G2/M transition at the ribosomal level
[26]. Here we have described the role of Cpc2p in modulating the
pheromone-response pathway. In a previously described yeast 2-
hybid screen for interacting partners of Gpa1p, we identified
Cpc2p [16]. Based upon the similarity of Cpc2p to the Asc1p (a
Gbc-like subunit for Gpa2p involved in the glucose-sensing
pathway from budding yeast) [10] we investigate the potential
for Cpc2p to act as the Gbc-subunit within the pheromone-
response pathway in fission yeast. Despite performing a significant
role in pheromone-mediated signaling, Cpc2p does not appear to
regulate Gpa1p and attempts to validate this interaction in vivo
proved unsuccessful. Indeed, it is highly probable that Gpa1p does
not require a chaperone to target it to the plasma membrane.
Gpa1p contains a consensus MG2XXXS6 myristoylation sequence
[47], and a downstream cysteine, which is likely to be a target for
palmitoylation, so facilitating association with membranes. More-
over, mutational analysis suggests that the N-terminal first 40
amino acids of Gpa1p are necessary and sufficient to enable its
association with membrane structures (Figure S2).
Our data has confirmed that Cpc2p performs a role in
regulating sexual differentiation in S. pombe. Cells lacking Cpc2p
display little change in the transcription levels of ste11 mRNA
despite but are sterile [25]. Interestingly, cpc2 depleted cells do
however, display decreased reduce protein concentration of
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Figure 4. Overexpression of cpc2 mediates its pheromone effects in a G1-dependent manner. (A) Cell morphology and size, at division
(micrometers 6 S.D.) for strains JY1520 (h2, cyr12, sxa2.lacZ, rum12), JY1637 (h2, cyr12, sxa2.lacZ, rum12+ oe-cpc2+), JY1714 (h2, sxa22, rum12)
and JY1715 (h2, sxa22, rum12+oe-cpc2+) grown in minimal medium at 29uC and stained with calcofluor. Scale bars 10 mm. (B) Number of non-
septated, septated and multiple septa containing cells for the strains JY448 (h2, sxa22), JY1714 (h2, sxa22, rum12), JY1715 (h2, sxa22, rum12+oe-
cpc2+), JY546 (h2, cyr12, sxa2.lacZ), JY1520 (h2, cyr12, sxa2.lacZ, rum12 ) and JY1637 (h2, cyr12, sxa2.lacZ, rum12+oe-cpc2+) were determined
from 400 individual cells. Values shown correspond to the percentage of the total population. Cells were stained with calcofluor white, to enable
visualization of septum material. (C) Pheromone-dependent transcription for the strains JY546, JY1520, JY1637 and JY1710 (h2, cyr12, sxa2.lacZ,
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Ste11p that is insufficient to induce downstream targets. Our
studies have utilized a pheromone-reporter strain (sxa2.lacZ)
under the direct control of Ste11p (Figure 1A) so validating the
notion that cpc22 cells have reduced Ste11p activity.
Although Cpc2p does not appear to function as a Gb-like
subunit in S. pombe, our results suggest that in a pheromone-
stimulated environment, overexpression of Cpc2p causes signifi-
cant cellular effects including; defects in cell integrity, increased
mating efficiency, increased septum formation, reduced cell cycle
progression and increased cell morphological defects. Significantly,
Cpc2p appears to actively promote and prolong the pheromone-
induced G1 arrested state, preventing cells from adapting to the
presence of the pheromone and resuming mitotic growth.
Moreover, cells expressing RACK1 display the same cell cycle
progression defect when subjected to pheromone stimulation,
confirming functional similarity between these two orthologs.
The precise mechanism by which Cpc2p protracts the G1 arrest
upon pheromone stimulation remains to be determined. Initially,
it was tempting to speculate that this effect was due to the Cpc2p
interaction with Msa2p. Indeed, upon pheromone stimulation
Spk1p phosphorylates a negative regulator of Msa2p allowing
production of Ste11p. However, Msa2p is expected to negatively
regulate Cpc2p since it has been demonstrated that the cpc2 null
strain is phenotypically epistatic to an msa2 deleted strain [22]. It is
more plausible that the effects we observe following overexpression
of Cpc2p are due to its role as an inhibitor of the essential kinase,
Ran1p/Pat1p which has been reported to act by phosphorylating
Mei2p so regulating sexual differentiation [48,49]. Cpc2p has been
demonstrated to bind to Ran1p/Pat1p resulting in a change in its
cellular localization causing a loss of activity [17]. The partial
inhibition of Ran1p/Pat1p in starved haploid cells leads to a G1
cell cycle arrest. This is consistent with our observations for cells
lacking Cpc2p, which are sterile and fail to exhibit a pheromone-
induced G1 arrest. Moreover, it has been demonstrated that
Ran1p/Pat1p phosphorylates Ste11p to down regulate its activity
[50]. Thus overexpression of Cpc2p will lead to enhanced
inhibition of Ran1p/Pat1p so preventing negative regulation of
Ste11p [51] and prolonging the G1 arrest. Further experimental
work will be required to fully dissect the precise role that Cpc2p
performs in modulating Ran1p/Pat1p activity and consequently
Ste11p.
The pheromone-induced effects of Cpc2p are potentially re-
enforced through the action of Msa2p. It has been suggested that
upon pheromone stimulation, Spk1p phosphorylates an, as yet,
unidentified negative regulator of Msa2p, so allowing increased
production of Ste11p [25]. Overexpression of Cpc2p results in
enhanced activation of Ste11p and coincides with abnormal
morphologies and defects in cytokinesis (probably relating from
reduced Cdc4p activity). Both these effects are consistent with a
reduction in Msa2p activity since it negatively regulates Ste11p
translation and also stabilizes cdc4 mRNA [22]. Cpc2p modulates
the activity of Atf1p and acts as a positive translational regulator of
mRNA for Pyp1p and Pyp2p activity so reducing Pmk1p activity.
This consequently decreases Msa2p activity.
Further to its roles in regulating sexual development through
modulating Ran1p/Pat1p activity, Cpc2p has been described as
being associated with the 40S ribosomal subunit so modulating
gene transcription [27]. Paul and colleagues provided evidence to
suggest that Cpc2p, through association with Moc2p and Rpl32-
2p, may act to increase sexual differentiation [52]. Specifically,
Rpl32-2p expression was shown to increase upon nitrogen
starvation, analogous to Ste11p levels. In addition, deletion of
moc1 or moc3 results in reduced ste11 expression. Indeed it has been
suggested that all Moc proteins and Cpc2p might act as a
translational regulator involved in controlling sexual differentia-
tion. Thus it is apparent that Cpc2p may play numerous roles in
regulating the pheromone response by modulating ste11 gene
expression.
Previous investigations of Cpc2p activity within S. pombe have
suggested that, in contrast to a role in modulating the G1/S
transition, that Cpc2p acts to positively regulate the G2/M
transition for mitotically growing cells [26]. However, as the
authors themselves highlight, S. pombe cells spend most of their
time (about three-quarters of the cell cycle) in G2 whereas for
mammalian cells the longest phase of the cell cycle is G1 [26].
However, the addition of pheromone to S. pombe cells (subjected to
nutrient limitation or removal of cyr1) causes them to initiate the
meiotic mating-response pathway, resulting in cells remaining in
the G1 phase of the cell cycle for longer. Under these conditions
addition of exogenous RACK1/Cpc2p results in a protraction of
the G1 arrest and prevents a return to mitotic growth. By the
addition of pheromone to nitrogen starved S. pombe cells these now
mimic mammalian cells by exhibiting an extended G1 so enabling
RACK1/Cpc2p to suppress G1/S transition. These observations
were confirmed by removal of Rum1p (the single CKI in fission
yeast) or Pyp2p (MAPK phosphatases) both of which results in
cells failing to enter G1 and consequently, were unaffected by the
addition of exogenous Cpc2p. By manipulating the duration of the
G1 phase of the cell cycle we have uncovered a subtle role that
Cpc2p plays in S. pombe.
Materials and Methods
Strains, Reagents and General Methods
Fission yeast strains used in this study are listed in Table 1.
Culture media used was YE - yeast extract for routine cell growth,
amino acid (AA) medium for auxotrophic selection and DMM – a
defined minimal medium for selective growth and all the assays.
DMM is a variant of EMM and contains little nutritional
supplement for the yeast. As a consequence cells can appear
slightly more rounded than wild type strains. Nutritional limitation
has previously been described as reducing the rate of cell growth
and size [37]. As described previously lithium acetate was used for
transformation of yeast [29,36]. Cell concentrations were deter-
mined using a Coulter Channelyser (Beckman Coulter, Luton,
UK). DNA manipulations were performed by standard methods.
Oligonucleotides were synthesized by Invitrogen Ltd. (Paisley,
Scotland, UK). Amplification by the polymerase chain reaction
(PCR) used Pwo DNA polymerase (from Pyrococcus woesei) according
to the supplier’s instructions (Boehringer–Mannheim Biochemi-
cals, Lewes, East Sussex, UK). All constructs generated by PCR
were confirmed by sequencing.
rum12, cpc22) was determined using the sxa2.lacZ reporter. Cells were stimulated with pheromone for 16 h in minimal media and assayed for b-
galactosidase production using ONPG. Activity is expressed as OD420 units per 10
6 cells. Values are means of triplicate determinations6 S.E.M. (D) The
strains JY1520 and JY1637 were grown in minimal medium containing 10 mM of pheromone for the times indicated. Cells were harvested and fixed
prior to staining with propidium iodide prior to analysis using flow cytometry (see methods). The proportion of cells exhibiting 1C or 2C DNA content
was determined using FACSDiva v4.1 software for the assigned gates indicated by the blue and red shapes (E) The strains JY1520, JY1710 and JY1637
were grown to mid-exponential phase over 32 h in minimal media. Cells were then stained with calcofluor white to visualize septation (top panel)
and imaged bright field microscopy (bottom panel) after 32 h exposure to pheromone. Scale bars 10 mm.
doi:10.1371/journal.pone.0065927.g004
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Figure 5. Overexpression of Cpc2 in pheromone stimulated cells mimics prolonged pheromone stimulation. (A) Cell morphology and
size, at division (micrometers 6 S.D.) for the strains JY1716 (h2, sxa22, pmp12) and JY948 (h2, cyr12, sxa2.lacZ, pmp12) grown in minimal medium
at 29uC and stained with calcofluor white. (B) Strains from A strains were exposure to 10 mM of pheromone for 32 h and stained with calcofluor white.
(C) The percentage of cells containing a 1C content (arrested in G1) for the strains JY448, JY1716, JY546 and JY948 as determined using flow
cytometry. Cells lacking Pmp1p show a failure to exit from a G1 arrest analogous to strains where the cpc2 ORF has been deleted. (D) Cell morphology
and size, at division (micrometers 6 S.D.) for strains JY710 (h2, sxa22 pyp22) and JY1717 (h2, sxa22, pyp22+oe-cpc2+) grown in minimal medium at
29uC and stained with calcofluor white (top panel). Cell morphology and size at division (micrometers 6 S.D.) for the strains JY709 (h2, cyr12,
sxa2.lacZ, pyp22) and JY1661 (h2, cyr12, sxa2.lacZ, pyp22+oe-cpc2+) grown in minimal medium at 29uC and stained with calcofluor white (bottom
panel). (E) Numbers of non-septated, septated and multiple septa containing cells for the strains JY448, JY1714, JY1715, JY546, JY987 and JY1661
were determined from 400 individual cells. Values shown correspond to the percentages of the total population. Cells were stained with calcofluor
white, to enable visualization of septum material. (F) Pheromone-dependent transcription for the strains JY546, JY709, JY1661 and JY948 was
determined using the sxa2.lacZ reporter. Cells were stimulated with pheromone for 16 h in minimal media and assayed for b-galactosidase
production using ONPG. Activity is expressed as OD420 units per 10
6 cells. Values are means of triplicate determinations6 S.E.M. (G) The strains JY709
and JY1661 were grown in minimal medium containing 10 mM of pheromone for the times indicated. Cells were harvested and fixed prior to staining
with propidium iodide prior to analysis using flow cytometry (see methods). The proportion of cells exhibiting 1C or 2C DNA content was determined
using FACSDiva v4.1 software for the assigned gates indicated by the blue and red shapes. (H) The percentage of cells containing a 1C content
(arrested in G1) as determined for the strains JY448, JY546, JY710, JY1717, JY709 and JY1661.
doi:10.1371/journal.pone.0065927.g005
Table 1. S. pombe strains used in this study.
Strain Genotype Source/reference
JY383 mat1-P, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18 [56]
JY402 mat1-M, Dmat2/3::LEU22, ade6-M216, leu1-32 ura4-D18 [57]
JY448 mat1-M, Dmat2/3::LEU22, leu1-322, ade6-M216, ura4-D18, sxa2-D15 [57]
JY546 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ [45]
JY709 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, pyp2::ura42 This study
JY710 mat1-M, Dmat2/32::LEU22, leu1-32, ade6-M216, ura4-D18, sxa2-D15, pyp2::ura42 This study
JY948 mat1-M, Dmat2/3::LEU2–, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, pmp1::ura42 This study
JY1034 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, pREP3x-1240Gpa1-GFP This study
JY1314 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, gnr1::ura42 [12]
JY1315 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, gnr1::ura42, pREP3x-1240Gpa1-GFP This study
JY1316 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, pREP3x-Gnr1 This study
JY1317 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, gnr1::ura42, pREP3x-Gnr1 This study
JY1520 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, rum1::ura42 This study
JY1578 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, pREP3x-Cpc2 This study
JY1628 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, cpc2::ura42 This study
JY1629 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, cpc2::ura42, pREP3x-1240Gpa1-GFP This study
JY1633 mat1-P, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, pREP3x-Cpc2 This study
JY1634 mat1-M,Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, pREP3x-Cpc2 This study
JY1635 mat1-P, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cpc2::ura42 This study
JY1636 mat1-M,Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cpc2::ura42 This study
JY1637 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, rum1::ura42, pREP3x-Cpc2 This study
JY1661 mat1-M, Dmat2/3::LEU2–, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, pyp2::ura42, pREP3x-Cpc2 This study
JY1662 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, cpc2::ura42, pREP3x-RACK1 This study
JY1663 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, pREP3x-RACK1 This study
JY1710 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, rum1::ura42, cpc2::ura42 This study
JY1711 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, sxa2-D15, pREP3x-Cpc2 This study
JY1712 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, sxa2-D15, cpc2::ura42 This study
JY1713 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, cyr1-D51, sxa2.lacZ, cpc2::ura42, pREP3x-Cpc2 This study
JY1714 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, sxa2-D15, rum1::ura42 This study
JY1715 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, sxa2-D15, rum1::ura42, pREP3x-Cpc2 This study
JY1716 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, sxa2-D15, pmp1::ura42 This study
JY1717 mat1-M, Dmat2/3::LEU22, leu1-32, ade6-M216, ura4-D18, sxa2-D15, pyp2::ura42, pREP3x-Cpc2 This study
doi:10.1371/journal.pone.0065927.t001
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Disruption of ndogenous S. pombe cpc2
The upstream region of cpc2 locus was amplified from S. pombe
genomic DNA using sense oligonucleotide JO2836 (aaaTCTA-
GACTAGAGCATTATTCAAGATAAATTTC; position 954 to
928 relative to cpc2 ATG, XbaI site underlined) and antisense
oligonucleotide JO2837 (aaaGGATCCCCCCTT-
CACTGGTCGGGATGTC; position 35 to 3 relative to cpc2
ATG, BamHI site underlined). The downstream region of cpc2
locus was amplified from S. pombe genomic DNA using sense
oligonucleotide JO2838 (aaaGGATCCGGGAAATAAGATTT-
TAATTGTTGTCCC; position 4 to 40 relative from cpc2 STOP
anticodon, BamHI site underlined) and antisense oligonucleotide
JO2839 (aaaCCCGGGGAACAACAACTATTCAGCCACCCC-
CAGCGAAGG; position 444 to 485 relative from cpc2 STOP
anticodon (italics), SmaI site underlined). A 1.8 kb fragment of the
S. pombe ura4+ cassette was amplified using sense oligonucleotide
JO1049 (CTGGATCCACCATGTAGCTACAAATCC) and an-
tisense oligonucleotide JO1050 (CTGGATCCACCATGTAGT-
GATATTGAC). Both up and downstream PCR products were
cloned respectively into pKS+ Bluescript (Stratagene) digested with
BamHI. The ura4+ cassette (JD3725) was cloned into the unique
BamHI site within the cpc2 ORF to create cpc2::ura4+. The strains
JY448 (h2, sxa22) and JY546 (h2, cyr12, sxa2.lacZ) were
transformed with the XbaI/SmaI fragment from JD3725 and
integration of the ura4 cassette selected by growth on medium
lacking uracil. To enable consistent comparison with the parent
strains, which were ura42, the Ura4 ORF was subsequently
deleted from the cpc2 locus using a BamHI digest of JD437 (pKS+
Bluescript containing the 59 and 39 un-translated regions of the
ura4 cassette separated by an EcoRV site). We have used similar
techniques for disruption of other members of the S. pombe
pheromone-response pathway [11]. Transformants were selected
by growth on minimal media supplemented with 5-fluoro-orotic
acid (FOA). The resultant strains produced were JY1712 (h2,
sxa22, cpc22) and JY1628 (h2, cyr12, sxa2.lacZ, cpc22).
Disruption of Endogenous Rum1
A similar two-step technique as described for cpc2 was used for
the disruption of rum1. Briefly, the rum1 locus was amplified from
S. pombe genomic DNA using sense oligonucleotide JO2658
(gggACTAGTTTTTAAATTCTAACATTAG; position -569 to
-545 relative to rum1 ATG, SpeI site underlined) and antisense
oligonucleotide JO2659 (cccACTAGTTATTGAGAATAACA-
GAC; position 550 to 568 relative from rum1 STOP anticodon,
SpeI site underlined). This product was cloned into pKS+
Bluescript digested with PvuII. The ORF was removed from this
construct and replaced with a unique BglII site by inverse PCR to
generate JD3674 using the antisense oligonucleotide JO2661
(AGATCTAGCGAACTGACAATCC; position -1 to -16 relative
to rum1 ATG, BglII site underlined) and sense oligonucleotide
JO2660 (AGATCTCGCATTTTGTAATTGTGTTTG; position
10 to 31 relative from rum1 STOP anticodon, BglII site
underlined). The 1.8 kb ura4+ cassette was cloned into the unique
BglII site of JD3674 to create the rum1::ura4+ contained within
pKS+ Bluescript (JD3675). The strains JY1628 (h2, cyr12,
sxa2.lacZ, cpc22) and JY546 (h2, cyr12, sxa2.lacZ) were
transformed with the SpeI fragment from JD3675 and integration
of the ura4 cassette selected by growth on medium lacking uracil.
Removal of the Ura4 ORF from the locus of rum1 was achieved as
described for cpc2. The resultant strains produced were JY1710
(h2, sxa22, cpc22, rum12), JY1520 (h2, cyr12, sxa2.lacZ, rum12).
Disruption of Endogenous pmp1 and pyp2
We have previously described the generation of the strain JY723
that lacks pmp1 (h2, cyr12, sxa2.lacZ, pmp1::ura4+) [45]. Removal
of the Ura4 ORF from this strain generated JY948 (h2, cyr12,
sxa2.lacZ, pmp1::ura42). A similar two-step method was used to
disrupt pmp1 from JY448 (h2, sxa22) generating JY1716 (h2,
sxa22, pmp1::ura42). Disruption of pyp2 was again accomplished
using a two-step integration strategy. The pyp2 locus was amplified
using sense oligonucleotide JO842 (gggcagCTGTTCAACAT-
CAATAGGCAA; position -528 to -508 relative to pyp2 ATG,
PvuII site underlined) and antisense oligonucleotide JO843
(gggcagCTGGTAACAATGCAAATCAAC; position 531 to 551
relative from pyp2 STOP anticodon) and cloned into pKS+
Bluescript digested with PvuII. The Pyp2 ORF was removed from
this construct and replaced with a unique BamHI site by inverse
PCR to generate JD970 using the antisense oligonucleotide JO844
(ggggatccTTGAAAACACCTTGGAAGATG; position -16 to -
36, relative to pyp2 ATG, BamHI site underlined) and sense
oligonucleotide JO845 (ggggatccGATGACTTAACGAAAC-
GACTG; position -7 to 14 relative from pyp2 STOP anticodon).
The 1.8 kb ura4+ cassette was cloned into the unique BamHI site of
JD970 to create the pyp2::ura4+ contained within pKS+ Bluescript
(JD978). The strains JY448 (h2, sxa22) and JY546 (h2, cyr12,
sxa2.lacZ) were transformed with the PvuII fragment from JD978
and integration of the ura4 cassette selected by growth on medium
lacking uracil. Removal of the Ura4 ORF from the locus of pyp2
was achieved as described for cpc2. The resultant strains produced
were JY709 (h2, cyr12, sxa2.lacZ, pyp22) and JY710 (h2, sxa22,
pyp22). All gene replacements were confirmed by PCR from
genomic DNA.
The Mating-response Assay
Cells were cultured in liquid DMM to a density of 5x106 cells/
ml. 200 ml of each mating type strain were mixed and harvested by
centrifugation (2000 rpm for 3 min). Cells were suspended in
10 ml of sterile water and spotted onto low nitrogen containing
DMM plates. Non-mixed controls were also spotted onto the
plates. Following 72 h incubation at 29uC, each colony was
collected from the spots and suspended in 1 ml of sterile water.
Two separate 1 in 100 dilutions were then made from each 1 ml
culture. One of these was plated onto separate YE plates at final
dilution factors of 1 in 1,000 and 1 in 10,000 respectively. The
other was placed in a 55uC heat block for 10 min to heat-
inactivate everything except spores formed from mating events.
This heat-treated sample was then also plated onto separate YE
plates at final dilution factors of 1 in 1,000 and 1 in 10,000.
Following 72 h incubation, the number of colonies on each plate
was counted using a G-Box iChemi gel documentation system
with GeneTool analysis software (Syngene, Cambridge, UK). The
number of colonies as a percentage of the total (colony survival)
can then be calculated for mated strains and controls, then the
mating efficiency calculated as colony survival (mated strains) -
colony survival (non-mated control strain).
pREP Expression Constructs
pREP series of S. pombe vectors allows expression of genes under
the control of the thiamine-repressible nmt1 promoter [53].
pREP3x-Cpc2 has been kindly offered by Jose Cansado (Univer-
sity of Murcia, Spain). The ORF of mammalian RACK1 was
amplified from a plasmid donated by Dorit Ron (University of
California, USA) using the sense primer JO2996 (GCCACCATG-
GATTACAAGGAT), and the antisense primer JO1606
(TTAGCGGGTACCAATAGTCACCT) which contains the stop
anticodon (italics). The PCR product was cloned into the unique
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EcoRV site of a modified pREP3x vector to generate (pREP3x-
RACK1).
1240Gpa1 was first amplified using a sense oligonucleotide
beginning at the initiating ATG (JO1605) (ATGGGATG-
CATTCGAGTAAATACGC) and an antisense oligonucleotide
containing half an EcoRV site (underlined) (JO2684) (atcTG-
GAACTCGAGCGTTTTG). The PCR product was cloned into
the unique EcoRV site of a modified pREP3x vector containing
GFP.
Assay of b-galactosidase Activity
Assays were performed using a method modified from Dohlman
et al. (1995) [45,54]. S. pombe cells were cultured to a density of
,5x106 cells/ml in DMM and 500ml aliquots transferred to 2 ml
Safe-Lock tubes (Eppendorf, Hamburg, Germany) containing 5 ml
of the appropriate ligand (in HPLC-grade methanol). Tubes were
incubated at 29uC for 16 h on a rotating wheel, and 50 ml
transferred to 750 ml Z-buffer containing 2.25 mM o-nitrophenyl-
b-D-galactopyranoside (ONPG). Reactions were stopped after
90 min by adding 200 ml of 2 M Na2CO3 and b-galactosidase
activity calculated as optical density at 420 nm (OD420) per 10
6
cells (determined using a Coulter Channelyzer).
Confocal Microscopy
In order to measure cell size at division and percentage of multi-
septated cells, strains were grown in low nitrogen containing
DMM medium to an ,5x106 cells/ml and stained with calcofluor
white (Sigma), which specifically stains cell wall and septum
[54,55]. Minimums of 200 cells, chosen at random, were used in
calculating septation rate for each mutant. For life cell imaging
cells were placed on a solid DMM (2% agarose) pad on a
CoverWellTM imaging chamber (Grace Bio-Labs, Oregon, USA)
coverslip was placed over the cells on the agar pad and sealed with
a Vaseline, Lanolin and Paraffin equal parts by weight mixture to
prevent drying of the sample. Images were then obtained using a
True Confocal Scanner Leica TCS SP5 microscope (Leica
Microsystems Ltd., Milton Keynes, UK). Series of images were
taken using Z stacks at time = 0 h and subsequently every 15 min
for a period of 16 h. The imaging procedure was set up such that
cells were focused at 0 h and the Z position noted (Zfocus). The Z-
stack was then defined such that 20 Z-slice images would be
obtained from Zfocus - 10 mm to Zfocus +10 mm to allow for drift in
the focal plane over the course of the experiment. The time-series
experiment was setup such that both bright field and fluorescence
images were generated, and imported into ImageJ (http://rsb.info.
nih.gov/ij/). Following analysis the image in the z–stack with the
highest intensity was chosen.
Flow Cytometry
Flow cytometry was performed using a Becton, Dickinson and
Company (BD) LSR II flow cytometer (BD Biosciences, Oxford,
UK). For cell cycle progression analysis, cells were grown under
standard conditions and following sonication, harvested by
centrifugation and fixed in 1 ml of ice cold 70% ethanol overnight.
300 ml of fixed cells were then washed in 3 ml of fresh 50 mM
sodium citrate and re-suspended in 500 ml of fresh 50 mM sodium
citrate containing 0.1 mg/ml RNase A. Cells were incubated at
37uC for 2 h before the addition of 500 ml of 50 mM sodium
citrate containing 8 g/ml propidium iodide (Sigma). Up to 30,000
particles per sample were then analyzed using the flow cytometer,
measuring the intensities of staining with propidium iodide.
Excitation was achieved using a 488 nm laser, and emission
detected using a 575/26 nm band pass filter with a 550 nm long
pass filter. All analysis was performed using FACSDiva v4.1 (BD
Biosciences).
Data analysis. Data were analyzed using linear and non-
linear regression as appropriate using GraphPad Prism v6.0b
(GraphPad Software Inc, San Diego, CA). Statistical significance
was determined using a one-way ANOVA with a Tukey multiple
comparison post-test or an un-paired Student’s t test.
Supporting Information
Figure S1 Characterization of Gnr1p a potential Gb-
subunit mimic in the pheromone-response pathway.
Pheromone-dependent transcription for cells either lacking or
overexpressing (using the thiamine repressible nmt1 promoter)
Gnr1p, was determined using the sxa2.lacZ reporter. Cells were
stimulated with pheromone for 16 h in minimal media and
assayed for b-galactosidase production using ONPG. Activity is
expressed as OD420 units per 10
6 cells (see methods).
(TIF)
Figure S2 The N-terminal domain alone of Gpa1 is
sufficient to ensure correct plasma membrane localiza-
tion. The strains JY546 (h2, cyr12, sxa2.lacZ), JY1314 (h2,
cyr12, sxa2.lacZ, gnr12) and JY1628 (h2, cyr12, sxa2.lacZ,
cpc22) containing pGFP or p1240Gpa1-GFP were imaged using
fluorescence microscopy. Scale bars 10 mm. The N-terminal 40
amino acids of Gpa1 are sufficient to promote plasma membrane
localization of GFP. This suggests that Gpa1p does not have a
requirement for a classical Gbc to enable plasma membrane
localization.
(TIF)
Figure S3 Pheromone-dependent transcription for the strains
JY546 (h2, cyr12, sxa2.lacZ), JY1662 (h2, cyr12, sxa2.lacZ,
cpc22, +oe-RACK1+) and JY1663 (h2, cyr12, sxa2.lacZ, +oe-
RACK1+) was determined using the sxa2.lacZ reporter (A).
Mammalian RACK1 was expressed using the thiamine repressible
nmt1 promoter and cells were cultured in the absence of thiamine
to ensure maximal levels of transcription. Cells were stimulated
with pheromone for 16 h in minimal media and assayed for b-
galactosidase production using ONPG. Activity is expressed as
OD420 units per 10
6 cells (see methods). (B) The strains JY546 and
JY1663 were treated described in Figure 3, and the number of cells
containing a 1C content of DNA (expressed as a percentage of
total cells) determined. Consistent with overexpression of Cpc2,
RACK1 containing cells fail to desensitize from pheromone
stimulation and remain arrested for the time frame analyzed.
(TIF)
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